Sentence,class,file
"The annual mean surface temperatures (red line) at the Houtman Abrolhos Islands (28°–29°S) off the midwest  coast of Western Australia between 1900 and 2013, from the HadISST data set ( http://apdrc.soest.hawaii.edu/datadoc/ hadisst1.php ), and the 11-year moving average to approximate decadal variability (blue line).",OADS,/arxiv_data1/oa_pdf/e5/d8/biw111.PMC5421442.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/01/gox009.PMC5421450.pdf
"The maneuver performed to transplant the fat graft was demonstrated in Supple- mental Digital Content, Videos 1 and 2, http://links.lww.com/SCS/ A260 and http://links.lww.com/SCS/A261.",Non-OADS,/arxiv_data1/oa_pdf/32/0f/jcrsu-28-0629.PMC5421456.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/a8/gox012.PMC5421457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
39. https://clinicaltrials.gov/ct2/show/NCT02344823.40.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
52. http://www.clinicaltrialsregister.eu/ctr-search/trial/2014– 004624–21/ES.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
53. http://www.clinicaltrialsregister.eu/ctr-search/trial/2011– 001139–22/AT.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
69. https://clinicaltrials.gov/ct2/show/NCT02230683.70.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
88. https://clinicaltrials.gov/ct2/show/NCT02802228.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
98. https://clinicaltrials.gov/ct2/show/NCT01897051.99.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
114. https://clinicaltrials.gov/ct2/show/NCT02643212.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
221. https://clinicaltrials.gov/ct2/show/NCT00592475 and http:// www.clinicaltrialsregister.eu/ctr-search/trial/2007–001661–15/ES.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
223. https://clinicaltrials.gov/ct2/show/NCT02929407.224.,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/gox011.PMC5421460.pdf
"Statistical analysis between concentrations of the different buffers showed signi ﬁcant changes in the phosphate, citrate, and Tris buffer concentrations of P,0.05 (see SDC 1, Supplemental Digital Content 1, http://links.lww.com/ICO/A516).",Non-OADS,/arxiv_data1/oa_pdf/be/0e/cornea-36-712.PMC5421463.pdf
"Statistical analysis of the different buffer concentrations showed signi ﬁcant changes in the borate, phosphate, and citrate buffer concentrations of P,0.05 (see SDC 1, Supplemental Digital Content 1, http://links.lww.com/ICO/ A516).",OADS,/arxiv_data1/oa_pdf/be/0e/cornea-36-712.PMC5421463.pdf
Available at: http://www.pei.,Non-OADS,/arxiv_data1/oa_pdf/be/0e/cornea-36-712.PMC5421463.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/56/gox010.PMC5421465.pdf
Email: alvaro.altamiranoufion@advocatehealth.com doi: https://doi.org/10.14740/cr524w,Non-OADS,/arxiv_data1/oa_pdf/a5/f8/cr-08-031.PMC5421483.pdf
Email: thitsu@jcom.home.ne.jpdoi: https://doi.org/10.14740/cr545w,Non-OADS,/arxiv_data1/oa_pdf/c4/70/cr-08-036.PMC5421484.pdf
Email: angel.lopez17@upr.edu doi: https://doi.org/10.14740/cr541w,Non-OADS,/arxiv_data1/oa_pdf/ba/d7/cr-08-044.PMC5421485.pdf
Email: fionasan@rediffmail.com doi: https://doi.org/10.14740/cr530w Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/73/04/cr-08-052.PMC5421486.pdf
Email: ghlmurtaza@gmail.com doi: https://doi.org/10.14740/cr534e,Non-OADS,/arxiv_data1/oa_pdf/62/1a/cr-08-057.PMC5421487.pdf
Email: samroberto@mac.com doi: https://doi.org/10.14740/cr534w,Non-OADS,/arxiv_data1/oa_pdf/b4/97/cr-08-063.PMC5421488.pdf
Email: omarbassamanwar@gmail.com doi: https://doi.org/10.14740/cr537w,Non-OADS,/arxiv_data1/oa_pdf/ca/e1/cr-08-068.PMC5421489.pdf
Email: fionasan@rediffmail.com doi: https://doi.org/10.14740/cr532w,Non-OADS,/arxiv_data1/oa_pdf/05/2b/cr-08-073.PMC5421490.pdf
Email: kkumar1@bronxleb.org doi: https://doi.org/10.14740/cr538w,Non-OADS,/arxiv_data1/oa_pdf/3b/c2/cr-08-077.PMC5421491.pdf
Email: fionasan@rediffmail.com doi: https://doi.org/10.14740/cr540w,Non-OADS,/arxiv_data1/oa_pdf/e2/11/cr-08-081.PMC5421492.pdf
A score is avail- able in order to identify those who may benefit from thisstrategy: http://www.daptstudy.org/.,Non-OADS,/arxiv_data1/oa_pdf/19/4b/sux021.PMC5421493.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/68/ckw113.PMC5421499.pdf
"Available at: http://www.ats.ucla.edu/stat/stata/webbooks/reg/default.htm 22 Fedewa SA, Cullati S, Bouchardy C, et al.",OADS,/arxiv_data1/oa_pdf/ab/68/ckw113.PMC5421499.pdf
"Available at: http://www.bfs.admin.ch/bfs/ portal/en/index/themen/01/06/blank/key/06/02.html, 30 Cuzick J, Myers O, Hunt WC, et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/68/ckw113.PMC5421499.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/83/ckw186.PMC5421500.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/76/ckw152.PMC5421501.pdf
"Available at: http://www.istat.it/it/archivio/48875 (15 June 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/5e/76/ckw152.PMC5421501.pdf
"Available at: http://www.euro.who.int/__data/assets/pdf_file/0010/98398/ wa540ga199heeng.pdf (22 July 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/5e/76/ckw152.PMC5421501.pdf
"Available at: http://progettodemetra.it/index.php/it/con sensus-document-recommendations-2015/file 26 Connor S, Sepulveda C. Global Atlas of Palliative Care at the End-of- Life.",Non-OADS,/arxiv_data1/oa_pdf/5e/76/ckw152.PMC5421501.pdf
"Available at: http://www.thewpca.org/resources/global-atlas-of-palliative- care/ 27 Bremner KE, Krahn MD, Warren JL, et al., An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.",OADS,/arxiv_data1/oa_pdf/5e/76/ckw152.PMC5421501.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/9b/gox013.PMC5421503.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/dc/gox007.PMC5421505.pdf
2012. http://www.worldgastroenterology.org/assets/export/userfiles/Acute%20Diarrhea_long_FINAL_120604.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/93/bd/AMS-AD-1-27480.PMC5421526.pdf
"Standar - tized mortality from coronary heart disease in Lithua- nia, 2013. http://www.hi.lt/sveikatos-statistika.html 2.",Non-OADS,/arxiv_data1/oa_pdf/81/d4/AMS-AD-1-29036.PMC5421528.pdf
The four prim- ers used in this research were designed by the on-line website Primer1: http://primer1.soton.ac.uk/primer1.html.,OADS,/arxiv_data1/oa_pdf/44/32/AMS-AD-1-27453.PMC5421535.pdf
SWISS-MODEL (http://swissmodel.expasy.org)  was used for protein modeling of mutant pro-tein.,OADS,/arxiv_data1/oa_pdf/44/32/AMS-AD-1-27453.PMC5421535.pdf
"In this study, the primers  for amplification of ITGB3 rs5918 were designed using the online website Primer1: http://prim-er1.soton.ac.uk/primer1.html.",OADS,/arxiv_data1/oa_pdf/44/32/AMS-AD-1-27453.PMC5421535.pdf
"The  10-year CVD risk was assessed by the QRISK2  score, provided by the University of Nottingham,  UK [24] at http://www.qrisk.org/.",Non-OADS,/arxiv_data1/oa_pdf/19/07/AMS-AD-1-28289.PMC5421542.pdf
"Guidelines of Met-abolic Syndrome, 2009. http://www.turkendokrin.org/files/pdf/metabolik_sendrom.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/AMS-AD-1-29072.PMC5421546.pdf
E-mail address: mkounnas@neuro-genx.com http://dx.doi.org/10.1016/j.trci.2016.09.003 2352-8737/ /C2112016 NeuroGenetic Pharmaceuticals Inc.,Non-OADS,/arxiv_data1/oa_pdf/b3/af/main.PMC5421551.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/af/main.PMC5421551.pdf
Elife 2015;4 http://dx.doi.org/10.7554/eLife.11182.,Non-OADS,/arxiv_data1/oa_pdf/b3/af/main.PMC5421551.pdf
"http://dx.doi.org/10.1016/j.gendis.2016.09.004 2352-3042/Copyright ª2016, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/4f/c6/main.PMC5421560.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2016) 3, 263e276",Non-OADS,/arxiv_data1/oa_pdf/4f/c6/main.PMC5421560.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/c6/main.PMC5421560.pdf
"Keywords Sleep; Nobile; polar exploration; aviation history; human error; mishap This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License ( http://creativecommons.org/licenses/by-nc/4.0/ ), permitting all non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/0d/nihms819088.PMC5421565.pdf
"Free Lance-Star; Fredericksburg, V A. Tuesday, 18 Feb;  1930. p. 3Accessed on the internet at http://news.google.com/newspapers?",Non-OADS,/arxiv_data1/oa_pdf/e3/0d/nihms819088.PMC5421565.pdf
doi: http://dx.doi.org/ 10.1371/journal.pone.0151770 .,Non-OADS,/arxiv_data1/oa_pdf/e3/0d/nihms819088.PMC5421565.pdf
doi: http://dx.doi.org/10.1371/ journal.pcbi.1000418 .,Non-OADS,/arxiv_data1/oa_pdf/e3/0d/nihms819088.PMC5421565.pdf
doi: http://dx.doi.org/10.1371/ journal.pone.0045987 .,Non-OADS,/arxiv_data1/oa_pdf/e3/0d/nihms819088.PMC5421565.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/1e/bkw046.PMC5421578.pdf
http://www.bfr.,Non-OADS,/arxiv_data1/oa_pdf/c0/1e/bkw046.PMC5421578.pdf
EFSA (2012) Food Additives Intake Model (FAIM) template –version 1.0 – December 2012 http://www.efsa.europa.eu/sites/default/ ﬁles/assets/faimtem plateinstructions.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/c0/1e/bkw046.PMC5421578.pdf
"39 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/50/hyw143.PMC5421579.pdf
http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/34/50/hyw143.PMC5421579.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/14/hyw140.PMC5421580.pdf
"MeSH Keywords:  Apoptosis • Caspase 3 • Genes, bcl-2 • Genes, p53 • Laryngeal Neoplasms  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901381Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Radiation Oncology, Tianjin Medical University Cancer Institute  and Hospital, Tianjin, P.R.",Non-OADS,/arxiv_data1/oa_pdf/90/1f/medscimonit-23-2059.PMC5421584.pdf
"MeSH Keywords:  Calcitriol • Hypertension, Portal • Liver Cirrhosis • T-Lymphocytes, Helper-Inducer  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904271Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Gastrointestinal Surgery, Renji Hospital, School of Medicine,  Shanghai Jiao Tong University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/43/0d/medscimonit-23-2049.PMC5421585.pdf
"MeSH Keywords:  Coronary Artery Disease • Coronary Occlusion • Percutaneous Coronary Intervention  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/902560Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Cardiology, Hospital East Limburg, Genk, Belgium 2 Department of Cardiology and Intensive Care, Centre Hospitalier Chrétien,   Site St Joseph, Liège, Belgium 3 Faculty of Medicine and Life Sciences, University of Hasseltt, Hasselt, Belgium 4 Department of Cardiology and Intensive Care, Augusta Hopsital, Düsseldorf,  Germany 5 Department of Interventional Cardiology, Center Hospital Regional of The Citadel,  Liège, Belgium ISSN 1941-5923 © Am J Case Rep, 2017; 18: 472-477 DOI: 10.12659/AJCR.902560 472 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/cd/ce/amjcaserep-18-472.PMC5421587.pdf
"MeSH Keywords:  Brachial Plexus Neuropathies • Central Nervous System • Fluorodeoxyglucose F18 • Multiple Myeloma  • Neoplasm Invasiveness • Positron-Emission Tomography  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903761Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Nuclear Medicine and Radiology, Institute of Development, Aging,  and Cancer, Tohoku University, Sendai, Japan 2 Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast,  U.K. 3 Department of Radiology, Diagnostic Imaging Center, Sendai Seiryo Clinic, Sendai,  JapanISSN 1941-5923 © Am J Case Rep, 2017; 18: 478-481 DOI: 10.12659/AJCR.903761 478 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/66/fc/amjcaserep-18-478.PMC5421593.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/e3/tjw214.PMC5421610.pdf
"Resulting forward and reverse sequence data weremanually aligned, and these individual contigs were compared withpublicly available databases using the blast-n algorithm at theNational Center for Biotechnology Information (http://blast.ncbi.nlm.nih.gov), as well as MycoBank at the International MycologicalAssociation Fungal Database (http://www.mycobank.org).Results and Discussion A combination of morphological evaluation, microscopic observa-tions, and molecular techniques were utilized to identify fungalspores recovered from 45 house flies.",OADS,/arxiv_data1/oa_pdf/59/e3/tjw214.PMC5421610.pdf
"401 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/d6/hyx019.PMC5421611.pdf
"473 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/e1/hyx037.PMC5421614.pdf
"438 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/d6/hyx011.PMC5421626.pdf
"GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012 .http://globocan.iarc.fr/Pages/fact_sheets_ population.aspx (3 November 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/59/d6/hyx011.PMC5421626.pdf
http://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/800126_2499412D1024_1_04 .,OADS,/arxiv_data1/oa_pdf/59/d6/hyx011.PMC5421626.pdf
This is an open access article under the CC BY -NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/05/main.PMC5421642.pdf
Staiano) http://dx.doi.org/10.1016/j.jshs.2016.11.005 2095-2546/© 2017 Production and hosting by Elsevier B.V .,Non-OADS,/arxiv_data1/oa_pdf/44/05/main.PMC5421642.pdf
This is an open access article under the CC BY -NC-N D license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Available online at www.sciencedirect.com Journal of Sport and Health Science 6 (2017) 4–10 www.jshs.org.cnHOSTED BY ScienceDirec t,Non-OADS,/arxiv_data1/oa_pdf/44/05/main.PMC5421642.pdf
Available at: http://www.nielsen.,Non-OADS,/arxiv_data1/oa_pdf/44/05/main.PMC5421642.pdf
Available at:http://www.ninds.nih.gov/research/asp/asp_working_- group_report_052915.htm.,OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
Avail- able at:http://www.ninds.nih.gov/research/epilepsyweb/2014Bechmarks-Final-PDF.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
Available at:http://www.fda.- gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm071121.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
Available at:http://www.fda.gov/down-loads/drugs/guidancecomplianceregulatoryinformation/guidances/ ucm073137.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
Available at: http://www.cureepilepsy.org/research/is.asp.,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
"Bethesda, MD: National Center for Biotechnology Information (US).Available from: https://www.ncbi.nlm.nih.gov/books/NBK98152/ 64.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
Available at:http://www.dcn.ed.ac.uk/multipart/ about.html.,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
Available at:https://panache.ninds.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/EPI4-1-086.PMC5421644.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.cts-journal.com,Non-OADS,/arxiv_data1/oa_pdf/f3/61/CTS-10-185.PMC5421726.pdf
"Report by the Temporary Specialist Scientiﬁc Committee (TSSC), “FAAH (Fatty Acid Amide Hydrolase)”, on the causes of the accident during a phase 1 clinical trial in Rennes in January 2016. http://ansm.sante.fr, accessed September 2016.",Non-OADS,/arxiv_data1/oa_pdf/c6/42/CTS-10-122.PMC5421727.pdf
Clinical Study Protocol BIA 102474-101 http://www.youscribe.com/Product/Download/ 10.,Non-OADS,/arxiv_data1/oa_pdf/c6/42/CTS-10-122.PMC5421727.pdf
Available at: https://www.medicalalley.org/media/106052/combination-products- report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://www.evaluategroup.com/PDFs%20for%20Download/EvaluatePharma-World- Preview-2015-Outlook-to-2020-Executive-Summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://www.meddeviceonline.com/doc/combination-products-a- primer-for-medical-device-makers-0001.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://www.transparencymarketresearch.com/drug-device- combination.html.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://combinationproducts.com/wp- content/uploads/2014/07/May-23-2014-CPC-Paper-Improving-Patient-Care.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://www.fda.gov/downloads/ CombinationProducts/GuidanceRegulatoryInformation/UCM467128.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://blogs.fda.gov/fdavoice/index.php/2016/04/developing-a-consensus-voice- the-combination-products-policy-council/.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
Available at: http://www.fda.gov/CombinationProducts/AboutCombinationProducts/ucm519751.htm.,Non-OADS,/arxiv_data1/oa_pdf/8d/f9/CTS-10-124.PMC5421728.pdf
http://www.takeda.com.,Non-OADS,/arxiv_data1/oa_pdf/41/7d/CTS-10-208.PMC5421729.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/41/7d/CTS-10-208.PMC5421729.pdf
"The revised tool includes /223c60 variables, including patient characteristics, medical history, PCI indication, genotype results, antiplatelet therapy, and cardiovascular events within 12 months of PCI, and is freely available through the IGNITE website SPARK toolbox (https://ignite-genomics.org/spark-toolbox/researchers/).",OADS,/arxiv_data1/oa_pdf/48/e4/CTS-10-143.PMC5421730.pdf
<http://www.imshealth.com/ﬁles/web/IMSH% 20Institute/Reports/Medicines_Use_and_Spending_Shifts/Medicine-Spending-and- Growth_1995-2014.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/75/c6/CTS-10-172.PMC5421731.pdf
Available from: http://www.cancer.gov/about- cancer/treatment/clinical-trials/nci-supported/nci-match 6.,Non-OADS,/arxiv_data1/oa_pdf/c3/24/CTS-10-128.PMC5421732.pdf
Available from: http://hemonc.org/wiki/Category:Kinase_inhibitors 7.,Non-OADS,/arxiv_data1/oa_pdf/c3/24/CTS-10-128.PMC5421732.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.cts-journal.com,Non-OADS,/arxiv_data1/oa_pdf/26/56/CTS-10-201.PMC5421733.pdf
Available from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic- demande/guide-ld/bio/gd_cbs_ebc_ld-eng.php 2.,Non-OADS,/arxiv_data1/oa_pdf/53/55/CTS-10-217.PMC5421736.pdf
Available from: https://www.cadth.ca/media/pdf/Generic_prof_supplement_en.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/53/55/CTS-10-217.PMC5421736.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2009/09/WC500003126.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/53/55/CTS-10-217.PMC5421736.pdf
Available from: http://www.R-project.org 23.,Non-OADS,/arxiv_data1/oa_pdf/53/55/CTS-10-217.PMC5421736.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/53/55/CTS-10-217.PMC5421736.pdf
"June 21, 2016. https://grants.nih.gov/grants/guide/notice-ﬁles/NOT-OD-16-094.html 2.",Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
"Washington, D.C. November 17–18, 2005. https://archive.hhs.gov/ohrp/sachrp/documents/AltModIRB.pdf3.",OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
"March 5, 2009. http://www.hhs.gov/ohrp/newsroom/rfc/com030509.html 4.",Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
"July 26, 2011. https://www.gpo.gov/ fdsys/pkg/FR-2011-07-26/html/2011-18792.htm 5.",Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
"September 8, 2015. https://www.gpo.gov/fdsys/ pkg/FR-2015-09-08/pdf/2015--21756.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
"March 10, 2014. https://www.nsf.gov/pubs/2014/ nsb1418/nsb1418.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
2016. https://www.nap.edu/read/21824/ chapter/7 9.,Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
(Retrieved from: https://ncats.nih.gov/expertise/clinical/smartirb) Published 2017.,Non-OADS,/arxiv_data1/oa_pdf/a9/80/CTS-10-130.PMC5421738.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.cts-journal.com,Non-OADS,/arxiv_data1/oa_pdf/dd/5c/CTS-10-163.PMC5421739.pdf
"MeSH Keywords:  Rectal Fistula • Surgical Procedures, Minimally Invasive • Video-Assisted Surgery  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904055Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of General Surgery, Yangpu Hospital, Tongji University School of  Medicine, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/2e/7c/medscimonit-23-2065.PMC5421740.pdf
"MeSH Keywords:  Catheterization, Peripheral • Embolism and Thrombosis • Peripheral Arterial Disease  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901395Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Cardiology, Kocaeli University Medical Faculty, Kocaeli, Turkey 2 Department of Cardiovascular Surgery, Kocaeli University Medical Faculty,  Kocaeli, Turkeye-ISSN 1643-3750 © Med Sci Monit, 2017; 23: 2072-2077 DOI: 10.12659/MSM.901395 2072 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]   [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]   [Chemical Abstracts/CAS] [Index Copernicus]CLINICAL RESEARCH This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/2a/b1/medscimonit-23-2072.PMC5421741.pdf
"MeSH Keywords:  Fever of Unknown Origin • Lymphoma, B-Cell • Lymphoproliferative Disorders  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903816Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Internal Medicine, Hospital de Clinicas “Jose de San Martin”,  University of Buenos Aires, Buenos Aires, Argentina 2 Department of Pathology, Hospital de Clinicas “Jose de San Martin”, University of  Buenos Aires, Buenos Aires, ArgentinaISSN 1941-5923 © Am J Case Rep, 2017; 18: 482-486 DOI: 10.12659/AJCR.903816 482 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/59/c4/amjcaserep-18-482.PMC5421743.pdf
"MeSH Keywords:  Apoptosis • Autophagy • MAP Kinase Signaling System  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/900742Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medicine, Academy of Medical Sciences and Sichuan Provincial  People’s Hospital, Chengdu, Sichuan, P.R.",Non-OADS,/arxiv_data1/oa_pdf/04/21/medscimonit-23-2035.PMC5421746.pdf
"MeSH Keywords:  Alginates • Cytokines • Macrophage Activation • Ovarian Neoplasms  Full-text PDF:  http://www.basic.medscimonit.com/abstract/index/idArt/901576Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 School of Biochemical Engineering, Anhui Polytechnic University, Wuhu, Anhui,  P.R.",Non-OADS,/arxiv_data1/oa_pdf/a7/50/medscimonitbasicres-23-166.PMC5421747.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2017.04.004 2211-3207/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
"Brie ﬂy, all the nucleotide sequences that encode genes or subunits of ABC transporter subfamilies (A, B, C and G) of all nematodes wereextracted from available databases such as NCBI ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
"nlm.nih.gov/ ), Wormbase ( http://www.wormbase.org/#01-23-6 ), Broad Institute ( https://www.broadinstitute.org/ ) and NEMBASE4 (http://www.nematodes.org/nembase4/ ).",OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
These BLAST searches were helpful to locate each of the pu- tative ABC transporter genes in the scaffolds of the D. immitis nu- clear genome (version nDi.2.2.2) ( http://salmo.bio.ed.ac.uk/cgi-bin/ gbrowse/gbrowse/nDi.2.2.2/ ).,OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
D. immitis nuclear genome v2.2 ( http://nematodes.org/genomes/ diroﬁlaria_immitis/ ) was used as the reference genome.,OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
Transmembrane helices of these membrane pro- teins were predicted using online web tools such as Phobius ( http:// phobius.sbc.su.se/ ) and HMMTOP ( http://www.enzim.hu/hmmtop/ index.php ).,OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
"Such detrimental effects could be, for example, embryonic lethal/larval arrest, shortened life span, locomotion variant, organism development variant, sluggish/fainter, slow growth, egg size defective, pharyn- geal pumping variant, as known from the Wormbase website (http://legacy.wormbase.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
(2016) were different from those of their respective annota- tions in the D. immitis genome ( http://nematodes.org/genomes/ diroﬁlaria_immitis/ ).,OADS,/arxiv_data1/oa_pdf/a0/43/main.PMC5421822.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.04.005,OADS,/arxiv_data1/oa_pdf/d0/06/main.PMC5421823.pdf
11. http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/078215s000ltr.pdf accessed 6_1_16 12. https://www.drugs.com/pro/nulecit.html accessed 6_1_16 13. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guid ances/UCM358142.pdf accessed 6_1_16 14.,Non-OADS,/arxiv_data1/oa_pdf/6b/2e/CTS-10-194.PMC5421824.pdf
Available from: http://www.ema.euro pa.eu/docs/en_GB/document_library/Scientiﬁc_guideline/2011/04/WC500105048.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/2e/CTS-10-194.PMC5421824.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/6b/2e/CTS-10-194.PMC5421824.pdf
"Retrieved July 22, 2014, from http://www.economist.com/news/briefing/21584397-how-whole-class-weaponry-came-be-seen-indecent-shadow-ypres the Tokyo subway attack by a terrorist group in 1995.",Non-OADS,/arxiv_data1/oa_pdf/f9/0d/CTS-10-225.PMC5421825.pdf
"METHODS We performed a search on the video-sharing website YouTube (Google, Mountain View, CA; http://www.youtube.",Non-OADS,/arxiv_data1/oa_pdf/f9/0d/CTS-10-225.PMC5421825.pdf
"Retrieved July 24, 2014, from http://theweek.com/article/index/249224/a-brief-history-of-chemical-Warfare 3.",Non-OADS,/arxiv_data1/oa_pdf/f9/0d/CTS-10-225.PMC5421825.pdf
"Retrieved July 8, 2014, from http://world.time.com/2013/05/07/syrias-lurking-terror-a-history-of-sarin-gas/ 12.",Non-OADS,/arxiv_data1/oa_pdf/f9/0d/CTS-10-225.PMC5421825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/35/main.PMC5421973.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.03.004,OADS,/arxiv_data1/oa_pdf/44/35/main.PMC5421973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/6a/main.PMC5421998.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2016) 3,3e6 http://dx.doi.org/10.1016/j.gendis.2016.01.002 2352-3042/Copyright ª2016, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/03/6a/main.PMC5421998.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/6a/main.PMC5421998.pdf
"1- Senior Researcher,  Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences,  Tehran, Iran   2- Senior Researcher, Department of Psychology, School  of Psychology and Educational Sciences, Alzahra University, Tehran, Iran   3- Psychiatrist , Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences,  Tehran, Iran   4- Senior Researcher, Shiraz HIV/AIDS Research  Center, Shiraz University of Medical Sciences, Shiraz, Iran   5- Senior Researcher, Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran   Correspondence to: Reza Daneshmand MD , Email: re.daneshmand@uswr.ac.ir     136 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  HIV Programs in Iran (Persia), Iraq and Saudi Arabia: A Brief Review of  Current Evidence in West and Southwest Asia   Omid Massah MD1, Afsaneh Mora di PhD2, Ali Farhoudian MD3, Mahmood Amini -Lari MSc4,  Hassan Joulaei MD, PhD5, Reza Daneshmand MD3    Abstract   Background:  In Western and Southwest Asia, literature is not documented on human immunodeficiency  virus (HIV) programs in Iran, Iraq and Saudi Arabia.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 137    http://ahj.kmu.ac.ir,    5 July  Introduction   Globally, human immunedeficiency virus (HIV) is  a serious health concern.1,2 For example, HIV  epidemic is in its fourth decade in Western and  Southwest Asia.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"138 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  three countries.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 139    http://ahj.kmu.ac.ir,    5 July  Saudi Arabia in Southwest Asia   Saudi Arabia is the origin of Islam and some  Arabs on the southern border of the Persian Gulf  region.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"140 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  In Iraq, the only report shows that free ART  has been provided.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 141    http://ahj.kmu.ac.ir,    5 July  contribute to eliminating HIV stigma in order to  implement the strategic plans  by the  governments.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"142 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Public Health 2014; 43(10): 1424 -35.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
[cited 2016]; Available from: URL:  http://worldpopulationreview.com/countries/iran - population   10.,Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
[cited 2014]; Available from: URL:  http://files.unaids.org/en/knowyourresponse/countr yprogressreports/2014countries/IRN_narrative_rep ort_2014_en.pdf   11.,OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
[cited 2016]; Available from: URL:  http://worldpopulationreview.com/countries/iraq - population/   12.,Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
[cited 2016]; Available from: URL:  http://worldpopulationreview.com/countries/saudi - arabia -population/   15.,Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 143    http://ahj.kmu.ac.ir,    5 July  Addressing the needs of sexual partners of people  who inject drugs through peer prevention programs  in Iran.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"1- پژوهشگر ارشد، مرکز تحقیقات سوء مصرف و وابستگی به مواد، دانشگاه علوم بهزیستی و توان بخشی، تهران، ایران  2- پژوهشگر ارشد ، گروه روان شناسی، دانشکده روان شناسی و علوم تربیتی، دانشگاه الزهراء، تهران، ایران  3- روان پزشک، مرکز تحقیقات سوء مصرف و وابستگی به مواد، دانشگاه علوم بهزیستی و توان بخشی، تهران، ایران  4- پژوهشگر ارشد ، مرکز تحقیقات HIV/ AIDS ،دانشگاه علوم پزشکی شیراز، شیراز، ایران   5- پژوهشگر ارشد ، مرکز تحقیقات سیاست سالمت، دانشگاه علوم پزشکی شیراز، شیراز، ایران  نویسنده‌‌مسؤول: دکتر رضا دانشمند  Email:  re.daneshmand@uswr.ac.ir     144 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  برنامه‌های‌ HIV‌در‌ایران‌(پرشیا)،‌عراق‌و‌عربستان:‌مرور‌کوتاهی‌از‌شواهد‌موجود‌در‌‌ غرب‌و‌جنوب‌غربی‌آسیا‌   دکتر امید مساح1 ،دکتر افسانه  مرادی2 ، دکتر علیفرهودیان 3 ، محمود امینیالری4 ،  دکتر حسن جوالیی5 ،دکتر رضا دانشمند 3      چکیده  مقدمه:‌در غرب و جنوب غربی آسیا، ادبیات  پژوهش درباره برنامه های HIV ( Human immunodeficiency virus  ) در ایران، عراق و عربستان سعودی مستند شده نیست.",Non-OADS,/arxiv_data1/oa_pdf/26/60/AHJ-08-136.PMC5422010.pdf
"1- PhD Candidate, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,  Kerman, Iran   2- Associate Professor, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,  Kerman, Iran   3- Assistant Professor, Cognitive and Neuroscience Research Center, Tehran Medical Sciences Branch, Islamic Azad University,  Tehran, Iran   4- Professor, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran   Correspondence to: Vahid Sheibani  PhD, Email: v_sheibani@kmu.ac.ir     Addict Health, Summer 2016 ; Vol 8, No 3 145    http://ahj.kmu.ac.ir,    5 July  Estrogen and Progesterone Replacement Therapy Prevent  Methamphetamine -Induced Synaptic Plasticity Impairment in  Ovariectomized Rats   Hamed Ghazvini MSc1, Mohammad Shabani PhD2, Majid Asadi -Shekaari PhD2,   Solmaz Khalifeh PhD3, Khadijeh Esmaeilpour MSc1, Mehdi Khodamoradi MSc1,   Vahid Sheibani PhD4    Abstract   Background:  Methamphetamine (METH) is one of the most popular psychostimulants which produce long  lasting learning and memory impairment.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"146 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Introduction   Amphetamines are one of the most powerful and  addictive psychostimulant drugs in many  countries and modern societies.1-3 One of the   well -known forms of amphetamines, i.e.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 147    http://ahj.kmu.ac.ir,    5 July  treatment began 3 weeks after full recovery   from surgery.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"148 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  LTP was induced by applying high frequency  stimulation (HFS) consisting a trains of 10 pulses at  400 Hz with an inter -stimulus interval of 7 s during  70 s with the same stimulation intensity used for  baseline recordings.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 149    http://ahj.kmu.ac.ir,    5 July    (A)    (B)  Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"150 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July               (A)    (B)  Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 151    http://ahj.kmu.ac.ir,    5 July  studies demonstrated that administration of a  neurotoxic METH regimen led to morphological  changes ranging from neuronal degeneration to  changes in the density of spines and damage of  the blood -brain barrier.8,35-37 In this manner, a  study from Thompson et al.38 revealed that METH  consumption led to memory dysfunction, which  was related to a decrease of hippocampal volume  and white -matter hypertrophy.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"152 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  alter protective effects of estr ogen on spatial  learning and memory in OXV female rats.51  Furthermore, in OVX female rats, co -treatment  with estrogen and progesterone exhibited either  basal synaptic transmission or LTP to similar  levels observed in gonadally intact animals.53 On  the othe r hand, in cycling female rat,  quantification of morphological alteration showed  that the number of dendritic spines and the  density of synapses in hippocampal CA1  increased during proestrus when estrogen and  progesterone are at their higher levels, then  reduced during estrus when estrogen and  progesterone are at lower levels.54,55 In addition, a  study by Warren et al.21 revealed that LTP varied  across estrus cycle and LTP was greater during  proestrus compared to estrus in female rats.",OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 153    http://ahj.kmu.ac.ir,    5 July  277: 392 -402.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"154 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  on the methamphetamine -induced cognitive  impairment in ovariectomized rats.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 155    http://ahj.kmu.ac.ir,    5 July  caspase -3 me diated proteolysis of alpha II -spectrin  and tau in rat brain after methamphetamine  exposure: A similar profile to traumatic brain  injury.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"1- دانشجوی دکتری، مرکز تحقیقات علوم اعصاب، پژوهشکده نوروفارماکولوژی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  2- دانشیار، مرکز تحقیقات علوم اعصاب، پژوهشکده نوروفارماکولوژی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  3- استادیار، مرکز تحقیقات علوم اعصاب و شناخت، دانشگاه آزاد اسالمی، واحد علوم پزشکی تهران، تهران، ایران  4- استاد، مرکز تحقیقات علوم اعصاب، پژوهشکده نوروفارماکولوژی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  نویسنده‌‌مسؤول: دکتر وحید شیبانی  Email:  v_sheibani@kmu.ac.ir     156 Addict  Health,  Summer  2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,     5 July  جلوگیری از اختالل پالستیسیته سیناپسی ناشی ازمت  آمفتامین در موش های اوارکتومی شده با  درمان جایگزین استروژن یا پروژسترون    حامد قزوینی1 ،دکتر  محمد شعبانی2 ،دکتر  مجید اسدی شکاری2 ،دکتر  سولماز خلیفه3 ،  خدیجه اسماعیل پور1، مهدی خدامرادی1 ،دکتر  وحید شیبانی4      چکیده  مقدمه:‌مت‌آمفتامین‌یکی‌از‌شناخته‌ شده‌ترین‌مواد‌محرک‌است‌که‌منجر‌به‌اختالل‌شناختی‌طوالنی‌مدت‌ می‌گردد.‌مطالعات‌قبلی‌نشان‌ داده‌ است‌که‌درمان‌جایگزین‌با‌استروژن‌و‌پروژسترون ،‌اختالالت‌شناختی‌را‌در‌طیف‌ گسترد‌ای‌از‌بیماری‌های‌نورودژنراتیو‌کاهش‌ می‌دهد.‌مطالعه‌  حاضر‌به‌منظور‌ارزیابی‌اثرات‌استروژن،‌پروژسترون‌به‌تنهایی‌و‌یا‌توأمان‌بر‌تقویت‌طوالنی‌مدت‌اولیه ‌( Early long -term potentiation ‌‌یا‌ E-LTP)‌‌در‌ناحیه CA1‌( Cornu Ammonis‌)هیپوکمپ،‌در‌موش‌های‌رت‌اوارکتومی‌شده‌که‌ مت‌آمفتامین‌دریافت‌کرده‌بودند ،‌انجام‌گردید.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/AHJ-08-145.PMC5422011.pdf
"1- PhD Candidate, Department of Reproductive Health, School of Nursing and Midwifery, Shahroud University of Medical Sciences,  Shahroud  AND Lecturer, Faculty Member, Department of Midwifery , School of Nursing and Midwifery, Iran University of Medical  Sciences, Tehran, Iran   2- Assistant Professor, Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Med ical Sciences,  Shahroud, Iran   3- Assistant Professor , Addiction and Sexual Risk Behavior Management and Prevention, Iranian National Center of Addiction Studies,  Tehran University of Medical Sciences, Tehran, Iran   4- Associate Professor, Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences,  Shahroud, Iran   Correspondence to: Seyed Abbas Mousavi  MD, Email: pordelshad15@gmail.com     Addict Health, Summer 2016 ; Vol 8, No 3 157    http://ahj.kmu.ac.ir,    5 July  Sexual Risk Behaviors Constructed in Iranian Women’s Life with  Substance Use Disorders: A New Implication of Human Ecological Theory   Mansoureh Jamshidimanesh MSc1, Seyed  Abbas Mousavi MD2, Effat Merghati -Khoe i PhD3,  Mohammad Hassan Emamian PhD4, Afsaneh Keramat PhD4    Abstract   Background:  Drug abuse is one of the important variables influencing protective sexual behavior.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"158 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Introduction   Drug abuse is one of the important variables  influencing protective sexual behavior.1 With the  introduction of industrial stimulants, the global  and national drug use pattern has also been  transformed from traditional drugs such as opium  and hashish to industrial drugs such as heroin,  crack cocaine and crystal meth.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 159    http://ahj.kmu.ac.ir,    5 July  To obtain a rich source of data, details of the  parameters involved in the study phenomenon  was collected and used to explain and evaluate  the activity.14 By exploring the inner world and  the experiences of individuals, which make up  their distinct truth, the researcher could explore  the meanings of phenomena from the individuals’  own perspectives.15 After evaluation and context  mapping, five centers did not meet the study  criteria and only  two volunteered to take part in  the study.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"160 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  context.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 161    http://ahj.kmu.ac.ir,    5 July  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"162 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Zanbagh's perception of sex had not been  formed by reviewing her sexual past, which  should have been learnt at home -the smallest  social unit.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 163    http://ahj.kmu.ac.ir,    5 July  education (i.e.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"164 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  one minute.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 165    http://ahj.kmu.ac.ir,    5 July  men on the street.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"166 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  inappropriate environment like home where their  families were divorced or using drug, had low  education and similar problems from   micro -system.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 167    http://ahj.kmu.ac.ir,    5 July  These findings have implication for strategies  based on training skills in an intervention to  incorporate specific features of cultural relevance  derive d from targeted population .",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
[cited  2014 ]; Available from: URL:   http://www.khabaronline.ir/detail/334514/society/soc ial-damage   6.,OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"168 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Appraising evidence for nursing practice.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
[cited 2001]; Available  from: URL:   http://www.floridahealth.gov/alternatesites/ cms- kids/providers/early_steps/training/documents/bronfe nbrenners_ecological.pdf   22.,Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
[cited 2008] ; Available from: URL:  https://www.guttmacher.org/report/views -adults - adolescent -sexual -and-reproductive -health - qualitative -evidence -ghana   26.,Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"1- دانشجوی دکتری، گروه  بهداشت باروری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شاهرود، شاهرود و مربی، عضو هیأت علمی، گروه مامایی، دانشکده پرستاری و مامایی، دانشگاه علوم  پزشکی ایران، تهران، ایران   2- استادیار، مرکز تحقیقات علوم رفتاری و اجتماعی در سالمت، دانشگاه علوم پزشکی شاهرود، شاهرود، ایران  3-  استادیار،مدیریت و پیشگیری  اعتیاد و رفتارهای پرخطر جنسی، مرکز ملی مطالعات اعتیاد، دانشگاه علوم پزشکی تهران، تهران، ایران   4-  دانشیار،مرکز تحقیقات علوم رفتاری  و اجتماعی در سالمت، دانشگاه علوم پزشکی شاهرود، شاهرود، ایران  نویسنده‌‌مسؤول: دکتر سید عباس موسوی  Email:  pordelshad15@gmail.com     Addict Health, Summer 2016 ; Vol 8, No 3 169    http://ahj.kmu.ac.ir,    5 July  رفتارهای پرخطر جنسی در زنان ایرانیبا اختالل مصرف مواد : یک کاربرد جدید از   تئوری اکولوژی انسانی     منصوره جمشیدی منش1 ،دکتر  سید عباس موسوی2، دکتر عفت مرقاتی خویی3 ،  دکتر محمد حسن امامیان4، دکتر افسانه کرامت4      چکیده  مقدمه:‌یکی از متغیرهای مهم و  تأثیرگذار بر رفتار جنسی ایمن ، مصرف مواد غیر قانونی است.",Non-OADS,/arxiv_data1/oa_pdf/af/18/AHJ-08-157.PMC5422012.pdf
"1- PhD Student, Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Scienc es,  Kerman, Iran   2- Associate Professor, Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medica l  Sciences, Kerman, Iran   3- Professor, HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures  Studies in Health, Kerman University of Medical Sciences, Kerman, Iran   4- MSc Student, Department of Nursing and Midwifery, School of Nursing and Midwifery, Kerman University of Medical Sciences,  Kerman, Iran   5- Resident , Physiology Research Center AND Department of Obstetrics and Gynaecology, School of Medicine , Kerman University of  Medical Sciences, Kerman, Iran   6- Associate Professor, HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillan ce, Institute for  Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran   Correspondence to: Farzaneh Zolala PhD , Email: zolalafarzaneh@gmail.com     170 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Estimating the Size and Age -gender Distribution of Women’s   Active Social Networks   Maryam Zamanian MSc1, Mohammad Reza Baneshi PhD2, Ali Akbar Haghdoost PhD3,   Tayebeh Mokhtari -Sorkhani4, Fatemeh Amiri MD5, Farzaneh Zolala PhD6    Abstract   Background:  Network Scale -up (NSU) method is an indirect method for the estimation of hidden behaviors.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 171    http://ahj.kmu.ac.ir,    5 July  Introduction   Estimating the size of hidden/hard to reach  subpopulations (such as injecting drug users,  female sex workers) is a highly challenging issue  in the public health context .1 These groups are  hidden in the society because of fear of legal  punishment and the stigma surrounding these  behaviors.2-4 The use of standard methods of  sampling and direct estimations requires huge  sample sizes due to the relatively low prevalence  of such behaviors in the general population.3-7  Another problem of direct methods for size  estimation of these groups is that re spondents  may refuse to answer or may provide wrong  answers because of the stigma surrounding these  behaviors and the tendency to maintain privacy.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"172 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  was used in this study.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 173    http://ahj.kmu.ac.ir,    5 July  sizes of the eligible reference groups.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"174 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 175    http://ahj.kmu.ac.ir,    5 July  another study18 included 26 subpopulations plus  14 first names.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"176 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  We could not find similar studies in other  places or involving the opposite gender in ord er to  compare our results about network distribution.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 177    http://ahj.kmu.ac.ir,    5 July  12.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
[cited 2010]; Available  from: URL:   http://files.unaids.org/en/media/unaids/contentassets/ documents/epidemiology/2010/JC2032_20102_epial ert_en.pdf   13.,OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
[cited 2012 May];  Available from: URL:   http://www.epidem.org/sites/default/files/reports/Co nsultation%20on%20network%20scale -up.pdf   14.,OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"1- دانشجوی دکتری، مرکز تحقیقات مدلسازی در سالمت، پژوهشکده آینده پژوهی در سالمت، دانشگاه علوم پزشکی کرمان، کرمان، ایران  2- دانشیار، مرکز تحقیقات مدلسازی در سالمت، پژوهشکده آینده پژوهی در سالمت، دانشگاه علوم پزشکی کرمان، کرمان، ایران  3- استاد، مرکز تحقیقات مراقبت HIV و بیماری  های آمیزشی،  مرکز همکار سازمان جهانی بهداشت، پژوهشکده آینده پژوهی در سالمت، دانشگاه علوم پزشکی کرمان، کرمان، ایران  4- دانشجوی کارشناسی ارشد، گروه پرستاری و مامایی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  5- دستیار، مرکز تحقیقات فیزیولوژی و گروه زنان و زایمان، دانشکده پزشکی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  6- دانشیار، مرکز تحقیقات مراقبت HIV و بیماری  های آمیزشی،  مرکز همکار سازمان جهانی بهداشت، پژوهشکده آینده پژوهی در سالمت، دانشگاه علوم پزشکی کرمان، کرمان، ایران  نویسنده‌‌مسؤول: دکتر فرزانه ذوالعلی  Email: zolalafarzaneh@gmail.com     178 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  برآورد اندازه و توزیع سنی- جنسی شبکه اجتماعی فعال زنان    مریم زمانیان1، دکتر محمدرضا بانشی2، دکتر علی اکبر حقدوست3، طیبه مختاری سرخانی4،   دکتر فاطمه امیری5، دکتر فرزانه ذوالعلی6      چکیده  مقدمه:‌روش تعمیم شبکه ای، روش غیر مستقیمی به منظور برآورد رفتارهای پنهان می باشد.",Non-OADS,/arxiv_data1/oa_pdf/a8/6c/AHJ-08-170.PMC5422013.pdf
"1- Neuroscience Research Center, Institute of Neuropharmacology  AND Department of Biochemistry, School of Medicine, Kerman  University of Medical Sciences, Kerman, Iran   2- Associate Professor , Department of Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran   3- Assistant Professor , Department of Laboratory Sciences, School of Paramedicine, Rafsanjan University of Medical Sciences,  Rafsanjan, Iran   4- PhD Student, Department of Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran   5- Professor, Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences  AND Department of  Biochemistry, School of Medicin e, Kerman University of Medical Sciences, Kerman, Iran   Correspondence to: Gholamreza Asadikaram  PhD, Email: gh_asadi@kmu.ac.ir     Addict Health, Summer 2016 ; Vol 8, No 3 179    http://ahj.kmu.ac.ir,    5 July  Effects of Opium Addiction and Cigarette Smoking on Hematological  Parameters   Gholamabbas Shahabinejad MSc1, Majid Sirati -Sabet PhD2, Mohammad Kazemi -Arababadi  PhD3,  Saeideh Nabati MSc4, Gholamreza Asadikaram PhD5    Abstract   Background:  The aim of the present study was to investigate the effects of opium addiction and cigarette  smoking on the complete blood count (CBC) .",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"180 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Introduction   Cigarette smoking is considered as a major  leading causes of health problem in word over.1  There are more than 4000 chemicals found in  cigarette smoke, and a cigarette smoker is  exposed to a number of harmful substances  including nicotine, free radicals, carbon monoxide  and other gaseous products.1,2 In a number of  studies, it has been found that smokers have  higher white blood cell (WBC) counts than  nonsmokers.2 Tarazi et al.",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 181    http://ahj.kmu.ac.ir,    5 July  opioids or cigarette in case group.",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"182 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Moreover, some opium side effects on the  number of WBCs may be mediated through  infection.5 The release of catecholamines which  are important factor to elevate the leukocyte count  are induced by morphine.21 Opium components  change some multi -functional cytokines, such as  Interleukin -6 (IL-6), which induces inflammatory  process that leads to elevations in the peripheral  blood leukocyte count.22 Consistent with our  results, Asakura et al.23 showed that the risk of  acute infection is higher in he roin addicted  patients.",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 183    http://ahj.kmu.ac.ir,    5 July  important RBC  indices that represent average size  and hemoglobin composition of the RBCs.37 We  found that MCV level in OACS and OANCS  groups was significantly decreased compared  with NOANCS.",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"184 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  noscapine and papaverine on breast cancer stem  cells.",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"1- مرکز تحقیقات علوم اعصاب، پژوهشکده نوروفارماکولوژی و گروه بیوشیمی، دانشکده پزشکی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  2- دانشیار، گروه بیوشیمی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران  3-  استادیار، گروه علومآزمایشگاهی، دانشکده پیراپزشکی، دانشگاه علوم پزشکی رفسنجان، رفسنجان،  ایران  4- دانشجوی دکتری، گروه بیوشیمی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران  5- استاد، مرکز تحقیقات غدد و متابولیسم، پژوهشکده علوم پایه و بالینی فیزیولوژی و گروه بیوشیمی، دانشکده پزشکی، دانشگاه علوم پزشکی کرمان، کرمان، ایران  نویسنده‌‌مسؤول: دکتر غالمرضا اسدی کرم  Email:  gh_asadi@kmu.ac.ir     Addict Health, Summer 2016 ; Vol 8, No 3 185    http://ahj.kmu.ac.ir,    5 July   اثرات اعتیاد به تریاک و مصرف سیگار برشاخص  های خونی    غالم عباس شهابی نژاد1 ،دکتر  مجید سیرتی ثابت2 ،دکتر  محمد کاظمی عرب آبادی3، سعیده نباتی4 ،  دکتر غالمرضا اسدی کرم5      چکیده  مقدمه:‌هدف از  انجام مطالعه حاضر، ارزیابی اثرات اعتیاد به تریاک و سیگار بر شمارش کامل سلول های خونی ( Complete blood count   یا CBC) .بود  روش‌ها: 86 مرد شامل 31 فرد معتاد سیگاری، 19 فرد معتاد غیر سیگاری، 17 فرد سیگاری غیر معتاد و 19 فرد بدون اعتیاد به تریاک و سیگار  در مطالعه حاضر شرکت کردند و آزمایش CBC  بر روی خون تمام افرادانجام گرفت.",Non-OADS,/arxiv_data1/oa_pdf/67/35/AHJ-08-179.PMC5422014.pdf
"  1- Assistant Professor, Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences,  Tehran, Iran   2- Assistant Professor, Department of Epidemiology and Biostatics, University of California, San Francisco, CA, USA AND HIV/STI  Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman  University of Medical Sciences, Kerman, Iran   3- Psychiatrist, Iranian National Center for Addiction Studies AND PhD Student, Department of Neuroscience and Addiction, School  of  Advanced Technolo gies in Medicine, Tehran University of Medical Sciences, Tehran, Iran   4- Assistant Professor, HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for F utures  Studies in Health, Kerman University of Medical Sci ences, Kerman, Iran   5- Senior Lecturer, Department of Public Health, La Trobe University, Melbourne, Australia   6- PhD Student, Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran,  Iran  7- Associate  Professor, Psychosis Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran   8- Associate  Professor, Social Determinants of Health Research Center AND Department of Nursing, University of Social Welfare and  Rehabil itation Sciences, Tehran, Iran   9- PhD Student, Department of Health Education and Health Promotion , Student Research Committee, School of  Health, Shahid  Beheshti University of Medical Sciences, Tehran, Iran   10- Associate Professor, Research Center for Addiction and Risky Behavior, Iran University of Medical Sciences, Tehran, Iran   Correspondence to: Mehdi Noroozi PhD , Email: noroozimehdi04@gmail.com     186 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Injecting and Sexual Networks  and Sociodemographic Factors and Dual  HIV Risk among People Who Inject Drugs: A Cross -sectional Study in  Kermanshah Province, Iran   Mehdi Noroozi PhD1, Ali Mirzazadeh PhD2, Alireza Noroozi MD3, Hamid Sharifi PhD4,   Peter Higgs PhD5, Zahra Jorjoran -Shushtari MSc6, Ali Farhoudian MD1, Farbod Fadai MD7,  Farahnaz Mohhamadi -Shahboulaghi PhD8, Bahram Armoon MSc9,   Ahmad Hajebi MD10, Omid Massah MD1    Abstract   Background:  Few studies suggest that social network factors, including size of sexual network may associate  with drug -related and sexual high -risk behaviors.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 187    http://ahj.kmu.ac.ir,    5 July  Introduction   National reports showed that HIV prevalence  concentrated among people who inject drugs  (PWID) and sharing syringes has been the main  mode of HIV transmission in Iran.1,2 There are  approximately 170000 -230000 PWID in Iran, of  whom, 15% infected with HIV.3,4 High risk drug - related behaviors such as sharing of needle,  syringe and other drug paraphernalia, and  unprotected sex are being considered as the main  routes of HIV, ot her blood -borne diseases and  sexually transmitted diseases transmission.5-8 In  Iran, over two -third of all new identified HIV  cases have been attributed to unsafe injection.9-11  Furthermore, high risk sexual practices were  reported relatively high in this population.1 This  results to spread of HIV infection among both  injection and sexual networks.12,13 A recent study  on the prevalence of HIV infection among male  injecting drug users, and their female partners  showed that HIV prevalence among female  partner s was as high as 2.8%.6 Furthermore,  report of National Survey in 2010 showed more  than 60% of the PWID reported unprotect sex in  their last sexual encounter.1 Effective HIV  prevention interventions for PWID include opioid  maintenance treatments (OMTs), HI V testing and  counseling programs, needle, syringe programs  (NSP s) delivered through fixed -site centers and  outreach teams, condom distribution, risk  reduction psychoeducation programs, and  antiretroviral treatment.14-17 Although unsafe  injection and parti cularly needle/syringe sharing  has declined in Iran with the expansion of legal  sources of sterile syringes, many PWID continue  to engage in unprotected sex.9 Similarly, other  factors including social network factors may play  an important role in risky beh aviors among  PWID.18,19 Few studies suggest that social network  factors, including size of sexual network, may  associated with receptive syringe sharing (RSS)  and unprotected sex.20,21 Many research reported  that large networks provide more opportunities  for sharing syringes and paraphernalia.22 The  previous studies on risk behaviors associated with  HIV infection among PWIDs often focuses  separately on injecting and sexual risk, but PWI Ds  may engage in different types  of high -risk  behaviors, concurrently.23 PWID who engage in  both using a previously used syringe by someone else and unprotected sex [dual HIV risk (DHR)]  are most at -risk for HIV infection as compared to  general population of PWID.20 Many research on  PWID showed injecting and sexual risk factors  were associated with HIV infection.8,24 One study  from Russia suggest the injection and sexual risks  increased the odds of HIV infection among  PWID  and DHR play an  important role in spread of HIV  among PWID.25 To know these factors can help to  implement and develop strategies that address  DHR among PWID and to reduce DHR among this  population.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"188 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  over the 12 months before the interview.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 189    http://ahj.kmu.ac.ir,    5 July  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"190 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 191    http://ahj.kmu.ac.ir,    5 July   (AOR: 1.8) was not significant.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"192 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  conflicts of interest to be declared .",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
[cited 2008 Jan]; Available from: URL:   http://www.arums.ac.ir/file/download/page/1473488 467-iran-ungass -report -2008 -ver14 -persian -9179.pdf   10.,Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 193    http://ahj.kmu.ac.ir,    5 July  19.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"1- استادیار، مرکز تحقیقات سوء مصرف و وابستگی به مواد، دانشگاه علوم بهزیستی و توان بخشی، تهران، ایران   2- استادیار، گروه اپیدمیولوژی و آمار  زیستی، دانشگاه کالیفرنیا، سانفرانسیسکو، آمریکا  و مرکز تحقیقات مراقبت HIV و بیماری های آمیزشی، مرکز همکار سازمان جهانی بهداشت، مرکز   آینده پژوهی در سالمت، دانشگاه علوم پزشکی کرمان، کرمان، ایران  3- روان پزشک، مرکز ملی مطالعات اعتیاد و دانشجوی  دکتری، گروه اعتیاد و علوم اعصاب، دانشکده فن  آوری های نوین پزشکی، دانشگاه علوم پزشکی تهران، تهران، ایران  4- 3 استادیار،مرکز تحقیقات مراقبت HIV و بیماری های آمیزشی، مرکز همکار سازمان جهانی بهداشت، مرکز آینده  پژوهی در سالمت، دانشگاه علوم پزشکی کرمان، کرمان، ایران   5- مربی ارشد، دانشکده بهداشت عمومی، دانشگاه التروب، ملب ورن، استرالیا   6-  دانشجوی دکتری، مرکز تحقیقاتعوامل اجتماعی  مؤثر بر سالمت، دانشگاه علوم بهزیستی و توان  بخشی، تهران، ایران  7- دانشیار، مرکز تحقیقات سایکوز ، دانشگاه علوم بهزیستی و توان بخشی، تهران، ایران   8- دانشیار، مرکز تحقیقات عوامل اجتماعی مؤثر بر سالمت  و گروه پرستاری، دانشگاه علوم بهزیستی و توان بخشی، تهران، ایران   9- دانشجوی دکتری،  گروه آموزش بهداشت و ارتقای سالمت، کمیته تحقیقات دانشجویی، دانشکده بهداشت، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران  10- دانشیار، مرکز تحقیقات اعتیاد و رفتارهای پرخطر، دانشگاه علوم پزشکی ایران، تهران، ایران  نویسنده‌‌مسؤول: دکتر مهدی نوروزی  Email:  noroozimehdi04@gmail.com     194 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  اندازه شبکه اجتماعی و عوامل اقتصادی- اجتماعی مرتبط با رفتارهای پرخطر تزریقی و جنسی:  یک مطالعه مقطعی در مصرف کنندگان تزریقی در کرمانشاه    دکتر مهدی نوروزی1، دکتر علی میرزازاده2 ، دکتر علیرضانوروزی 3، دکتر حمید شریفی4، دکتر پیتر هیگز5 ،  زهرا جرجران شوشتری6، دکتر علی فرهودیان1 ، دکتر فربدفدایی7، دکتر فرحناز محمدی شاهبالغی 8 ،  بهرام آرمون9 ،دکتر احمد حاجبی 10 ،دکتر امید م ساح1      چکیده  مقدمه:‌مطالعات  اندکی به بررسی نقش عوامل اجتماعی از جمله اندازه شبکه اجتماعی و ارتباط  آن با رفتارهای پرخطر تزریقی و جنسی   پرداخته اند.",Non-OADS,/arxiv_data1/oa_pdf/d7/38/AHJ-08-186.PMC5422015.pdf
"ir    Addict Health, Summer 2016 ; Vol 8, No 3 195    http://ahj.kmu.ac.ir,    5 July  Prevalence of HIV/AIDS among Iranian Prisoners: A Review Article   Morteza  Akbari MSc1, Maryam Akbari MSc2, Ahmad Naghibzadeh -Tahami MSc3,   Hassan Joulaei PharmD, PhD1, Maryam Nasiriyan  PhD4, Maryam Hesampour MSc5,   Kamran B agheri -Lankarani  MD6    Abstract   Background:  Worldwide, prisoners are more at risk of being infected by human immunodeficiency virus (HIV )  as well as hepatitis C and B in comparison with other risk groups.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"196 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Introduction   Prisoners worldwide are subject to infection by  human immunodeficiency virus (HIV ), hepatitis  C and band other diseases with those who use  intravenous drugs at greater risk.1,2  Acquired immune deficiency syndrome  (AIDS ), addiction, and prison are a combination  of risk factors that threaten the health of society.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 197    http://ahj.kmu.ac.ir,    5 July    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"198 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July      Table 1.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 199    http://ahj.kmu.ac.ir,    5 July              Table 2.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"200 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Frequency of imprisonment   Prisons play a key role in expanding the incidence  of HIV/AIDS in society, especially among  intravenous drug users.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 201    http://ahj.kmu.ac.ir,    5 July  values are similar to other countries’ sta tistics  including Ireland (70.5 %), Greece (49.8%),  Belgium (47 .0%), Italy (34 .0%), France (32 .0%),  and Sweden (30 .0%).21,40 This suggests that  measures implemented i n the form of harm  reduction programs in the prisons have not  shown considerable results without training   and knowledge.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"202 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  therefore considered as one of the main parts of  HIV prevention.52 One study showed 12.10% of  prisoners experienced sexual intercourse a nd of  this population only 15.4 % used condoms.53 In a  study involving 5530 prisoners in 2 7 Iranian  prisons in 2001, 24.7 % of prisoners had not used a  condom in their last sexual intercourse.53  Incidence of HIV among groups at risk such as  prisoners can be prevented by appropriate  distribution of condoms  within prisons and  training about disease transmission.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 203    http://ahj.kmu.ac.ir,    5 July  References 1.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"204 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  25.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 205    http://ahj.kmu.ac.ir,    5 July  reduction Programs in prisons from the attitude and  viewpoint of Iranian prison staff.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
[cited 2009]; Available from:  URL: http://www.who.int/hiv/topics/condoms/en/   53.,Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"ir     206 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  جمع‌بندی‌اطالعات‌ و‌گزارش‌های‌منتشر‌شده‌در‌زمینه‌شیوع‌ HIV‌در‌زندان‌های‌کشور‌   مرتضی اکبری1 ،مریم اکبری 2 ، احمدنقیب  زاده تهامی3 ،دکتر  حسن جوالیی1 ،دکتر  مریم نصیریان4 ،  مریم حسام پور5 ،دکتر  کامران باقری  لنکرانی6      چکیده  مقدمه:‌در سراسر دنیا، زندانیان بیشتر از گروه  های پرخطر دیگر در معرض ابتال به عفونت HIV ( Human immunodeficiency virus )  ، هپاتیت B  وC قرار دارند.",Non-OADS,/arxiv_data1/oa_pdf/2a/98/AHJ-08-195.PMC5422016.pdf
"1- Department of Geriatrics, Neuroscience and Orthopedics, School of Medicine, Institute of Psychiatry, Catholic University,   Rome, Italy   2- Department of Geriatrics, Neuroscience and Orthopedics , School of Medicine , Institute  of Psychiatry, Catholic University Medical  School AND Department of Human Sciences, School of Psychology , Lumsa University , Rome, Italy   Correspondence to: Riccardo Guglielmo MD, PhD , Email: ricguglielmo@gmail.com     Addict Health, Summer 2016 ; Vol 8, No 3 207    http://ahj.kmu.ac.ir,    5 July  Is Pathological Trading an Overlooked Form of Addiction?",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/AHJ-08-207.PMC5422017.pdf
"208 Addict Health, Summer 2016 ; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/AHJ-08-207.PMC5422017.pdf
"Addict Health, Summer 2016 ; Vol 8, No 3 209    http://ahj.kmu.ac.ir,    5 July  on the health of the subject.",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/AHJ-08-207.PMC5422017.pdf
[cited 2014 Mar 12]; Available  from: URL: http://www.webcitation.org/6fUQp9F4s   3.,OADS,/arxiv_data1/oa_pdf/ef/b2/AHJ-08-207.PMC5422017.pdf
"  210 Addict Health, Summer  2016; Vol 8, No 3    http://ahj.kmu.ac.ir,    5 July      The editor in chief would like to draw the readers’ attention to the errors in the following article:   Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone  Program: Implicati ons for Education and Treatment.1  An author’s name was presented incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/bd/cd/AHJ-08-210.PMC5422018.pdf
"E-mail: eunjicheong@yonsei.ac.kr https://doi.org/10.5483/BMBRep.2017.50.3.033Received 28 February 2017Keywords: Afterhyperpolarization, Anoctamin-2, Calcium-activated chloride channel, Spike-frequency adaptation, Thalamocortical neuron Abbreviations:  AHP , Afterhyperpolarization; ANO2, Anoctamin-2; CACC, Calcium-activated chloride channel; TC, Thalamocortical Perspective to:  Go Eun Ha (2016) The Ca2+-activated chloride  channel anoctamin-2 mediates spike-frequency adaptation and reg-ulates sensory transmission in thalamocortical neurons.",Non-OADS,/arxiv_data1/oa_pdf/45/40/bmb-50-109.PMC5422021.pdf
The CACC anoctamin-2 mediates spike-frequency adaptation Go Eun Ha and Eunji Cheong 110 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/45/40/bmb-50-109.PMC5422021.pdf
"Tel: +82-43-240-6113; Fax: +82-43-240-  6129; E-mail: ksahn@kribb.re.kr https://doi.org/10.5483/BMBRep.2017.50.3.221Received 20 December 2016Keywords: Botanical drug, IND, Natural product, Plant extract  bank, Reverse pharmacology ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The worldwide trend of using botanical drugs and strategies  for developing global drugs Kyungseop Ahn * Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Korea Natural product drugs, or botanical drugs, are drugs composed  of natural substances which have constituents with health- enhancing or medicinal activities.",Non-OADS,/arxiv_data1/oa_pdf/6c/c5/bmb-50-111.PMC5422022.pdf
Botanical drug and strategies for developing global drugs Kyungseop Ahn 112 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/c5/bmb-50-111.PMC5422022.pdf
Botanical drug and strategies for developing global drugs Kyungseop Ahn 113 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/c5/bmb-50-111.PMC5422022.pdf
Botanical drug and strategies for developing global drugs Kyungseop Ahn 114 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/c5/bmb-50-111.PMC5422022.pdf
"Botanical drug and strategies for developing global drugs Kyungseop Ahn 115 http://bmbreports.org BMB Reportsidentifying excellence for cultivation at the central inland area,  they massively cultivated wild seeds proving phytoequivalence between wild type and cultivated type seeds.",Non-OADS,/arxiv_data1/oa_pdf/6c/c5/bmb-50-111.PMC5422022.pdf
Botanical drug and strategies for developing global drugs Kyungseop Ahn 116 BMB Reports http://bmbreports.orgceutical Industries against the Implementation of the  Nagoya Protocol Regarding Access and Benefit-sharing.,Non-OADS,/arxiv_data1/oa_pdf/6c/c5/bmb-50-111.PMC5422022.pdf
"https://doi.org/10.5483/BMBRep.2017.50.3.222 Received 8 December 2016Keywords: Cancer, Cancer stem cell, Cancer therapy, Plasticity, Re- programming ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Cancer stem cell heterogeneity: origin and new perspectives on  CSC targeting Kiyoung Eun#, Seok Won Ham# & Hyunggee Kim * Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea Most of the cancers are still incurable human diseases.",Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
118 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
"119 http://bmbreports.org BMB ReportsMoreover, mechanisms of EMT and CSCs share many identical  TFs, such as Twist, ZEB1/2, and HIFs, and signaling pathways of TGF-, WNT/-Catenin, Notch, and Hedgehog (28).",OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
"120 BMB Reports http://bmbreports.orgrelated TFs such as ZEB1, and Twist (52, 53).",OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
121 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
"122 BMB Reports http://bmbreports.orgCSC plasticity in the prostate cancer, which is strongly related  to metastatic capability (92).",Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
"123 http://bmbreports.org BMB ReportsProgram (PJ01107701), and from Korea University.",Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
124 BMB Reports http://bmbreports.org3845 36.,Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
"125 http://bmbreports.org BMB ReportsMol Cell 39, 761-772 70.",Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmb-50-117.PMC5422023.pdf
"Jee-Yin Ahn, Tel: +82-31-299-6134; Fax:  +82-31-299-6139; E-mail: jeeahn@skku.edu, Won Soon Park, Tel: +82-2-3410-3523; Fax: +82-2-3410-0043; E-mail: wonspark@skku.edu, ws123.park@samsung.com https://doi.org/10.5483/BMBRep.2017.50.3.190Received 14 November 2016, Revised 25 November 2016,  Accepted 1 December 2016 Keywords: CNS injury, Development, Neuron, P48Ebp1, Regenera- tion ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Neuron-specific expression of p48 Ebp1 during murine brain  development and its contribution to CNS axon regeneration Hyo Rim Ko1, Inwoo Hwang1, So Yoon Ahn2,3, Yun Sil Chang2,3,4, Won Soon Park2,3,4,* & Jee-Yin Ahn1,4,* 1Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan Univer sity  School of Medicine, Suwon 16419, 2Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine,  Seoul 06351, 3Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul 06351, 4Department of Health Sciences and  Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Korea P48 Ebp1 is expressed in rapidly proliferating cells such as  cancer cells and accelerates cell growth and survival.",Non-OADS,/arxiv_data1/oa_pdf/35/e9/bmb-50-126.PMC5422024.pdf
127 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/35/e9/bmb-50-126.PMC5422024.pdf
128 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/35/e9/bmb-50-126.PMC5422024.pdf
129 http://bmbreports.org BMB Reportsaxon regeneration.,Non-OADS,/arxiv_data1/oa_pdf/35/e9/bmb-50-126.PMC5422024.pdf
130 BMB Reports http://bmbreports.org29) with the following modifications.,Non-OADS,/arxiv_data1/oa_pdf/35/e9/bmb-50-126.PMC5422024.pdf
131 http://bmbreports.org BMB Reportscancer cells.,Non-OADS,/arxiv_data1/oa_pdf/35/e9/bmb-50-126.PMC5422024.pdf
"Tel: +82-2-2220-2562; Fax: +82-2-2298-  2562; E-mail: incheol@hanyang.ac.kr https://doi.org/10.5483/BMBRep.2017.50.3.189Received 11 November 2016, Revised 2 December 2016,  Accepted 6 December 2016 Keywords: Breast cancer cell, EGFR, Glut, Integrin 1, Triple-neg- ative breast cancer ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Glut1 promotes cell proliferation, migration and invasion by  regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells Sunhwa Oh1, Hyungjoo Kim1, KeeSoo Nam1 & Incheol Shin1,2,* 1Department of Life Science, 2Natural Science Institute, Hanyang University, Seoul 04763, Korea Elevated glucose levels in cancer cells can be attributed to  increased levels of glucose transporter (GLUT) proteins.",Non-OADS,/arxiv_data1/oa_pdf/aa/56/bmb-50-132.PMC5422025.pdf
133 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/aa/56/bmb-50-132.PMC5422025.pdf
134 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/aa/56/bmb-50-132.PMC5422025.pdf
"135 http://bmbreports.org BMB ReportsA high expression level of the M2 isoform of pyruvate kinase  (PKM2) has been detected in several types of cancer cells (15), indicating its involvement in mediating the Warburg effect.",Non-OADS,/arxiv_data1/oa_pdf/aa/56/bmb-50-132.PMC5422025.pdf
"136 BMB Reports http://bmbreports.orgspecific shRNA respectively (Santa Cruz Biotechnology, CA,  USA) using Viafect (Promega, WI, USA) according to the manufacturer’s protocol.",OADS,/arxiv_data1/oa_pdf/aa/56/bmb-50-132.PMC5422025.pdf
137 http://bmbreports.org BMB Reports(Toyobo).,Non-OADS,/arxiv_data1/oa_pdf/aa/56/bmb-50-132.PMC5422025.pdf
"Jae-sung Bae, Tel: +82-53-420-4815; Fax:  +82-53-424-3349; E-mail: jsbae@knu.ac.kr, Hee Kyung Jin, Tel: +82-53-950-5966; Fax: +82-53-950-5955; E-mail: hkjin@knu.ac.kr https://doi.org/10.5483/BMBRep.2017.50.3.191Received 15 November 2016, Revised 9 December 2016,  Accepted 19 December 2016 Keywords: Bone loss, Hematopoietic stem/progenitor cell, Mobili- zation, Neuropeptide Y-based recombinant peptides, Osteoclasts ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Neuropeptide Y-based recombinant peptides ameliorate bone  loss in mice by regulating hematopoietic stem/progenitor cell mobilization Min Hee Park1,2,3, Namoh Kim1,2,3, Hee Kyung Jin1,4,* & Jae-sung Bae1,2,3,* 1Stem Cell Neuroplasticity Research Group, Kyungpook National University, Daegu 41566, 2Department of Physiology, Cell and Matrix  Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, 3Department of Biomedical Science, BK21 Plus  KNU Biomedical Convergence Program, Ky ungpook National University, Daegu 41944, 4Department of Laboratory Animal Medicine,  College of Veterinary Medicine, Kyungpoo k National University, Daegu 41566, Korea Ovariectomy-induced bone loss is related to an increased  deposition of osteoclasts on bone surfaces.",Non-OADS,/arxiv_data1/oa_pdf/f1/bf/bmb-50-138.PMC5422026.pdf
139 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/f1/bf/bmb-50-138.PMC5422026.pdf
140 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/f1/bf/bmb-50-138.PMC5422026.pdf
141 http://bmbreports.org BMB Reportsperformed tartrate-resistant acid phosphatase (TRAP) staining  in the trabecular region of each group.,Non-OADS,/arxiv_data1/oa_pdf/f1/bf/bmb-50-138.PMC5422026.pdf
142 BMB Reports http://bmbreports.orgdays at 37oC and 5% CO 2 according to the manufacturer’s  instructions.,Non-OADS,/arxiv_data1/oa_pdf/f1/bf/bmb-50-138.PMC5422026.pdf
"143 http://bmbreports.org BMB ReportsREFERENCES 1. van den Bergh JP, van Geel TA and Geusens PP (2012)  Osteoporosis, frailty and fracture: implications for case  finding and therapy.",Non-OADS,/arxiv_data1/oa_pdf/f1/bf/bmb-50-138.PMC5422026.pdf
"https://doi.org/10.5483/BMBRep.2017.50.3.197Received 30 November 2016, Revised 21 December 2016,  Accepted 6 February 2017 Keywords: Apoptosis, Celecoxib, Ceramide, ER stress, Sphingolipid ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Celecoxib-mediated activation of endoplasmic reticulum stress  induces de novo ceramide biosynthesis and apoptosis in  hepatoma HepG2 cells Hyo Jin Maeng1,#, Jae-Hwi Song1,#, Goon-Tae Kim1, Yoo-Jeong Song1, Kangpa Lee2, Jae-Young Kim1 & Tae-Sik Park1,* 1Department of Life Science, Gachon University, Seongnam 13120, 2Department of Physiology, Konkuk University School of Medicine,  Seoul 05030, Korea Ceramides are the major sphingolipid metabolites involved in  cell survival and apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/a6/23/bmb-50-144.PMC5422027.pdf
145 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/a6/23/bmb-50-144.PMC5422027.pdf
146 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a6/23/bmb-50-144.PMC5422027.pdf
"147 http://bmbreports.org BMB Reports22.43% or 31.48% of AdGFP or Ad-SPTLC1 infected cells in  the apoptotic phase, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/a6/23/bmb-50-144.PMC5422027.pdf
148 BMB Reports http://bmbreports.orgMATERIALS AND METHODS Cell culture HepG2 hepatoma cells were obtained from the American  Type Culture Collection (ATCC).,OADS,/arxiv_data1/oa_pdf/a6/23/bmb-50-144.PMC5422027.pdf
149 http://bmbreports.org BMB Reports7.,Non-OADS,/arxiv_data1/oa_pdf/a6/23/bmb-50-144.PMC5422027.pdf
"ac.kr https://doi.org/10.5483/BMBRep.2017.50.3.223Received 21 December 2016, Revised 1 January 2017,  Accepted 25 February 2017 Keywords: Afatinib, Bone resorption, Differentiation, Osteoclast,  RANK signaling ISSN: 1976-670X (electronic edition) Copyright ⓒ 2017 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Afatinib ameliorates osteoclast  differentiation and function  through downregulation of RANK signaling pathways Hye Jung Ihn1, Ju Ang Kim1, Yong Chul Bae2, Hong-In Shin1, Moon-Chang Baek3,* & Eui Kyun Park1,* Departments of 1Oral Pathology and Regenerative Medicine, 2Anatomy and Neurobiology, School of Dentistry, Kyungpook National  University, Daegu 41940, 3Department of Molecular Medicine, CMRI, School of Medicine, Kyungpook Nation al University, Daegu 41944,  Korea Non-small-cell lung cancer (NSCLC) is the third most common  cancer that spreads to the bone, resulting in osteolytic lesions caused by hyperactivation of osteoclasts.",Non-OADS,/arxiv_data1/oa_pdf/f7/3a/bmb-50-150.PMC5422028.pdf
151 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/3a/bmb-50-150.PMC5422028.pdf
152 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/3a/bmb-50-150.PMC5422028.pdf
"153 http://bmbreports.org BMB Reportsrylation of Akt/PKB, c-Jun N-terminal kinase (JNK), p38,  extracellular signal-related kinase (ERK), I B, and p65 was  induced from 5 min after RANKL stimulation (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f7/3a/bmb-50-150.PMC5422028.pdf
"154 BMB Reports http://bmbreports.orgSelleckchem, (Houston, TX, USA).",Non-OADS,/arxiv_data1/oa_pdf/f7/3a/bmb-50-150.PMC5422028.pdf
155 http://bmbreports.org BMB ReportsREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f7/3a/bmb-50-150.PMC5422028.pdf
"To view a copy of the  license, visit http://creativecommons.org/licenses/by/4.0/ References 1 ICH Harmonised Tripartitite Guideline, Comparability of  Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process, Q5E, Current Step 4 version, dated 18 November 2004.  www.ich.org/fileadmin/Public_Web_Site 2 Europeans Medicines Agency, Comparability of biotechnology products, clinical and non-clinical issues, EMEA/CHMP/BMWP/101695/2006.",Non-OADS,/arxiv_data1/oa_pdf/a3/66/rme-11-483.PMC5422032.pdf
"https://ct.catapult.org.uk/whitepapers-and-resources 11 ICH Harmonised Tripartitite Guideline, Quality Risk Management, Q9, Current Step 4 version, dated 9 November 2005.  www.ich.org/fileadmin/Public_Web_Site 12 EudraLex, The Rules Governing Medicinal Products in the European Union, Volume 4, EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human",Non-OADS,/arxiv_data1/oa_pdf/a3/66/rme-11-483.PMC5422032.pdf
"http://ec.europa.eu/health/files/eudralex 13 Europeans Medicines Agency, Guideline on the risk-based approach according to annex I, part IV of Directive 2001/83/EC applied to advanced therapy medicinal products, 11 February 2013, EMA/CAT/CPWP/686637/2011.",Non-OADS,/arxiv_data1/oa_pdf/a3/66/rme-11-483.PMC5422032.pdf
"http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc 15 FDA Guidance for Industry, Comparability Protocols for Human Drugs and Biologics: Chemistry, Manufacturing and Controls Information, Draft Guidance, April 2016, Revision 1.   www.fda.gov/downloads/Drugs/ 16 Concerning the Examination of Variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products, Official Journal of the European Union, Commission Regulation (EC) No 1234/2008 of 24 November 2008.  http://eurlex.europa.eu/LexUriServ 17 Gourraud PA, Gilson L, Girard M, Peschanski M. The role of human leukocyte antigen matching in the development of multiethnic “haplobank” of induced pluripotent stem cell lines.",Non-OADS,/arxiv_data1/oa_pdf/a3/66/rme-11-483.PMC5422032.pdf
"This is an open access article, published under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0).",Non-OADS,/arxiv_data1/oa_pdf/c3/76/JVR-08-01.PMC5422076.pdf
"Confocal image stacks of YFP +neural somata were captured using an Olympus FV-1000 microscope with a × 100/NA1.4 oil objective (HUNTOPTICS & IMAGING, Pittsburgh, PA, USA), collapsed and quantitated usingImage J (https://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/af/ab/mp2016188a.PMC5422144.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)SST+GABAergic interneurons in MDD T Fuchs et al 930 Molecular Psychiatry (2017), 920 –930",Non-OADS,/arxiv_data1/oa_pdf/af/ab/mp2016188a.PMC5422144.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d2/97/bctt-9-297.PMC5422314.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d2/97/bctt-9-297.PMC5422314.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 297–299Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 297 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S126909 Metaplastic breast carcinoma with upper limb  gangrene Reynu Rajan1 Norlia Abdullah1 Nik Muhd Aslan Abdullah2  Abdul Yazid Mohd Kassim3 1Department of Surgery, 2Department  of Oncology and Radiotherapy,   3Department of Orthopedic Surgery  and Traumatology, Universiti  Kebangsaan Malaysia Medical Centre,  Kuala Lumpur (UKMMC), MalaysiaAbstract:  Metaplastic breast carcinomas (MBCs) are rapidly growing tumors with histologi- cal heterogeneity, and triple negative receptor status.",Non-OADS,/arxiv_data1/oa_pdf/d2/97/bctt-9-297.PMC5422314.pdf
"The tumor had infiltrated the anterior chest wall and was even seen over the  Correspondence: Norlia Abdullah   Department of Surgery, Division of Breast Reconstructive Surgery, Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, MalaysiaTel +60 3 9145 5795Fax +60 3 9145 6684Email norlia@ppukm.ukm.edu.myJournal name: Breast Cancer - Targets and Therapy Article Designation: CASE REPORTY ear: 2017V olume: 9Running head verso: Rajan et alRunning head recto: Metaplastic breast carcinoma with gangreneDOI: http://dx.doi.org/10.2147/BCTT.S126909",Non-OADS,/arxiv_data1/oa_pdf/d2/97/bctt-9-297.PMC5422314.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d2/97/bctt-9-297.PMC5422314.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 299 Metaplastic breast carcinoma with gangrene tive therapy is still favored by some over modern medicine,  due to deep-rooted cultural beliefs.",Non-OADS,/arxiv_data1/oa_pdf/d2/97/bctt-9-297.PMC5422314.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9c/47/copd-12-1351.PMC5422315.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1351–1361International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1351OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9931 8 Pri-micro rna-124 rs531564 polymorphism  minor allele increases the risk of pulmonary artery  hypertension by abnormally enhancing proliferation  of pulmonary artery smooth muscle cells Quanzhong li Zongjie Qian linqing Wang Department of Cardiology, The  affiliated hospital of guilin Medical  University, guilin, guangxi, People’s  republic of ChinaAbstract:  MicroRNA-124 (miR-124) has been reported to be downregulated in the cells  exposed to hypoxia, which was confirmed in our study.",Non-OADS,/arxiv_data1/oa_pdf/9c/47/copd-12-1351.PMC5422315.pdf
"Typically, PAH appears when airflow limitation is severe and is associated with  chronic hypoxemia, with the main pathophysiological cause being chronic alveolar  hypoxia, although new mechanisms have emerged recently.1 Alveolar hypoxia is prob - ably the most important factor leading to an increased peripheral vascular resistance.2  Acute hypoxia induces in humans, as well as in almost all species of mammals, a  rise of peripheral vascular resistance and pulmonary artery pressure that is caused by  hypoxic pulmonary vasoconstriction.3Correspondence: Quanzhong li Department of Cardiology, The  Affiliated Hospital of Guilin Medical  University, 15#, lequn rd, guilin,  guangxi 541001, People’s  republic of China Tel +86 773 286 8287 email pah531564@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: rs531564 is associated with risk of PAH in COPD DOI: http://dx.doi.org/10.2147/COPD.S99318",Non-OADS,/arxiv_data1/oa_pdf/9c/47/copd-12-1351.PMC5422315.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9c/47/copd-12-1351.PMC5422315.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/47/copd-12-1351.PMC5422315.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9a/16/clep-9-251.PMC5422316.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9a/16/clep-9-251.PMC5422316.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 251–260Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 251 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S106250 Prevalence and prognosis of stress disorders:  a review of the epidemiologic literature Jaimie L Gradus1–4 1National Center for PTSD, VA Boston  Healthcare System, 2Department  of Psychiatry, Boston University  School of Medicine, 3Department  of Epidemiology, Boston University School of Public Health, Boston,  MA, USA;  4Department of Clinical  Epidemiology, Aarhus University Hospital, Aarhus, DenmarkAbstract:  Given the ubiquity of traumatic events, it is not surprising that posttraumatic stress  disorder (PTSD) – a common diagnosis following one of these experiences – is characterized  as conferring a large burden for individuals and society.",Non-OADS,/arxiv_data1/oa_pdf/9a/16/clep-9-251.PMC5422316.pdf
"6 First, the definition of Correspondence: Jaimie L Gradus   National Center for PTSD, VA Boston  Healthcare System, 150 S. Huntington Avenue, 116B-3, Boston, MA 02130, USA   Tel +1 857 364 6688   Email jaimie.gradus@va.govJournal name: Clinical Epidemiology Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: GradusRunning head recto: Prognosis of stress disordersDOI: http://dx.doi.org/10.2147/CLEP .S106250",Non-OADS,/arxiv_data1/oa_pdf/9a/16/clep-9-251.PMC5422316.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/9a/16/clep-9-251.PMC5422316.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 169–177Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 169 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S137571 Effect of vitamin K supplementation on insulin  sensitivity: a meta-analysis Naeti Suksomboon1 Nalinee Poolsup2 Htoo Darli Ko Ko1 1Department of Pharmacy, Faculty  of Pharmacy, Mahidol University,   Bangkok, Thailand; 2Department  of Pharmacy, Faculty of Pharmacy,  Silpakorn University, Nakhon-Pathom,  ThailandObjective: To perform a systematic review and meta-analysis of randomized, placebo-controlled  trials to assess the effect of vitamin K supplementation on insulin sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"11,12 Apart from cofactor function, Correspondence: Nalinee Poolsup Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon-Pathom 73000, ThailandTel +66 34 255 800Fax +66 34 255 801Email: poolsup_n@su.ac.th, npoolsup@hotmail.com Journal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Suksomboon et alRunning head recto: Vitamin K supplementation and insulin sensitivityDOI: http://dx.doi.org/10.2147/DMSO.S137571",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"Data sources Clinical studies of vitamin K were identified through elec-tronic databases including MEDLINE, The Cochrane Library, CINAHL, Web of Science, Scopus, http://clinicaltrials.gov, and http://clinicaltrialresults.org.",OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"MEDLINE, CINAHL, the Cochrane Library , Web of Science, Scopus , http://clinicaltrials.gov , http://clinicaltrialresults.org, and historical search up to January 2017 Reports identified and screened (n=326) Reports excluded (n=306) Studies excluded (n=10) Not randomized controlled trials Studies excluded (n=2) Assessed vitamin K co- supplementation versus placebo (n=1) Duplicate report (n=1)Full-text articles retrieved for detailed evaluation (n=20) Randomized controlled trials assessed for eligibility (n=10) Studies included in the systematic review and meta-analysis30–37 (n=8) Figure 1 Flow of study selection.",OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 177 Vitamin K supplementation and insulin sensitivity  44.,Non-OADS,/arxiv_data1/oa_pdf/a9/8d/dmso-10-169.PMC5422317.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/04/dddt-11-1383.PMC5422318.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1383–1391Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1383Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13302 0 atorvastatin, a double weapon in osteoporosis  treatment: an experimental and clinical study naglaa el-nabarawi1 Mohamed el-Wakd2 Mostafa salem3 1Faculty of Medicine, national  egyptian center of environmental  and T oxicological research,   2rheumatology and rehabilitation  Department, 3clinical Pathology  Department, Faculty of Medicine,   cairo University, cairo, egyptObjective:  The aim of this study was to evaluate the effect of atorvastatin on the bone formation  and resorption markers in ovariectomized rats (experimental study), and to study its effect on  the bone mineral density (BMD) in postmenopausal osteoporotic women (clinical study).",Non-OADS,/arxiv_data1/oa_pdf/4d/04/dddt-11-1383.PMC5422318.pdf
"Such antiresorptive  therapies include calcitonin, estrogen replacement therapy, selective estrogen receptor correspondence: naglaa el-nabarawi national egyptian center of  environmental and Toxicological  research (necTer), Faculty of Medicine,  cairo University, cairo, egypt email n.a.nabarawy@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: El-Nabarawi et al Running head recto: Atorvastatin, double weapon in osteoporosis treatment DOI: http://dx.doi.org/10.2147/DDDT.S133020",Non-OADS,/arxiv_data1/oa_pdf/4d/04/dddt-11-1383.PMC5422318.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/04/dddt-11-1383.PMC5422318.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/04/dddt-11-1383.PMC5422318.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1325–1337International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1325OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S13330 7 The effect of indacaterol/glycopyrronium versus  tiotropium or salmeterol/fluticasone on the  prevention of clinically important deterioration  in COPD antonio r anzueto1,2 Claus F Vogelmeier3 Konstantinos Kostikas4 Karen Mezzi4  sebastian Fucile5 giovanni Bader4 steven shen5 Donald Banerji5 robert Fogel5 1University of Texas health science  Center, 2south Texas Veterans  healthcare system, University of  T exas, san antonio, TX, United states;   3Department of Medicine, Pulmonary  and Critical Care Medicine, University  Medical Center giessen and Marburg,   Philipps-Universität Marburg,   Marburg, germany; 4novartis Pharma  ag, Basel, switzerland; 5novartis  Pharmaceuticals Corporation, east  hanover, nJ, United statesBackground:  Endpoints that evaluate deterioration rather than improvement of disease may  have clinical utility in COPD.",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"Indeed, deterioration in lung function, health status, and exacerbation  frequency are all predictors of COPD worsening and/or mortality.2–6 These, too, are Correspondence: robert Fogel novartis Pharmaceuticals Corporation,  1 health Plaza, east hanover 07936, nJ,  United states Tel +1 862 778 4884 email robert.fogel@novartis.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Anzueto et al Running head recto: Clinically important deterioration in COPD: differential treatment effects DOI: http://dx.doi.org/10.2147/COPD.S133307",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"Available from: http://goldcopd.or g. Accessed March 26, 2017.",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"Available from: http://goldcopd.or g. Accessed March 26,  2017.",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"Available from: http://goldcopd.or g. Accessed March 26, 2017.",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"Available from: http://goldcopd.or g. Accessed March 26, 2017.",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/d5/copd-12-1325.PMC5422319.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f9/87/btt-11-055.PMC5422320.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f9/87/btt-11-055.PMC5422320.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2017:11 55–63Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  55 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S128308Development of a potent invigorator of immune  responses endowed with both preventive and  therapeutic properties Gursaran P Talwar1 Jagdish C Gupta1 Abu S Mustafa2 Hemanta K Kar3 Kiran Katoch4 Shreemanta K Parida5 Prabhakara P Reddi6 Niyaz Ahmed7 Vikram Saini8 Somesh Gupta9 1Talwar Research Foundation,   New Delhi, India; 2Department of  Microbiology, Kuwait University,   Kuwait; 3Department of Dermatology,   Paras Hospital, Gurgaon, 4National  JALMA Institute of Leprosy and Other Mycobacterial Diseases,  Agra, India;  5German Centre of  Infection, Justus Liebig University,  Giessen, Germany;  6Department of  Comparative Biosciences, University of Illinois Urbana Champaign, IL,  USA;  7Department of Biotechnology  and Bioinformatics, University of Hyderabad, Hyderabad, India;   8Department of Microbiology,   University of Alabama, Birmingham,  AL, USA;  9Department of  Dermatology and Venereology, All India Institute of Medical Sciences,  New Delhi, IndiaAbstract:  This article reviews briefly the making of an immunoprophylactic-cum-immuno- therapeutic vaccine against leprosy.",Non-OADS,/arxiv_data1/oa_pdf/f9/87/btt-11-055.PMC5422320.pdf
"He was unable to grow it in any of the many media that he Correspondence: Gursaran P Talwar Talwar Research Foundation,   E-8 Neb Valley, Neb Sarai, New Delhi 110068, IndiaTel +91 11 6502 2405Email gptalwar@gmail.comJournal name: Biologics: Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 11Running head verso: Talwar et alRunning head recto: Prophylactic/therapeutic vaccine for leprosyDOI: http://dx.doi.org/10.2147/BTT.S128308",Non-OADS,/arxiv_data1/oa_pdf/f9/87/btt-11-055.PMC5422320.pdf
"Biologics: Targets and Therapy 2017:11submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/f9/87/btt-11-055.PMC5422320.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 63 Prophylactic/therapeutic vaccine for leprosy by drugs.,Non-OADS,/arxiv_data1/oa_pdf/f9/87/btt-11-055.PMC5422320.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1369–1382Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1369Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12497 7 Developing selective histone deacetylases ( hDacs)  inhibitors through ebselen and analogs Yuren Wang1 Jason Wallach2 stephanie Duane1 Yuan Wang1 Jianghong Wu1 Jeffrey Wang1 adeboye adejare2 haiching Ma1 1reaction Biology corp., Malvern,   2Department of Pharmaceutical  sciences, Philadelphia college of  Pharmacy, University of the sciences,   Philadelphia, P a, UsaAbstract:  Histone deacetylases (HDACs) are key regulators of gene expression in cells and  have been investigated as important therapeutic targets for cancer and other diseases.",Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
"As these processes  are affected by malignant transformation, HDAC inhibitors are developed as antine - oplastic drugs and exhibit encouraging efficacy in cancer patients.4,5 Five pan HDAC correspondence: haiching Ma reaction Biology corp., 1 great  Valley Parkway, suite 2, Malvern,  Pa 19355, Usa Tel +1 610 722 0200 Fax +1 610 722 0246 email haiching.ma@reactionbiology.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Wang et al Running head recto: Inhibition of HDACs by ebselen and analogs DOI: http://dx.doi.org/10.2147/DDDT.S124977",Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
"Acetylon Pharmaceuticals, Inc. has developed a  pipeline of optimized, orally administered, HDAC6 selec - tive compounds ( http://www.acetylon.co m).",Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
Available from:   http://www.enzolifesciences.com/BML-2843/screen-well-fda- approved-drug-library-v2 /.,Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/8c/dddt-11-1369.PMC5422321.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 321–324Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 321 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S114473 Ethnopsychiatry fosters creativity and the  adoption of critical and reflexive thinking in higher  education students: insights from a qualitative  analysis of a preliminary pilot experience at the Faculty of Medicine and Surgery, University of  Genoa, Italy  Anna Siri1 Giovanni Del Puente2 Mariano Martini3 Nicola Luigi Bragazzi1–3 1Department of Mathematics (DIMA),   2Department of Neuroscience,   Rehabilitation (DINOGMI), 3Section  of History of Medicine and Ethics,   Department of Health Sciences (DISSAL), University of Genoa,  Genoa,  ItalyAbstract: Creativity is an ability that plays a major role in the modern economy and society.",Non-OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
"The degree of novelty of which the person is capable, or which he habitually Correspondence: Nicola Luigi Bragazzi School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Via Antonio Pastore 1, Genoa 16132, ItalyTel +39 010 353 7664 Fax +39 010 353 7669Email robertobragazzi@gmail.com Journal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Siri et alRunning head recto: Ethnopsychiatry fosters creativity and adoption of thinking DOI: http://dx.doi.org/10.2147/AMEP .S114473",Non-OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 324 Siri et al  4.,Non-OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
Available from http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32008D1350&from=EN.,Non-OADS,/arxiv_data1/oa_pdf/02/16/amep-8-321.PMC5422322.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bd/62/dddt-11-1393.PMC5422323.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1393–1398Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1393Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13230 8 Effect of electromagnetic fields and antioxidants  on the trace element content of rat teeth Mehmet sinan Dogan1 Mehmet cihan Yavas2 Yasemin Yavuz3 sait erdogan4 l˙smail Yener4 l˙brahim simsek1 Zeki akkus5 Veysel eratilla6 abdulsamet Tanik7 Mehmet Zulkuf akdag2 1Department of Pediatric Dentistry,   Faculty of Dentistry, harran  University, Şanlıurfa, 2Department  of Biophysics, Faculty of Medicine,   3Department of restorative Dentistry,   Faculty of Dentistry, 4Department  of chemistry, Faculty of science,   5Department of Biostatistics,   Faculty of Medicine, 6Department  of Prosthodontics, 7Department of  Periodontology, Faculty of Dentistry,   Dicle University, Diyarbakir, T urkeyAbstract:  The purpose of this study was to examine the possible effect of extremely  low-frequency electromagnetic fields (ELF-EMFs), from a high-voltage source, on rat teeth in  terms of changes in trace elements (TEs) and the effect of antioxidants (melatonin [MLT] and  Ganoderma lucidum [GL]) in counteracting these effects.",Non-OADS,/arxiv_data1/oa_pdf/bd/62/dddt-11-1393.PMC5422323.pdf
"MLT is an endogenous hormone that is released into  the blood from the pineal gland.10 It stimulates the release of antioxidant enzymes and  releases free radicals that are formed in the body.11 Reductions in MLT production correspondence: Mehmet sinan Dogan Department of Pediatric Dentistry,  Faculty of Dentistry, harran University,  Şanlıurfa 63300, Turkey email dtlider@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Dogan et al Running head recto: Electromagnetic fields, antioxidants, trace elements, rats DOI: http://dx.doi.org/10.2147/DDDT.S132308",Non-OADS,/arxiv_data1/oa_pdf/bd/62/dddt-11-1393.PMC5422323.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bd/62/dddt-11-1393.PMC5422323.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/62/dddt-11-1393.PMC5422323.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0b/15/cia-12-753.PMC5422324.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 753–757Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  753OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13449 6 relationships of pancreatic beta-cell function with  microalbuminuria and glomerular filtration rate  in middle-aged and elderly population without  type 2 diabetes mellitus: a Chinese community- based analysis shihui Fu1,2 shanjing Zhou3 leiming luo1 Ping Ye1 1Department of geriatric Cardiology,   2Department of Cardiology and  hainan Branch, 3Department of  Traditional Chinese Medicine and  hainan Branch, Chinese People’s  liberation Army general hospital,   Beijing, People’s republic of ChinaBackground:  Relationships of pancreatic beta-cell function abnormality with microalbuminuria  (MA) and glomerular filtration rate (GFR) may differ by age, ethnicity and accompanied  diseases.",Non-OADS,/arxiv_data1/oa_pdf/0b/15/cia-12-753.PMC5422324.pdf
"Keywords:  pancreatic beta-cell function, microalbuminuria, glomerular filtration rate, Chinese  community-dwelling population, middle-aged and elderly Background The primary defects observed in type 2 diabetes mellitus (T2DM) are developed  insulin resistance and abnormal insulin secretion by pancreatic beta-cells.1 Insulin  sensitivity and beta-cell function may have independent relationships to microvascular Correspondence: leiming luo; Ping Ye Department of geriatric Cardiology,  Chinese People’s liberation Army  general hospital, Fuxing road 28, Beijing  100853, People’s republic of China email lleim@sina.co m; sci301@126.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Fu et al Running head recto: Relationships of pancreatic beta-cell function with MA and GFR DOI: http://dx.doi.org/10.2147/CIA.S134496",Non-OADS,/arxiv_data1/oa_pdf/0b/15/cia-12-753.PMC5422324.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0b/15/cia-12-753.PMC5422324.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0b/15/cia-12-753.PMC5422324.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/87/copd-12-1309.PMC5422326.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1309–1324International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1309OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12454 7 hydrogen coadministration slows the  development of COPD-like lung disease  in a cigarette smoke-induced rat model Xiaoyu liu1,* Cuiqing Ma2,* Xiaoyu Wang1 Wenjing Wang1 Zhu li1 Xiansheng Wang1 Pengyu Wang1 Wuzhuang sun1 Baojian Xue3 1Department of respiratory  Medicine, The First hospital of hebei  Medical University, 2Department of  Immunology, hebei Medical University,   shijiazhuang, 3life science research  Center, hebei north University,   Zhangjiakou, People’s republic  of China *These authors contributed equally  to this workBackground:  Chronic obstructive pulmonary disease (COPD) is a progressive pulmonary  disease caused by harmful gases or particles.",Non-OADS,/arxiv_data1/oa_pdf/6d/87/copd-12-1309.PMC5422326.pdf
"Smoking- derived substances and chemicals can cause airway and vasculature inflammatory Correspondence: Wuzhuang sun Department of respiratory Medicine,  The First hospital of hebei Medical  University, 89 Donggang road,  shijiazhuang 050031, People’s  republic of China Tel +86 186 3388 9856 email sunwuzhuang2016@163.co m  Baojian Xue life science research Center, hebei  north University, 11 Zuan-shinan  road, Zhangjiakou 075000, People’s  republic of China email baojian-xue@uiowa.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liu et al Running head recto: The effects of hydrogen in COPD DOI: http://dx.doi.org/10.2147/COPD.S124547",Non-OADS,/arxiv_data1/oa_pdf/6d/87/copd-12-1309.PMC5422326.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6d/87/copd-12-1309.PMC5422326.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/87/copd-12-1309.PMC5422326.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/74/96/ceg-10-083.PMC5422327.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/74/96/ceg-10-083.PMC5422327.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2017:10 83–90Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  83 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S123942Fatigue in patients with inflammatory bowel  disease is associated with distinct differences  in immune parameters Lauran Vogelaar1,*  Colin de Haar2,*  Bas RJ Aerts1  Maikel P Peppelenbosch1  Reinier Timman3  Bettina E Hanssen1  C Janneke van der Woude1 1Department of Gastroenterology and  Hepatology, Erasmus MC, Rotterdam,   2Applied T umor Immunology,   Laboratory of Translational  Immunology, UMC Utrecht,  Utrecht,  3Department of Psychiatry,   Section of Medical Psychology and Psychotherapy, Erasmus MC,  Rotterdam, the Netherlands *These authors contributed equally to  this workBackground: Although it is well recognized that fatigue is an important problem in many of  the quiescent inflammatory bowel disease (IBD) patients, it is unknown whether the immune  status is different in fatigued versus non-fatigued patients.",Non-OADS,/arxiv_data1/oa_pdf/74/96/ceg-10-083.PMC5422327.pdf
"1,3,5Correspondence: Lauran Vogelaar   Department of Gastroenterology  and Hepatology, Erasmus MC, ‘s Gravendijkwal 230, Room HS 306, 3000 CA Rotterdam, the Netherlands   Email l.vogelaar@erasmusmc.nlJournal name: Clinical and Experimental Gastroenterology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: V ogelaar et alRunning head recto: Fatigue in patients with IBDDOI: http://dx.doi.org/10.2147/CEG.S123942",Non-OADS,/arxiv_data1/oa_pdf/74/96/ceg-10-083.PMC5422327.pdf
"Clinical and Experimental Gastroenterology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/74/96/ceg-10-083.PMC5422327.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 90 Vogelaar et al 45.,Non-OADS,/arxiv_data1/oa_pdf/74/96/ceg-10-083.PMC5422327.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 155–160Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 155 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S128502 Hearing thresholds in adult Nigerians with  diabetes mellitus: a case–control study Jones Ndubuisi Nwosu Ethel Nkechi Chime Department of Otorhinolaryngology,   College of Medicine, University of Nigeria, Enugu Campus, Enugu, NigeriaObjectives:  To determine the prevalence, types and severity of hearing loss and associated  factors in a hospital population of adult Nigerians with diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
"P.M.B 01129, Enugu, NigeriaTel +234 703 973 2600Email jones.nwosu@unn.edu.ngJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Nwosu and ChimeRunning head recto: Hearing threshold in diabetes mellitusDOI: http://dx.doi.org/10.2147/DMSO.S128502",Non-OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/58839/1/WHO_PDH_91.1.pdf Accessed June 12, 2014.",OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 160 Nwosu and Chime,Non-OADS,/arxiv_data1/oa_pdf/80/f6/dmso-10-155.PMC5422328.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/ed/ijn-12-3447.PMC5422330.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3447–3461International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3447OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12972 0 Development of 99mTc-radiolabeled nanosilica for  targeted detection of her2-positive breast cancer Paolo rainone1,2,* Benedetta riva3,* sara Belloli1 Francesco sudati4 Marilena ripamonti1 Paolo Verderio3 Miriam colombo3 Barbara colzani3 Maria carla gilardi1 rosa Maria Moresco5 Davide Prosperi3 1Institute of Molecular Bioimaging  and Physiology, cN r, segrate (MI),   2Doctorate school of Molecular and  Translational Medicine, University  of Milan, Milan, 3NanoBio lab,   Dipartimento di Biotecnologie e  Bioscienze, Università di Milano- Bicocca, Milano, 4PeT and Nuclear  Medicine Unit, san raffaele scientific  Institute, Milan, 5Department of  Medicine and surgery, University of  Milano-Bicocca, Monza, Italy *These authors contributed equally  to this workAbstract:  The human epidermal growth factor receptor 2 (HER2) is normally associated with  a highly aggressive and infiltrating phenotype in breast cancer lesions with propensity to spread  into metastases.",Non-OADS,/arxiv_data1/oa_pdf/a3/ed/ijn-12-3447.PMC5422330.pdf
"Molecular imaging techniques such as positron emission tomography (PET) and  single photon emission computed tomography (SPECT) allow the in vivo detection of  molecular targets during tumor progression and diffusion.6 These radionuclide-based correspondence: sara Belloli Institute of Molecular Bioimaging  and Physiology of cNr, Via Fratelli  cervi 93, 20090 segrate, Italy Tel +39 02 2643 3640 Fax +39 02 2643 2717 email belloli.sara@hsr.i t  Davide Prosperi NanoBiolab, Dipartimento di  Biotecnologie e Bioscienze, Università  di Milano-Bicocca, Piazza della  scienza 2, 20126 Milano, Italy Tel +39 02 6448 3302 Fax +39 02 6448 3565 email davide.prosperi@unimib.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Rainone et al Running head recto: Radiolabeled nanosilica for breast cancer imaging DOI: http://dx.doi.org/10.2147/IJN.S129720",Non-OADS,/arxiv_data1/oa_pdf/a3/ed/ijn-12-3447.PMC5422330.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a3/ed/ijn-12-3447.PMC5422330.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/ed/ijn-12-3447.PMC5422330.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/d6/cia-12-745.PMC5422331.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 745–752Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  745OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13001 4 Body mass index is associated with type 2  diabetes mellitus in Chinese elderly Qianping Zhao1 Jari A laukkanen2,3 Qifu li4 gang li1 1Division of Cardiology, Department  of geriatrics, The First Affiliated  hospital of Chongqing Medical  University, Chongqing, People’s  republic of China; 2Institute of  Public health and Clinical nutrition,   University of eastern Finland, Kuopio,   Finland; 3Department of Medicine,   Central Finland Central hospital,   Jyväskylä, Finland; 4Department of  endocrinology, The First Affiliated  hospital of Chongqing Medical  University, Chongqing, People’s  republic of ChinaBackground:  There is limited information on the association between metabolic syndrome  components including body mass index (BMI) and type 2 diabetes mellitus in elderly Chinese  population.",Non-OADS,/arxiv_data1/oa_pdf/93/d6/cia-12-745.PMC5422331.pdf
"Therefore, we collected recently diagnosed type 2 DM elderly patients  retrospectively in a cross-sectional study in order to investigate the correlation between  metabolic syndrome components including BMI and type 2 DM in Chinese elderly.Correspondence: gang li Division of Cardiology, Department of  Geriatrics, The First Affiliated Hospital  of Chongqing Medical University, no 1  Youyi road, Yuzhong, Chongqing 400016,  People’s republic of China Tel +86 23 8901 3841 Fax +86 23 6881 1487 email ganglicqmu@126.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhao et al Running head recto: BMI and type 2 DM in the elderly DOI: http://dx.doi.org/10.2147/CIA.S130014",Non-OADS,/arxiv_data1/oa_pdf/93/d6/cia-12-745.PMC5422331.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/93/d6/cia-12-745.PMC5422331.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/93/d6/cia-12-745.PMC5422331.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6d/28/dmso-10-151.PMC5422332.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6d/28/dmso-10-151.PMC5422332.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 151–154Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 151 SHORT REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S131340 Do we need to measure vitamin B12 and  magnesium in morbidly obese patients with type  2 diabetes mellitus?",Non-OADS,/arxiv_data1/oa_pdf/6d/28/dmso-10-151.PMC5422332.pdf
"3,4 Our impression from daily work, treating Correspondence: Hans-Erik Johansson Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala Science Park, 75185 Uppsala, SwedenTel +46 1 8611 0000Fax +46 1 8611 7976Email hans-erik.johansson@pubcare.uu.seJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: SHORT REPORTY ear: 2017V olume: 10Running head verso: Wåhlén et alRunning head recto: Metformin alters vitamin B12 and magnesium in obese T2DM patientsdoi: http://dx.doi.org/10.2147/DMSO.S131340",Non-OADS,/arxiv_data1/oa_pdf/6d/28/dmso-10-151.PMC5422332.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/6d/28/dmso-10-151.PMC5422332.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 154 Wåhlén et al,Non-OADS,/arxiv_data1/oa_pdf/6d/28/dmso-10-151.PMC5422332.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6d/f2/cmar-9-159.PMC5422333.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6d/f2/cmar-9-159.PMC5422333.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 159–166Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  159 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S117799Oligodendrogliomas in pediatric and adult  patients: an outcome-based study from the  Surveillance, Epidemiology, and End Result  database Christine SM Lau1,2 Krishnaraj Mahendraraj1 Ronald S Chamberlain1–4 1Department of Surgery, Saint  Barnabas Medical Center, Livingston,   NJ, USA; 2Saint George’s University  School of Medicine, Grenada, West Indies;  3Department of Surgery,   New Jersey Medical School, Rutgers University, Newark, NJ,  4Department  of Surgery, Banner MD Anderson Cancer Center, Gilbert, AZ, USAIntroduction: Oligodendrogliomas (OGs) account for <20% of all intracranial tumors and  25% of gliomas.",Non-OADS,/arxiv_data1/oa_pdf/6d/f2/cmar-9-159.PMC5422333.pdf
"1 Oligodendrogliomas (OGs) account for <20% of all intracranial  tumors and 25% of gliomas.1Correspondence: Ronald S Chamberlain Department of Surgery, Banner MD Anderson Cancer Center, 2940 East Banner Gateway Drive, Gilbert, AZ 85234, USATel +1 480 256 4737Fax +1 480 256 4734Email ronald.chamberlain@bannerhealth.comJournal name: Cancer Management and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Lau et alRunning head recto: OligodendrogliomaDOI: http://dx.doi.org/10.2147/CMAR.S117799",Non-OADS,/arxiv_data1/oa_pdf/6d/f2/cmar-9-159.PMC5422333.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/6d/f2/cmar-9-159.PMC5422333.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 166 Lau et al in the treatment of pediatric OGs are required to optimize  the management and survival in these patients.,Non-OADS,/arxiv_data1/oa_pdf/6d/f2/cmar-9-159.PMC5422333.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/96/dddt-11-1353.PMC5422334.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1353–1365Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1353Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12056 4 Methanol leaf extract of Actinodaphne sesquipedalis   (lauraceae) enhances gastric defense against  ethanol-induced ulcer in rats hanita Omar1,2 noraziah nordin3 Pouya hassandarvish4 Maryam hajrezaie5 ainnul hamidah syahadah  azizan1 Mehran Fadaeinasab6 nazia abdul Majid7 Mahmood ameen abdulla5 najihah Mohd hashim3 hapipah Mohd ali1 1Department of chemistry, Faculty  of science, 2centre for Foundation  studies in science, 3Department  of Pharmacy, 4Department of  Microbiology, 5Department of  Biomedical sciences, Faculty of  Medicine, 6center for natural  Products and Drug research  (cenar), 7institute of Biological  sciences, Faculty of science,   University of Malaya, Kuala  lumpur, MalaysiaAbstract:  Actinodaphne sesquipedalis  Hook.",Non-OADS,/arxiv_data1/oa_pdf/7a/96/dddt-11-1353.PMC5422334.pdf
"Gastric ulcer  is a condition where an erosion or a lesion in the gastric mucosa penetrates into the  submucosa or deeper.1 One of the causes of this disorder is an imbalance between the  protective factors (prostaglandin, bicarbonate, nitric oxide [NO] and growth factors)  and destructive factors (infection by Helicobacter pylori , use of nonsteroidal anti- inflammatory drugs and lifestyle),1–3 resulting in disruption of the gastric mucosal  defensive barrier leading to gastric ulcer.4 Gastroprotective agents prescribed for  ulcer are generally nonspecific, by which the secretion of gastric acid is controlled correspondence: hanita Omar centre for Foundation studies in science,  University of Malaya, 50603 Kuala  lumpur, Malaysia Tel +60 3 7967 5980 Fax +60 3 7957 6478 email hanita74@um.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Omar et al Running head recto: Actinodaphne sesquipedalis  leaf extract prevents gastric ulcer DOI: http://dx.doi.org/10.2147/DDDT.S120564",Non-OADS,/arxiv_data1/oa_pdf/7a/96/dddt-11-1353.PMC5422334.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7a/96/dddt-11-1353.PMC5422334.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/96/dddt-11-1353.PMC5422334.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/63/copd-12-1339.PMC5422335.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1339–1349International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1339RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S12780 2 Is periodontitis a comorbidity of COPD or can  associations be explained by shared risk factors/ behaviors?",Non-OADS,/arxiv_data1/oa_pdf/5a/63/copd-12-1339.PMC5422335.pdf
"GOLD  now recognizes the significance of extra-pulmonary effects of COPD and that comor - bidities contribute to the overall severity of disease and as such should be actively Correspondence: elizabeth Sapey Centre for Translational Inflammation  Research, Institute of Inflammation  and Ageing, Queen elizabeth Hospital,  Mindelsohn way, edgbaston,  Birmingham, B15 2Gw, UK Tel/fax +44 121 627 2000 email e.sapey@bham.ac.u k Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Hobbins et al Running head recto: Periodontitis and COPD DOI: http://dx.doi.org/10.2147/COPD.S127802",Non-OADS,/arxiv_data1/oa_pdf/5a/63/copd-12-1339.PMC5422335.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5a/63/copd-12-1339.PMC5422335.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/63/copd-12-1339.PMC5422335.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 301–311Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 301 Original researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S126390 Prognostic value of histone chaperone F aCT  subunits expression in breast cancer Kristopher attwood1 Daria Fleyshman2 laura Prendergast2 geraldine Paszkiewicz2 angela r Omilian3 Wiam Bshara3 Katerina gurova2 1Department of Biostatistics and  Bioinformatics, 2Department of  Cell stress Biology, 3Department  of Pathology, roswell Park Cancer  institute, Buffalo, nY, UsaAbstract:  Understanding the underlying reasons for tumor aggressiveness, such as why some  tumors grow slowly and locally, while others rapidly progress to a lethal metastatic disease, is  still limited.",Non-OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
"Since the introduction of mammography as a routine screening for Correspondence: Katerina gurova Department of Cell stress Biology, roswell Park Cancer institute, elm and Carlton streets, Buffalo, nY 14263, UsaTel +1 716 845 4760Fax +1 716 845 3944email katerina.gurova@roswellpark.orgJournal name: Breast Cancer - Targets and Therapy Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Attwood et alRunning head recto: FACT as prognostic marker for breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S126390",Non-OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 311 FaCT as prognostic marker for breast cancer Acknowledgments We would like to acknowledge Noreen Ersing for help  with IHC staining, Leighton Stein with slide annotations, and Bruce Specht, Mary Morgan, and Sara Tyrpak for administrative support.",Non-OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
Available from: http://biostats.bepress.com/mskccbiostat/paper16/.,Non-OADS,/arxiv_data1/oa_pdf/d4/da/bctt-9-301.PMC5422336.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 161–167Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 161 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S122767 Role of sodium glucose cotransporter-2 inhibitors  in type I diabetes mellitus Hala Ahmadieh1 Nisrine Ghazal2 Sami T Azar3 1Faculty of Medicine, Clinical Sciences  Department, Beirut Arab University,   2Department of Endocrinology and  Metabolism, American University of  Beirut, Beirut, Lebanon; 3Department  of Internal Medicine, Division of Endocrinology, American University of Beirut, New Y ork, NY, USA Abstract:  The burden of diabetes mellitus (DM) in general has been extensively increasing  over the past few years.",Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
"Despite the clear beneficial advances over the past years in insulin formulation  and its way of delivery in patients with T1D, continuous subcutaneous insulin infusion and continuous glucose monitoring (CGM) systems still fail to achieve the optimal Correspondence: Sami T Azar Department of Internal Medicine, Division of Endocrinology, American University of Beirut, 3 Dag Hammarskjold Plaza, 8th Floor, New York, NY 10017, USA Tel +1 961 323 4250Fax +1 961 174 4703Email sazar@aub.edu.lbJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Ahmadieh et alRunning head recto: Sodium glucose cotransporter-2 inhibitors in type 1 diabetes DOI: http://dx.doi.org/10.2147/DMSO.S122767",Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
Available from: https://www.astrazeneca.com/media-centre/press-releases/2012/FORXIGA-dapagliflozin-now-approved-in-European-Union-for-treatment-of-type-2-diabetes-14112012.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce-ments/ucm345848.htm.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
Available from: https://www.drugs.com/newdrugs/fda-approves-jardiance-empagliflozin-type-2-diabetes-4064.html.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 167 Sodium glucose cotransporter-2 inhibitors in type 1 diabetes  43.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
Available from: http://www.fda.gov/ downloads/Drugs/DrugSafety/UCM446954.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/6d/dmso-10-161.PMC5422337.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 317–320Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 317 LEttEr open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S133328 Advances in medical education and practice:  student perceptions of the flipped classroom Mohammed Salik Sait1 Zohaib Siddiqui2 Yasir Ashraf3 1Barts and the London School of  Medicine and Dentistry, 2King’s  College School of Medicine, 3School  of Medicine, Imperial College London,   London, UKDear editor We read with great interest the article by Ramnanan and Pound  which reviews the  benefits and limitation of the “flipped classroom” (FC) approach to teaching in medical schools.",Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
"Reduced instructor contact can also negatively affect  Correspondence: Yasir Ashraf School of Medicine, Imperial College London, London, SW7 2AZ, UKtel +44 777 431 2398Email sya12@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LetterY ear: 2017V olume: 8Running head verso: Sait et alRunning head recto: Student perceptions of FCDOI: http://dx.doi.org/10.2147/AMEP .S133328",Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
Available from: http://www.smd.qmul.ac.uk/undergraduate/rankings/nss/.,Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
Available from: http://www.kcl.ac.uk/lsm/research/divisions/hscr/study/undergra-dops/kumec/MBBS-2020.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 320 Sait et al Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/f9/aa/amep-8-317.PMC5422339.pdf
"https://doi.org/10.1177/1176935117705381 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Cancer Informatics Volume 16: 1–54 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176935117705381 Introduction Since the development of microarray for high-throughput  analysis of gene expressions,1 this technology has been widely  used in many biomedical studies.2–8 Cancer research is one of  the main areas that apply this technology.2,9–14 Among this,  breast cancer research is the most common one.15–19 Although the development of microarrays and the ability to  perform massively parallel gene expression analysis of human tumors has been shown great contribution to breast cancer clas-sification, prognostication, and prediction during the last dec-ade, 20 the heterogeneous nature of breast cancer and the lack of  reliable pathological or molecular markers still reflects the com-plexity of the molecular alterations that underlie the development and progression of this disease and poses serious problems to clinical management.",Non-OADS,/arxiv_data1/oa_pdf/e7/54/10.1177_1176935117705381.PMC5422340.pdf
"Accepted for publication Apr 07, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.02 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.02 Introduction In Japan, treatment guidelines for gastric cancer (GC) have been issued, and a standard therapeutic strategy for GC by stage has been established.",Non-OADS,/arxiv_data1/oa_pdf/51/d6/cjcr-29-2-100.PMC5422411.pdf
"Accepted for publication Feb 23, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.03 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.03 Introduction Gastric cancer is the fourth leading cause of cancer deaths worldwide  (1)  and  the  third  in  China  (2).",Non-OADS,/arxiv_data1/oa_pdf/cd/50/cjcr-29-2-109.PMC5422412.pdf
"Accepted for publication Apr 17, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.05 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.05 Introduction Helicobacter pylori (H. pylori) infection has been recognized as the leading cause of chronic gastritis, peptic ulcer disease and gastric cancer (1,2).",Non-OADS,/arxiv_data1/oa_pdf/2e/29/cjcr-29-2-127.PMC5422414.pdf
Available online: http://www.iarc.fr/en/publications/pdfs-online/7.134 Wang et al.,OADS,/arxiv_data1/oa_pdf/2e/29/cjcr-29-2-127.PMC5422414.pdf
"Accepted for publication Mar 17, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.06 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.06 Introduction Gastric  neuroendocrine  tumors  (gNETs)  are  rare, occurring in 1 to 2 cases/1,000,000 persons per year, and accounting for 8.7% of all gastrointestinal neuroendocrine tumors (1), less than 2% of all neuroendocrine tumors and less  than  1%  of  all  gastric  cancers  (1-3).",Non-OADS,/arxiv_data1/oa_pdf/78/3d/cjcr-29-2-137.PMC5422415.pdf
Available online: http://www.nccn.org/professionals/ physician_gls/pdf/neuroendocrine.pdf18.,Non-OADS,/arxiv_data1/oa_pdf/78/3d/cjcr-29-2-137.PMC5422415.pdf
"Accepted for publication Apr 18, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.07 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.07  Protocol  © Chinese Journal of Cancer Research.",Non-OADS,/arxiv_data1/oa_pdf/2a/a9/cjcr-29-2-144.PMC5422416.pdf
"Randomization and allocation concealment After confirming fulfillment of the eligibility criteria, registration is made by a web-based system to the Data Center (https://crabyter.sinyoo.net/).",OADS,/arxiv_data1/oa_pdf/2a/a9/cjcr-29-2-144.PMC5422416.pdf
"Sample size calculation and statistical analysis According  to  the  statistical  tools  on  SWOG  center (http://www.swogstat.org/), the required sample size will be 564 patients (282 patients per arm), with a one-sided alpha level of 5% and a power of 80%.",Non-OADS,/arxiv_data1/oa_pdf/2a/a9/cjcr-29-2-144.PMC5422416.pdf
Clinical trials registry This trial has been registered in the ClinicalTrials.gov as NCT02867839 (https://clinicaltrials.gov/).,Non-OADS,/arxiv_data1/oa_pdf/2a/a9/cjcr-29-2-144.PMC5422416.pdf
"Accepted for publication Mar 29, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.08 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.08 Introduction Esophageal cancer is a highly aggressive malignancy with a poor overall outcome.",Non-OADS,/arxiv_data1/oa_pdf/72/11/cjcr-29-2-149.PMC5422417.pdf
"Accepted for publication Apr 17, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.10 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.10 Dysregulated pseudo-hypoxia (through its effects on cell survival, angiogenesis, metabolism, invasion) and epigenetic dysregulation [through widespread suppression of tumor suppressor genes involved in cell cycle, apoptosis, adhesion, immune evasion, etc.",Non-OADS,/arxiv_data1/oa_pdf/33/44/cjcr-29-2-166.PMC5422419.pdf
"Accepted for publication Apr 10, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.11 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.11 Introduction With  the  development  of  medical  technology  and refinement of disciplines, the scope of individual professional or discipline knowledge is not sufficient to cope with complicated cases, and the importance of multidisciplinary team (MDT) in clinical practice and scientific research has become increasingly prominent.",Non-OADS,/arxiv_data1/oa_pdf/4f/c4/cjcr-29-2-168.PMC5422420.pdf
"Accepted for publication Apr 17, 2017. doi: 10.21147/j.issn.1000-9604.2017.02.01 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2017.02.01 Introduction Sentinel  nodes  (SNs)  are  the  first  possible  sites  of metastasis via lymphatic drainage from a primary tumor.",Non-OADS,/arxiv_data1/oa_pdf/32/22/cjcr-29-2-93.PMC5422421.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.Appendix See Tables 7,8and9.",Non-OADS,/arxiv_data1/oa_pdf/7a/7c/40271_2017_Article_224.PMC5422446.pdf
Geneva: WHO;2011. http://www.euro.who.int/en/publications/abstracts/ palliative-care-for-older-people-better-practices .,Non-OADS,/arxiv_data1/oa_pdf/7a/7c/40271_2017_Article_224.PMC5422446.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Appendix See Table 6.",Non-OADS,/arxiv_data1/oa_pdf/52/f0/40261_2017_Article_517.PMC5422449.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/43/5d/40271_2016_Article_211.PMC5422451.pdf
http://www.fda.gov/downloads/Drugs/Guidances/ UCM193282.pdf .,Non-OADS,/arxiv_data1/oa_pdf/43/5d/40271_2016_Article_211.PMC5422451.pdf
http://www.acc.org/StatinIntoleranceApp .,OADS,/arxiv_data1/oa_pdf/43/5d/40271_2016_Article_211.PMC5422451.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/45/ec/40257_2017_Article_258.PMC5422452.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/93/ndt-13-1211.PMC5422454.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1211–1214Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1211OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12416 8 anorexia nervosa of the restrictive type and  celiac disease in adolescence renata Nacinovich1 lucio Tremolizzo2 Fabiola corbetta1 elisa conti2 Francesca Neri1 Monica Bomba1 1child and adolescent Mental health  Department, 2Neurology Unit and  lab of Neurobiology, san gerardo  hospital, school of Medicine and  surgery and Milan center for  Neuroscience (Neuro-M i), University  of Milano-Bicocca, Monza, italyBackground:  Anorexia nervosa (AN) is usually present in adolescence with symptoms partially  overlapping celiac disease (CD), but the relationship between these two conditions has received  little attention in the literature.",Non-OADS,/arxiv_data1/oa_pdf/aa/93/ndt-13-1211.PMC5422454.pdf
"It is a serious, potentially life-threatening ED characterized by  self-starvation, with important weight loss associated with an intense fear of weight  gain and persistent behavior to prevent weight gain and by self-esteem overly related  to body image.3 AN presents usually in the adolescence with symptoms partially over - lapping CD (in particular, weight loss and psychiatric disorders), but the relationship  between these two conditions has received little attention in the literature,4 with few  case reports and small case series published,4,5 again often in adult patients.6 Only  recently, Basso et al7 reported the prevalence of CD in a population of 177 adolescents  affected by AN (males and females, restrictive and binge/purging type) and found  that the overall prevalence of CD in their sample was the same as that in the general correspondence: renata Nacinovich child and adolescent Mental health  Department, san gerardo hospital,  University of Milano Bicocca, via Pergolesi  33, 20900 Monza (MB), italy Tel +39 039 233 3579 Fax +39 039 233 3321 email renata.nacinovich@unimib.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Nacinovich et al Running head recto: Anorexia nervosa and celiac disease DOI: http://dx.doi.org/10.2147/NDT.S124168",Non-OADS,/arxiv_data1/oa_pdf/aa/93/ndt-13-1211.PMC5422454.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/aa/93/ndt-13-1211.PMC5422454.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/93/ndt-13-1211.PMC5422454.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 273–279International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  273RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10679 6 Radiation-induced vaginal stenosis: current  perspectives Lucinda Morris1 viet Do1 Jennifer Chard1 Alison H Brand2,3 1Crown Princess Mary Cancer Centre  Westmead, Radiation Oncology  Network, Westmead, 2Discipline  of Obstetrics, Gynaecology and  Neonatology, Westmead Clinical  School, University of Sydney,   Camperdown, 3Department of  Gynaecological Oncology, Westmead  Hospital, Westmead, NSW, AustraliaAbstract:  Treatment of gynecological cancer commonly involves pelvic radiation therapy (RT)  and/or brachytherapy.",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"In a retrospective study of women with Stage 1B to Stage 4 cervical  cancer treated with pelvic RT and/or brachytherapy, the prospectively recorded incidence Correspondence: Alison H Brand Department of Gynaecological Oncology,  Westmead Hospital, PO Box 533,  Westmead, NSW 2045, Australia email alison.brand@health.nsw.gov.a u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Morris et al Running head recto: Radiation-induced vaginal stenosis  DOI: http://dx.doi.org/10.2147/IJWH.S106796",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"Available from: https://ctep.cancer.gov/protocolDevelopment/ electronic_applications/docs/ctcaev3.pd f. Accessed February 11, 2017.",OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"2009 Available from: https://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pd f. Accessed  February 11, 2017.",OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
Available from: http://www.icru.org/ content/reports/prescribing-recording-and-reporting-brachytherapy- for-cancer-of-the-cervix-report-no-8 9.,Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"Available from: http://www.slhd.nsw.gov.au/services/ sgog/VD_Therapy.htm l. Accessed February 11, 2017.",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"Available from:  https://www.eviq.org.au/Protocol/tabid/66/categoryid/180/id/1867/ Supporting+Document+-+Management+of+Radiation+Induced +Vag inal+Stenosis.asp x. Accessed February 11, 2017.",OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijwh-9-273.PMC5422455.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/82/ijn-12-3471.PMC5422456.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3471–3483International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3471OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11606 3 a novel nanoemulsion-based method to produce  ultrasmall, water-dispersible nanoparticles from  chitosan, surface modified with cell-penetrating  peptide for oral delivery of proteins and peptides ghullam reza Barbari1 Farid abedin Dorkoosh1 Mohsen amini2 Mohammad sharifzadeh3 Fateme atyabi1 saeed Balalaie4 Niyousha rafiee T ehrani5 Morteza rafiee T ehrani1 1Department of Pharmaceutics,   2Department of Medicinal  chemistry, 3Department of  Pharmacology, School of Pharmacy,   T ehran University of Medical sciences,   4Department of chemistry, Khaje  Nasiroddin University, 5Department  of Biochemistry, school of Medicine,   T ehran University of Medical sciences,   T ehran, IranAbstract:  A simple and reproducible water-in-oil (W/O) nanoemulsion technique for making  ultrasmall ( ,15 nm), monodispersed and water-dispersible nanoparticles (NPs) from chitosan  (CS) is reported.",Non-OADS,/arxiv_data1/oa_pdf/69/82/ijn-12-3471.PMC5422456.pdf
"Among the large number of peptides and hydrophilic compounds,  insulin is the main peptide whose oral delivery has been the dream of many accredited  universities and pharmaceutical companies around the world.2,3 Oral delivery of insulin  has some crucial advantages, including high patient compliance, ease of administration  and more patient adherence to the therapy, and, more importantly, it is the sole route  of administration that potentially mimics the physiological insulin secretion seen in  nondiabetic individuals,4 thus relieving the patients from hyperinsulinemia and its  consequent complications such as nephropathy and neuropathy.5 However, oral delivery  of insulin has two main bottlenecks, the harsh and degrading enzymatic situation of  the gastrointestinal tract that inactivates insulin very quickly and the mucosal barrier  that limits insulin’s oral bioavailability.6,7 Numerous approaches have been applied  to bypass the enzyme barrier, and some of them have achieved promising results.8 Correspondence: Morteza Rafiee Tehrani Department of Pharmaceutics, school  of Pharmacy, Tehran University of  Medical Sciences, North Kargar St,  amirabad, Tehran, Iran email rafitehr@ams.ac.i r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Barbari et al Running head recto: Nanoemulsion-based method to produce ultrasmall, water-dispersible NPs DOI: http://dx.doi.org/10.2147/IJN.S116063",Non-OADS,/arxiv_data1/oa_pdf/69/82/ijn-12-3471.PMC5422456.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/82/ijn-12-3471.PMC5422456.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/82/ijn-12-3471.PMC5422456.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/a6/ijn-12-3485.PMC5422457.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3485–3494International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3485OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13523 9 Preparation of zein nanoparticles by using  solution-enhanced dispersion with supercritical  cO2 and elucidation with computational fluid  dynamics sining li Yaping Zhao school of chemistry and chemical  engineering, shanghai Jiao Tong  University, shanghai, chinaAbstract:  Nanoparticles have attracted more and more attention in the medicinal field.",Non-OADS,/arxiv_data1/oa_pdf/3f/a6/ijn-12-3485.PMC5422457.pdf
"In this way the  SF acts both as an antisolvent and as a “spray enhancer” through hydro mechanical correspondence: Yaping Zhao school of chemistry and chemical  engineering, shanghai Jiao Tong  University, 800 Dong chuan road,  shanghai 200240, china email ypzhao@sjtu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li and Zhao Running head recto: Preparation of zein nanoparticles by using solution-enhanced dispersion DOI: http://dx.doi.org/10.2147/IJN.S135239",Non-OADS,/arxiv_data1/oa_pdf/3f/a6/ijn-12-3485.PMC5422457.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3f/a6/ijn-12-3485.PMC5422457.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/ijn-12-3485.PMC5422457.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/de/12/tcrm-13-593.PMC5422458.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 593–602Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  593ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S13118 5 Minimally invasive endoscopic resection for the  treatment of sinonasal malignancy: the outcomes  and risk factors for recurrence ning he,1–3 Xiaohong  Chen,2 luo Zhang,2 Xuejun  Chen,2 Zhigang huang,2 Qi  Zhong,2 hongzhi Ma,2 ling  Feng,2 lizhen hou,2 Jugao  Fang1,2,4 1Department of Otolaryngology –  head and neck surgery, Beijing  T ongren hospital, Capital Medical  University, 2Key laboratory of  Otorhinolaryngology, head and neck  surgery, Ministry of education, Beijing  institute of Otorhinolaryngology,   Beijing, 3Department of  Otolaryngology & head and neck  Oncology, The People’s hospital  of guangxi Zhuang autonomous  Region, nanning, guangxi Zhuang  autonomous Region, 4Beijing Key  laboratory of head and neck  Molecular Diagnostic Pathology,   Beijing, People’s Republic of ChinaPurpose:  The role of minimally invasive endoscopic resection (MIER) in the treatment of  sinonasal malignancy is controversial.",Non-OADS,/arxiv_data1/oa_pdf/de/12/tcrm-13-593.PMC5422458.pdf
"Due to the low incidence of SNM and insufficient evidence, a widely accepted Correspondence: Jugao Fang Department of Otolaryngology – head  and neck surgery, Beijing Tongren  hospital, Capital Medical University,  1 Dongjiaominxiang, Dongcheng, Beijing  100703, People’s Republic of China Tel/fax +86 10 5826 9512 email fangjugao@163.co m  Xiaohong Chen Key laboratory of Otorhinolaryngology,  head and neck surgery, Ministry  of education, Beijing institute  of Otorhinolaryngology, 1  Dongjiaominxiang, Dongcheng, Beijing  100005, People’s Republic of China Tel/fax +86 10 5826 9512 email trchenxh@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: He et al Running head recto: Minimally invasive endoscopic resection for the treatment of SNM DOI: http://dx.doi.org/10.2147/TCRM.S131185",Non-OADS,/arxiv_data1/oa_pdf/de/12/tcrm-13-593.PMC5422458.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/de/12/tcrm-13-593.PMC5422458.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/12/tcrm-13-593.PMC5422458.pdf
Or use: http://youtu.be/_eDYDDrpzs UVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/de/12/tcrm-13-593.PMC5422458.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/0f/ott-10-2389.PMC5422459.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2389–2401OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12632 0 immunogenicity of oncolytic vaccinia viruses JX- gFP and Tg6002 in a human melanoma in vitro  model: studying immunogenic cell death, dendritic  cell maturation and interaction with cytotoxic  T lymphocytes B heinrich1 J Klein1 M Delic1 K goepfert1 V engel1 l geberzahn1 M lusky2 P erbs2 X Preville3 M Moehler1 1First Department of internal  Medicine, University Medical center  Mainz, Mainz, germany; 2Transgene  sa, illkirch-graffenstaden, 3amoneta  Diagnostics, huningue, FranceAbstract:  Oncolytic virotherapy is an emerging immunotherapeutic modality for cancer  treatment.",Non-OADS,/arxiv_data1/oa_pdf/8d/0f/ott-10-2389.PMC5422459.pdf
"Therapeutic agents, which cause an immu - nogenic type of cell death, correlate with better prognosis and overall survival (OS).1–3  Several studies indicated that a long-term cure of cancer might be immune driven.4–7  A higher amount of tumor-infiltrating lymphocytes in the microenvironment correlates  with a better outcome.8 Oncolytic viruses offer an approach for immunotherapy.9–11 correspondence: M Moehler First Department of internal  Medicine, University Medical center  Mainz, langenbeckstrasse 1, 55131  Mainz, germany Tel +49 6131 17 6076 Fax +49 6131 17 6472 email markus.moehler@unimedizin- mainz.d e Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Heinrich et al Running head recto: Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 DOI: http://dx.doi.org/10.2147/OTT.S126320",Non-OADS,/arxiv_data1/oa_pdf/8d/0f/ott-10-2389.PMC5422459.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8d/0f/ott-10-2389.PMC5422459.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/0f/ott-10-2389.PMC5422459.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 255–264International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  255OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12513 3 Factors associated with psychological distress  among young women in Kisumu, Kenya Deborah a gust1 roman gvetadze1 Melissa Furtado2 Mumbi Makanga3 Victor akelo3 Kenneth Ondenge3 Beatrice nyagol3 eleanor Mclellan-lemal1 1Division of HIV/ aIDs Prevention,   centers for Disease control and  Prevention, 2engility corporation,   atlanta, ga, Usa; 3HIV research  Branch, Kenya Medical research  Institute, Kisumu, KenyaBackground:  Attention to mental health issues is growing globally.",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
"In addition, among women in relationships, those who correspondence: Deborah a gust clinical Trials Team, epidemiology  Branch, Division of HIV/aIDs Prevention,  centers for Disease control and  Prevention, 1600 clifton road, Mail-stop  e-45, atlanta, ga 30333, Usa Fax +1 404 639 6127 email dgust@cdc.go v Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Gust et al Running head recto: Psychological distress among women in Kisumu, Kenya DOI: http://dx.doi.org/10.2147/IJWH.S125133",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
Available from:  http://www.who.int/mental_health/action_plan_2013/en /.,Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
Available from: http://citeseerx.ist.psu.edu/viewdoc/ download?doi =10.1.1.175.9529&rep =rep1&type =pdf.,OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
"Available from: http://www.popcouncil.org/uploads/pdfs/2012PGY_ SmartSavingsProgramBrief.pd f. Accessed September 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
Available from:  http://www.cdc.gov/violenceprevention/pdf/TogetherforGirlsBklt-a.,Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
"Available from: http://csis.org/files/media/csis/ pubs/090420_cooke_pubhealthafrica_web.pd f. Accessed February 8,  2016.",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ijwh-9-255.PMC5422460.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f3/5e/prbm-10-137.PMC5422461.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f3/5e/prbm-10-137.PMC5422461.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2017:10 137–146Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 137 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S113743 Revisiting the etiological aspects of dissociative  identity disorder: a biopsychosocial perspective Vedat Şar1  Martin J Dorahy2  Christa Krüger3 1Department of Psychiatry, Koç  University School of Medicine,   Istanbul, T urkey; 2Department of  Psychology, University of Canterbury,  Christchurch, New Zealand;   3Department of Psychiatry, University  of Pretoria, Pretoria, South AfricaAbstract: Dissociative identity disorder (DID) is a chronic post-traumatic disorder where  developmentally stressful events in childhood, including abuse, emotional neglect, disturbed  attachment, and boundary violations are central and typical etiological factors.",Non-OADS,/arxiv_data1/oa_pdf/f3/5e/prbm-10-137.PMC5422461.pdf
"4,5 The latter points to the acute transient crisis Correspondence: Vedat Şar  Department of Psychiatry, Koç University  School of Medicine, Rumelifeneri Yolu, 34450 Sarıyer, Istanbul, Turkey Email vsar@ku.edu.trJournal name: Psychology Research and Behavior Management Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Şar et alRunning head recto: Etiology of DIDDOI: http://dx.doi.org/10.2147/PRBM.S113743",Non-OADS,/arxiv_data1/oa_pdf/f3/5e/prbm-10-137.PMC5422461.pdf
"Psychology Research and Behavior Management 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/f3/5e/prbm-10-137.PMC5422461.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c5/c5/imcrj-10-159.PMC5422494.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c5/c5/imcrj-10-159.PMC5422494.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 159–162International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 159 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S133469Multimodal images of chronic branch retinal  vein occlusion Stephen G Schwartz Armando Monroig Harry W Flynn Jr Department of Ophthalmology,   Bascom Palmer Eye Institute,  University of Miami Miller School of Medicine, Miami, FL, USAAbstract:  Two illustrative cases of chronic branch retinal vein occlusion are presented with  multimodal imaging, including commercially available optical coherence tomography angiog- raphy.",Non-OADS,/arxiv_data1/oa_pdf/c5/c5/imcrj-10-159.PMC5422494.pdf
"The OCT -A retina slab (6×6 mm) demonstrated marked capillary  Correspondence: Stephen G Schwartz Department of Ophthalmology, Bascom Palmer Eye Institute, 3880 Tamiami Trail North, Naples, FL 34103, USATel +1 239 659 3937Email sschwartz2@med.miami.eduJournal name: International Medical Case Reports Journal Article Designation: CASE SERIESY ear: 2017V olume: 10Running head verso: Schwartz et alRunning head recto: Multimodal images of chronic BRVODOI: http://dx.doi.org/10.2147/IMCRJ.S133469",Non-OADS,/arxiv_data1/oa_pdf/c5/c5/imcrj-10-159.PMC5422494.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/c5/c5/imcrj-10-159.PMC5422494.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 162 Schwartz et al References 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/c5/imcrj-10-159.PMC5422494.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/65/c9/jpr-10-1033.PMC5422496.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/65/c9/jpr-10-1033.PMC5422496.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1033–1043Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1033 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132026Efficacy of CR4056, a first-in-class imidazoline-2  analgesic drug, in comparison with naproxen   in two rat models of osteoarthritis eleonora comi1,2 Marco Lanza1 Flora Ferrari1 Valeria Mauri1,3 gianfranco caselli1 Lucio Claudio Rovati1 1Department of Pharmacology and  T oxicology, Rottapharm Biotech, 2PhD  Program in Neuroscience, University  of Milan-Bicocca, 3Department of  Surgery and Translational Medicine,  University of Milan-Bicocca,   Monza,  ItalyPurpose:  CR4056, (2-phenyl-6-(1H-imidazol-1yl) quinazoline), an imidazoline-2 (I2) receptor  ligand, is a promising analgesic drug that has been reported to be effective in several animal mod- els of pain.",Non-OADS,/arxiv_data1/oa_pdf/65/c9/jpr-10-1033.PMC5422496.pdf
"4 However, Correspondence: Marco Lanza Department of Pharmacology and Toxicology, Rottapharm Biotech, via Valosa di Sopra 9, 20900 Monza, ItalyTel+39 39 906 6094Fax +39 39 906 6165Email marco.lanza@rottapharmbiotech.comJournal name: Journal of Pain Research  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Comi et alRunning head recto: I2 ligand CR4056 improves OA pain in ratsDOI: http://dx.doi.org/10.2147/JPR.S132026",Non-OADS,/arxiv_data1/oa_pdf/65/c9/jpr-10-1033.PMC5422496.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/65/c9/jpr-10-1033.PMC5422496.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1043 I2 ligand CR4056 improves OA pain in rats Sham: vehicle MIA: vehicle MIA: 10 mg/kg naproxen MIA: 20 mg/kg CR4056∆ We ight (g) 090 80 70 60 50 40 30 20 10 –10 –20 Day 14 baselineDay 14 90 minutes post-drugDay 17 90 minutes post-drug* Figure S2 Determination of HPWD in the MIA model of OA in Wistar rats: effect of 20 mg/kg CR4056.,Non-OADS,/arxiv_data1/oa_pdf/65/c9/jpr-10-1033.PMC5422496.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/78/75/ijnrd-10-091.PMC5422499.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/78/75/ijnrd-10-091.PMC5422499.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 91–95International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 91 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S123638 Early manifestations of renal disease in patients  with tuberous sclerosis complex Laura Malaga-Dieguez1 Robert Spencer1 Laura J Pehrson1 Suzanne Vento1 Kimberly Menzer2 Orrin Devinsky2 Howard Trachtman1 1Division of Pediatric Nephrology,   2Department of Neurology,   Comprehensive Epilepsy Center, New  Y ork University School of Medicine,  New Y ork, NY, USAObjectives: Renal manifestations are the second most significant cause of morbidity and  mortality in patients with tuberous sclerosis complex (TSC), and include renal cysts, angiomyo- lipomas, fat-poor lesions, and malignant tumors.",Non-OADS,/arxiv_data1/oa_pdf/78/75/ijnrd-10-091.PMC5422499.pdf
"Disease-causing mutations can be identified by mutation analysis in 60%–89% of patients who meet the diagnostic criteria for TSC, including ~50% with mutations in Correspondence: Laura Malaga-Dieguez Division of Pediatric Nephrology, Comprehensive Epilepsy Center, New York University School of Medicine, 403 E 34 th St., Room 104, New York, NY  10016, USATel +1 646 501 2669Fax +1 212 263 4053Email laura.malaga-dieguez@nyumc.orgJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Malaga-Dieguez et alRunning head recto: TSC mutations and early manifestations of renal diseaseDOI: http://dx.doi.org/10.2147/IJNRD.S123638",Non-OADS,/arxiv_data1/oa_pdf/78/75/ijnrd-10-091.PMC5422499.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/78/75/ijnrd-10-091.PMC5422499.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 95 TSC mutations and early manifestations of renal disease Conclusion On the basis of eGFR and blood pressures, our findings  are consistent with the hypothesis that TSC2 mutations are associated with earlier and more severe renal involvement in children.",Non-OADS,/arxiv_data1/oa_pdf/78/75/ijnrd-10-091.PMC5422499.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/67/imcrj-10-149.PMC5422500.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/67/imcrj-10-149.PMC5422500.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 149–152International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 149 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S132489Dyschromatosis symmetrica hereditaria  with cutaneous lupus erythematosus and  hyperthyroidism Fahad Al-Saif1 Ahmed Alhumidi2 Rama Ayed Alhallaf1 1Dermatology Department,   2Pathology Department, College  of Medicine, King Saud University,   Riyadh, Saudi ArabiaAbstract: Dyschromatosis symmetrica hereditaria (DSH) is a rare genodermatosis characterized  by various sizes of both hyper- and hypopigmented macules arranged in reticulated patterns on  the face and the dorsal aspects of the extremities.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/imcrj-10-149.PMC5422500.pdf
"There were extensive Correspondence: Rama Ayed Alhallaf Dermatology Department, College of Medicine, King Saud University, PO Box 42589, Riyadh 11551, Saudi ArabiaTel +966 11456 7071Fax +966 11207 0427Email rama.alhallaf@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Al-Saif et alRunning head recto: Dyschromatosis symmetrica hereditariaDOI: http://dx.doi.org/10.2147/IMCRJ.S132489",Non-OADS,/arxiv_data1/oa_pdf/fc/67/imcrj-10-149.PMC5422500.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/imcrj-10-149.PMC5422500.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 152 Al-Saif et al  3.,Non-OADS,/arxiv_data1/oa_pdf/fc/67/imcrj-10-149.PMC5422500.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/e4/jir-10-041.PMC5422501.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/e4/jir-10-041.PMC5422501.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2017:10 41–47Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 41 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S124944 Identification of expanded T -cell clones by  spectratyping in nonfunctioning kidney transplants Maria Cappuccilli1 Gabriele Donati1 Giorgia Comai1 Olga Baraldi1 Diletta Conte1 Irene Capelli1 Valeria Aiello1 Andrea Pession2 Gaetano La Manna1 1Department of Experimental  Diagnostic and Specialty Medicine  (DIMES), Nephrology, Dialysis,  and Renal Transplant Unit,   2Molecular Laboratory of Pediatrics,   Hematology–Oncology Unit, St Orsola Hospital, University of Bologna, Bologna, ItalyBackground: The aim of this study was the application of complementarity-determining  region-3 spectratyping analysis to determine T -cell-repertoire complexity and to detect T -cell- clone expansion, as a measure of immune response in nonfunctioning kidney transplants (group  hemodialysis-transplant [HD-Tx]), nontransplanted dialysis patients (group hemodialysis [HD]),  and normal subjects as controls (group C).",Non-OADS,/arxiv_data1/oa_pdf/5e/e4/jir-10-041.PMC5422501.pdf
"7–9 There is much  evidence suggesting how immunosuppressive therapy remains too aspecific a strategy Correspondence: Gaetano La Manna Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Nephrology, Dialysis and Renal Transplant Unit, St Orsola Hospital, University of Bologna, 9 Via Giuseppe Massarenti – Pad 15, Bologna 40138, ItalyTel +39 051 214 4577Fax +39 051 344 439Email gaetano.lamanna@unibo.itJournal name: Journal of Inflammation Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Cappuccilli et alRunning head recto: Spectratyping in renal transplantsDOI: http://dx.doi.org/10.2147/JIR.S124944",Non-OADS,/arxiv_data1/oa_pdf/5e/e4/jir-10-041.PMC5422501.pdf
"Journal of Inflammation Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/5e/e4/jir-10-041.PMC5422501.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 47 Spectratyping in renal transplants 20.,Non-OADS,/arxiv_data1/oa_pdf/5e/e4/jir-10-041.PMC5422501.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/dd/ott-10-2411.PMC5422502.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2411OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2411ReTRacTiO nopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S14081 3 FAM172A expression in circulating tumor cells for prediction of high-risk  subgroups of colorectal cancer [Retraction] Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W .",Non-OADS,/arxiv_data1/oa_pdf/86/dd/ott-10-2411.PMC5422502.pdf
The authors of this paper have advised Dove Medical Press  that a collaborating laboratory had originally generated the Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2017 Volume: 10 Running head verso: Dove Medical Press Running head recto: FAM172A expression in circulating tumor cells for prediction of high-risk DOI: http://dx.doi.org/10.2147/OTT.S140813 key technology and data that was used in the published  study.,Non-OADS,/arxiv_data1/oa_pdf/86/dd/ott-10-2411.PMC5422502.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/86/dd/ott-10-2411.PMC5422502.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s,Non-OADS,/arxiv_data1/oa_pdf/86/dd/ott-10-2411.PMC5422502.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/2c/ott-10-2413.PMC5422503.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2413–2424OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2413Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13008 7 characteristics of circulating tumor cells in organ  metastases, prognosis, and T lymphocyte mediated  immune response Wen-Wen sun1,* Zhi-hong Xu1,* Peng lian1 Bei-li gao2 Jia-an hu1 1Department of geriatrics,   2Department of respiration, ruijin  hospital, shanghai Jiaotong University,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  Circulating tumor cells (CTCs) possess profound influence on tumor metastases and  disease progression.",Non-OADS,/arxiv_data1/oa_pdf/89/2c/ott-10-2413.PMC5422503.pdf
"T-cell–mediated immunity correspondence: Jia-an hu Department of geriatrics, ruijin hospital,  shanghai Jiaotong University, shanghai  200025, People’s republic of china Tel +86 1360 1737 014 Fax +86 21 5419 8967 email hujiaan@aliyun.co m Bei-li gao Department of respiration, ruijin  hospital, shanghai Jiaotong University,  shanghai 200025, People’s republic  of china Tel +86 1360 1772 598 Fax +86 21 5419 8967 email beiligao@aliyun.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Sun et al Running head recto: Circulating tumor cells and non-small cell lung cancer DOI: http://dx.doi.org/10.2147/OTT.S130087",Non-OADS,/arxiv_data1/oa_pdf/89/2c/ott-10-2413.PMC5422503.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/89/2c/ott-10-2413.PMC5422503.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/2c/ott-10-2413.PMC5422503.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/82/ott-10-2377.PMC5422505.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2377–2388OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2377Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13005 5 curcumin exerts its antitumor activity through  regulation of mir-7/skp2/p21 in nasopharyngeal  carcinoma cells shaoyan Feng,1,2,* Yu Wang,3,*  rongkai Zhang,4,* guangwei  Yang,5 Zibin liang,5 Zhiwei  Wang,3 gehua Zhang1 1Department of Otorhinolaryngology,   head and neck surgery, The Third  affiliated hospital of sun Yat- sen  University, guangzhou, 2Department  of Otolaryngology, head and neck  surgery, The Fifth affiliated hospital  of sun Yat-sen University, Zhuhai,   3The cyrus Tang hematology center  and collaborative innovation center  of hematology, Jiangsu institute  of hematology, the First affiliated  hospital, soochow University, suzhou,   4Department of Orthopaedics,   5Department of radiation Oncology,   The Fifth affiliated hospital of sun  Yat-sen University, Zhuhai, People’s  republic of china  *These authors contributed equally  to this workAbstract:  Curcumin, a natural polyphenol compound, exhibits tumor suppressive activity in  a wide spectrum of cancers, including nasopharyngeal carcinoma cells.",Non-OADS,/arxiv_data1/oa_pdf/53/82/ott-10-2377.PMC5422505.pdf
"Consistent with this,  high expression of oncogenic miRNAs and down-regulation of antitumor miRNAs  are observed in many cancers.7 For example, miR-7 has been considered as a tumor  suppressive miRNA in a variety of human malignancies,8,9 and down-regulation of correspondence: gehua Zhang Department of Otorhinolaryngology,  head and neck surgery, The Third  Affiliated Hospital of Sun Yat-Sen  University, no 600 Tianhe road,  guangzhou, guangdong, 510630,  People’s republic of china email gehuazhanggz@163.co m Zhiwei Wang The cyrus Tang hematology center  and collaborative innovation center  of hematology, Jiangsu institute of  Hematology, the First Affiliated Hospital,  soochow University, 199 renai road,  suzhou, Jiangsu, 215123, People’s  republic of china email zwang6@bidmc.harvard.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Feng et al Running head recto: Curcumin upregulates miR-7 expression DOI: http://dx.doi.org/10.2147/OTT.S130055",Non-OADS,/arxiv_data1/oa_pdf/53/82/ott-10-2377.PMC5422505.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/53/82/ott-10-2377.PMC5422505.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/82/ott-10-2377.PMC5422505.pdf
"https://doi.org/10.1177/1179172116686075Ophthalmology and Eye Diseases Volume 9: 1–7 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179172116686075 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Age-related macular degeneration (AMD) is a leading cause of  irreversible vision loss worldwide and has a profound impact on the quality of life of many individuals.",Non-OADS,/arxiv_data1/oa_pdf/d8/c4/10.1177_1179172116686075.PMC5422508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/9f/ott-10-2425.PMC5422532.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2425OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7e/9f/ott-10-2425.PMC5422532.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 2425ReTRacTiO nopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S14049 8 The coexpression of EphB4 and EphrinB2 is associated with poor  prognosis in HER2-positive breast cancer [Retraction] Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M.  The coexpression of EphB4 and EphrinB2 is associated with  poor prognosis in HER2-positive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/7e/9f/ott-10-2425.PMC5422532.pdf
2017;10:1735–1742.The authors have advised us of concerns about the  specificity of the primary antibody which have resulted in  misleading and false results.Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2017 Volume: 10 Running head verso: Dove Medical Press Running head recto: The coexpression of EphB4 and EphrinB2 DOI: http://dx.doi.org/10.2147/OTT.S140498,Non-OADS,/arxiv_data1/oa_pdf/7e/9f/ott-10-2425.PMC5422532.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b4/1b/tcrm-13-603.PMC5422533.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 603–611Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  603Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S9761 9 Differential cardiovascular profiles of sodium- glucose cotransporter 2 inhibitors: critical  evaluation of empagliflozin vani P Sanon1 Shalin Patel1 Saurabh Sanon2 Ruben Rodriguez1 Son v Pham1 Robert Chilton1 1Division of Cardiology, University of  Texas Health Science Center at San  Antonio, Audie L Murphy vA Hospital,   San Antonio, TX, 2interventional  Cardiology-Structural Heart  Disease, Cardiology Consultants at  Baptist Heart and vascular institute,   Pensacola, FL, USAAbstract:  One of the most feared repercussions of type 2 diabetes mellitus is the risk of adverse  cardiovascular outcomes.",Non-OADS,/arxiv_data1/oa_pdf/b4/1b/tcrm-13-603.PMC5422533.pdf
"This may be in part due to an US FDA mandate released in  2008 which stated that cardiovascular safety could be assessed in new antidiabetic Correspondence: Robert Chilton Division of Cardiology, University of  Texas Health Science Center, 7703 Floyd  Curl Dr, San Antonio, TX 78229, USA email chiltonr@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Sanon et al Running head recto: Differential cardiovascular profiles of SGLT2 inhibitors DOI: http://dx.doi.org/10.2147/TCRM.S97619",Non-OADS,/arxiv_data1/oa_pdf/b4/1b/tcrm-13-603.PMC5422533.pdf
"Available from: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm071627.pd f.  Accessed February 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b4/1b/tcrm-13-603.PMC5422533.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b4/1b/tcrm-13-603.PMC5422533.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/1b/tcrm-13-603.PMC5422533.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 979–987Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  979 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S131979Factors associated with prescription opioid  misuse in a cross-sectional cohort of patients  with chronic non-cancer pain Jennifer M Hah1 John A Sturgeon1 Jennifer Zocca2 Yasamin Sharifzadeh3 Sean C Mackey1 1Division of Pain Medicine,   2Department of Anesthesiology,   Perioperative, and Pain Medicine,   3Stanford Systems Neuroscience and  Pain Lab, Stanford University, Palo  Alto, CA, USAObjective:  To examine demographic features, psychosocial characteristics, pain-specific behav - ioral factors, substance abuse history, sleep, and indicators of overall physical function as predic- tors of opioid misuse in patients presenting for new patient evaluation at a tertiary pain clinic.",Non-OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
"2 Due to the lack of  evidence for long-term efficacy of these medications and, further, the concerns that opioids may prime patients for greater physical and psychosocial problems, there has Correspondence: Jennifer M Hah Division of Pain Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University, 1070 Arastradero Road, Suite 200, Palo Alto, CA 94304, USATel +1 650 736 9415Fax +1 650 725 9642Email jhah@stanford.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Hah et alRunning head recto: Prescription opioid misuse in patients with chronic non-cancer painDOI: http://dx.doi.org/10.2147/JPR.S131979",Non-OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
"Data collection  Data were collected using the CHOIR system (http://choir.stanford.edu.laneproxy.stanford.edu), which is an open-source, open platform health outcome registry, and learning health system.",OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
Detailed description of PROMIS item banks are available online (http://www.nihpromis.org/measures/domainframework1 ).,OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
Available from: https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs/summary.,Non-OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 987 Prescription opioid misuse in patients with chronic non-cancer pain 27.,Non-OADS,/arxiv_data1/oa_pdf/42/bd/jpr-10-979.PMC5422534.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/10/34/ijn-12-3509.PMC5422535.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3509–3520International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3509OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12880 2 gold nanoparticles attenuate metastasis  by tumor vasculature normalization and  epithelial–mesenchymal transition inhibition Wei li1 Xin li1 shuhao liu1 Wende Yang1 Fan Pan1 Xiao-Yan Yang1,2 Bin Du3 li Qin4 Yunlong Pan1 1Department of general surgery,   The First affiliated hospital of  Jinan University, 2Key laboratory  of Functional Protein research  of guangdong higher education  Institutes, Institute of life and health  engineering, college of life science  and T echnology, Jinan University,   3Department of Pathology, The First  affiliated hospital of Jinan University,   4Department of histology, and  embryology, Medical school of Jinan  University, guangzhou, People’s  republic of chinaAbstract:  Angiogenesis is a process by which vessels are formed through preexisting ones, and  this plays a key role in the progression of solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/10/34/ijn-12-3509.PMC5422535.pdf
"However, a few clinical studies have demonstrated that such a mono - therapy fails to provoke significant response rates or improve overall survival (OS),  even in colon cancer (average 6–8 weeks) due to resistance.4,5 A randomized trial of  anti-VEGF plus irinotecan and 5-fluorouracil showed no difference either in median OS  (22.0 vs 25.0 months, P=0.1391) or in the response rate (36.8% vs 35.2%) in patients  with advanced colorectal cancer.6 Similarly, there was no difference in the median  OS: 25.4 (95% CI: 22.2–28.9) months in the anti-VEGF continuation arm versus 23.8  (95% CI: 21–26.8) months in the no continuation arm (hazard ratio [HR] 0.83; 95%  CI: correspondence: Yunlong Pan Department of general surgery,  The First Affiliated Hospital of Jinan  University, 613 huangpu West road,  guangzhou, guangdong 510630, People’s  republic of china Tel +86 20 3868 8429 email tpanyl@jnu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: Gold nanoparticles attenuate metastasis DOI: http://dx.doi.org/10.2147/IJN.S128802",Non-OADS,/arxiv_data1/oa_pdf/10/34/ijn-12-3509.PMC5422535.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/10/34/ijn-12-3509.PMC5422535.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/34/ijn-12-3509.PMC5422535.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/c1/opth-11-835.PMC5422537.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 835–840Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  835Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S13527 2 goldmann tonometer error correcting prism:  clinical evaluation sean McCafferty1–3 garrett lim2 William Duncan2 eniko T enikov4 Jim schwiegerling1 Jason levine1,3 Corin Kew3 1Department of Ophthalmology,   College of Optical science, University  of arizona, 2intuor T echnologies,   3arizona eye Consultants,   4Department of aerospace and  Mechanical, College of engineering,   University of arizona, T ucson, aZ, UsaPurpose:  Clinically evaluate a modified applanating surface Goldmann tonometer prism  designed to substantially negate errors due to patient variability in biomechanics.",Non-OADS,/arxiv_data1/oa_pdf/89/c1/opth-11-835.PMC5422537.pdf
"The problems associated with GAT errors were highlighted by the Ocular  Hypertension Treatment Study (OHTS), noting that pressure readings tend to be  overestimated in thick and underestimated in thin corneas leading to a misdiagnosis  of glaucoma.14,15 Central corneal thickness (CCT) correction is an incomplete cor - rection for total GAT error and its use without other corrections has questionable Correspondence: sean McCafferty arizona eye Consultants, llC 6422 e.  speedway Blvd, Tucson, suite 100,  aZ 85710, Usa Tel +1 520 327 3487 email sjmccafferty66@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: McCafferty et al Running head recto: Goldmann tonometer error correcting prism DOI: http://dx.doi.org/10.2147/OPTH.S135272 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/89/c1/opth-11-835.PMC5422537.pdf
Or use: http://youtu.be/qppbjAsSyo YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/89/c1/opth-11-835.PMC5422537.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/89/c1/opth-11-835.PMC5422537.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/c1/opth-11-835.PMC5422537.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/0f/tcrm-13-613.PMC5422538.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 613–622Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  613ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12630 1 Clinical and genetic characteristics in a  group of 45 patients with T urner syndrome  (monocentric study) simona Bucerzan1 Diana Miclea1,2 Radu Popp2 Camelia alkhzouz1 Cecilia lazea1 ioan Victor Pop2 Paula grigorescu-sido1 1emergency hospital for Children,   “Iuliu Haţieganu” University of  Medicine and Pharmacy, Cluj-n apoca,   Romania; 2Department of Molecular  Sciences, “Iuliu Hatieganu” University  of Medicine and Pharmacy, Cluj- napoca, RomaniaIntroduction:  Recent years have seen a shift in perspective on Turner syndrome, as it is no  longer considered a significant disability due to therapeutic advances.",Non-OADS,/arxiv_data1/oa_pdf/66/0f/tcrm-13-613.PMC5422538.pdf
"At the same time, the consequences  of gonadal dysgenesis are mitigated by improved pharmacological feminization  and by the possibility of procreating using either oocytes from a healthy donor or, Correspondence: Diana Miclea emergency hospital for Children,  Department of Molecular sciences,  “Iuliu Hatieganu” University of Medicine  and Pharmacy, 8, Victor Babes street,  400012, Cluj-napoca, Romania email b olca12diana@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Bucerzan et al Running head recto: Clinical and genetic characteristics in a group of patients with Turner syndrome DOI: http://dx.doi.org/10.2147/TCRM.S126301",Non-OADS,/arxiv_data1/oa_pdf/66/0f/tcrm-13-613.PMC5422538.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/66/0f/tcrm-13-613.PMC5422538.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/0f/tcrm-13-613.PMC5422538.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/cf/ijwh-9-295.PMC5422539.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 295–305International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  295ClInIC al TrIal repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S13457 6 Efficacy and safety of a flexible extended regimen  of ethinylestradiol/drospirenone for the treatment  of dysmenorrhea: a multicenter, randomized,  open-label, active-controlled study Mikio Momoeda1 Masami Kondo2 Joerg Elliesen3 Masanobu Yasuda2 Shigetomo Yamamoto4 Tasuku Harada5 1Department of Integrated Women’s  Health, St Luke’s International  Hospital, T okyo, 2product  Development, Bayer Yakuhin Ltd,   Osaka, Japan; 3Global Clinical  Development, Bayer AG, Berlin,   Germany; 4Medical Affairs, Bayer  Yakuhin Ltd, Osaka, 5Department of  Obstetrics and Gynecology, Tottori  University Faculty of Medicine,   T ottori, JapanBackground:  Dysmenorrhea is a common condition in women, which is characterized by  menstrual pain.",Non-OADS,/arxiv_data1/oa_pdf/34/cf/ijwh-9-295.PMC5422539.pdf
"Keywords:  oral contraceptive, dysmenorrhea, ethinylestradiol/drospirenone, flexible extended  regimen, pain relief Introduction Dysmenorrhea is characterized by menstrual pain, including lower abdominal pain,  low back pain, and pain radiating to the legs, which starts around the beginning or  just before the beginning of menstruation.1 In some cases, it is accompanied by sys - temic symptoms including nausea, headache, dizziness, insomnia, anxiety/irritability,  diarrhea, and feeling depressed.1 Dysmenorrhea is common, affecting between Correspondence: Mikio Momoeda Department of Integrated Women’s  Health, St Luke’s International  Hospital, 9-1 Akashi-cho, Chuo-ku,  Tokyo 104-8560, Japan Tel +81 33 541 5151 Fax +81 33 544 0649 email momoeda-tky@umin.ac.j p Journal name: International Journal of Women’s Health Article Designation: Clinical Trial Report Y ear: 2017 Volume: 9 Running head verso: Momoeda et al Running head recto: Flexible extended regimen of ethinylestradiol/drospirenone DOI: http://dx.doi.org/10.2147/IJWH.S134576",Non-OADS,/arxiv_data1/oa_pdf/34/cf/ijwh-9-295.PMC5422539.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/34/cf/ijwh-9-295.PMC5422539.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/cf/ijwh-9-295.PMC5422539.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bc/69/ott-10-2427.PMC5422540.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2427–2447OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2427Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13356 3 sialylation facilitates self-assembly of 3D  multicellular prostaspheres by using cyclo- rgDfK(TPP) peptide sabah haq1 Vanessa samuel1 Fiona haxho1 roman akasov2,3 Maria leko4 sergey V Burov4 elena Markvicheva2 Myron r szewczuk1 1Department of Biomedical and  Molecular sciences, Queen’s  University, Kingston, On , canada;   2Polymers for Biology laboratory,   shemyakin-Ovchinnikov institute  of Bioorganic chemistry, russian  academy of sciences, 3sechenov First  Moscow state Medical University,   institute for regenerative Medicine,   Moscow, 4synthesis of Peptides and  Polymer Microspheres laboratory,   institute of Macromolecular  compounds, russian academy of  sciences, st Petersburg, russiaBackground:  Prostaspheres-based three dimensional (3D) culture models have provided insight  into prostate cancer (PCa) biology, highlighting the importance of cell–cell interactions and the  extracellular matrix (EMC) in the tumor microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/bc/69/ott-10-2427.PMC5422540.pdf
"The focus is  to establish more innovative and accurate in vitro models that mimic the in vivo tumor  and to simulate the tumor microenvironment.1,2 An understanding of the inter-com - plexity between cancer cells and their organ-specific microenvironments has provided correspondence: Myron r szewczuk Department of Biomedical and  Molecular sciences, Queen’s University,  18 stuart street, Kingston,   On K7l 3n6, canada Tel +1 613 533 2457 Fax +1 613 533 6796 email szewczuk@queensu.c a Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Haq et al Running head recto: Self-assembly of 3D multicellular prostaspheres DOI: http://dx.doi.org/10.2147/OTT.S133563",Non-OADS,/arxiv_data1/oa_pdf/bc/69/ott-10-2427.PMC5422540.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bc/69/ott-10-2427.PMC5422540.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/69/ott-10-2427.PMC5422540.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/16/opth-11-829.PMC5422553.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 829–834Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  829Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13359 4 short-term outcomes in patients with branch  retinal vein occlusion who received intravitreal  aflibercept with or without intravitreal ranibizumab Y oshihito sakanishi ayumi Usui-Ouchi Kazunori Tamaki Keitaro Mashimo rei ito nobuyuki ebihara Department of Ophthalmology,   Juntendo University Urayasu hospital,   Urayasu City, Chiba, JapanPurpose:  The purpose of this study was to determine the short-term outcomes for patients  who received intravitreal aflibercept (IVA) with or without intravitreal ranibizumab (IVR) for  macular edema (ME) due to branch retinal vein occlusion (BRVO).",Non-OADS,/arxiv_data1/oa_pdf/72/16/opth-11-829.PMC5422553.pdf
"The short-term outcomes of treatments involving aflibercept and Correspondence: Yoshihito sakanishi Department of Ophthalmology,  Juntendo University Urayasu hospital,  1-2-1 Tomioka, Urayasu City, Chiba  279-0021, Japan Tel +81 47 353 3111 Fax +81 47 355 5949 email ysakani@juntendo.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Sakanishi et al Running head recto: Outcomes of switching from IVR to IVA in BRVO DOI: http://dx.doi.org/10.2147/OPTH.S133594",Non-OADS,/arxiv_data1/oa_pdf/72/16/opth-11-829.PMC5422553.pdf
"Available from:  https://www.census.gov/prod/2008pubs/p70-117.pd f. Accessed  February 16, 2010.",OADS,/arxiv_data1/oa_pdf/72/16/opth-11-829.PMC5422553.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/72/16/opth-11-829.PMC5422553.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/16/opth-11-829.PMC5422553.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/d3/ijn-12-3495.PMC5422559.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3495–3507International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3495OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13245 9 Multifunctional and biomimetic fish collagen/ bioactive glass nanofibers: fabrication, antibacterial  activity and inducing skin regeneration in vitro  and in vivo Tian Zhou1 Baiyan sui1 Xiumei Mo2,* Jiao sun1,* 1Shanghai Biomaterials Research  and Testing Center, Shanghai Key  Laboratory of Stomatology, Ninth  People’s Hospital, Shanghai Jiao  T ong University School of Medicine,   2College of Chemistry, Chemical  Engineering and Biotechnology,   Donghua University, Shanghai,   People’s Republic of China *These authors contributed equally  to this workAbstract:  The development of skin wound dressings with excellent properties has always  been an important challenge in the field of biomedicine.",Non-OADS,/arxiv_data1/oa_pdf/44/d3/ijn-12-3495.PMC5422559.pdf
"These key problems are very important correspondence: Xiumei Mo No 2999 North Ren-ming Road,  Songjiang District, Shanghai 201620,  People’s Republic of China Tel +86 21 6779 2653 email xmm@dhu.edu.c n  Jiao sun No 427, Ju-men Road, Shanghai 200023,  People’s Republic of China Tel +86 21 6303 4903 email jiaosun59@shsmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhou et al Running head recto: Multifunctional and biomimetic fish Col/BG nanofibers DOI: http://dx.doi.org/10.2147/IJN.S132459",Non-OADS,/arxiv_data1/oa_pdf/44/d3/ijn-12-3495.PMC5422559.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/44/d3/ijn-12-3495.PMC5422559.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/d3/ijn-12-3495.PMC5422559.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/56/opth-11-817.PMC5422561.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 817–827Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  817CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13070 6 prospective evaluation of intense pulsed light and  meibomian gland expression efficacy on relieving  signs and symptoms of dry eye disease due to  meibomian gland dysfunction Steven J Dell1 ronald n Gaster2 Sheila C Barbarino1 Derek n Cunningham1 1Dell laser Consultants, austin, TX,   2Gaster eye Center, Beverly Hills,   Ca, USaPurpose:  The aim of this study was to estimate the efficacy of intense pulsed light (IPL),  followed by meibomian gland expression (MGX), for reducing the number and severity of signs  and symptoms of dry eye disease (DED) secondary to meibomian gland dysfunction (MGD).",Non-OADS,/arxiv_data1/oa_pdf/d1/56/opth-11-817.PMC5422561.pdf
"The pathogenesis of both conditions, MGD and DED, was  recently described as two vicious cycles linked by inflammation:3 the MGD vicious Correspondence: Steven J Dell Dell laser Consultants, 901 South Mopac  expressway, Building 4, Suite 350, austin,  TX 78746, USa Tel +1 512 347 0255 email steven@dellmd.co m Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2017 Volume: 11 Running head verso: Dell et al Running head recto: Evaluation of IPL and MGX on relieving DED signs and symptoms DOI: http://dx.doi.org/10.2147/OPTH.S130706 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/d1/56/opth-11-817.PMC5422561.pdf
Or use: http://youtu.be/OlT6gmSn74 oVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/d1/56/opth-11-817.PMC5422561.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d1/56/opth-11-817.PMC5422561.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/56/opth-11-817.PMC5422561.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 281–293International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  281RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S11972 4 Self-management and psychological-sexological  interventions in patients with endometriosis:  strategies, outcomes, and integration into  clinical care Laura Buggio1,2 Giussy Barbara3 Federica Facchin4 Maria Pina Frattaruolo1,2 Giorgio Aimi2 Nicola Berlanda2 1Department of Clinical Sciences  and Community Health, Università  degli Studi di Milano, 2Departmental  Operating Unit of Surgical  Gynecology and endometriosis,   Fondazione Istituto di Ricovero e  Cura a Carattere Scientifico Ca’  Granda Ospedale Maggiore Policlinico,   3Department of Obstetrics and  Gynecology and Service for Sexual  and Domestic violence (SvSeD),   Fondazione Istituto di Ricovero e  Cura a Carattere Scientifico  Ca’  Granda, Ospedale Maggiore  Policlinico, 4Faculty of Psychology,   Catholic University of Milan, Milan,   ItalyAbstract:  Endometriosis has a multifactorial etiology.",Non-OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
"Moreover, several studies have demonstrated that endometriosis, especially when  symptomatic, may negatively impact mental health and quality of life (QoL),7 sug- gesting that affected women may have an increased risk of developing psychological Correspondence: Laura Buggio Departmental Operating Unit of  Surgical Gynecology and endometriosis,  Fondazione Istituto di Ricovero e Cura  a Carattere Scientifico Ca’ Granda  Ospedale Maggiore Policlinico, 12 via  della Commenda, Milan 20122, Italy Tel +39 02 5503 2917 Fax +39 02 5032 0264 email buggiolaura@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Buggio et al Running head recto: Self-management of endometriosis DOI: http://dx.doi.org/10.2147/IJWH.S119724",Non-OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
"Available  from: http://apps.who.int/iris/bitstream/10665/66783/1/WHO_EDM_ TRM_2000.1.pd f. Accessed December 26, 2016.",OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
"Available at http://www.nhs.uk/Conditions/vitamins-minerals/Pages/ vitamins-minerals.asp x. Accessed April 13, 2017.",Non-OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/a8/ijwh-9-281.PMC5422563.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 989–998Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  989 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S134330Cannabis as a substitute for prescription   drugs – a cross-sectional study James M Corroon Jr1  Laurie K Mischley2  Michelle Sexton3 1Center for Medical Cannabis  Education, Del Mar, CA, 2Bastyr  University Research Institute,   Kenmore, WA, 3Department of  Medical Research, Center for the Study of Cannabis and Social Policy,  Seattle, WA, USABackground: The use of medical cannabis is increasing, most commonly for pain, anxiety and  depression.",Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
"2Correspondence: James M Corroon Jr Center for Medical Cannabis Education, 428 8th Street, Del Mar, CA 92014, USA   Tel +1 858 367 0393   Email jamie@corroon.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Corroon Jr et alRunning head recto: Cannabis as a substitute for prescription drugs – a cross-sectional studyDOI: http://dx.doi.org/10.2147/JPR.S134330",Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
Available from: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx.,Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
Available from: https://bastyr.edu/research/studies/survey-cannabis-use.,OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
Available from: https://www.cdc.gov/vitalsigns/opioid-prescribing/.,Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
Available from: http://www.samhsa.gov/data/.,OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
Available from: https://www.cdc.gov/drugoverdose/epidemic/.,Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 998 Corroon Jr et al,Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jpr-10-989.PMC5422566.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/de/ijwh-9-307.PMC5422567.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 307–313International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  307OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJWH.S12345 5 Trends and causes of maternal mortality in  Jimma University specialized Hospital, southwest  ethiopia: a matched case–control study T egene legesse1 Misra abdulahi2 anteneh Dirar2 1Department of Public Health,   collage of Health science, Mizan- T epi University, Mizan T eferi, ethiopia;   2Department of Population and Family  Health, college of Health sciences,   Jimma University, Jimma, Oromia  regional state, ethiopiaIntroduction:  Measures of maternal death are fundamental to a country’s health and  development status.",Non-OADS,/arxiv_data1/oa_pdf/14/de/ijwh-9-307.PMC5422567.pdf
"Countries in sub-Saharan Africa (SSA) correspondence: Tegene legesse Department of Public Health, collage of  Health science, Mizan-Tepi University,  Mizan Teferi, snnPr region, ethiopia Tel +251 91 612 5736 email tegegnlegesse@mtu.edu.e t Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Legesse et al Running head recto: Trend and causes of maternal mortality DOI: http://dx.doi.org/10.2147/IJWH.S123455",Non-OADS,/arxiv_data1/oa_pdf/14/de/ijwh-9-307.PMC5422567.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/14/de/ijwh-9-307.PMC5422567.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/de/ijwh-9-307.PMC5422567.pdf
Available from: http://www.bridge.ids.ac.uk/reports/ re38c.pd f 2.,Non-OADS,/arxiv_data1/oa_pdf/14/de/ijwh-9-307.PMC5422567.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1027–1032Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1027 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125449Analgesic efficacy, adverse effects, and safety of  oxycodone administered as continuous intravenous  infusion in patients after total hip arthroplasty Bogumił Olczak1 Grzegorz Kowalski1,2 Wojciech Leppert2 Iwona  Zaporowska-Stachowiak3 Katarzyna Wieczorowska-T obis 2 1Department of Anesthesiology, Józef  Struś Multiprofile Municipal Hospital,   2Department of Palliative Medicine,   Poznan University of Medical Sciences,   3Department of Pharmacology, Poznan  University of Medical Sciences, PolandBackground: Total hip arthroplasty (THA) causes extensive tissue damage and severe pain.",Non-OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
"It is also a prerequisite for early  Correspondence: Wojciech Leppert Department of Palliative Medicine, Poznan University of Medical Sciences, Osiedle Rusa 55, 61–245, PolandTel +48 61 738 000Email wojciechleppert@wp.plJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Olczak et alRunning head recto: Efficacy and safety of intravenous oxycodoneDOI: http://dx.doi.org/10.2147/JPR.S125449",Non-OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
Available from: http://www.nfz.gov.pl/download/gfx/nfz/pl/defaultstronaopisowa/349/30/1/cbe_za_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1032 Olczak et al 21.,Non-OADS,/arxiv_data1/oa_pdf/ba/96/jpr-10-1027.PMC5422568.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4e/1e/ijn-12-3463.PMC5422569.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3463–3470International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3463OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13251 0 Photoresponsive nanocapsulation of cobra  neurotoxin and enhancement of its central  analgesic effects under red light Qian Yang chuang Zhao Jun Zhao Y ong Ye Department of Pharmaceutical  engineering, school of chemistry and  chemical engineering, south china  University of T echnology, guangzhou,   People’s republic of chinaAbstract:  Cobra neurotoxin (CNT), a peptide isolated from snake venom of Naja naja atra ,  shows central analgesic effects in our previous research.",Non-OADS,/arxiv_data1/oa_pdf/4e/1e/ijn-12-3463.PMC5422569.pdf
"Many methods of BBB permeation have been studied to help correspondence: Yong Ye Department of Pharmaceutical  engineering, school of chemistry  and chemical engineering, south  china University of Technology,  381 Wushan road, guangzhou 510640,  People’s republic of china Tel +86 20 8711 0234 email yeyong@scut.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Y ang et al Running head recto: Central analgesic cobra neurotoxin nanocapsules DOI: http://dx.doi.org/10.2147/IJN.S132510",Non-OADS,/arxiv_data1/oa_pdf/4e/1e/ijn-12-3463.PMC5422569.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4e/1e/ijn-12-3463.PMC5422569.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/1e/ijn-12-3463.PMC5422569.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5b/aa/imcrj-10-153.PMC5422570.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5b/aa/imcrj-10-153.PMC5422570.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 153–158International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 153 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S129171Choroidal extranodal marginal zone lymphoma  diagnosed by full-thickness retinochoroidal biopsy:  case report and review of the literature Ali Dirani1,2 Guy Allaire3,4 Sonia Callejo1,2 Marie Lyne Belair1,2 Katarzyna Biernacki1,2 Christine Corriveau1,2 Karim Hammamji1,2 1Department of Ophthalmology,   University of Montreal, 2Department  of Ophthalmology, University of  Montreal Health Center (CHUM),   3Department of Pathology, University  of Montreal, 4Department of  Pathology, University of Montreal Health Center (CHUM), Montreal,  CanadaAbstract:  The case of an 89-year-old man who was referred for a painless decrease of vision  in his right eye (RE) is reported.",Non-OADS,/arxiv_data1/oa_pdf/5b/aa/imcrj-10-153.PMC5422570.pdf
"Slit lamp examination (SLE) showed small keratic precipitates in the RE with no cells or flare in the anterior chamber; dilated fundus examination (DFE) of the RE showed an acellular vitreous, an elevated amelanotic yellow-creamy lesion located  Correspondence: Karim Hammamji Department of Ophthalmology, University of Montreal Health Center (CHUM), Notre-Dame Hospital, 1560 rue Sherbrooke E, Montreal, QC, Canada H2L 4M1Tel +1 514 890 8000Email karim.hammamji@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Dirani et alRunning head recto: Choroidal extranodal marginal zone lymphomaDOI: http://dx.doi.org/10.2147/IMCRJ.S129171",Non-OADS,/arxiv_data1/oa_pdf/5b/aa/imcrj-10-153.PMC5422570.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/5b/aa/imcrj-10-153.PMC5422570.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 158 Dirani et al,Non-OADS,/arxiv_data1/oa_pdf/5b/aa/imcrj-10-153.PMC5422570.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/19/9b/jpr-10-1019.PMC5422571.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/19/9b/jpr-10-1019.PMC5422571.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1019–1025Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1019 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132862Incidence and risk factors of persistent low back  pain following posterior decompression and  instrumented fusion for lumbar disk herniation Hui Wang1 Tao Wang1 Qian Wang2 Wenyuan Ding1 1Department of Spine Surgery,   2Financial Statistics Department, The  Third Hospital of Hebei Medical  University, Shijiazhuang, People’s Republic of ChinaIntroduction: The aim of this study was to explore the incidence and risk factors of persistent  low back pain (PLBP) following posterior decompression and instrumented fusion for lumbar  disk herniation and to provide references in decision-making and surgical planning for both  spinal surgeons and surgically treated patients.",Non-OADS,/arxiv_data1/oa_pdf/19/9b/jpr-10-1019.PMC5422571.pdf
"Introduction Posterior decompression and instrumented fusion, including posterior lumbar inter - body fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF), is supposed  to be the most commonly used surgical strategy for lumbar disk herniation.1–3 Fusion  is performed at the level of the intervertebral joint, and the anterior column is recon-structed as the load-bearing structures are restored, which create a biomechanically Correspondence: Wenyuan Ding Department of Spine Surgery, The Third Hospital of Hebei Medical University, 139 Ziqiang Road, Shijiazhuang 050051, People’s Republic of China   Email dingwenyuan2012@126.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Wang et alRunning head recto: Incidence and risk factors of PLBPDOI: http://dx.doi.org/10.2147/JPR.S132862",Non-OADS,/arxiv_data1/oa_pdf/19/9b/jpr-10-1019.PMC5422571.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/19/9b/jpr-10-1019.PMC5422571.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1025 Incidence and risk factors of PLBP  20.,Non-OADS,/arxiv_data1/oa_pdf/19/9b/jpr-10-1019.PMC5422571.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 583–592Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  583ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S13066 6 association between use of disease-modifying  antirheumatic drugs and diabetes in patients  with ankylosing spondylitis, rheumatoid arthritis,  or psoriasis/psoriatic arthritis: a nationwide,  population-based cohort study of 84,989 patients hsin-hua Chen1–7 Der-Yuan Chen1–6 Chi-Chen lin1,2 Yi-Ming Chen1–4 Kuo-lung lai3,4 Ching-heng lin1 1Department of Medical Research,   Taichung Veterans general hospital,   2institute of Biomedical science  and Rong hsing Research Center  for Translational Medicine, Chung- hsing University, Taichung, 3school  of Medicine, national Yang-Ming  University, Taipei, 4Division of allergy,   immunology and Rheumatology,   Department of internal Medicine,   Taichung Veterans general hospital,   5school of Medicine, Chung- shan  Medical University, 6Department of  Medical education, Taichung Veterans  general hospital, Taichung, 7institute  of Public health and Community  Medicine Research Center, national  Yang-Ming University, Taipei, TaiwanPurpose:  The aim of this study is to investigate the association between the use of disease- modifying antirheumatic drugs (DMARDs) and diabetes mellitus (DM) in patients with ankylos - ing spondylitis (AS), rheumatoid arthritis (RA), or psoriasis/psoriatic arthritis (PS/PSA).",Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
"Keywords:  ankylosing spondylitis, rheumatoid arthritis, psoriasis, psoriatic arthritis, diabetes  mellitus Introduction Individuals with chronic inflammation have an increased risk of cardiovascular  disease,1–3 and some of this increased risk is mediated by the development of increased  insulin resistance and diabetes mellitus (DM).4,5 More specifically, cardiovascular  disease is a major cause of death in patients with rheumatoid arthritis (RA),6 and indi - viduals with RA or psoriasis (PS) have an increased risk of insulin resistance and  DM.7  Other researches have indicated that patients with PS may experience accelerated  development of insulin resistance and onset of DM.8,9 Patients with systemic lupus  erythematosus (SLE) also have an increased risk of DM.10 The tumor necrosis factor (TNF) is a cytokine that performs diverse functions, and  its actions may underlie the relationship of autoimmune diseases with an increased Correspondence: hsin-hua Chen Division of allergy, immunology and  Rheumatology, Department of internal  Medicine, Taichung Veterans general  hospital, no 1650, section 4, Taiwan  Boulevard, Taichung 40705, Taiwan Tel +886 4 2359 2525 (ext 4300) Fax +886 4 2350 3285 email shc5555@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chen et al Running head recto: DMARDs and DM in AS, RA, or PSA DOI: http://dx.doi.org/10.2147/TCRM.S130666",Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
Available from: http://law.moj.gov.tw/LawClass/LawSingleIf.,Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
Available  from: https://www.nice.org.uk/guidance/cg7 9  22.,Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/bb/tcrm-13-583.PMC5422572.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/ott-10-2367.PMC5422573.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2367–2376OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2367Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13270 8 Knockdown of a Dis3l2 promoter upstream  long noncoding rna (ac105461.1) enhances  colorectal cancer stem cell properties in vitro  by down-regulating Dis3l2 Wei liu1,* Qiang Yu2,* Jun Ma1 Y ong cheng1 hongbo Zhang1 Wengguang luo1 Jie Yao3 hongyan Zhang1 1Department of radiation Oncology,   anhui Provincial hospital, hefei,   2Department of hepatobiliary surgery,   3cancer center, chinese P la general  hospital & chinese P la Medical  school, Beijing, People’s republic  of china *These authors contributed equally  to this workAbstract:  A large number of studies have identified plentiful long noncoding RNAs (lncRNAs)  associated with the development of multiple cancers.",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/ott-10-2367.PMC5422573.pdf
"Keywords:  AC105461.1, DIS3L2, long noncoding RNA, colorectal cancer, stem cell properties Introduction It is well acknowledged that colorectal cancer (CRC) is the third most commonly  diagnosed cancer worldwide and also associated with high morbidity and mortality.1  Although the treatment for CRC has achieved advances to some extent in recent decades, correspondence: hongyan Zhang Department of radiation Oncology,  anhui Provincial hospital,  lujiang road 17, hefei 230001,  People’s republic of china email hongyanzhang1602@163.co m  Jie Yao cancer center, chinese Pla  general hospital & chinese Pla  Medical school, no 28, Fuxing road,  haidian District, Beijing 100039,  People’s republic of china email jackyao99520@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Liu et al Running head recto: A promising biomarker and therapeutic target for CRC DOI: http://dx.doi.org/10.2147/OTT.S132708",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/ott-10-2367.PMC5422573.pdf
"Among them, we explored a potential lncRNA named  AC105461.1 (data from UCSC website; http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/cb/ff/ott-10-2367.PMC5422573.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/ott-10-2367.PMC5422573.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/ff/ott-10-2367.PMC5422573.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/ott-10-2403.PMC5422574.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2403–2410OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2403Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13721 0 The voice quality after laser surgery versus  radiotherapy of T1a glottic carcinoma:  systematic review and meta-analysis guanjiang huang1,* Mengsi luo2,* Jingxuan Zhang1 hongbing liu1 1Department of Otolaryngology  –  head and neck surgery, 2Department  of anesthesiology, The second  affiliated hospital of nanchang  University, nanchang, Jiangxi, People’s  republic of china *These authors contributed equally  to this workBackground and objectives:  The voice quality assessment of laser surgery (LS) in com - parison with radiotherapy (RT) remains uncertain in T1a glottic carcinoma treatment.",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/ott-10-2403.PMC5422574.pdf
"Therefore, open surgery should not  be used any more for primary treatment of T1a glottic carcinoma.correspondence: hongbing liu Department of Otolaryngology – head  and Neck Surgery, The Second Affiliated  hospital of nanchang University, no 1  Minde road, nanchang, Jiangxi 330006,  People’s republic of china Tel +86 139 7000 2792 email liuhb1992@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Huang et al Running head recto: Voice quality assessment of laser surgery and radiotherapy DOI: http://dx.doi.org/10.2147/OTT.S137210",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/ott-10-2403.PMC5422574.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/ott-10-2403.PMC5422574.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/3e/ott-10-2403.PMC5422574.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 999–1017Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  999 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S130530Evaluation of a specialized yoga program  for persons with a spinal cord injury: a pilot  randomized controlled trial Kathryn Curtis1 Sander L Hitzig2,3 Gitte Bechsgaard4 Candice Stoliker5 Charlene Alton3 Nicole Saunders3 Nicole Leong6 Joel Katz1 1Department of Psychology, Faculty  of Health, Y ork University, 2St John’s  Rehab Research Program, Sunnybrook  Research Institute, Sunnybrook Health Sciences Centre,  3Lyndhurst Centre,   T oronto Rehabilitation Institute,  University Health Network,  4Vidya  Institute, 5Student Life, University of  T oronto, T oronto, 6Community Care  Access Centre, London, ON, CanadaObjectives:  The purpose of this randomized controlled trial was to evaluate the effects of a  specialized yoga program for individuals with a spinal cord injury (SCI) on pain, psychological,  and mindfulness variables.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
"3Correspondence: Kathryn Curtis Department of Psychology, Faculty of Health, York University, 4700 Keele Street, Toronto, ON M3J 1P3, CanadaTel +1 647 995 5289Fax +1 416 736 5814Email kjbc@yorku.caJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Curtis et alRunning head recto: Y oga for spinal cord injuryDOI: http://dx.doi.org/10.2147/JPR.S130530",Non-OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
"The yoga program was offered to outpatients on the wait- ing list for the activity room and other individuals with SCI who were connected with the LC, which included persons interacting with Spinal Cord Injury Canada (http://sci-can.ca), an SCI consumer-advocacy organization.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1017 Y oga for spinal cord injury,Non-OADS,/arxiv_data1/oa_pdf/67/c2/jpr-10-999.PMC5422575.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)EMT and tumor metastasis in lung cancer Z-M Shi et al 2588 Oncogene (2017) 2577 –2588",Non-OADS,/arxiv_data1/oa_pdf/7d/59/onc2016414a.PMC5422710.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Mechanisms of cancer cell-speci ﬁc CD40 death CJ Dunnill et al 2528 Oncogene (2017) 2515 –2528",Non-OADS,/arxiv_data1/oa_pdf/96/24/onc2016401a.PMC5422712.pdf
"   Case Rep Gastroenterol 2017;11:178 –183  DOI: 10.1159/000462966   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d4/16/crg-0011-0178.PMC5422721.pdf
"   Case Rep Oncol 2017;10:276 –280  DOI: 10.1159/000464101   Published online: March 29, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f7/76/cro-0010-0276.PMC5422722.pdf
"   Case Rep Oncol 2017;10:290 –295  DOI: 10.1159/000461576   Published online: April 4, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/8d/b3/cro-0010-0290.PMC5422723.pdf
"   Case Rep Oncol 2017;10:328 –332  DOI: 10.1159/000468981   Published online: April 6, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ad/f2/cro-0010-0328.PMC5422724.pdf
"   Case Rep Oncol 2017;10:265 –271  DOI: 10.1159/000468980   Published online: March 28, 2017  © 2017 The Author(s)   Published by S. Karger AG , Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/16/58/cro-0010-0265.PMC5422726.pdf
"   Case Rep Dermatol 2017;9:95 –102  DOI: 10.1159/000468977   Published online: April 7, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karg er.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/39/67/cde-0009-0095.PMC5422727.pdf
"   Case Rep Gastroenterol 2017;11:184 –189  DOI: 10.1159/000464277   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/49/17/crg-0011-0184.PMC5422728.pdf
"   Case Rep Oncol 2017;10:272 –275  DOI: 10.1159/000466687   Published online: March 29, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/11/a4/cro-0010-0272.PMC5422729.pdf
"   Case Rep Dermatol 2017;9:103 –107  DOI: 10.1159/000456650   Published online: April 7, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2c/64/cde-0009-0103.PMC5422730.pdf
"   Case Rep Gastroenterol 2017;11:190 –200  DOI: 10.1159/000468514   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/4a/7c/crg-0011-0190.PMC5422731.pdf
"   Case Rep Oncol 2017;10:308 –315  DOI: 10.1159/000464280   Published online: April 4, 2017  © 2017 The Author(s)   Publish ed by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/fe/5b/cro-0010-0308.PMC5422732.pdf
"2015. http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (accessed  January 5, 2017).",Non-OADS,/arxiv_data1/oa_pdf/fe/5b/cro-0010-0308.PMC5422732.pdf
"   Case Rep Oncol 2017;10:296 –300  DOI: 10.1159/000463379   Published online: April 4, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/cro-0010-0296.PMC5422733.pdf
"   Case Rep Gastroenterol 2017;11:207 –211  DOI: 10.1159/000468509   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f5/77/crg-0011-0207.PMC5422734.pdf
"   Case Rep Oncol 2017;10:258 –264  DOI: 10.1159/000464440   Published online: March 28, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is  licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c4/99/cro-0010-0258.PMC5422735.pdf
"   Case Rep Gastroenterol 2017;11:201 –206  DOI: 10.1159/000468516   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c2/28/crg-0011-0201.PMC5422736.pdf
"   Case Rep Dermatol 2017;9:86 –89  DOI: 10.1159/000468920   Published online: March 29, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/75/28/cde-0009-0086.PMC5422737.pdf
"   Case Rep Dermatol 2017;9:90 –94  DOI: 10.1159/000456065   Published online: March 29, 2017  © 2017 Th e Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/96/da/cde-0009-0090.PMC5422738.pdf
"   Case Rep Oncol 2017;10:321 –324  DOI: 10.1159/000467390   Published online: April 6, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1c/60/cro-0010-0321.PMC5422740.pdf
"   Case Rep Ophthalmol 2017;8:245 –249  DOI: 10.1159/000471790   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/40/11/cop-0008-0245.PMC5422741.pdf
"   Case Rep Oncol 2017;10:316 –320  DOI: 10.1159/000470831   Published online: April 6, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/95/a0/cro-0010-0316.PMC5422743.pdf
"   Case Rep Ophthalmol 2017;8:200 –207  DOI: 10.1159/00 0468143   Published online: April 3, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
http://www.aao.org/bcscsnippetdetail.aspx?id=58b9c973 –7a74 –41ae -913f -0d8fc8d7dfb3.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
http://emedicine.medscape.com.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
1998. http://journals.lww.com/anesthesia - analgesia/Fulltext/1998/04000/Collapsed_Anterior_Chamber_During_Hypothermic.59.asp.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
https://store.aao.org/clinical -educ ation/product -line/basic - and-clinical -science -course - bcsc.html?product_line=Basic+and+Clinical+Science+Course+%28BCSC%29&topic=Glaucoma.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
6 International Anesthesia Research Society (IARS): “Variation in blood pressure during heart surgery  linked to mortality  risk.” http://newswise.com/articles/variations -in-blood -pressure -during -heart - surgery -linked -to-mortality -risk.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
https://www.uptodate.com/contents/coronary -artery -bypass -graft - surgery -beyond -the-basics.,Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
"April 3, 2015.  http://EyeRounds.org/cases/212 -PION.htm.",Non-OADS,/arxiv_data1/oa_pdf/22/ab/cop-0008-0200.PMC5422744.pdf
"   Case Rep Oncol 2017;10:281 –289  DOI: 10.1159/000464279   Published online: March 29, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f2/e5/cro-0010-0281.PMC5422745.pdf
"   Case Rep Oncol 2017;10:325 –327  DOI: 10.1159/000470833   Published online: April 6, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/57/ca/cro-0010-0325.PMC5422746.pdf
"   Case Rep Ophthalmol 2017;8:237 –244  DOI: 10.1159/000462961   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karge r.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/db/ce/cop-0008-0237.PMC5422747.pdf
"1000genomes.org/], Exome Aggregation Consortium database [http://exac.broadinstitute.",OADS,/arxiv_data1/oa_pdf/db/ce/cop-0008-0237.PMC5422747.pdf
"org/], and Human Genetic Variation Database [http://www.hgvd.",OADS,/arxiv_data1/oa_pdf/db/ce/cop-0008-0237.PMC5422747.pdf
"   Case Rep Ophthalmol 2017;8:221 –231  DOI: 10.1159/000468144   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/55/01/cop-0008-0221.PMC5422748.pdf
"   Case Rep Oncol 2017;10:301 –307  DOI: 10.1159/000468983   Published online: April 4, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/de/f1/cro-0010-0301.PMC5422749.pdf
"   Case Rep Ophthalmol 2017;8:195 –199  DOI: 10.1159/000464402   Published online: March 30, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/20/b9/cop-0008-0195.PMC5422750.pdf
"   Case Rep Ophthalmol 2017;8:214 –220  DOI: 10.1159/000469702   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/70/c0/cop-0008-0214.PMC5422752.pdf
"   Case Rep Ophthalmol 2017;8:232 –236  DOI: 10.1159/000469701   Published online: April 10, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www .karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/34/23/cop-0008-0232.PMC5422758.pdf
"   Case Rep Dermatol 2017;9:108 –113  DOI: 10.1159/000469656   Published online: April 7, 2017  © 2017 The Author(s)   Publish ed by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d0/31/cde-0009-0108.PMC5422832.pdf
"   Case Rep Ophthalmol 2017;8:208 –213  DOI: 10.1159/000462956   Published online: April 4, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/cb/69/cop-0008-0208.PMC5422833.pdf
"   Case Rep Ophthalmol 2017;8:190 –194  DOI: 10.1159/000464349   Published online: March 30, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/cop-0008-0190.PMC5422834.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDERTHE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.101 6/j.jacbts.2016.06.009,Non-OADS,/arxiv_data1/oa_pdf/d6/e0/main.PMC5422992.pdf
This is anopen access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/e0/main.PMC5422992.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Laurino Grossi, MD, Associate Professor,   Gastroenterology, G. d’Annunzio University Chieti-Pescara,  School of Gastroenterology c/o Digestive Sciences - Ospedale  Spirito Santo, Via Fonte Romana, 8 65124 Pescara,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/60/5f/WJG-23-3011.PMC5423037.pdf
"l.grossi@unich.i t Telephone:  +39-085-4252460 Received:  January 25, 2017 Peer-review started:  February 1, 2017 First decision:  March 3, 2017 Revised:  March 14, 2017 Accepted:  April 12, 2017 Article in press:  April 12, 2017 Published online: May 7, 2017 Abstract Esophagitis is mainly a consequence of gastro - esophageal reflux disease, one of the most common EDITORIAL 3011 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3011World J Gastroenterol   2017 May 7; 23(17): 3011-3016  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/60/5f/WJG-23-3011.PMC5423037.pdf
"World J  Gastroenterol  2017; 23(17): 3011-3016  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i17/3011.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i17.3011 INTRODUCTION The term esophagitis refers to an inflammatory con­ dition of the esophageal mucosa, usually associated  with characteristic symptoms, such as heartburn, chest  pain and dysphagia.",Non-OADS,/arxiv_data1/oa_pdf/60/5f/WJG-23-3011.PMC5423037.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/60/5f/WJG-23-3011.PMC5423037.pdf
"World J  Gastroenterol  2017; 23(17): 3017-3021  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i17/3017.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i17.3017Checkpoint inhibitors in gastrointestinal cancers:  Expectations and reality Hampig Raphael Kourie, Samer Tabchi, Marwan Ghosn Hampig Raphael Kourie, Samer Tabchi, Marwan Ghosn,  Department of Oncology, Faculty of Medicine, Saint Joseph  University, Beirut 166830, Lebanon Author contributions:  Kourie HR and Tabchi S initiated and  wrote the editorial; Ghosn M reviewed the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/f6/cc/WJG-23-3017.PMC5423038.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript correspondence to: Marwan Ghosn, M d, Department of  Oncology, Faculty of Medicine, Saint Joseph University, Alfred  Naccache, Beirut 166830,  Lebanon.",Non-OADS,/arxiv_data1/oa_pdf/f6/cc/WJG-23-3017.PMC5423038.pdf
"Gastrointestinal (GI) cancers EDITORIAL 3017 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3017World J Gastroenterol   2017 May 7; 23(17): 3017-3021  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/f6/cc/WJG-23-3017.PMC5423038.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/f6/cc/WJG-23-3017.PMC5423038.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Fergal Kelleher, MB, BCh, BAO,  BMedSc, MSc, AFRCSI, FRCPI, MD,  Department of Medical  Oncology, Specialty Certification Medical Oncology Royal  College of Physicians United Kingdom, European Certification in  Medical Oncology, The Adelaide and Meath Hospital, Tallaght,  24 Dublin, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/8a/ae/WJG-23-3022.PMC5423039.pdf
"fergalkelleher@hotmail.com Telephone:  +35-314-14 2000 Fax:  +35-314-142689 Received:  October 25, 2016 Peer-review started:  October 28, 2016 First decision:  March 3, 2017 Revised:  March 19, 2017FRONTIER May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3022World J Gastroenterol   2017 May 7; 23(17): 3022-3029  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/8a/ae/WJG-23-3022.PMC5423039.pdf
World J Gastroenterol  2017;  23(17): 3022-3029  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8a/ae/WJG-23-3022.PMC5423039.pdf
com/1007-9327/full/v23/i17/3022.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/ae/WJG-23-3022.PMC5423039.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/8a/ae/WJG-23-3022.PMC5423039.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Arturo Panduro, MD, PhD, FAASLD,  Department of Molecular Biology in Medicine, Civil Hospital  of Guadalajara “Fray Antonio Alcalde”, Hospital # 278, Col. El  Retiro, Guadalajara, Jalisco 44280,  México.",Non-OADS,/arxiv_data1/oa_pdf/59/23/WJG-23-3030.PMC5423040.pdf
"Thus, an integrated approach  based on the understanding of the gene-emotions-gut  microbiota interaction is the next frontier that awaits  the gastroenterologist to prevent and treat GI disorders  associated with obesity and negative emotions.REVIEW 3030 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3030World J Gastroenterol   2017 May 7; 23(17): 3030-3042  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/59/23/WJG-23-3030.PMC5423040.pdf
World J Gastroenterol  2017; 23(17):  3030-3042  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/59/23/WJG-23-3030.PMC5423040.pdf
com/1007-9327/full/v23/i17/3030.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/23/WJG-23-3030.PMC5423040.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/59/23/WJG-23-3030.PMC5423040.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Zhi Chen, Professor,  State Key  Laboratory for Diagnosis and Treatment of Infectious Diseases,  The First Affiliated Hospital, Zhejiang University School of  Medicine, 866 Yuhong Road, Hangzhou 310003, Zhejiang  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/f5/97/WJG-23-3043.PMC5423041.pdf
"zjuchenzhi@zju.edu.cn Telephone:  +86-571-87236579 Fax:  +86-571-87068731 Received:  November 1, 2016 Peer-review started:  November 3, 2016REVIEW 3043 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3043World J Gastroenterol   2017 May 7; 23(17): 3043-3052  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/f5/97/WJG-23-3043.PMC5423041.pdf
World J Gastroenterol  2017; 23(17): 3043-3052   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i17/3043.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/WJG-23-3043.PMC5423041.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/f5/97/WJG-23-3043.PMC5423041.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Na Zhang,  Department of Pathology,  Dagang Hospital, Tianjin Binhai New Area, Tianjin 300211,  China.",Non-OADS,/arxiv_data1/oa_pdf/54/1a/WJG-23-3053.PMC5423042.pdf
"METHODS In 160 cases of gastric cancer, the expression of  CXCR7 and CXCL12 in tumor and matched tumor- adjacent non-cancer tissues, in the lymph nodes  around the stomach and in the liver was detected using immunohistochemistry to analyze the relation - ship between CXCR7/CXCL12 expression and clini - copathological features and to determine whether  CXCR7 and CXCL12 constitute a biological axis to  3053 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE CXCR7/CXCL12 axis is involved in lymph node and liver  metastasis of gastric carcinomaBasic Study Qi Xin, Na Zhang, Hai-Bo Yu, Qin Zhang, Yan-Fen Cui, Chuan-Shan Zhang, Zhe Ma, Yan Yang, Wei LiuSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3053World J Gastroenterol   2017 May 7; 23(17): 3053-3065  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/54/1a/WJG-23-3053.PMC5423042.pdf
wjgnet.com/1007-9327/full/v23/i17/3053.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/1a/WJG-23-3053.PMC5423042.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/54/1a/WJG-23-3053.PMC5423042.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript  Correspondence to: Zhong- fu Li, MD,  Department of General  Surgery, Chongqing Emergency Medical Center, no.",Non-OADS,/arxiv_data1/oa_pdf/5a/cd/WJG-23-3066.PMC5423043.pdf
"RESULTS Slightly elevated lesions showed a significantly lower  3066 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Low-grade slightly elevated and polypoid colorectal  adenomas display differential β-catenin-TCF/LEF activity,  c-Myc, and cyclin D1 expressionBasic Study Tian-wen Yang, Yun-han Gao, Sha-Ying Ma, Qiang wu, Zhong-fu LiSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3066World J Gastroenterol   2017 May 7; 23(17): 3066-3076  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/5a/cd/WJG-23-3066.PMC5423043.pdf
"World J Gastroenterol  2017; 23(17): 3066-3076  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i17/3066.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i17.3066 INTRODUCTION Colorectal cancer is the third most common malignancy  worldwide, with a global five-year prevalence of  approximately 3.2 million cases[1].",Non-OADS,/arxiv_data1/oa_pdf/5a/cd/WJG-23-3066.PMC5423043.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/5a/cd/WJG-23-3066.PMC5423043.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Roberto Salvia, MD, PhD,  General and  Pancreatic Surgery Department, Pancreas Institute, University  and Hospital Trust of Verona, Policlinico GB Rossi, Piazzale L.A.  Scuro, 10, 37134 Verona, Italy.",Non-OADS,/arxiv_data1/oa_pdf/83/37/WJG-23-3077.PMC5423044.pdf
"Results from a tertiary  referral centerRetrospective Cohort Study Salvatore Paiella, Matteo De Pastena, Tommaso Pollini, Giovanni Zancan, Debora Ciprani, Giulia De Marchi,  Luca Landoni, Alessandro Esposito, Luca Casetti, Giuseppe Malleo, Giovanni Marchegiani, Massimiliano  Tuveri, Enrico Marrano, Laura Maggino, Erica Secchettin, Deborah Bonamini, Claudio Bassi, Roberto SalviaSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3077World J Gastroenterol   2017 May 7; 23(17): 3077-3083  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/83/37/WJG-23-3077.PMC5423044.pdf
World J Gastroenterol  2017;  23(17): 3077-3083  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/83/37/WJG-23-3077.PMC5423044.pdf
com/1007-9327/full/v23/i17/3077.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/37/WJG-23-3077.PMC5423044.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/83/37/WJG-23-3077.PMC5423044.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Johanna Wilmsen,  Department  of Gastroenterology and Interventional Endoscopy, Asklepios  Hospital Barmbek, Semmelweis University, Medical Faculty,  Campus Hamburg, Rübenkamp 220, 22291 Hamburg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/13/64/WJG-23-3084.PMC5423045.pdf
"j.wilmsen@asklepios.com Telephone:  +49-40-1818828499 Fax:  +49-40-1818823809  Received:  December 27, 2016 Peer-review started:  December 28, 2016 First decision:  January 19, 2017 Revised:  February 20, 2017 Accepted:  March 21, 2017    Article in press:  March 21, 2017 Published online: May 7, 2017 Abstract   AIM To report about the combination and advantages of a Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3084 3084 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 7; 23(17): 3084-3091  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE New flexible endoscopic controlled stapler technique for  the treatment of Zenker's diverticulum: A case seriesRetrospective Study Johanna Wilmsen, Robert Baumbach, Dietmar Stüker, Vincens Weingart, Frank Neser, Stefan Karl Gölder,  Christof Pfundstein, Ellen Claudia Nötzel, Thomas Rösch, Siegbert Faiss",Non-OADS,/arxiv_data1/oa_pdf/13/64/WJG-23-3084.PMC5423045.pdf
World J Gastroenterol   2017; 23(17): 3084-3091  Available from: URL: http://www.wjgnet.com/1007-9327/full/v23/i17/3084.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/64/WJG-23-3084.PMC5423045.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/13/64/WJG-23-3084.PMC5423045.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Salvatore Paiella, MD,  General and  Pancreatic Surgery Department, Pancreas Institute, University  and Hospital Trust of Verona, Policlinico GB Rossi, Piazzale L.A.  Scuro, 10, 37134 Verona, Italy.",Non-OADS,/arxiv_data1/oa_pdf/65/73/WJG-23-3092.PMC5423046.pdf
"salvatore.paiella@univr.i t Telephone:  +39-04-58124553 Fax:  +39-04-58124826 Received:  October 24, 2016 Peer-review started:  October 26, 2016 3092 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Comparison of imaging-based and pathological dimensions  in pancreatic neuroendocrine tumorsRetrospective Study Salvatore Paiella, Harmony Impellizzeri, Elisabetta Zanolin, Giovanni Marchegiani, Marco Miotto, Anna  Malpaga, Riccardo De Robertis, Mirko D'Onofrio, Borislav Rusev, Paola Capelli, Sara Cingarlini, Giovanni  Butturini, Maria Vittoria Davì, Antonio Amodio, Claudio Bassi, Aldo Scarpa, Roberto Salvia, Luca LandoniSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3092World J Gastroenterol   2017 May 7; 23(17): 3092-3098  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/65/73/WJG-23-3092.PMC5423046.pdf
"World J Gastroenterol  2017; 23(17): 3092-3098  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i17/3092.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i17.3092 INTRODUCTION Pancreatic neuroendocrine tumors (PanNET) account  for 5% of all pancreatic tumors, with an incidence  of 1/100000 per year[1].",Non-OADS,/arxiv_data1/oa_pdf/65/73/WJG-23-3092.PMC5423046.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/65/73/WJG-23-3092.PMC5423046.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Carlos Jiménez-Romero, MD,  PhD, FACS, Head  of HPB Surgery and Abdominal Organ  Transplantation Unit, University Hospital “Doce de Octubre”, 4ª  Planta, Ctra Andalucía Km 5, 4, 28041 Madrid,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/01/22/WJG-23-3099.PMC5423047.pdf
"After excluding the  patients with hepatitis C virus cirrhosis (16 in group A  and 10 in group B), the 1, 3 and 5-year patient ( P =  0.657) and graft ( P = 0.419) survivals were practically  3099 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Octogenarian liver grafts: Is their use for transplant  currently justified?Retrospective Study Carlos Jiménez-Romero, Felix Cambra, Oscar Caso, Alejandro Manrique, Jorge Calvo, Alejandro Marcacuzco,  Paula Rioja, David Lora, Iago JustoSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3099World J Gastroenterol   2017 May 7; 23(17): 3099-3110  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/01/22/WJG-23-3099.PMC5423047.pdf
"World J  Gastroenterol  2017; 23(17): 3099-3110  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i17/3099.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i17.3099 INTRODUCTION Liver transplantation (LT) is the universally accepted  procedure for patients who suffer life-threatening  chronic and acute liver disease, hepatocarcinoma and  several metabolic diseases.",Non-OADS,/arxiv_data1/oa_pdf/01/22/WJG-23-3099.PMC5423047.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/01/22/WJG-23-3099.PMC5423047.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to: Kazushi Numata, MD,  Gastroenterological  Center, Yokohama City University Medical Center, 4-57 Urafune- cho, Minami-ku, Yokohama, Kanagawa 232-0024,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/97/a1/WJG-23-3111.PMC5423048.pdf
"Follow-up examinations  were performed at 3-mo intervals to monitor for signs  3111 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Rate of local tumor progression following radiofrequency  ablation of pathologically early hepatocellular carcinomaRetrospective Study Yoshiteru Hao, Kazushi Numata, Tomohiro Ishii, Hiroyuki Fukuda, Shin Maeda, Masayuki Nakano,  Katsuaki TanakaSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3111World J Gastroenterol   2017 May 7; 23(17): 3111-3121  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/97/a1/WJG-23-3111.PMC5423048.pdf
World J Gastroenterol  2017; 23(17): 3111-3121   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i17/3111.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/97/a1/WJG-23-3111.PMC5423048.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/97/a1/WJG-23-3111.PMC5423048.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Rong-Ping Guo, MD,  Department of  Hepatobiliary Surgery, Cancer Center of Sun Yat-Sen University,  651 Dongfeng East Road, Guangzhou 510275, Guangdong  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/20/0f/WJG-23-3122.PMC5423049.pdf
"guorp@sysucc.org.cn Telephone:  +86-20-87343115 Received:  October 13, 2016 Peer-review started:  October 14, 2016 First decision:  December 28, 2016 Revised:  January 16, 2017 Accepted:  February 17, 2017  Article in press:  February 17, 2017 Published online: May 7, 2017 3122 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Prognostic value of the neutrophil-to-lymphocyte ratio for  hepatocellular carcinoma patients with portal/hepatic vein  tumor thrombosisRetrospective Study Shao-Hua Li, Qiao-Xuan Wang, Zhong-Yuan Yang, Wu Jiang, Cong Li, Peng Sun, Wei Wei, Ming Shi,  Rong-Ping GuoSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3122World J Gastroenterol   2017 May 7; 23(17): 3122-3132  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/20/0f/WJG-23-3122.PMC5423049.pdf
World J Gastroenterol  2017; 23(17):  3122-3132  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/20/0f/WJG-23-3122.PMC5423049.pdf
com/1007-9327/full/v23/i17/3122.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/0f/WJG-23-3122.PMC5423049.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/20/0f/WJG-23-3122.PMC5423049.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: En-Hua Xiao, MD, Professor,  Department  of Radiology, The Second Xiangya Hospital of Central South  University, No.139 Ren Min Zhong Lu, Fu Rong District,  Changsha 410011, Hunan Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/08/51/WJG-23-3133.PMC5423050.pdf
"Pearson’s product- moment correlation analysis was used to evaluate  the relationship between the REh and the levels of   3133 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Diagnostic value of gadobenate dimeglumine-enhanced  hepatocyte-phase magnetic resonance imaging in  evaluating hepatic fibrosis and hepatitisClinical Trials Study Xiu-Mei Li, Zhu Chen, En-Hua Xiao, Quan-Liang Shang, Cong MaSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3133World J Gastroenterol   2017 May 7; 23(17): 3133-3141  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/08/51/WJG-23-3133.PMC5423050.pdf
World J Gastroenterol  2017; 23(17): 3133-3141  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i17/3133.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i17.3133 INTRODUCTION Hepatic fibrosis is an unavoidable process when chronic liver disease (CLD) develops into cirrhosis.,Non-OADS,/arxiv_data1/oa_pdf/08/51/WJG-23-3133.PMC5423050.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/08/51/WJG-23-3133.PMC5423050.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Alban Zarzavadjian Le Bian,   Department of Digestive Surgery, Centre Hospitalier Simone  Veil, 14, rue des Saint Prix, 95600 Eaubonne,  France.",Non-OADS,/arxiv_data1/oa_pdf/58/13/WJG-23-3142.PMC5423051.pdf
"Patients  presenting with metabolic syndrome [defined as at  least three criteria among overweight (BMI ≥ 28  kg/m²), diabetes mellitus, arterial hypertension and  dyslipidemia] were compared to patients without  3142 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Consequences of metabolic syndrome on postoperative  outcomes after pancreaticoduodenectomyObservational Study Alban Zarzavadjian Le Bian, David Fuks, Sophie Chopinet, Sébastien Gaujoux, Manuela Cesaretti,  Renato Costi, Ajay P Belgaumkar, Claude Smadja, Brice GayetSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3142World J Gastroenterol   2017 May 7; 23(17): 3142-3149  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/58/13/WJG-23-3142.PMC5423051.pdf
World J Gastroenterol  2017;  23(17): 3142-3149  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/58/13/WJG-23-3142.PMC5423051.pdf
com/1007-9327/full/v23/i17/3142.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/13/WJG-23-3142.PMC5423051.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/58/13/WJG-23-3142.PMC5423051.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript   Correspondence to: Dr. Mirko Tarocchi,  Department of  Experimental and Clinical Biomedical Sciences, University of  Florence, Viale Morgagni 50, 50134 Florence,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/11/f2/WJG-23-3150.PMC5423052.pdf
"The effect of the treatment was evaluated  monitoring liver enzymes, metabolic parameters,  cardiovascular risk indexes, NAFLD severity [assessed  3150 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Effect of a counseling-supported treatment with the  Mediterranean diet and physical activity on the severity of  the non-alcoholic fatty liver diseaseObservational Study Chiara Gelli, Mirko Tarocchi, Ludovico Abenavoli, Laura Di Renzo, Andrea Galli, Antonino De LorenzoSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3150World J Gastroenterol   2017 May 7; 23(17): 3150-3162  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/11/f2/WJG-23-3150.PMC5423052.pdf
World J Gastroenterol  2017;  23(17): 3150-3162  Available from: URL: http://www.wjgnet.com/1007-9327/full/v23/i17/3150.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/f2/WJG-23-3150.PMC5423052.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/11/f2/WJG-23-3150.PMC5423052.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Marcelo Soto,  Fundació Clínic per a  la Recerca Biomèdica, Roselló 149-153, 08036 Barcelona,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/8e/eb/WJG-23-3163.PMC5423053.pdf
"3163 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Cost-effectiveness of enhanced liver fibrosis test to assess  liver fibrosis in chronic hepatitis C virus and alcoholic liver  disease patientsProspective Study Marcelo Soto, Laura Sampietro-Colom, Luis Lasalvia, Aurea Mira, Wladimiro Jiménez, Miquel NavasaSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3163World J Gastroenterol   2017 May 7; 23(17): 3163-3173  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/8e/eb/WJG-23-3163.PMC5423053.pdf
World J Gastroenterol  2017; 23(17): 3163-3173   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i17/3163.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/8e/eb/WJG-23-3163.PMC5423053.pdf
Available from: URL: http://www.msssi.gob.es/estadEstudios/ estadisticas/cmbd.htm 39 Vidal Vademecum Spain.,Non-OADS,/arxiv_data1/oa_pdf/8e/eb/WJG-23-3163.PMC5423053.pdf
"Available from: URL: http://www.vademecum.es/ 40 Fenwick E , O’Brien BJ, Briggs A.",Non-OADS,/arxiv_data1/oa_pdf/8e/eb/WJG-23-3163.PMC5423053.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/8e/eb/WJG-23-3163.PMC5423053.pdf
Clinical trial registration statement:  The study is registrered in  the Regional Research Ethics Committee of Stockholm database  http://www.epn.se/stockholm/om-naemnden/.,Non-OADS,/arxiv_data1/oa_pdf/47/b5/WJG-23-3174.PMC5423054.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Francisco Baldaque-Silva, MD,  Gastrocentrum, Institute of Medicine, Karolinska Institutet,  Karolinska University Hospital, Karolinska vägen, 14186  Stockholm, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/47/b5/WJG-23-3174.PMC5423054.pdf
"fbaldaquesilva@gmail.co m Telephone:  +46-8-58582328  Fax:  +46-8-58582335 Received:  October 5, 2016 Peer-review started:  October 7, 2016 First decision:  November 9, 2016 3174 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Impact of gastroesophageal reflux control through tailored  proton pump inhibition therapy or fundoplication in patients  with Barrett’s esophagusProspective Study Francisco Baldaque-Silva, Michael Vieth, Mumen Debel, Bengt Håkanson, Anders Thorell, Nuno Lunet,  Huan Song, Miguel Mascarenhas-Saraiva, Gisela Pereira, Lars Lundell, Hanns-Ulrich MarschallSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3174World J Gastroenterol   2017 May 7; 23(17): 3174-3183  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/47/b5/WJG-23-3174.PMC5423054.pdf
World J Gastroenterol  2017;  23(17): 3174-3183  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/47/b5/WJG-23-3174.PMC5423054.pdf
com/1007-9327/full/v23/i17/3174.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/b5/WJG-23-3174.PMC5423054.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/47/b5/WJG-23-3174.PMC5423054.pdf
Clinical trial registration statement:  The study was registered  at http://www.chictr.org.cn/showproj.aspx?proj=10604.,Non-OADS,/arxiv_data1/oa_pdf/ad/d6/WJG-23-3184.PMC5423055.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: En-Qiang Linghu, PhD,  Department of  Gastroenterology and Hepatology, Chinese People’s Liberation  Army General Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/ad/d6/WJG-23-3184.PMC5423055.pdf
"The size of each PCN was determined  3184 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comORIGINAL ARTICLE Comparison of endoscopic ultrasound, computed  tomography and magnetic resonance imaging in assessment  of detailed structures of pancreatic cystic neoplasmsProspective Study Chen Du, Ning-Li Chai, En-Qiang Linghu, Hui-Kai Li, Li-Hua Sun, Lei Jiang, Xiang-Dong Wang, Ping Tang,  Jing YangSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3184World J Gastroenterol   2017 May 7; 23(17): 3184-3192  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/ad/d6/WJG-23-3184.PMC5423055.pdf
"World J  Gastroenterol  2017; 23(17): 3184-3192  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i17/3184.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i17.3184 INTRODUCTION Pancreatic cystic lesions (PCLs) include true cysts,  pseudocysts and cystic neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/ad/d6/WJG-23-3184.PMC5423055.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/ad/d6/WJG-23-3184.PMC5423055.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Eugene Lipov, MD,  Department of  Anesthesiology, Advocate Illinois Masonic Medical Center, 3000  N Halsted St 700, Chicago, IL 60657,  United States.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/WJG-23-3193.PMC5423056.pdf
World J Gastroenterol  2017;  23(17): 3193-3194  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/WJG-23-3193.PMC5423056.pdf
com/1007-9327/full/v23/i17/3193.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/WJG-23-3193.PMC5423056.pdf
"The exact mechanism LETTERS TO THE EDITOR 3193 May 7, 2017 |Volume 23 |Issue 17 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i17.3193World J Gastroenterol   2017 May 7; 23(17): 3193-3194  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/8a/09/WJG-23-3193.PMC5423056.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  7",Non-OADS,/arxiv_data1/oa_pdf/8a/09/WJG-23-3193.PMC5423056.pdf
"In contrast, since the dawn of the industrial revolution, designers have been typicallyReceived: 22 October 2016 Revised: 1 March 2017 Accepted: 24 April 2017 Heliyon 3 (2017) e00299 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"The urge to design products for all round sustainable development has led to the advent of methodologies such as design for circularity ( Ghisellini et al., 2016 ), Article No~e00299 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"The designer needs to hew to theprinciples of these schemes, in the design phase, while leaving room for trade offs Article No~e00299 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"Other than approaching net-shapes, manufacturing processes should also be utilized to impart beneficial features such as ultrafine-grained microstructures and Article No~e00299 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"The equations summarizing the proposed factor of frugality are given by, F¼ Sþ MS (1) Article No~e00299 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"In contrast, a maximum value of one is possible for MS2andMS5 since this would correspond to net shape fabrication without removal of excess material and a product comprising entirely of parts salvaged from EOL systems Article No~e00299 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
No Factor of frugality FSFactor of safety S No of material saving schemes Material saved MS (F −S) 1 7.544 5 3.5 2 4.81.31.3 5 3.5 3 7.31.31.3 10 6 44440 0 Article No~e00299 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Approach S Conservation Schemes FSOutcome MS 1 MS 2 MS 5 1 Classical (Basic) 1.5 - - - 1.51.5Solid Shaft 2 Frugal 1.5 0.5 - - 21.5Hollow Shaft 3 Frugal 1.5 0.5 1 - 31.5Tube Extrusion 4 Frugal 1.5 0.5 1 1 41.5Salvage Extruded Tube Article No~e00299 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"The increasing value of the factor of frugality beyond 1.5, against a maximum of 5, signifies increasing savings in the Article No~e00299 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
Article No~e00299 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00299 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/main.PMC5423081.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Cellular & Molecular Immunology website (http://www.nature.com/cmi)Hepatitis B virus impairs NK cell functions via exosomes YY a n g et al 475 Cellular & Molecular Immunology",Non-OADS,/arxiv_data1/oa_pdf/c1/8b/cmi201624a.PMC5423088.pdf
This image was generated by using the online tools provided by CIMminer (http://discover.nci.nih.gov/cimminer/home.do)FAK regulates EZH2 in HCC D Gnani et al 894 Cell Death and Differentiation,OADS,/arxiv_data1/oa_pdf/05/10/cdd201734a.PMC5423113.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)FAK regulates EZH2 in HCC D Gnani et al 902 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/05/10/cdd201734a.PMC5423113.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)GFI1 suppresses colorectal cancer metastasis W Xing et al 943 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/13/b9/cdd201750a.PMC5423119.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2016.10.003 1574-7891/ ª2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 1595 e1602,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2016.10.003 .,OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1016/ j.transci.2016.07.012 .,OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.2217/ imt.15.3 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1371/journal.pone.0047365 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"BMC Cancer 13,466. http://dx.doi.org/10.1186/1471-2407-13-466 .",Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"Tumori 100 (1), 60 e68.http://dx.doi.org/10.1700/ 1430.15817 .",Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender .fcgi?artid ¼2112509&tool ¼pmcentrez&rendertype ¼abstract (Accessed 17 March 2016).,OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1080/03637750903310360 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1039/c4lc00662c .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1200/ JCO.2009.24.9342 .,OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.3109/07357907.2013.789905 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"BMC Cancer 14, 176. http://dx.doi.org/10.1186/1471-2407-14- 176.",Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
Available at: http://www.ncbi.nlm.nih.gov/ pubmed/15069548 (Accessed 30 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/ 10.1002/elps.201000598 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
Available at:http://www.ncbi.nlm.nih.gov/pubmed/6307529 (Accessed 17 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"Int.2014, 179486. http://dx.doi.org/10.1155/2014/179486 .",OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1016/ j.jtho.2016.05.034 .,OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"64 (1), 9 e29.http://dx.doi.org/10.3322/ caac.21208 .",Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1038/ncb1800 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"110 (1), 13 e21.http://dx.doi.org/ 10.1016/j.ygyno.2008.04.033 .",OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"Methods 87, 3 e10.http://dx.doi.org/10.1016/ j.ymeth.2015.02.019 .",OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
Available at: http://lungecancer.dk/documents/ED76D14E- 3915-4D9C-9033-55D1B03402FB.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/10.1038/nri2567 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
"Cancer 10, 127. http://dx.doi.org/10.1186/ 1476-4598-10-127 .",Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
http://dx.doi.org/ 10.1038/ncb1596 .,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
Available at: http://www.ncbi.nlm.nih.gov/ pubmed/24400444 (Accessed 3 December 2015).MOLECULAR ONCOLOGY 10 (2016) 1595 e1602 1602,Non-OADS,/arxiv_data1/oa_pdf/6e/07/MOL2-10-1595.PMC5423137.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2015.12.011 1574-7891/ ª2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/1f/MOL2-10-704.PMC5423153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 704 e718,Non-OADS,/arxiv_data1/oa_pdf/87/1f/MOL2-10-704.PMC5423153.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/1f/MOL2-10-704.PMC5423153.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2015.12.011 .,OADS,/arxiv_data1/oa_pdf/87/1f/MOL2-10-704.PMC5423153.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
"1Honorary Director Institut Gustave Roussy, France.available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2015.12.007 1574-7891/ ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 645 e651,Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
Supplementary ﬁle Supplementary ﬁle related to this article can be found at http://dx.doi.org/10.1016/j.moslonc.2015.12.007 .,Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
http://europa.eu/ rapid/press-release_SPEECH-02-408_en.htm .MOLECULAR ONCOLOGY 10 (2016) 645 e651 650,Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
"EurocanPlatform http://eurocanplatform.eu/ .National Institutes of Health, 2014.",Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
http://grants.nih.gov/gr ants/guide/pa-ﬁles/PAR- 14-353.html .,Non-OADS,/arxiv_data1/oa_pdf/eb/8f/MOL2-10-645.PMC5423159.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2015.12.010 1574-7891/ ª2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/a7/MOL2-10-693.PMC5423162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 693 e703,Non-OADS,/arxiv_data1/oa_pdf/23/a7/MOL2-10-693.PMC5423162.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/a7/MOL2-10-693.PMC5423162.pdf
"Differential expression ofSNORA55 was conﬁrmed on an independent microarray exper-iment (LTL-313H vs. LTL-313B), which is publically available:http://www.livingtumorcentre.com/GeneExpression/searchform.php .",OADS,/arxiv_data1/oa_pdf/23/a7/MOL2-10-693.PMC5423162.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2015.12.010 .,OADS,/arxiv_data1/oa_pdf/23/a7/MOL2-10-693.PMC5423162.pdf
http://dx.doi.org/10.1101/pdb.prot5439 pdb.prot5439.,Non-OADS,/arxiv_data1/oa_pdf/23/a7/MOL2-10-693.PMC5423162.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/d3/MOL2-10-895.PMC5423170.pdf
1Shine-Gwo Shiah and Shiow-Lian Catherine Jin contributed equally to this work.available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2016.03.001 1574-7891/ ª2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/91/d3/MOL2-10-895.PMC5423170.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 895 e909,Non-OADS,/arxiv_data1/oa_pdf/91/d3/MOL2-10-895.PMC5423170.pdf
"Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2016.03.001 .REFERENCES Agrawal, N., Frederick, M.J., Pickering, C.R., Bettegowda, C., Chang, K., Li, R.J., Fakhry, C., Xie, T.X., Zhang, J., Wang, J., Zhang, N., El-Naggar, A.K., Jasser, S.A., Weinstein, J.N., Trevino, L., Drummond, J.A., Muzny, D.M., Wu, Y., Wood, L.D.,Hruban, R.H., Westra, W.H., Koch, W.M., Califano, J.A.,Gibbs, R.A., Sidransky, D., Vogelstein, B., Velculescu, V.E., Papadopoulos, N., Wheeler, D.A., Kinzler, K.W., Myers, J.N., 2011.",Non-OADS,/arxiv_data1/oa_pdf/91/d3/MOL2-10-895.PMC5423170.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2016.04.004 1574-7891/ ª2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 1043 e1053,Non-OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
Data was uploaded and analyzedin R2: microarray analysis and visualization platform ( http://r2.amc.nl ) revealed a very strong correlation between the expression of miR-200c with (A) miR-375 and (B) miR-141.MOLECULAR ONCOLOGY 10 (2016) 1043 e1053 1049,OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2016.04.004 .,OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
Data obtained from Guenther study at R2: microarray analysis and visualization platform ( http://r2.amc.nl ).MOLECULAR ONCOLOGY 10 (2016) 1043 e1053 1051,OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
http://dx.doi.org/10.1038/ onc.2015.344 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/13/92/MOL2-10-1043.PMC5423177.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2016.03.005 1574-7891/ ª2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 981 e992,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2016.03.005 .MOLECULAR ONCOLOGY 10 (2016) 981 e992 990,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
"8, 69. http://dx.doi.org/10.1186/1472-6750-8-69 .",Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1371/ journal.pone.0026971 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1038/nmeth.2697 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/ 10.1007/s13402-012-0089-1 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
"6, 22 e33.http://dx.doi.org/10.4251/ wjgo.v6.i1.22 .",Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1093/nar/gkn188 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
"http://dx.doi.org/10.1038/ nrm3838 .Jarry, J., Schadendorf, D., Greenwood, C., Spatz, A., van Kempen, L.C., 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1016/ j.molonc.2014.02.009 .,OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1016/j.molcel.2012.05.036 .,OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1371/ journal.pone.0024145 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1373/clinchem.2010.157198 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/ 10.1038/bjc.2015.340 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1038/nmeth.3014 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
"BMC Genomics 15, 395. http://dx.doi.org/10.1186/1471-2164-15-395 .",OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.2144/000113367 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
http://dx.doi.org/10.1373/clinchem.2015.239459 .,Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
"http://dx.doi.org/10.1038/ nrclinonc.2014.5 .St€uckrath, I., Rack, B., Janni, W., J €ager, B., Pantel, K., Schwarzenbach, H., 2015.",Non-OADS,/arxiv_data1/oa_pdf/5b/b5/MOL2-10-0981.PMC5423189.pdf
He was also started on http://dx.doi.org/10.1016/j.idcr.2017.04.009 Received 4 January 2017; Received in revised form 18 April 2017; Accepted 18 April 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ee/10/main.PMC5423293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ee/10/main.PMC5423293.pdf
Indian J Med Microbiol 2015;33(April –June (2)):307 –10.http://dx.doi.org/10.4103/0255-0857.154893 .,Non-OADS,/arxiv_data1/oa_pdf/ee/10/main.PMC5423293.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/4d/main.PMC5423298.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.021 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/4d/main.PMC5423298.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 145 e146,Non-OADS,/arxiv_data1/oa_pdf/a3/4d/main.PMC5423298.pdf
"Woyen, et al., Characteristics and clinical outcome of bone and joint tuberculosis from 1994 to 2011: a retrospective register-based study in Denmark, Clin Infect Dis 61 (4) (2015 Aug 15) 554 e562, http://dx.doi.org/10.1093/cid/civ326 .",OADS,/arxiv_data1/oa_pdf/a3/4d/main.PMC5423298.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/27872320 .,Non-OADS,/arxiv_data1/oa_pdf/a3/4d/main.PMC5423298.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.04.009 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/25/42/main.PMC5423299.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/42/main.PMC5423299.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/25/42/main.PMC5423299.pdf
"After agalsidase beta shortage due to viral contamination at manufacturing, many patients had to reduced doses or switch to agalsidase alpha for an http://dx.doi.org/10.1016/j.ymgmr.2017.02.005 Received 23 November 2016; Received in revised form 13 February 2017; Accepted 13 February 2017⁎Corresponding author at: Dirección Simón Bolivar 487, C1181ACH Buenos Aires, Argentina.",Non-OADS,/arxiv_data1/oa_pdf/88/8a/main.PMC5423300.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/88/8a/main.PMC5423300.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.04.014 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC5423301.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC5423301.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC5423301.pdf
"http://nccd.cdc.gov/dnpabmi/Calculator.aspx (Accessed on Oc- tober 10, 2015).",OADS,/arxiv_data1/oa_pdf/2d/3c/main.PMC5423301.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/72/main.PMC5423302.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.020Urology Case Reports 13 (2017) 123 e125,Non-OADS,/arxiv_data1/oa_pdf/7c/72/main.PMC5423302.pdf
"Accepted for publication: 20 March 2017 To cite this article: Yosupov N, Haimov H, Juodzbalys G. Mobilization, Isolation and Characterization of Stem Cells from Peripheral Blood: a Systematic Review J Oral Maxillofac Res 2017;8(1):e1 URL: http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1.pdf doi: 10.5037/jomr.2017.8101 http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
"The protocol registration number:  CRD42016051837, can be accessed through the  following link: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016051837 Focus questions The aim of this review is to find answers from the data  extracted from the current literature to the following  questions:  1.",Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
[URL: http://training.cochrane.org/handbook ]  18.,OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
"[Medline: 23199456 ] [doi: 10.1016/j.patbio.2012.10.003 ] To cite this article: Yosupov N, Haimov H, Juodzbalys G. Mobilization, Isolation and Characterization of Stem Cells from Peripheral Blood: a Systematic Review J Oral Maxillofac Res 2017;8(1):e1 URL: http://www.ejomr.org/JOMR/archives/2017/1/e1/v8n1e1.pdf doi: 10.5037/jomr.2017.8101 Copyright ©  Yosupov N, Haimov H, Juodzbalys G. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 31 March 2017.",Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/5d/ae/jomr-08-e1.PMC5423306.pdf
"Accepted for publication: 28 March 2017 To cite this article: Starch-Jensen T, Christensen AE, Lorenzen H. Scalloped Implant-Abutment Connection Compared to Conventional Flat Implant-Abutment Connection: a Systematic  Review and Meta-Analysis J Oral Maxillofac Res 2017;8(1):e2 URL: http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2.pdf doi: 10.5037/jomr.2017.8102 http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
The protocol can be accessed at: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42017057312 Registration number: CRD42017057312.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
"[URL: http://training.cochrane.org/handbook ]  19. den Hartog L, Raghoebar GM, Slater JJ, Stellingsma K, Vissink A, Meijer HJ.",OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
"[Medline: 25123298 ]  [doi: 10.1111/clr.12464 ] To cite this article: Starch-Jensen T, Christensen AE, Lorenzen H. Scalloped Implant-Abutment Connection Compared to Conventional Flat Implant-Abutment Connection: a Systematic  Review and Meta-Analysis J Oral Maxillofac Res 2017;8(1):e2 URL: http://www.ejomr.org/JOMR/archives/2017/1/e2/v8n1e2.pdf doi: 10.5037/jomr.2017.8102 Copyright ©  Starch-Jensen T, Christensen AE, Lorenzen H. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 31 March 2017.",Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/37/93/jomr-08-e2.PMC5423307.pdf
In Vitro Comparison of Biological Effects of Coe-Pak and Reso-Pac Periodontal Dressings J Oral Maxillofac Res 2017;8(1):e3 URL: http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3.pdf doi: 10.5037/jomr.2017.8103 http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
"In Vitro Comparison of Biological Effects of Coe-Pak and Reso-Pac Periodontal Dressings J Oral Maxillofac Res 2017;8(1):e3 URL: http://www.ejomr.org/JOMR/archives/2017/1/e3/v8n1e3.pdf doi: 10.5037/jomr.2017.8103 Copyright ©  Kadkhodazadeh M, Baghani Z, Torshabi M, Basirat B.",Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
"Published in the JOURNAL OF ORAL &   MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 31 March 2017.",Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/b4/b4/jomr-08-e3.PMC5423308.pdf
"Accepted for publication: 29 March 2017 To cite this article: Diab HA, Salameh Z, Hamadeh GN, Younes G, Ayoub F. Oral Health Status of Institutionalized Individuals with Intellectual Disabilities in Lebanon J Oral Maxillofac Res 2017;8(1):e4 URL: http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4.pdf doi: 10.5037/jomr.2017.8104 http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
[URL: http://www.who.int/publications/en/ ] 20.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
[URL: https://www.jscimedcentral.com/PublicHealth/ ],Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
[URL: http://www.edentj.com/index.php/ijcd/ ] 29.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
[URL: http://www.bsdh.org  ] 30.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
[URL: http://www.ijcmr.com ] 32.,Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
"[doi: 10.1155/2014/535316 ] To cite this article: Diab HA, Salameh Z, Hamadeh GN, Younes G, Ayoub F. Oral Health Status of Institutionalized Individuals with Intellectual Disabilities in Lebanon J Oral Maxillofac Res 2017;8(1):e4 URL: http://www.ejomr.org/JOMR/archives/2017/1/e4/v8n1e4.pdf doi: 10.5037/jomr.2017.8104 Copyright ©  Diab HA, Salameh Z, Hamadeh GN, Younes G, Ayoub F. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 31 March 2017.",Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/15/b3/jomr-08-e4.PMC5423309.pdf
"Accepted for publication: 20 March 2017 To cite this article: Titsinides S, Nikitakis N, Piperi E, Sklavounou A  MALT Lymphoma of Minor Salivary Glands in a Sjögren’s Syndrome Patient: a Case Report and Review of Literature J Oral Maxillofac Res 2017;8(1):e5 URL: http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5.pdf doi: 10.5037/jomr.2017.8105 http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.",Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5ht.htm  J Oral Maxillofac Res 2017 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
"To cite this article: Titsinides S, Nikitakis N, Piperi E, Sklavounou A  MALT Lymphoma of Minor Salivary Glands in a Sjögren’s Syndrome Patient: a Case Report and Review of Literature J Oral Maxillofac Res 2017;8(1):e5 URL: http://www.ejomr.org/JOMR/archives/2017/1/e5/v8n1e5.pdf doi: 10.5037/jomr.2017.8105 Copyright ©  Titsinides S, Nikitakis N, Piperi E, Sklavounou A  Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 31 March 2017.",Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/77/36/jomr-08-e5.PMC5423310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/9d/main.PMC5423311.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.020 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/9d/main.PMC5423311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 142 e144,Non-OADS,/arxiv_data1/oa_pdf/84/9d/main.PMC5423311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/04/main.PMC5423312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/04/main.PMC5423312.pdf
http://dx.doi.org/10.1016/j.eucr.2017.04.001Urology Case Reports 13 (2017) 120 e122,Non-OADS,/arxiv_data1/oa_pdf/35/04/main.PMC5423312.pdf
"© 2017 The Author(s) Published by S. Karger AG, BaselReceived: September 21, 2016 Accepted: January 27, 2017 Published online: Ap ril 7, 2017EX TR A Dag Eckersten, MD, PhDDepartment of Nephrology, Lund University Skåne University Hospital SE–205 02 Malmö (Sweden)E-Mail dag.eckersten  @  med.lu.sewww.karger.com/nne This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/7a/65/nne-0007-0033.PMC5423313.pdf
"In nonproteinuric CKD patients, 88, 90, 89, and 91%, respec -Published online: Ap ril 7, 2017EX TR A John Humphreys 3rd Floor, Mayo Building Salford Royal NHS Foundation Trust Stott Lane, Salford M6 8HD (UK)E-Mail John.Humphreys  @  srft.nhs.ukwww.karger.com/nne This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/60/a4/nne-0007-0018.PMC5423314.pdf
"http://qof.hscic.gov.uk/index.asp (accessed July 28, 2014).",Non-OADS,/arxiv_data1/oa_pdf/60/a4/nne-0007-0018.PMC5423314.pdf
"University Hospitals of Leicester NHS Trust, 2013. http://clahrc-gm.nihr.ac.uk/cms/wp-content/uploads/IMPAKT-CKD-Improvement-Guide.pdf (accessed June 16, 2014).",Non-OADS,/arxiv_data1/oa_pdf/60/a4/nne-0007-0018.PMC5423314.pdf
"Salford Royal NHS Foundation Trust, 2015. http://clahrc-gm.nihr.ac.uk/our-work/primary-care/kidney-health/ahsn-kidney-health/4/.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/nne-0007-0018.PMC5423314.pdf
"MsTBI is associated with volumetric de ﬁcits in the http://dx.doi.org/10.1016/j.nicl.2017.03.014 Received 12 January 2017; Received in revised form 9 March 2017; Accepted 13 March 2017⁎Corresponding author at: Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033, USA.",Non-OADS,/arxiv_data1/oa_pdf/35/61/main.PMC5423316.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/35/61/main.PMC5423316.pdf
Tensor-based morphometry Each subject's T1-weighted anatomical data (both time points) was N3-corrected using c3d ( http://www.itksnap.org ) to correct for inten- sity inhomogeneities.,OADS,/arxiv_data1/oa_pdf/35/61/main.PMC5423316.pdf
Volumes were automatically skull-stripped usingBrainsuite ( http://brainsuite.org ) and these masks were manually edited by trained neuroanatomical experts (ELD and FR).,Non-OADS,/arxiv_data1/oa_pdf/35/61/main.PMC5423316.pdf
"This exemplar subject was registered to the ICBM template using the fsl tool ﬂirt(http://fsl.fmrib.ox.ac.uk ), using 7 degrees of freedom registration, with trilinear interpolation, and using mutualinformation as the similarity function for alignment.",OADS,/arxiv_data1/oa_pdf/35/61/main.PMC5423316.pdf
"Neurology Published online before print March 15, 2017. http://dx.doi.org/10.1212/WNL.0000000000003808 .",Non-OADS,/arxiv_data1/oa_pdf/35/61/main.PMC5423316.pdf
This production system is Received 13 February 2017; accepted 13 April 2017; http://dx.doi.org/10.1016/j.omtm.2017.04.005 .,Non-OADS,/arxiv_data1/oa_pdf/36/ee/main.PMC5423317.pdf
5 June 2017 165 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/ee/main.PMC5423317.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.,Non-OADS,/arxiv_data1/oa_pdf/36/ee/main.PMC5423317.pdf
"For liver-directed gene therapy,the most advanced or promising vector system today is recombinantadeno-associated virus (AAV) that has yielded mixed success for Received 29 November 2016; accepted 14 April 2017; http://dx.doi.org/10.1016/j.omtn.2017.04.013 .",Non-OADS,/arxiv_data1/oa_pdf/3c/7f/main.PMC5423318.pdf
339 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/7f/main.PMC5423318.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials and Methods and three ﬁgures and can be found with this article online athttp://dx.doi.org/10.1016/j.omtn.2017.04.013 .,Non-OADS,/arxiv_data1/oa_pdf/3c/7f/main.PMC5423318.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.01.013,Non-OADS,/arxiv_data1/oa_pdf/88/4e/main.PMC5423319.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,2 4 –27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/88/4e/main.PMC5423319.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectra of these species are available online ( http://mediterranee-infection.com/article.php?laref= 256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/88/4e/main.PMC5423319.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,2 4 –27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/88/4e/main.PMC5423319.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,2 4 –27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/88/4e/main.PMC5423319.pdf
Received 28 November 2016; accepted 18 April 2017; http://dx.doi.org/10.1016/j.omtn.2017.04.015 .,Non-OADS,/arxiv_data1/oa_pdf/06/b8/main.PMC5423320.pdf
7 June 2017 Crown Copyright ª2017 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/b8/main.PMC5423320.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials and Methods and ten ﬁgures and can be found with this article online athttp://dx.doi.org/10.1016/j.omtn.2017.04.015 .,Non-OADS,/arxiv_data1/oa_pdf/06/b8/main.PMC5423320.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.009 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/ff/main.PMC5423322.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  73–74 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/7b/ff/main.PMC5423322.pdf
Physical examination http://dx.doi.org/10.1016/j.idcr.2017.04.012 Received 21 October 2016; Received in revised form 2 April 2017; Accepted 10 April 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/b7/c0/main.PMC5423323.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/c0/main.PMC5423323.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.04.017 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/f7/44/main.PMC5423324.pdf
"The posterior wall of the bladder had an irregular mucosal surface with http://dx.doi.org/10.1016/j.gore.2017.04.007 Received 12 February 2017; Received in revised form 26 April 2017; Accepted 27 April 2017⁎Corresponding author at: Thomas Je ﬀerson University Hospital, 833 Chestnut Street, 1st Floor, Philadelphia, PA 19107, USA.",Non-OADS,/arxiv_data1/oa_pdf/5d/9d/main.PMC5423326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/9d/main.PMC5423326.pdf
"FDA, Silver Spring (MD) Available at: http://www.fda.",Non-OADS,/arxiv_data1/oa_pdf/5d/9d/main.PMC5423326.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/22/main.PMC5423327.pdf
E-mail address: ralph.n.martins@gmail.com http://dx.doi.org/10.1016/j.dadm.2017.04.003 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/22/main.PMC5423327.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/22/main.PMC5423327.pdf
All samples were assayed in duplicate via a multiplex biomarker assay plat-form using ECL on the SECTOR Imager 2400A fromMeso Scale Discovery (MSD; http://www.mesoscale.com ).,OADS,/arxiv_data1/oa_pdf/38/22/main.PMC5423327.pdf
"Revelations obtained from the work have led to a markedly clear http://dx.doi.org/10.1016/j.gdata.2017.04.001 Received 4 February 2017; Received in revised form 13 April 2017; Accepted 17 April 2017⁎Corresponding author at: Jadavpur University, Kolkata 700032, West Bengal, India.",Non-OADS,/arxiv_data1/oa_pdf/de/c4/main.PMC5423328.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/de/c4/main.PMC5423328.pdf
Available: http://bioconductor.org/ packages/Rqc/.,OADS,/arxiv_data1/oa_pdf/de/c4/main.PMC5423328.pdf
"McMurdie, S. Holmes, phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data, PLoS ONE 8 (4) (2013) e61217http://dx.plos.org/10.1371/journal.pone.0061217 .",OADS,/arxiv_data1/oa_pdf/de/c4/main.PMC5423328.pdf
"http://dx.doi.org/10.1016/j.ejro.2017.04.003 Received 16 February 2017; Received in revised form 17 April 2017; Accepted 18 April 2017⁎Corresponding author at: 111-3 1-Jodori 24-Chome, Asahikawa, Hokkaido 078-8211, Japan.",Non-OADS,/arxiv_data1/oa_pdf/72/db/main.PMC5423330.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/72/db/main.PMC5423330.pdf
2a and See Supplementary Video S1 in the online version at DOI: http://dx.doi.org/10.1016/j.ejro.2017.04.003 ).,OADS,/arxiv_data1/oa_pdf/72/db/main.PMC5423330.pdf
"(2012), http://dx.doi.org/10.1155/816920 .",Non-OADS,/arxiv_data1/oa_pdf/72/db/main.PMC5423330.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/fc/main.PMC5423331.pdf
Care  was  taken  to  preserve  the left  gastroepiploic  and  the  inferior  splenic  pole  vessels  to  maintain http://dx.doi.org/10.1016/j.ijscr.2017.04.015 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/65/fc/main.PMC5423331.pdf
Available from: https://www.ods.od.nih.gov/Health_ Information/Dietary_Reference_Intakes.aspx.,Non-OADS,/arxiv_data1/oa_pdf/80/6e/AMHSR-6-341.PMC5423333.pdf
Available from: http://www.raosoft.com/samplesize.,Non-OADS,/arxiv_data1/oa_pdf/16/d1/AMHSR-6-362.PMC5423336.pdf
Available from: http://www.unfpa.org/sites/default/files/ pub‑pdf/partnering_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/d6/AMHSR-6-367.PMC5423337.pdf
Available from: http://www.indexmundi.,Non-OADS,/arxiv_data1/oa_pdf/d0/d6/AMHSR-6-367.PMC5423337.pdf
Available from: http://www.countrymeters.info/ en/Nigeria.,Non-OADS,/arxiv_data1/oa_pdf/d0/d6/AMHSR-6-367.PMC5423337.pdf
Available from: http://www.quantitativeskills.com/ sisa/statistics/fishrhlp.htm.,OADS,/arxiv_data1/oa_pdf/d0/d6/AMHSR-6-367.PMC5423337.pdf
(http://www.who.int/medicines/areas/ priority_medicines/BP6_24LBP.pdf) 3.,Non-OADS,/arxiv_data1/oa_pdf/3b/bc/AMHSR-6-375.PMC5423338.pdf
(http://apps.who.int/iris/ bitstream/10665/42407/1/9241545429.pdf) 5.,Non-OADS,/arxiv_data1/oa_pdf/3b/bc/AMHSR-6-375.PMC5423338.pdf
(https://www.ninds.nih.,Non-OADS,/arxiv_data1/oa_pdf/3b/bc/AMHSR-6-375.PMC5423338.pdf
Lancet 2013;  http://dx.doi.org/10.1016/S0140‑6736(13)61132‑0.,OADS,/arxiv_data1/oa_pdf/49/2b/AMHSR-6-380.PMC5423339.pdf
"Elevated opening pressure of 49 cm H 2O was recorded, http://dx.doi.org/10.1016/j.idcr.2017.04.010 Received 30 March 2017; Received in revised form 18 April 2017; Accepted 18 April 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/3c/bd/main.PMC5423343.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3c/bd/main.PMC5423343.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/main.PMC5423344.pdf
Contrast  enhanced  CT(CECT)  abdomen  revealed  a  diffuse  con- centric  long  segmental  circumferential  wall  thickening  of  terminal http://dx.doi.org/10.1016/j.ijscr.2017.04.016 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/main.PMC5423344.pdf
http://www.scareguideline.com,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/main.PMC5423344.pdf
"64  (6)  (2012)  580–588,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/main.PMC5423344.pdf
"Upon http://dx.doi.org/10.1016/j.redox.2017.04.038 Received 3 April 2017; Received in revised form 26 April 2017; Accepted 30 April 2017⁎Correspondence to: Cardiac Aging & Redox Signaling Laboratory, Center for Free Radical Biology, Division of Molecular & Cellular Pathology, Department of Pathology, UAB –The University of Alabama at Birmingham, BMR2 Room 533|901, 19th Street South, Birmingham, AL 35294-2180, United States.",Non-OADS,/arxiv_data1/oa_pdf/12/d8/main.PMC5423345.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/12/d8/main.PMC5423345.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.04.038 .,OADS,/arxiv_data1/oa_pdf/12/d8/main.PMC5423345.pdf
"Hypoxia how- ever aggravated despite non-invasive ventilation, which necessitated an http://dx.doi.org/10.1016/j.idcr.2017.04.016 Received 20 April 2017; Received in revised form 26 April 2017; Accepted 26 April 2017⁎Corresponding author at: Department of Medicine IV, Faculty of Medicine, University of Freiburg, Germany, Hugstetterstrasse 55, 79106 Freiburg, Germany.",Non-OADS,/arxiv_data1/oa_pdf/d2/a5/main.PMC5423347.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/a5/main.PMC5423347.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Perceived risk Prostate cancerAfrican AmericansSocial determinants of healthHealth promotion 1.,Non-OADS,/arxiv_data1/oa_pdf/87/14/main.PMC5423348.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.04.010 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/14/main.PMC5423348.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/14/main.PMC5423348.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/87/14/main.PMC5423348.pdf
"14ACE2 knockout studies re- vealed that the loss of ACE2 leads to exacerbation of liver injury,which can be attenuated by administration of recombinant ACE2 15 or by adeno-associated ACE2 gene therapy.16Similar therapeutic ef- fects were shown by administration of Ang-(1-7)17and as a side-effect of AngII receptor blocker (ARB) therapy.18,19Interestingly, unlike ob- servations in liver ﬁbrosis, ACE2 levels are markedly decreased in lung tissue from patients suffering from idiopathic pulmonary ﬁbrosis (IPF).20In murine models, two studies showed that intraperitoneal injection of exogenous ACE2 protein in bleomycin-induced lung Received 3 January 2017; accepted 7 April 2017; http://dx.doi.org/10.1016/j.omtn.2017.04.006 .",Non-OADS,/arxiv_data1/oa_pdf/85/84/main.PMC5423349.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/84/main.PMC5423349.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2017.,Non-OADS,/arxiv_data1/oa_pdf/85/84/main.PMC5423349.pdf
"It has been demon- strated that lipidomics analysis serves as a powerful tool for under-standing the biochemical mechanisms underlying lipid-related disease processes through quantifying the changes of individual lipid classes, http://dx.doi.org/10.1016/j.redox.2017.04.030 Received 24 March 2017; Received in revised form 10 April 2017; Accepted 23 April 2017⁎Corresponding author at: College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.",Non-OADS,/arxiv_data1/oa_pdf/1a/53/main.PMC5423350.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/53/main.PMC5423350.pdf
"(2016),http://dx.doi.org/10.1002/mas.21492 .",Non-OADS,/arxiv_data1/oa_pdf/1a/53/main.PMC5423350.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/3b/main.PMC5423351.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.013 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/3b/main.PMC5423351.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 147 e150,Non-OADS,/arxiv_data1/oa_pdf/32/3b/main.PMC5423351.pdf
"The sequencing  data were then compared against reference sequences  (VSX1 : NG_008101, SOD1 : NG_008689) using NCBI BLAST  (https://blast.ncbi.nlm.nih.gov/Blast.cgi).",OADS,/arxiv_data1/oa_pdf/3c/7d/JOVR-12-135.PMC5423365.pdf
"To identify interactions between this protein  and other partners that may play important roles in  the pathogeneses of KCN and other eye disorders, we  used STRING software (Search tool for the Retrieval of  Interacting Genes/Proteins: string.embl.de/) and we  identified that VSX1 protein had interactions  with several  essential proteins expressed in eyes according to the National Eye Institute (https://neibank.nei.nih.gov/)  such as ubiquitin‑conjugating enzyme E2I (UBE2I)  and NK2 homeobox 1 (NKX2‑1) [ Figure  3].",OADS,/arxiv_data1/oa_pdf/3c/7d/JOVR-12-135.PMC5423365.pdf
Atlanta: Centers for Disease Control and Prevention; Available  from: http://www.cdc.gov/parasites/acanthamoeba/health_ professionals/acanthamoeba_keratitis_hcp.html.,Non-OADS,/arxiv_data1/oa_pdf/aa/4b/JOVR-12-193.PMC5423374.pdf
https://amiro.lcsr.jhu.,Non-OADS,/arxiv_data1/oa_pdf/71/28/JOVR-12-212.PMC5423376.pdf
Available  from: http://www.ox.ac.uk/news/2016‑ 09‑12‑world‑first‑robot‑ eye‑operation.,Non-OADS,/arxiv_data1/oa_pdf/71/28/JOVR-12-212.PMC5423376.pdf
can be downloaded from http://netland-ntu.github.io/NetLand/.,Non-OADS,/arxiv_data1/oa_pdf/86/4a/btx022.PMC5423452.pdf
"1583 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/4a/btx022.PMC5423452.pdf
Availability and Implementation: https://github.com/AndersenLab/VCF-kit Contact: erik.andersen@northwestern.edu 1 Introduction Population and quantitative genetics investigate how individuals within a population differ.,Non-OADS,/arxiv_data1/oa_pdf/58/d0/btx011.PMC5423453.pdf
"1581 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/d0/btx011.PMC5423453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.TRANSCRIPTION 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"2, 120 –125 http://dx.doi.org/10.1080/21541264.2017.1285851",Non-OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"], and by the NHMRC [APP1100653].ORCID Nan Hao http://orcid.org/0000-0001-5836-3507 Adam C. Palmer http://orcid.org/0000-0001-5028-7028 Ian B. Dodd http://orcid.org/0000-0003-2969-6841 Keith E. Shearwin http://orcid.org/0000-0002-7736-2742 References [1] Palmer AC, Egan JB, Shearwin KE.",Non-OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Transcription 2011; 2:9-14;PMID:21326903;http://dx.doi.org/10.4161/trns.2.1.13511 [2] Shearwin KE, Callen BP, Egan JB.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Trends Genet 2005; 21:339-345; PMID:15922833;http://dx.doi.org/10.1016/j.tig.2005.04.009 [3] Callen BP, Shearwin KE, Egan JB.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"molcel.2004.05.010 [4] Dodd IB, Shearwin KE, Sneppen K. Modelling transcrip- tional interference and DNA looping in gene regulation.J Mol Biol 2007; 369:1200-1213; PMID:17498740; http://dx.doi.org/10.1016/j.jmb.2007.04.041 [5] Hao N, Palmer AC, Ahlgren-Berg A, Shearwin KE, Dodd IB.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"The role of repressor kinetics in relief of transcrip-tional interference between convergent promoters.Nucleic Acids Res 2016; 44:6625-6638; PMID:27378773; http://dx.doi.org/10.1093/nar/gkw600 [6] Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet- Revillet H, Balestrino D, Loh E, Gripenland J, Tiensuu T,Vaitkevicius K et al.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Nature 2009; 459:950-956;PMID:19448609; http://dx.doi.org/10.1038/nature08080 [7] Chatterjee A, Johnson CM, Shu CC, Kaznessis YN, Ramkrishna D, Dunny GM, Hu WS.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Genes Dev 2005; 19:2695-2704;PMID:16291644; http://dx.doi.org/10.1101/gad.1367605 [9] Hongay CF, Grisa ﬁPL, Galitski T, Fink GR.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Cell 2006; 127:735-745; PMID:17110333; http://dx.doi.org/10.1016/j.cell.2006.09.038 [10] van Werven FJ, Neuert G, Hendrick N, Lardenois A, Bur- atowski S, van Oudenaarden A, Primig M, Amon A.Transcription of two long noncoding RNAs mediatesmating-type control of gametogenesis in budding yeast.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
Cell 2012; 150:1170-1181; PMID:22959267; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Cell2006; 127:1209-1221;PMID:17174895;http://dx.doi.org/10.1016/j.cell.2006.10.039 [12] Latos PA, Pauler FM, Koerner MV, Senergin HB, Hud- son QJ, Stocsits RR, Allhoff W, Stricker SH, Klement RM, Warczok KE et al.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Science 2012; 338:1469-1472; PMID:23239737;http://dx.doi.org/10.1126/science.1228110 [13] Bumgarner SL, Dowell RD, Grisa ﬁP, Gifford DK, Fink GR.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Embo J 2003; 22:4719-4727;PMID:12970184; http://dx.doi.org/10.1093/emboj/cdg452[16] Hao N, Krishna S, Ahlgren-Berg A, Cutts EE, Shear- win KE, Dodd IB.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Nucleic Acids Res 2014; 42:8861-8872;PMID:25034688; http://dx.doi.org/10.1093/nar/gku627 [17] Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman J S ,A r k i nA P ,L i mW A .R e p u r p o s i n gC R I S P Ra sa n RNA-guided platform for sequence-speci ﬁc control of gene expression.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Cell 2013; 152:11731183;PMID:23452860;http://dx.doi.org/10.1016/j.cell.2013.02.022 [18] Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraf ﬁni LA.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Nucleic Acids Res 2013; 41:74297437; PMID:23761437; http://dx.doi.org/10.1093/nar/gkt520 [19] Brophy JA, Voigt CA.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"Mol Systems Biol 2016;12:854; PMID:26769567; http://dx.doi.org/10.15252/msb.20156540 [20] Hoffmann SA, Kruse SM, Arndt KM.",OADS,/arxiv_data1/oa_pdf/c5/9a/ktrn-08-02-1285851.PMC5423467.pdf
"2, 67 –74 http://dx.doi.org/10.1080/21541264.2016.1276658",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Circ Res 2012;110:1238-1251; PMID:22539757; http://dx.doi.org/10.1161/CIRCRESAHA.111.246488 [2] Yu J, Auwerx J.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Ann N Y Acad Sci 2009; 1173 Suppl1:E10-E19; PMID:19751409; http://dx.doi.org/10.1111/j.1749-6632.2009.04952.x [3] Chalkiadaki A, Guarente L. The multifaceted functions of sirtuins in cancer.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Nat Rev Cancer 2015; 15:608-624;PMID:26383140; http://dx.doi.org/10.1038/nrc3985 [4] Taylor DM, Maxwell MM, Luthi-Carter R, Kazantsev AG.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Cell Mol Life Sci 2008; 65:4000-4018;PMID:18820996; http://dx.doi.org/10.1007/s00018-008-8357-y [ 5 ] M i c h i s h i t aE ,P a r kJ Y ,B u r n e s k i sJ M ,B a r r e t tJ C ,H o r i k a w aI .",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Mol Biol Cell2005; 16:4623-4635; PMID:16079181; http://dx.doi.org/10.1091/mbc.E05-01-0033 [6] Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L. Mammalian Sir2 homolog SIRT7 is an activator of RNApolymerase I transcription.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Genes Dev 2006; 20:1075-1080; PMID:16618798; http://dx.doi.org/10.1101/gad.1399706 [7] Chen S, Seiler J, Santiago-Reichelt M, Felbel K, Grummt I, Voit R. Repression of RNA polymerase Iupon stress is caused by inhibition of RNA-dependentdeacetylation of PAF53 by SIRT7.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Mol Cell 2013; 52:303-313; PMID:242070 24; http://dx.doi.org/ 10.1016/j.molcel.2013.10.010 [8] McDonald SL, Silver A.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Br J Cancer 2009; 101:209-214; PMID:19603030; http://dx.doi.org/10.1038/sj.bjc.6605174 [9] Dass RA, Sarshad AA, Carson BB, Feenstra JM, Kaur A, O b r d l i kA ,P a r k sM M ,P r a k a s hV ,L o v eD K ,P i e t r a sK .Wnt5a signals through DVL1 to repress ribosomal DNAtranscription by RNA polymerase I. PLoS Genet 2016; 12(8):e1006217; PMID:27500936; http://dx.doi.org/10.1371/journal.pgen.1006217 [10] Prieto JL, McStay B.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Genes Dev 2007; 21:2041-2054;PMID:17699751; http://dx.doi.org/10.1101/gad.436707 [11] Kos M, Tollervey D. Yeast pre-rRNA processing and modi ﬁcation occur cotranscriptionally.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
Mol Cell 2010; 37:809-820; PMID:20347423; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Mol Cell 2013; 51:539-551; PMID:23973377;http://dx.doi.org/10.1016/j.molcel.2013.08.011 [13] L €ubben B, Marshallsay C, Rottmann N, L €uhrmann R. Isolation of U3 snoRNP from CHO cells: a novel 55 kDa protein binds to the central part of U3 snoRNA.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"NucleicAcids Res 1993; 21:5377-5385; PMID:8265352; http://dx.doi.org/10.1093/nar/21.23.5377 [14] Watkins NJ, Bohnsack MT.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Wiley Inter-discip Rev RNA 2012; 3:397-414; PMID:22065625; http://dx.doi.org/10.1002/wrna.117 [15] Chen S, Blank MF, Iyer A, Huang B, Wang L, Grummt I, Voit R. SIRT7-dependent deacetlyation of the U3-55kprotein controls pre-rRNA processing.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Nat Commun2016; 7:10734; PMID:26867678; http://dx.doi.org/10.1038/ncomms10734 [16] Grob A, Roussel P, Wright JE, McStay B, Hernandez- Verdun D, Sirri V. Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"J Cell Sci 2009; 122:489-498; PMID:19174463; http://dx.doi.org/10.1242/jcs.042382 [17] Kiran S, Chatterjee N, Singh S, Kaul SC, Wadhwa R, Ramakrishna G. Intracellular distribution of humanSIRT7 and mapping of nuclear/nucleolar localization sig-nal.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"FEBS J 2013; 280:3451-3466; PMID:23680022; http://dx.doi.org/10.1111/febs.12346 [18] Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen Ket al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Nature 2012; 487:114-118;PMID:22722849; http://dx.doi.org/10.1038/nature11043 [19] Malik S, Villanova L, Tanaka S, Aonuma M, Roy N, Ber- ber E, Pollack JR, Michishita-Kioi E, Chua KF.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Sci Rep 2015; 5:9841; PMID:25923013; http://dx.doi.org/10.1038/srep09841 [20] Tsai YC, Greco TM, Boonmee A, Miteva Y, Cristea IM.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Mol Cell Proteomics 2012; 11:60-76; http://dx.doi.org/10.1074/mcp.A111.015156 [21] Lee N, Kim DK, Kim ES, Park SJ, Kwon JH, Shin J, Park SM, Moon YH, Wang HJ, Gho YS et al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Proteomics 2014;14:1610-1622; PMID:247824 48; http://dx.doi.org/ 10.1002/pmic.201400001 [22] Tsai YC, Greco TM, Cristea IM.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
Mol Cell Pro- teomics 2014; 13:73-83; PMID:24113281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Am J Pathol 2009; 174:1619-1628; PMID:19349354; http://dx.doi.org/10.2353/ajpath.2009.080874 [24] Shin J, He M, Liu Y, Paredes S, Villanova L, Brown K, Qiu X, Nabavi N, Mohrin M, Wojnoonski K et al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Cell Rep 2013; 5:654-665; PMID:24210820; http://dx.doi.org/10.1016/j.celrep.2013.10.007 [25] Tong Z, Wang Y, Zhang X, Kim DD, Sadhukhan S, Hao Q, Lin H. SIRT7 is activated by DNA and deacetylateshistone H3 in the chromatin context.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"ACS Chem Biol2016; 11:742-747; PMID:26907567; http://dx.doi.org/ 10.1021/acschembio.5b01084 [26] Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T, Braun T, Bober E. Sirt7 increasesstress resistance of cardiomyocytes and prevents apopto-sis and in ﬂammatory cardiomyopathy in mice.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Circ Res 2008; 102:703-710; PMID:18239138; http://dx.doi.org/10.1161/CIRCRESAHA.107.164558 [27] Ryu D, Jo YS, Lo Sasso G, Stein S, Zhang H, Perino A, Lee JU, Zeviani M, Romand R, Hottiger MO et al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Cell Metab 2014;20:856-869; PMID:25200183; http://dx.doi.org/10.1016/j.cmet.2014.08.001 [28] Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Park WS et al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Hepatology 2013; 57:1055-1067; PMID:23079745;http://dx.doi.org/10.1002/hep.26101 [29] Li L, Shi L, Yang S, Yan R, Zhang D, Yang J, He L, Li W, Yi X, Sun L et al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Nat Commun 2016; 7:12235; PMID:27436229;http://dx.doi.org/10.1038/ncomms12235 [30] Yoshizawa T, Karim MF, Sato Y, Senokuchi T, Miyata K, Fukuda T, Go C, Tasaki M, Uchimura K, Kadomatsu Tet al.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Cell Metab 2014;19:712-721; PMID:24703702; http://dx.doi.org/10.1016/j.cmet.2014.03.006 [31] Nunnari J, Suomalainen A. Mitochondria: in sickness and in health.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Nat Com- mun 2016; 7:12497; PMID:27511885; http://dx.doi.org/10.1038/ncomms12497 [33] Hubbi ME, Hu H, Kshitiz Gilkes DM, Semenza GL.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
J Biol Chem 2013; 288:20768-20775; PMID:23750001; http://dx.doi.org/10.1074/jbc.M113.476903TRANSCRIPTION 73,Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"[34] Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M. Nucleolar proteome dynamics.Nature 2005; 433:77-83; PMID:15635413; http://dx.doi.org/10.1038/nature03207 [35] Boisvert FM, Lamond AI.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Proteomics 2010:10:4087-4097; PMID:21080495; http://dx.doi.org/10.1002/ pmic.201000213 [36] Boulon S, Westman BJ, Hutten S, Boisvert FM, Lamond AI.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Mol Cell2010; 40:216-227; PMID:20965417; http://dx.doi.org/10.1016/j.molcel.2010.09.024 [37] Moore HM, Bai B, Boisvert FM, Latonen L, Rantanen V, Simpson JC, Pepperkok R, Lamond AI, Laiho M. Quantita-tive proteomics and dynamic imaging of the nucleolus reveal distinct responses to UV and ionizing radiation.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Mol Cell Proteomics 2011; 10:M111.009241; PMID:21778410; http://dx.doi.org/10.1074/mcp.M111.009241 [38] Zhang S, Chen P, Huang Z, Hu X, Chen M, Hu S, Hu Y, Cai T. SIRT7 promotes gastric cancer growth and inhibitsapoptosis by epigenetically inhibiting miR-34a.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Sci Rep2015; 5:9787; PMID:25860861; http://dx.doi.org/10.1038/srep09787 [39] Aljada A, Saleh AM, Alkathiri M, Shamsa HB, Al-Bawab A, Nasr A. Altered Sirtuin 7 expression is associated with earlystage breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Breast Cancer (Auckl) 2015; 9:3-8;PMID:25922576; http://dx.doi.org/10.4137/BCBCR.S23156[40] Wang HL, Lu RQ, Xie SH, Zheng H, Wen XM, Gao X, Guo L. SIRT7 exhibits oncogenic potential in humanovarian cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Asian Pac J Cancer Prev 2015;16:3573-3577; PMID:25921180; http://dx.doi.org/10.7314/APJCP.2015.16.8.3573 [41] Shi H, Zhang D, Liu Y, Fang P. MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Oncol Rep 2016; 36:3051-3057; PMID:27599551; http://dx.doi.org/10.3892/or.2016.5063 [42] Vazquez BN, Thackray JK, Simonet NG, Kane-Goldsmith N, Martinez-Redondo P, Nguyen T, Bunting S, Vaquero A,Tisch ﬁeld JA, Serrano L. SIRT7 promotes genomic integrity and modulates non-homologous end joining DNA repair.EMBO J 2016; 35:1488-1503; PMID:27225932; http://dx.doi.org/10.15252/embj.201593499 [43] Ogiwara H, Ui A, Otsuka A, Satoh H, Yokomi I, Naka- jima S, Yasui A, Yokota J, Kohno T. Histone acetylationby CBP and p300 at double-strand break sites facilitatesSWI/SNF chromatin remodeling and the recruitment ofnon-homologous end joining factors.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"Oncogene 2011;30:2135-2146; PMID:21217779; http://dx.doi.org/10.1038/onc.2010.592 [44] Mohrin M, Shin J, Liu Y, Brown K, Luo H, Xi Y, Haynes CM.",OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
Science 2015; 347:1374-1377; PMID:25792330;http://dx.doi.org/10.1126/science.aaa236174 M. F. BLANK AND I. GRUMMT,OADS,/arxiv_data1/oa_pdf/ba/4f/ktrn-08-02-1276658.PMC5423475.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.TRANSCRIPTION 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"2, 91 –98 http://dx.doi.org/10.1080/21541264.2016.1268245",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"ORCID Babita Singh http://orcid.org/0000-0002-7989-9084 Eduardo Eyras http://orcid.org/0000-0003-0793-6218 References [1] Hanahan D, Weinberg RA.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cell 2011; 144:646-674; PMID:21376230;http://dx.doi.org/10.1016/j.cell.2011.02.013 [2] Feinberg AP, Koldobskiy MA, G €ond€or A. Epigenetic modulators, modi ﬁers and mediators in cancer aetiology and progression.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Rev Genet 2016; 17:284-299; PMID:26972587; http://dx.doi.org/10.1038/nrg.2016.13 [3] Fu X-D, Ares M. Context-dependent control of alterna- tive splicing by RNA-binding proteins.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Rev Genet2014; 15:689-701; PMID:25112293; http://dx.doi.org/10.1038/nrg3778 [4] Chabot B, Shkreta L. Defective control of pre-messenger RNA splicing in human disease.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
J Cell Biol 2016; 212:13-27; PMID:26728853; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
RNA splicing factors as oncoproteins and tumour suppressors.Nat Rev Cancer 2016; 16:413-430; PMID:27282250;http://dx.doi.org/10.1038/nrc.2016.51 [6] Anczuk /C19ow O. Krainer AR Splicing-factor alterations in cancers.,Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"RNA 2016; 22:1285-1301; PMID:27530828;http://dx.doi.org/10.1261/rna.057919.116 [7] Sebesty /C19en E, Singh B, Mi ~nana B, Pag /C18es A, Mateo F, Pujana MA, Valc /C19arcel J, Eyras E. Large-scale analysis of genome and transcriptome alterations in multiple tumorsunveils novel cancer-relevant splicing networks.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"GenomeRes 2016; 26:732-744; PMID:27197215; http://dx.doi.org/10.1101/gr.199935.115 [8] Das S, Anczuk /C19ow O, Akerman M, Krainer AR.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nature 2010;463:364-368; PMID:20010808; http://dx.doi.org/10.1038/nature08697 [10] Hsu TY-T, Simon LM, Neill NJ, Marcotte R, Sayad A, Bland CS, Echeverria GV, Sun T, Kurley SJ, Tyagi S et al.The spliceosome is a therapeutic vulnerability in MYC- driven cancer.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nature 2015; 525:384-388;PMID:26331541; http://dx.doi.org/10.1038/nature14985 [11] Koh CM, Bezzi M, Low DH, Ang WX, Teo SX, Gay FP, Al- Haddawi M, Tan SY, Osato M, Sab /C18o A et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nature 2015; 523:96-100; PMID:25970242; http://dx.doi.org/10.1038/nature14351 [12] Lu Z, Huang Q, Park JW, Shen S, Lin L, Tokheim CJ, Henry MD, Xing Y. Transcriptome-wide landscape ofpre-mRNA alternative splicing associated with metastaticcolonization.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Mol Cancer Res 2015; 13:305-318;PMID:25274489; http://dx.doi.org/10.1158/1541-7786.MCR-14-0366 [13] Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Con- deelis JS, Oktay MH, Burge CB, Gertler FB.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"PLoSGenet 2011; 7:e1002218; PMID:21876675; http://dx.doi.org/10.1371/journal.pgen.1002218 [14] Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D, Bailey SL, Bhavsar EB, Chan B et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cell Rep 2015; 13:1033-1045; PMID:26565915; http://dx.doi.org/10.1016/j.celrep.2015.09.053 [15] Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, de laGrange P, Roman-Roman S et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"SF3B1 mutations areassociated with alternative splicing in uveal melanoma.Cancer Discov 2013; 3:1122-1129; PMID:23861464; http://dx.doi.org/10.1158/2159-8290.CD-13-0330 [16] Brooks AN, Choi PS, de Waal L, Sharifnia T, Imielinski M, Saksena G, Pedamallu CS, Sivachenko A, RosenbergM, Chmielecki J et al.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"PLoSOne 2014; 9:e87361; PMID:24498085; http://dx.doi.org/10.1371/journal.pone.0087361 [17] Sebestyen E, Zawisza M, Eyras E. Detection of recurrent alternative splicing switches in tumor samples reveals novelsignatures of cancer.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nucleic Acids Res 2015; 43:1345-1356;PMID:25578962; http://dx.doi.org/10.1093/nar/gku1392 [18] Jung H, Lee D, Lee J, Park D, Kim YJ, Park WY, Hong D, Park PJ, Lee E. Intron retention is a widespread mechanismof tumor-suppressor inactivation.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Genet 2015; 47:1242-1248; PMID:26437032; http://dx.doi.org/10.1038/ng.3414 [19] Alsafadi S, Houy A, Battistella A, Popova T, Wassef M, Henry E, Tirode F, Constantinou A, Piperno-Neumann S,Roman-Roman S et al.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Commun 2016; 7:10615; PMID:26842708;http://dx.doi.org/10.1038/ncomms10615 [20] Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramak- rishnan A, Li Y, Chung YR, Micol JB, Murphy ME et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"2015; 27:617-30; PMID:25965569; http://dx.doi.org/ 10.1016/j.ccell.2015.04.006 [21] Lee SC-W, Abdel-Wahab O.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Med 2016; 22:976-986;PMID:27603132; http://dx.doi.org/10.1038/nm.4165 [22] Supek F, Mi ~nana B, Valc /C19arcel J, Gabald /C19on T, Lehner B. Syn- o n y m o u sm u t a t i o n sf r e q u e n t l ya c ta sd r i v e rm u t a t i o n si n human cancers.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cell 2014; 156:1324-1335; PMID:24630730; http://dx.doi.org/10.1016/j.cell.2014.01.051 [23] Sterne-Weiler T, Sanford JR. Exon identity crisis: disease- causing mutations that disrupt the splicing code.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"GenomeBiol 2014; 15:201; PMID:24456648; http://dx.doi.org/10.1186/gb4150 [24] Salton M, Kasprzak WK, Voss T, Shapiro BA, Poulikakos PI MT.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Commun Dis 2015; 6:7103; PMID: 25971842; http://dx.doi.org/10.1038/ncomms8103 [25] Diederichs S, Bartsch L, Berkmann JC, Fr €ose K, Heit- mann J, Hoppe C, Iggena D, Jazmati D, Karschnia P, Lin-senmeier M et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"EMBO Mol Med 2016; 8:442-57; PMID:26992833; http://dx.doi.org/10.15252/emmm.201506055 [26] Corvelo A, Hallegger M, Smith CWJ, Eyras E. Genome- wide association between branch point properties andalternative splicing.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"PLoS Comput Biol 2010; 6:e1001016;PMID:21124863; http://dx.doi.org/10.1371/journal.pcbi.1001016 [27] Lovci MT, Ghanem D, Marr H, Arnold J, Gee S, Parra M, Liang TY, Stark TJ, Gehman LT, Hoon S et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Struct Mol Biol2013; 20:1434-1442; PMID:24213538; http://dx.doi.org/10.1038/nsmb.2699 [28] Naftelberg S, Schor IE, Ast G, Kornblihtt AR.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Annu Rev Biochem 2015; 84:165-198; PMID:26034889; http://dx.doi.org/10.1146/ annurev-biochem-060614-034242 [29] Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T. Epi- genetics in alternative pre-mRNA splicing.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cell 2011;144:16-26; PMID:21215366; http://dx.doi.org/10.1016/j.cell.2010.11.056 [30] Grosso AR, Leite AP, Carvalho S, Matos MR, Martins FB, V/C19ıtor AC, Desterro JM, Carmo-Fonseca M, de Almeida SF.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Elife 2015; 4:e09214; PMID:26575290; http://dx.doi.org/10.7554/eLife.09214 [31] Simon JM, Hacker KE, Singh D, Brannon AR, Parker JS, Weiser M, Ho TH, Kuan PF, Jonasch E, Furey TS et al.Variation in chromatin accessibility in human kidneycancer links H3K36 methyltransferase loss with wide- spread RNA processing defects.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Genome Res 2014;24:241-250; PMID:24158655; http://dx.doi.org/10.1101/ gr.158253.113 [32] Shkreta L, Chabot B.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Biomolecules 2015; 5:2935-2977;PMID:26529031; http://dx.doi.org/10.3390/biom5042935 [33] Shkreta L, Toutant J, Durand M, Manley JL, Chabot B. SRSF10 connects DNA damage to the alternative splicing of transcripts encoding apoptosis, cell-cycle control, and DNA repair factors.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
Cell Rep 2016; 17:1990-2003; PMID:27851963;http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
Mol Cell 2014; 54:445- 459; PMID:24746700; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Genome Med 2016; 8:85; PMID:27535130; http://dx.doi.org/10.1186/s13073-016-0339-3 [36] Bechara EG, Sebesty /C19en E, Bernardis I, Eyras E, Valc /C19arcel J. RBM5, 6, and 10 differentially regulate NUMB alterna- tive splicing to control cancer cell proliferation.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Mol Cell 2013; 52:720-733; PMID:24332178; http://dx.doi.org/10.1016/j.molcel.2013.11.010 [37] Ghigna C, Giordano S, Shen H, Benvenuto F, Castiglioni F, Comoglio PM, Green MR, Riva S, Biamonti G. Cellmotility is controlled by SF2/ASF through alternativesplicing of the Ron protooncogene.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
Mol Cell 2005;20:881-890; PMID:16364913; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"RNA Biol 2010; 7:495-503;PMID:20864806; http://dx.doi.org/10.4161/rna.7.4.12744 [39] Buljan M, Chalancon G, Eustermann S, Wagner GP, Fux- reiter M, Bateman A, Babu MM.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Mol Cell 2012;46:871-883; PMID:22749400; http://dx.doi.org/10.1016/j.molcel.2012.05.039 [40] Ellis JD, Barrios-Rodiles M, Colak R, Irimia M, Kim T, Calarco JA, Wang X, Pan Q, O ’Hanlon D, Kim PM et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
Cell Rep2016; 16(10):2605-2617; PMID:27568559; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Bioinfor-matics 2003; 19 (Suppl 1):i118-121; PMID:12855447;http://dx.doi.org/10.1093/bioinformatics/btg1015 [43] Shen S, Wang Y, Wang C, Wu YN, Xing Y. SURVIV for survival analysis of mRNA isoform variation.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nat Com- mun 2016; 7:11548; PMID:27279334; http://dx.doi.org/10.1038/ncomms11548 [44] Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Science 2011; 331:435-439; PMID:21163964;http://dx.doi.org/10.1126/science.1198056 [45] Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G, Shi H, Ate ﬁM, Titz B, Gabay MT et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nature 2011; 480:387-390;PMID:22113612; http://dx.doi.org/10.1038/nature10662 [46] Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR et al.Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cancer Discov 2015; 5:1282-1295; PMID:26516065; http://dx.doi.org/10.1158/2159-8290.CD-15-1020 [47] Kong-Beltran M, Seshagiri S, Zha J, Zhu W, Bhawe K, Mendoza N, Holcomb T, Pujara K, Stinson J, Fu L et al.Somatic mutations lead to an oncogenic deletion of Metin lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
Cancer Res 2006; 66:283-289;PMID:16397241; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cancer Discov2015; 5:850-860; PMID:25971938; http://dx.doi.org/10.1158/2159-8290.CD-15-0285 [49] Paik PK, Drilon A, Fan PD, Yu H, Rekhtman N, Gins- berg MS, Borsu L, Schultz N, Berger MF6, Rudin CMet al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Cancer Discov 2015; 5:842-849; PMID:25971939; http://dx.doi.org/10.1158/2159-8290.CD-14-1467 [50] Havens MA, Hastings ML.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Nucleic Acids Res2016; 44 6549-6563; PMID:27288447; http://dx.doi.org/10.1093/nar/gkw533 [51] Salton M, Misteli T. Small molecule modulators of pre- mRNA splicing in cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"Trends Mol Med2016; 22:28-37; PMID:26700537; http://dx.doi.org/10.1016/j.molmed.2015.11.005 [52] Zong FY, Fu X, Wei WJ, Luo YG, Heiner M, Cao LJ, Fang Z, Fang R, Lu D, Ji H et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"RNA 2014; 20:189-201;PMID:24335142; http://dx.doi.org/10.1261/rna.042168.113 [54] Fei DL, Motowski H, Chatrikhi R, Prasad S, Yu J, Gao S, Kielkopf CL, Bradley RK, Varmus H et al.",OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
PLoS Genet 2016; 12:e1006384; PMID:27776121;http://dx.doi.org/10.1371/journal.pgen.100638498 B. SINGH AND E. EYRAS,OADS,/arxiv_data1/oa_pdf/56/dd/ktrn-08-02-1268245.PMC5423477.pdf
"2, 75 –80 http://dx.doi.org/10.1080/21541264.2016.1257972",Non-OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"ORCID Julien Gagneur http://orcid.org/0000-0002-8924-8365 References [1] Schwanh €ausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quanti ﬁcation of mammalian gene expression control.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Nature 2011;473:337-342; PMID: 21593866; http://dx.doi.org/10.1038/nature10098 [2] Marguerat S, Lawler K, Brazma A, B €ahler J.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Contributions of transcription and mRNA decay to gene expression dynamics of ﬁssion yeast in response to oxidative stress.RNA Biol 2014; 11:12; PMID: 25007214; http://dx.doi.org/ 10.4161/rna.29196 [3] Rabani M, Raychowdhury R, Jovanovic M, Rooney M, Stumpo DJ, Pauli A, Hacohen N, Schier AF, BlackshearPJ, Friedman N et al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Cell 2014; 159:1698-1710; PMID:25497548; http://dx.doi.org/10.1016/j.cell.2014.11.015 [4] Raghavan A, Ogilvie RL, Reilly C, Abelson ML, V a s d e w a n iJ ,K r a t h w o h lM ,B o h j a n e nP R .G e n o m e -wide analysis of mRNA decay in resting and activatedprimary human T lymphocytes.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
Nucleic Acids Res2002; 30:5529-5538; PMID: 12490721; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Mol Cell Biol 2014; 34:4078-4087; PMID:25154419; http://dx.doi.org/10.1128/MCB.00535-14 [6] Munchel SE, Shultzaberger RK, Takizawa N, Weis K. Dynamic pro ﬁling of mRNA turnover reveals gene-spe- ciﬁc and system-wide regulation of mRNA decay.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Mol Biol Cell 2011; 22:2787-2795; PMID:21680716; http://dx.doi.org/10.1091/mbc.E11-01-0028 [7] Pai AA, Cain CE, Mizrahi-Man O, De Leon S, Lewellen N, Veyrieras J-B, Degner JF, Gaffney DJ, Pickrell JK, Stephens M et al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"PLoS Genet 2012; 8:e1003000; PMID:23071454;http://dx.doi.org/10.1371/journal.pgen.1003000 [8] Sun M, Schwalb B, Schulz D, Pirkl N, Etzold S, Larivi /C18ere L, Maier KC, Seizl M, Tresch A, Cramer P. Comparativedynamic transcriptome analysis (cDTA) reveals mutual feedback between mRNA synthesis and degradation.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Genome Res 2012; 22:1350-1359; PMID:22466169;http://dx.doi.org/10.1101/gr.130161.111 [9] Eser P, Demel C, Maier KC, Schwalb B, Pirkl N, Martin DE, Cramer P, Tresch A.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Periodic mRNA synthesis anddegradation co-operate during cell cycle gene expression.Mol Syst Biol 2014; 10:717; PMID:24489117; http://dx.doi.org/10.1002/msb.134886 [10] Zeisel A, K €ostler WJ, Molotski N, Tsai JM, Krauthgamer R, Jacob-Hirsch J, Rechavi G, Soen Y, Jung S, Yarden Yet al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Mol Syst Biol 2011; 7:529;PMID:21915116; http://dx.doi.org/10.1038/msb.2011.62 [11] Rabani M, Levin JZ, Fan L, Adiconis X, Raychowdhury R, Garber M, Gnirke A, Nusbaum C, Hacohen N, Friedman N et al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Nat Biotechnol 2011; 29:436-442;PMID:21516085; http://dx.doi.org/10.1038/nbt.1861 [12] Windhager L, Bonfert T, Burger K, Ruzsics Z, Krebs S, Kaufmann S, Malterer G, L ’hernault A, Schilhabel M, Schreiber S et al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
Genome Res 2012; 22:2031-2042; PMID:22539649; http://dx.doi.org/10.1101/gr.131847.111TRANSCRIPTION 79,OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"MolSyst Biol 2016; 12:857; PMID:26883383; http://dx.doi.org/10.15252/msb.20156526 [14] Wilhelm BT, Marguerat S, Watt S, Schubert F, Wood V, Goodhead I, Penkett CJ, Rogers J, B €ahler J.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Nature 2008; 453:1239-1243;PMID:18488015; http://dx.doi.org/10.1038/nature07002 [15] Khodor YL, Rodriguez J, Abruzzi KC, Tang C-HA, Marr MT, Rosbash M. Nascent-seq indicates widespreadcotranscriptional pre-mRNA splicing in Drosophila.Genes Dev 2011; 25:2502-2512; PMID:22156210; http://dx.doi.org/10.1101/gad.178962.111 [16] Gaidatzis D, Burger L, Florescu M, Stadler MB.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Nat Bio-tech 2015; 33:722-729; PMID: 26098447; http://dx.doi.org/10.1038/nbt.3269 [17] Holstege FC, Jennings EG, Wyrick JJ, Lee TI, Hengartner CJ, Green MR, Golub TR, Lander ES, Young RA.",Non-OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Cell 1998; 95:717-728; PMID:9845373; http://dx.doi.org/ 10.1016/S0092-8674(00)81641-4 [18] Wang Y, Liu CL, Storey JD, Tibshirani RJ, Herschlag D, Brown PO.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Mol Cell Biol 2004; 24:5534-5547; PMID:15169913;http://dx.doi.org/10.1128/MCB.24.12.5534-5547.2004 [20] D €olken L, Ruzsics Z, R €adle B, Mages RG, Hoffmann R, Dickinson P, Forster T. High-resolution geneexpression pro ﬁl i n gf o rs i m u l t a n e o u sk i n e t i cp a r a m e - t e ra n a l y s i so fR N As y n t h e s i sa n dd e c a yH i g h - r e s o l u -tion gene expression pro ﬁling for simultaneous kinetic parameter analysis of RNA synthesis and decay.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"RNA2008; 14:1959-1972; PMID:18658122; http://dx.doi.org/10.1261/rna.1136108 [21] Miller C, Schwalb B, Maier K, Schulz D, D €umcke S, Zacher B, Mayer A, Sydow J, Marcinowski L, D €olken L et al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Mol Syst Biol 2011;7:458; PMID:21206491; http://dx.doi.org/10.1038/msb.2010.112 [22] Barrass JD, Reid JEA, Huang Y, Hector RD, Sanguinetti G, Beggs JD, Granneman S. Transcriptome-wide RNAprocessing kinetics revealed using extremely short 4tU labeling.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Genome Biol 2015; 16:282; PMID:26679539; http://dx.doi.org/10.1186/s13059-015-0848-1 [23] Schwalb B, Michel M, Zacher B, Fr €uhauf K, Demel C, Tresch A ,G a g n e u rJ ,C r a m e rP .T T - s e qm a p st h eh u m a nt r a n s i e n ttranscriptome.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Science 2016; 352:1225-1228;PMID:27257258; http://dx.doi.org/10.1126/science.aad9841 [24] de Pretis S, Kress T, Morelli MJ, Melloni GEM, Riva L, Amati B, Pelizzola M, Pretis S De, Kress T, Morelli MJ et al.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"Bioinformatics2015; 31:1-7; PMID:25189783; http://dx.doi.org/10.1093/bioinformatics/btv288 [25] Burger K, M €uhl B, Kellner M, Rohrmoser M, Gruber-Eber A, Windhager L, Friedel CC, D €olken L, Eick D. 4-thiouridine inhibits rRNA synthesis and causes a nucleolar stress response.",Non-OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"RNA Biol 2013; 10:1623-1630; PMID:24025460; http://dx.doi.org/10.4161/rna.26214 [26] Pelechano V, Wei W, Steinmetz LM.",OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
Nature 2013; 497:127-131; PMID:23615609; http://dx.doi.org/10.1038/nature1212180 L. WACHUTKA AND J. GAGNEUR,Non-OADS,/arxiv_data1/oa_pdf/f9/f3/ktrn-08-02-1257972.PMC5423486.pdf
"OcAlphaMed Press 1083-7159/2017/$20.00/0 http://dx.doi.org/10.1634/theon- cologist.2016-0308 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/15/04/onco12081.PMC5423502.pdf
See http://www.TheOncologist.com for supplemental material available online.600 Periodic Steroid Premedication on Bone Metabolism Oc2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/04/onco12081.PMC5423502.pdf
Statistical inference is still  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/b0/emss-71931.PMC5423529.pdf
"INTERNATIONAL SOCIETY FOR PROSTHETICS AND ORTHOTICS https://doi.org/10.1177/0309364616685230Prosthetics and Orthotics International 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d7/3c/10.1177_0309364616685230.PMC5423530.pdf
"More definitive evaluation in the form of randomized cross-over trials comparing comfort and functional performance with the NU-FlexSIV Socket to the ICS in persons with unilat-eral TF amputation are needed, and fortunately underway (https://clinicaltrials.gov/ct2/show/NCT02678247).",Non-OADS,/arxiv_data1/oa_pdf/d7/3c/10.1177_0309364616685230.PMC5423530.pdf
"In: 12th World Congress of the International Society for Prosthetics and Orthotics, Vancouver, BC, Canada, 29 July–3 August 2007. http://www.ispoint.org/ sites/default/files/ispo2007-programme-july3.pdf  19.",Non-OADS,/arxiv_data1/oa_pdf/d7/3c/10.1177_0309364616685230.PMC5423530.pdf
"In: 41st American Academy of Orthotists and Prosthetists  annual meeting & scientific symposium, New Orleans, LA, 18–21 February 2015. http://www.oandp.org/publications/jop/2015/2015-36.pdf",Non-OADS,/arxiv_data1/oa_pdf/d7/3c/10.1177_0309364616685230.PMC5423530.pdf
"https://doi.org/10.1177/0309364616685229Prosthetics and Orthotics International 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/fc/24/10.1177_0309364616685229.PMC5423533.pdf
"For our socket, we consider a liner to “work well” if it has high compressive stiffness, high shear stiffness, high coefficient of friction, and high thermal conductivity using the definitions pro-vided on the prosthetic liner assistant website (http://www.linerassist.org/).",Non-OADS,/arxiv_data1/oa_pdf/fc/24/10.1177_0309364616685229.PMC5423533.pdf
"The O&P Edge, November 2002. http://www.oandp.com/ articles/2002-11_01.asp  19.",Non-OADS,/arxiv_data1/oa_pdf/fc/24/10.1177_0309364616685229.PMC5423533.pdf
"The  O&P Edge, June 2004. http://www.oandp.com/articles/   2004-06_03.asp  21.",Non-OADS,/arxiv_data1/oa_pdf/fc/24/10.1177_0309364616685229.PMC5423533.pdf
"https://doi.org/10.1177/0748730417693480JOURNAL OF BIOLOGICAL RHYTHMS, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f2/38/10.1177_0748730417693480.PMC5423535.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/73/1f/itt-6-017.PMC5423536.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/73/1f/itt-6-017.PMC5423536.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ImmunoTargets and Therapy  2017:6 17–29ImmunoTargets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 17 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/ITT .S125429FDA-approved immunosuppressants targeting  staphylococcal superantigens: mechanisms  and insights  T eresa Krakauer Department of Immunology,   Molecular Translational Sciences Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick,  MD, USAAbstract:  Immunostimulating staphylococcal enterotoxin B (SEB) and related superantigenic  toxins cause diseases in human beings and laboratory animals by hyperactivating cells of the  immune system.",Non-OADS,/arxiv_data1/oa_pdf/73/1f/itt-6-017.PMC5423536.pdf
"In addition, recognition of a superantigen:MHC II complex by the TCR is not restricted by the major histo-compatibility complex (MHC) and depends upon the variable region within a TCR β Correspondence: Teresa Krakauer Department of Immunology, Molecular Translational Sciences Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702-5011, USATel +1 301 619 4733Fax +1 301 619 2348Email Teresa.Krakauer.civ@mail.milJournal name: ImmunoTargets and Therapy  Article Designation: REVIEWY ear: 2017V olume: 6Running head verso: KrakauerRunning head recto: FDA-approved immunosuppressants targeting staphylococcal superantigensDOI: http://dx.doi.org/10.2147/ITT.S125429",Non-OADS,/arxiv_data1/oa_pdf/73/1f/itt-6-017.PMC5423536.pdf
"ImmunoTargets and Therapy  2017:6submit your manuscript | www.dovepress.com Dovepress Dovepress ImmunoTargets and Therapy  Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/immunotargets-and-therapy-journalImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/73/1f/itt-6-017.PMC5423536.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/1f/itt-6-017.PMC5423536.pdf
This is an o pen access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/82/fe/jbjiv01p0050.PMC5423556.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/82/fe/jbjiv01p0050.PMC5423556.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/08/23/jbjiv01p0025.PMC5423557.pdf
See http://ivyspring.com/t erms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/08/23/jbjiv01p0025.PMC5423557.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/bc/jbjiv01p0017.PMC5423558.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/92/bc/jbjiv01p0017.PMC5423558.pdf
This  is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jbjiv01p0001.PMC5423559.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jbjiv01p0001.PMC5423559.pdf
Material and Methods   The authors created a questionnaire using an  online tool: http://freeonlinesurvey.com.,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jbjiv01p0001.PMC5423559.pdf
http://ebjis.org/icm -on-pji.htm  [Accessed 5 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/e9/63/jbjiv01p0001.PMC5423559.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/5c/fc/jbjiv01p0042.PMC5423560.pdf
"http://www.jbji.net/v01p0042s1.pdf   Acknowledgement   Part of this work was presented at an  interdisciplinary seminar (Dental University Clinic,  Department of Infectious Diseases, and Department  of Orthopaedic Surg ery, 21 July 2016)  at the  University Hospital Bern, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/5c/fc/jbjiv01p0042.PMC5423560.pdf
http://orthodoc.aaos.org/davidgrimmmd/Antibiotic%20Prophylaxis%20for %20Patients%20after%20Total%20Joint%20Replacement.pdf   58.,Non-OADS,/arxiv_data1/oa_pdf/5c/fc/jbjiv01p0042.PMC5423560.pdf
http://www.aaos.org/research/guidelines/PUDP/PUDP_guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/fc/jbjiv01p0042.PMC5423560.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/9e/jbjiv01p0059.PMC5423561.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/d4/9e/jbjiv01p0059.PMC5423561.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/27/jbjiv01p0054.PMC5423562.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/5d/27/jbjiv01p0054.PMC5423562.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/jbjiv01p0020.PMC5423563.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/jbjiv01p0020.PMC5423563.pdf
http://www.idsociety.org/IDSA_Practice_Guidelines/ .,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/jbjiv01p0020.PMC5423563.pdf
http://www.rivm.nl/Onderwerpen/P/PREZIES/   Incidentieonderzoek_POWI/Definities .,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/jbjiv01p0020.PMC5423563.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/84/f5/jbjiv01p0007.PMC5423564.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/05/81/jbjiv01p0034.PMC5423565.pdf
"Clinical evaluati on was performed using the SF -12 Health  Survey score and the Harris Hip or the Knee Society Scores as appropriate; any signs of early SSI, including pain, redness, warmth, swelling, draining  wound, fistulas, etc., according to the CDC  Procedure- associated Module SSI (http://www.cdc.",Non-OADS,/arxiv_data1/oa_pdf/05/81/jbjiv01p0034.PMC5423565.pdf
Categorical data were analyzed using Fisher`s exact test; continuous data were compared using Student’s t test (http://graphpad.com/).,OADS,/arxiv_data1/oa_pdf/05/81/jbjiv01p0034.PMC5423565.pdf
https://www.stat.,Non-OADS,/arxiv_data1/oa_pdf/05/81/jbjiv01p0034.PMC5423565.pdf
This is an open access article distributed under the terms of the Creat ive Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/b2/jbjiv01p0065.PMC5423566.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/db/b2/jbjiv01p0065.PMC5423566.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/jbjiv01p0010.PMC5423567.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/jbjiv01p0010.PMC5423567.pdf
"GMS Interdisciplinary Plastic  and Reconstructive Surgery , DGPW  2012;:1.   http://www.egms.de/en/journals/iprs/2012-1/iprs000011.shtml   8.",Non-OADS,/arxiv_data1/oa_pdf/0b/57/jbjiv01p0010.PMC5423567.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/86/d9/jbjiv01p0031.PMC5423568.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/50/jbjiv02p0038.PMC5423569.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/38/jbjiv02p0023.PMC5423570.pdf
This is an open  access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/96/jbjiv02p0015.PMC5423571.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/e0/96/jbjiv02p0015.PMC5423571.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/f8/jbjiv02p0063.PMC5423572.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution ( CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/69/c0/jbjiv02p0003.PMC5423573.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/69/c0/jbjiv02p0003.PMC5423573.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/01/b9/jbjiv02p0001.PMC5423574.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/01/b9/jbjiv02p0001.PMC5423574.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/3b/jbjiv02p0052.PMC5423575.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/ad/3b/jbjiv02p0052.PMC5423575.pdf
"From:  https://en.wikipedia.org/wiki/File:Spongy_bone_ -_trabecules.jpg#filelinks Courtesy: Department of Histology, Jagiellonian University Medical College.",Non-OADS,/arxiv_data1/oa_pdf/ad/3b/jbjiv02p0052.PMC5423575.pdf
From: https://commons.wikimedia.or g/wiki/File%3AGray72 -en.svg.,Non-OADS,/arxiv_data1/oa_pdf/ad/3b/jbjiv02p0052.PMC5423575.pdf
This is an open access article distributed under the terms of  the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5a/89/jbjiv02p0029.PMC5423576.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/5a/89/jbjiv02p0029.PMC5423576.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d9/93/jbjiv02p0010.PMC5423577.pdf
"2      http://www.jbji.net  77  JJoouurrnnaall  ooff  BBoonnee  aanndd  JJooiinntt  IInnffeeccttiioonn   2017; 2(2): 77-83. doi: 10.7150/ jbji.17353  Research Paper   Efficacy of Antibiotic Suppressive Therapy in  Patients  with a Prosthetic Joint Infection   Marjan  Wouthuyzen -Bakker1, Jasperina M. Nijman1, Greetje A. Kampinga2, Sander van Assen1#, Paul C.  Jutte3  1Department of Internal Medicine/ Infectious diseases ; 2Department of Medical Microbiology ; 3Department of Orthopedic Surgery, University of Groningen,  University Medical Center Groningen, the Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC B Y-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
"2    http://www.jbji.net  78  and several host -factors.1-4 In general, if the infection  is considered as difficult to treat, a two -stage surgical  revision is indicated.",Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
2    http://www.jbji.net  79  Follow -up  Our patients visited the outpatient clinic at  regular intervals (on averag e with a 3 -6 month  interval) to evaluate treatment response.,Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
2    http://www.jbji.net  80  Treatment outcome and follow -up  The median follow -up of patients was 21 months  (range: 3 -81).,Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
"2    http://www.jbji.net  81  Antibiotic suppressive therapy and reported  side effects   The ‘regular’ antibiotic treatment, the type of  AST, the reported side effects and whether these side  effects led to a change in antibiotic treatment or dose  adjustments, are shown in T able 2.",Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
2    http://www.jbji.net  82      Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
"2    http://www.jbji.net  83  treatment regime in the 4 patients with a Clostridium  infection (2 patients were treated with with  dicloxacillin).16-17   In conclusion, for patients  with a PJI who are no  candidate for revi sion surgery antibiotic suppressive  therapy seems a reasonable alternative treatment, with the highest success rates in patients with a  standard -prosthesis or with a S. epidermidis  infection.",Non-OADS,/arxiv_data1/oa_pdf/1c/80/jbjiv02p0077.PMC5423578.pdf
2      http://www.jbji.net  73  Journal of Bone and Joint Infection    2017; 2(2): 73-76. doi: 10.7150/ jbji.17171  Research Paper   Which Orthopaedic Patients Are Infected with  Gram - negative Non -fermenting  Rods?,Non-OADS,/arxiv_data1/oa_pdf/84/30/jbjiv02p0073.PMC5423579.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org /licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/84/30/jbjiv02p0073.PMC5423579.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/84/30/jbjiv02p0073.PMC5423579.pdf
"2    http://www.jbji.net  74  various Gram -negative infections, nor the incidence or  Gram -negative nosocomial infections, which have  been already described elsewhere [2,3,15 -21].",Non-OADS,/arxiv_data1/oa_pdf/84/30/jbjiv02p0073.PMC5423579.pdf
2    http://www.jbji.net  75  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/84/30/jbjiv02p0073.PMC5423579.pdf
2    http://www.jbji.net  76  suggest a true lack of genuine Gram -negative  association.,Non-OADS,/arxiv_data1/oa_pdf/84/30/jbjiv02p0073.PMC5423579.pdf
"2      http://www.jbji.net  90  JJoouurrnnaall  ooff  BBoonnee  aanndd  JJooiinntt  IInnffeeccttiioonn   2017; 2(2): 90-95. doi: 10.7150/ jbji.17083  Research Paper   Septic Arthritis  of the Shoulder with Proximal Humerus  Osteomyelitis , Treated by  Ilizarov Shoulder Arthrodesis  John Kendall and M artin  McNally   Department of Limb Reconstruction, Bone Infection Unit , Nuffield Orthopaedic Centre , Oxford University , Hospitals NHS Foundation Trust, Windmill Road ,  Oxford , OX3 7HE     Corresponding author : martin.mcnally@ouh.nhs.uk , Tel: 01865 741155   © Ivyspring International Publisher.",Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
2    http://www.jbji.net  91  We present our experience of using Ilizarov  external fixation to manage a patient who had  significant pain and loss of function as a result of  septic arthritis of the should er with associated  proximal humerus osteomyelitis.,Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
2    http://www.jbji.net  92  she had significant muscle atrophy with very limited  true shoulder movement.,Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
2    http://www.jbji.net  93    Figure 5 .,Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
2    http://www.jbji.net  94  then change to symptom relief and optimisation of  residual function.,Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
"2    http://www.jbji.net  95  Plain radiographs are a useful first -line imaging  modality for assessing joint destruction, fracture  union and infective changes.",Non-OADS,/arxiv_data1/oa_pdf/10/de/jbjiv02p0090.PMC5423580.pdf
"2      http://www.jbji.net  84  JJoouurrnnaall  ooff  BBoonnee  aanndd  JJooiinntt  IInnffeeccttiioonn   2017; 2(2): 84-89. doi: 10.7150/ jbji.17507  Research Paper   Bone Inflammation, Bone Infection and  Dental Implants  Failure: Histological and Cytological Aspects Related to  Cement Excess    Marco Tatullo1, Massimo Marrelli2, Filiberto Mastrangelo3, Enrico Gherlone3  1.",Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY -NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
2    http://www.jbji.net  85  Implant cementation as a means of attaching the  coronal restoration to the implant fixture is a  well -known protocol and widely used by  prosthodontists.,Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
2    http://www.jbji.net  86  1).,Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
2    http://www.jbji.net  87    Figure 2 : Hematoxylin and eosin -stained section at the bone interface: we can see inflammatory infiltrate and wide portions of residual n ecrotic bone (see  the arrows).,Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
2    http://www.jbji.net  88  Implant failures can be related to several  different causes.,Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
"2    http://www.jbji.net  89  correlated the cement  excess with flogosis episodes of  soft tis sues around the cement -retained prosthesis, in  the recent years many techniques have been  developed to reduce the use of cement without  reducing the efficacy of its use.",Non-OADS,/arxiv_data1/oa_pdf/14/fd/jbjiv02p0084.PMC5423581.pdf
"https://doi.org/10.1177/2055116917706652 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons   Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial  use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Feline Medicine and Surgery Open  Reports  1 –6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2055116917706652 journals.sagepub.com/home/jfmsopenreports This paper was handled and processed   by the European Editorial Office (ISFM)   for publication in JFMS Open Reports Introduction Caecocolic intussusception (caecal inversion) is rare in  cats and uncommon in dogs.",Non-OADS,/arxiv_data1/oa_pdf/21/8c/10.1177_2055116917706652.PMC5423586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/14/main.PMC5423699.pdf
E-mail address: erogalski@gmail.com http://dx.doi.org/10.1016/j.trci.2016.08.005 2352-8737/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/14/main.PMC5423699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/14/main.PMC5423699.pdf
"https://doi.org/10.1177/2050313X17707153 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17707153 journals.sagepub.com/home/sco Introduction Systemic lupus erythematosus (SLE) is a complex autoim- mune disorder that can affect multiple organ systems.",Non-OADS,/arxiv_data1/oa_pdf/b0/ab/10.1177_2050313X17707153.PMC5423708.pdf
"https://doi.org/10.1177/2050313X17706875 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17706875 journals.sagepub.com/home/sco Introduction Methotrexate (MTX) is a folate antimetabolite used to treat  malignancies and certain auto-immune diseases.",Non-OADS,/arxiv_data1/oa_pdf/26/08/10.1177_2050313X17706875.PMC5423709.pdf
"A pilot study of dextromethorphan for the prevention and  treatment of methotrexate neurotoxicity—full text view— ClinicalTrials.gov 2017, https://clinicaltrials.gov/ct2/show/ NCT00176553?term=dextromethorphan+methotrexate&   rank=1  18.",Non-OADS,/arxiv_data1/oa_pdf/26/08/10.1177_2050313X17706875.PMC5423709.pdf
"FDA drug safety commu- nication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR, http://www.fda.gov/Drugs/ DrugSafety/ucm352085.htm (2013, accessed 10 August  2015).",Non-OADS,/arxiv_data1/oa_pdf/c6/50/10.1177_2050312117707687.PMC5423710.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/bc/main.PMC5423722.pdf
T HIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.10.001,Non-OADS,/arxiv_data1/oa_pdf/43/bc/main.PMC5423722.pdf
"https://doi.org/10.1177/2150131916686284Journal of Primary Care & Community Health 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/45/ee/10.1177_2150131916686284.PMC5423779.pdf
http://www.bankofcanada.,Non-OADS,/arxiv_data1/oa_pdf/45/ee/10.1177_2150131916686284.PMC5423779.pdf
http://www.oecd.org/std/ppp.,Non-OADS,/arxiv_data1/oa_pdf/45/ee/10.1177_2150131916686284.PMC5423779.pdf
"MeSH Keywords:  Heart Transplantation • Immunosuppression • Seizures • Tacrolimus  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903403Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Cardiology, Saint Luke’s Mid-America Heart Institute, Kansas City,  MO, U.S.A. 2 Department of Cardiovascular Imaging, Saint Luke’s Mid-America Heart Institute,  Kansas City, MO, U.S.A. 3 Department of Cardiology, University of Missouri – Kansas City School of  Medicine, Saint Luke’s Mid America Heart Institute, Kansas City, MO, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 487-490 DOI: 10.12659/AJCR.903403 487 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/40/c5/amjcaserep-18-487.PMC5423884.pdf
"MeSH Keywords:  Lung Abscess • Hypoxia-Inducible Factor-Proline Dioxygenases • Hypertrophy, Right Ventricular •  Airway Remodeling • Cell Hypoxia  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/900354Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Respiratory Medicine, Shanghai Jiaotong University Affiliated  Sixth People’s Hospital South Campus, Shanghai Fengxian District Central  Hospital, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/26/medscimonit-23-2083.PMC5423885.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f3/1b/13318_2016_Article_359.PMC5423921.pdf
"Ridgeﬁeld: Boehringer Ingelheim Pharmaceuticals, Inc.; 2016. http://www.gilotrif.com/ .",Non-OADS,/arxiv_data1/oa_pdf/f3/1b/13318_2016_Article_359.PMC5423921.pdf
"Summary of Product Characteristics, version 24 May 2016. http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/ human/002280/WC500152392.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f3/1b/13318_2016_Article_359.PMC5423921.pdf
1998. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm072127.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f3/1b/13318_2016_Article_359.PMC5423921.pdf
2010. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM204959.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f3/1b/13318_2016_Article_359.PMC5423921.pdf
2004. http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2009/09/WC500003123.,Non-OADS,/arxiv_data1/oa_pdf/f3/1b/13318_2016_Article_359.PMC5423921.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Live cell microscopy of Bcl-2 family protein interactions C Wong et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cf/5e/cddis201228a.PMC5424096.pdf
"Gene expression data (FPKM value) for each gene were calculatedby the commercial software OmicSoft (Cary, NC, USA) (http://www.omicsoft.com/).",OADS,/arxiv_data1/oa_pdf/bc/90/oncsis20142a.PMC5424097.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).TNIK ampliﬁcation in gastric cancer D-H Yu et al 8 Oncogenesis (2014), 1 – 8 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bc/90/oncsis20142a.PMC5424097.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Supplementary MovieAntitumor effects of nimbolide in WM cells K Chitta et al 10 Blood Cancer Journal © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/77/85/bcj201474a.PMC5424099.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Ribosomopathy in loss of dao-5 C-H Lee et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d1/32/cddis2014114a.PMC5424100.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Homer 1a protects against traumatic brain injury P Luo et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0b/6f/cddis2014116a.PMC5424101.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Inhibitory effect of SAIT301 on NPC cell invasion B-S Lee et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/18/45/cddis2014119a.PMC5424102.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PRSS1 expression promotes pancreatitis T Athwal et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/9a/71/cddis2014120a.PMC5424103.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Armc10/SVH and mitochondrial dynamics R Serrat et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/39/0b/cddis2014121a.PMC5424104.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Downregulation of FAP suppresses cell proliferation and metastasis H Wang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/6b/a0/cddis2014122a.PMC5424105.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/TKI axitinib resistance is associated with increased glucose metabolism in PDAC CD Hudson et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/30/12/cddis2014125a.PMC5424106.pdf
"miR-181a expression can be repressed by CEBP a.In an attempt to further uncover the transcriptional regulation ofmiR-181a, we analyzed the sequences in miR-181a gene promoter by using TransFac software (http://www.gene- regulation.com/pub/programs.html).",Non-OADS,/arxiv_data1/oa_pdf/49/8a/cddis2014130a.PMC5424108.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Implication of AC9 in APL cell differentiation LK Zhuang et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/49/8a/cddis2014130a.PMC5424108.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/Dual actions of CGP37157 in control and in neuronal excitotoxicity A Ruiz et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/79/00/cddis2014134a.PMC5424111.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)LKB1 regulates the centrosome K Werle et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/86/de/cddis2014135a.PMC5424112.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Jagged1 in colorectal cancer Y Dai et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4d/48/cddis2014137a.PMC5424114.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)c-FLIP Rin autoimmunity F Ewald et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/91/4d/cddis2014138a.PMC5424115.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Betulinic acid induces a rescue autophagy response L Potze et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4d/fb/cddis2014139a.PMC5424116.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-541 negatively regulates cardiac hypertrophy F Liu et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/16/0d/cddis2014141a.PMC5424117.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/Correspondence 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2d/32/cddis2014143a.PMC5424119.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/OXPHOS deﬁciency affects dendrites A Gioran et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c5/06/cddis2014144a.PMC5424120.pdf
"Cells 2017; 40(4): 243-253  243              Minireview       The Ciliary Transition Zone:  Finding the Pieces and Assembling the Gate    João Gonçalves1, and Laurence Pelletier1,2,*      1Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 6 00 University Avenue, Toronto, ON M5G 1X5, Canada,  2Department of Molecular Genetics, University of Toronto, Toront o, ON M5S 1A8, Canada  *Correspondence: pelletier@lunenfeld.ca  http://dx.doi.org/10.14348/molcells.2017.0054 www.molcells.org       Eukaryotic cilia are organelles that project from the surface o f  cells to fulfill motility and sensory functions.",Non-OADS,/arxiv_data1/oa_pdf/d5/26/molce-40-4-243.PMC5424270.pdf
"Cells 2017; 40(4): 254-261              Minireview       MicroRNA-296-5p Promotes Invasiveness  through Downregulation of Nerve Growth Factor  Receptor and Caspase-8    Hong Lee1, Chang Hoon Shin1, Hye Ree Kim1, Kyung Hee Choi1, and Hyeon Ho Kim1,2,*      1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology,  Sungkyunkwan University, Seoul 06351, Korea, 2Research Institute for Future Medicine, Samsung Medical Center,  Seoul 06351,  Korea  *Correspondence: hyeonhkim@skku.edu  http://dx.doi.org/10.14348/molcells.2017.2270 www.molcells.org       Glioblastomas (GBM) are very di fficult to treat and their ag- gressiveness is one of the main reasons for this as well as for   the frequent recurrences.",Non-OADS,/arxiv_data1/oa_pdf/fc/5a/molce-40-4-254.PMC5424271.pdf
"Cells 2017; 40(4): 262-270              Minireview       Identification and Expression of Equine  MER-Derived miRNAs    Jeong-An Gim1,2,3, and Heui-Soo Kim1,2,*      1Department of Biological Sciences, College of Natural Sciences,  2Genetic Engineering Institute, Pusan National University,  Busan 46241, Korea, 3The Genomics Institute, Life Sci ences Department, Ulsan Nationa l Institute of Science and T echnology  (UNIST), Ulsan 44919, Korea  *Correspondence: khs307@pusan.ac.kr http://dx.doi.org/10.14348/molcells.2017.2295  www.molcells.org       M i c r o R N A s  ( m i R N A s )  a r e  s i n g l e - s t r a n d e d ,  s m a l l  R N A s  ( 2 1 – 2 3   nucleotides) that function in ge ne silencing and translational  inhibition via the RNA interference mechanism.",Non-OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
"The genomic loca- tions of MER sequences were confirmed in the horse ge-nome (Broad/equCab2), using UCSC Genome Browser  (http://genome.ucsc.edu), and their sequences were ana- lyzed to identify regions that overlapped with transcripts, using Ensembl 84 (http://www.ensembl.org).",OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
"In the UCSC  table Browser, MER sequences and their genomic regions  were compared using RepeatMasker 3.3 (http://www.re-peatmasker.org).",OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
"The sequences of horse precursor miRNAs  and mature miRNAs were downloaded from miRBase v21.0  (http://www.mirbase.org), then their sequences were mapped and localized to the horse genome (equCab2).",OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
MER consensus sequences forming palindromic sequences  were predicted by RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi).,OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
"Next,  mature miRNAs derived from MER precursor forms (selected  for having minimum free energies) were predicted using MatureBayes program (http://mirna.imbb.forth.gr/Mature- Bayes.html).",OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
"The BM734541.1 transcript was  located in the intron of two transcripts, was predicted to  contain many palindromic structures, and may generate 10  precursor miRNAs as putative polycistronic clustered miRNAs (http://www.ncbi.nlm.nih.gov/nucest/BM734541).",Non-OADS,/arxiv_data1/oa_pdf/8d/f7/molce-40-4-262.PMC5424272.pdf
"Cells 2017; 40(4): 271-279  271              Minireview       Mind Bomb-Binding Partner RanBP9 Plays a  Contributory Role in Retinal Development    Kyeong-Won Yoo1, Maivannan Thiruvarangan1, Yun-Mi Jeong1, Mi-Sun Lee1, Sateesh Maddirevula1,  Myungchull Rhee1, Young-Ki Bae2, Hyung-Goo Kim3, and Cheol-Hee Kim1,*      1Department of Biology, Chungnam National University, Daejeon 34 134, Korea, 2Comparative Biomedicine Research Branch,  Research Institute, National Cancer Center, Goyang 10408, Korea , 3Department of OB/GYN, Department of Neuroscience and  Regenerative Medicine, Augusta University, GA 30912, USA  *Correspondence: zebrakim@cnu.ac.kr http://dx.doi.org/10.14348/molcells.2017.2308  www.molcells.org       Ran-binding protein family m ember, RanBP9 has been re- ported in various basic cellu lar mechanisms and neuropa- thological conditions i ncluding schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/4e/23/molce-40-4-271.PMC5424273.pdf
"Also, to study the evolutionary relationship between the  RanBP9 from the zebrafish and other organisms, the trans-lated amino acid sequences were aligned with the ‘Clus- talOmega’ Protein Alignment Tool, (https://www.ebi.ac.uk/  Tools/msa/clustalo/)   RNA and antisense morpholino oligonucleotides injection  Synthetic capped RNA for RanBP9 was transcribed in vitro   using linearized plasmid DNA as the template.",OADS,/arxiv_data1/oa_pdf/4e/23/molce-40-4-271.PMC5424273.pdf
"Cells 2017; 40(4): 280-290              Minireview       Neuroprotective Effects of Protein Tyrosine  Phosphatase 1B Inhibition against ER Stress- Induced Toxicity    Yu-Mi Jeon1, Shinrye Lee1, Seyeon Kim1, Younghwi Kwon1, Kiyoung Kim2, Chang Geon Chung3,  Seongsoo Lee4, Sung Bae Lee3, and Hyung-Jun Kim1,*      1Department of Neural Development and Disease, Korea Brain Resea rch Institute (KBRI), Daegu 41068, Korea, 2Department of  Medical Biotechnology, Soonchunhyang University, Asan 31538, Ko rea, 3D e p a r t m e n t  o f  B r a i n  &  C o g n i t i v e  S c i e n c e s ,  D a e g u   Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42 988, Korea, 4Gwangju Center, Korea Basic Science Institute  (KBSI), Gwangju 61186, Korea  *Correspondence: kijang1@kbri.re.kr http://dx.doi.org/10.14348/molcells.2017.2320  www.molcells.org       Several lines of evidence suggest that endoplasmic reticulum  (ER) stress plays a critical role in the pathogenesis of many  neurodegenerative diseases such as Alzheimer’s disease, Par- kinson’s disease, and amyotrophic lateral sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/b0/b8/molce-40-4-280.PMC5424274.pdf
"The following Dro- sophila  strains were obtained from the Bloomington Dro- sophila  Stock Center (USA, http://flystocks.bio-indiana.edu/):  w1118 as wild type; Da-Gal4 that drives ubiquitous transgene  expression and UAS- Ptp61f  RNAi (RNAi knockdown of  Ptp61f ).",Non-OADS,/arxiv_data1/oa_pdf/b0/b8/molce-40-4-280.PMC5424274.pdf
"Cells 2017; 40(4): 291-298   2 9 1               Minireview       Down-Regulation of MicroRNA-210 Confers  Sensitivity towards 1'S-1'-Acetoxychavicol  Acetate (ACA) in Cervical Cancer Cells by  Targeting SMAD4    Neoh Hun Phuah1, Mohamad Nurul Azmi2, Khalijah Awang2, and Noor Hasima Nagoor1,3,*      1Institute of Biological Sciences (Genetics and Molecular Biolog y), Faculty of Science, 2Centre for Natural Product Research and  Drug Discovery (CENAR), Department of Chemistry, Faculty of Sci ence, 3Centre for Research in Biotechnology for Agriculture  (CEBAR), University of Malaya, 50603, Kuala Lumpur, Malaysia *Correspondence: hasima@um.edu.my  http://dx.doi.org/10.14348/molcells.2017.2285  www.molcells.org       MicroRNAs (miRNAs) are short non-coding RNAs that regu- late genes posttranscriptionally.",Non-OADS,/arxiv_data1/oa_pdf/16/29/molce-40-4-291.PMC5424275.pdf
*Correspondence: choish@snu.ac.kr (SHC); hanc210@snu.ac.kr (NCH )  http://dx.doi.org/10.14348/molcells.2017.0015 www.molcells.org       The transcriptional activator AphB has been implicated in acid  resistance and pathogenesis in the food borne pathogens  Vibrio vulnificus  and Vibrio cholerae .,Non-OADS,/arxiv_data1/oa_pdf/74/42/molce-40-4-299.PMC5424276.pdf
"Cells 2017; 40(4): 307-313  307              Minireview       Caloric Restriction-Induced Extension of  Chronological Lifespan Requires Intact  Respiration in Budding Yeast    Young-Yon Kwon1, Sung-Keun Lee2, and Cheol-Koo Lee1,*      1Department of Biotechnology, College of Life Sciences and Biote chnology, Korea University, Seoul 02841, Korea, 2Department  of Pharmacology, College of Medi cine, Inha University, Incheon 22212, Korea  *Correspondence: cklee2005@korea.ac.kr  http://dx.doi.org/10.14348/molcells.2017.2279  www.molcells.org       Caloric restriction (CR) has been shown to extend lifespan  and prevent cellular senescence  in various species ranging  from yeast to humans.",Non-OADS,/arxiv_data1/oa_pdf/22/cf/molce-40-4-307.PMC5424277.pdf
*Correspondence: namayoon@gmail.com (HY); mhkim1@yuhs.ac (MHK) http://dx.doi.org/10.14348/molcells.2017.1311  www.molcells.org     Erratum to:  Mol.,Non-OADS,/arxiv_data1/oa_pdf/82/99/molce-40-4-314.PMC5424278.pdf
"Cells 2016; 39(5), 395-402  https://doi.org/10.14348/molcells.2016.2311        The original version of this article inadvertently contained a  mistake.",Non-OADS,/arxiv_data1/oa_pdf/82/99/molce-40-4-314.PMC5424278.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Vijay Srinivasan, MD, FCCM,  Department  of Anesthesiology and Critical Care Medicine, the Children’s  Hospital of Philadelphia, 34th Street and Civic Center Boulevard,  Philadelphia, PA 19104, United States.",Non-OADS,/arxiv_data1/oa_pdf/42/d0/WJCP-6-110.PMC5424279.pdf
Data were obtained on Submit a Manuscript: http://www.f6publishing.com DOI: 10.5409/wjcp.v6.i2.110World J Clin Pediatr  2017 May 8; 6(2): 110-117 ISSN 2219-2808 (online)World Journal of Clinical Pediatrics WJCP,Non-OADS,/arxiv_data1/oa_pdf/42/d0/WJCP-6-110.PMC5424279.pdf
World J Clin Pediatr  2017; 6(2): 110-117  Available  from: URL: http://www.wjgnet.com/2219-2808/full/v6/i2/110.,Non-OADS,/arxiv_data1/oa_pdf/42/d0/WJCP-6-110.PMC5424279.pdf
"htm  DOI: http://dx.doi.org/10.5409/wjcp.v6.i2.110INTRODUCTION Children admitted to the pediatric intensive care unit  (PICU) are often administered opioids in the form of  intravenous (IV) infusions to provide consistent seda­ tion and analgesia titrated to effect[1,2].",Non-OADS,/arxiv_data1/oa_pdf/42/d0/WJCP-6-110.PMC5424279.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/42/d0/WJCP-6-110.PMC5424279.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Amar Al Shibli, FRCPCH,  Department of  Pediatrics, Tawam Hospital, PO Box 15258, Al Ain,  United Arab Emirates.",Non-OADS,/arxiv_data1/oa_pdf/c3/58/WJCP-6-118.PMC5424280.pdf
"They also included complications  of thrombocytosis, including thromboembolic complica- tions such as cerebrovascular accident, acute coronary  syndrome, deep venous thrombosis, pulmonary embolus,  mesenteric thrombosis and arterial thrombosis and also hemorrhagic complications such as bleeding (spon - taneous hemorrhage in the skin, mucous membranes,  gastrointestinal, respiratory, or genitourinary tracts).Submit a Manuscript: http://www.f6publishing.com DOI: 10.5409/wjcp.v6.i2.118World J Clin Pediatr  2017 May 8; 6(2): 118-123 ISSN 2219-2808 (online)World Journal of Clinical Pediatrics WJCP",Non-OADS,/arxiv_data1/oa_pdf/c3/58/WJCP-6-118.PMC5424280.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c3/58/WJCP-6-118.PMC5424280.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Wikrom Karnsakul, MD, Associate  Professor,  Pediatric Liver Center, Johns Hopkins University  School of Medicine, CMSC-2 600 North Wolfe Street, Baltimore,  MD 21287, United States.",Non-OADS,/arxiv_data1/oa_pdf/28/f6/WJCP-6-124.PMC5424281.pdf
Published by Baishideng Publishing  Group Inc. All rights reserved.Submit a Manuscript: http://www.f6publishing.com DOI: 10.5409/wjcp.v6.i2.124World J Clin Pediatr  2017 May 8; 6(2): 124-131 ISSN 2219-2808 (online)World Journal of Clinical Pediatrics WJCP,Non-OADS,/arxiv_data1/oa_pdf/28/f6/WJCP-6-124.PMC5424281.pdf
World J Clin Pediatr  2017; 6(2): 124-131   Available from: URL: http://www.wjgnet.com/2219-2808/full/ v6/i2/124.htm  DOI: http://dx.doi.org/10.5409/wjcp.v6.i2.124 INTRODUCTION Functional gallbladder disorder (FGBD) is a motility  disorder of the gallbladder that results in decreased  contractility of the gallbladder and colicky pain in the  epigastrium and/or the right upper quadrant of the  abdomen (RUQ).,Non-OADS,/arxiv_data1/oa_pdf/28/f6/WJCP-6-124.PMC5424281.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/28/f6/WJCP-6-124.PMC5424281.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Jean-Marc Gornet,  Department of  Gastroenterology, AP-HP, Saint Louis Hospital, 1 Avenue Claude  Vellefaux, 75010 Paris, France.",Non-OADS,/arxiv_data1/oa_pdf/68/0d/WJH-9-613.PMC5424291.pdf
World J Hepatol  2017; 9(13): 613-626   Available from: URL:  http://www.wjgnet.com/ 1948-5182 /full/v9/ i13/613.htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i13.,Non-OADS,/arxiv_data1/oa_pdf/68/0d/WJH-9-613.PMC5424291.pdf
613Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i13.613World J Hepatol   2017  May 8; 9(13): 613-626 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/68/0d/WJH-9-613.PMC5424291.pdf
"Available from: URL: http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_Appro valHistory#apphist 87 Mease PJ , Ory P , Sharp JT, Ritchlin CT, V an den Bosch F, Wellborne  F, Birbara C, Thomson GT, Perdok RJ, Medich J, Wong RL, Gladman  DD.",OADS,/arxiv_data1/oa_pdf/68/0d/WJH-9-613.PMC5424291.pdf
Available from: URL: http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/68/0d/WJH-9-613.PMC5424291.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/68/0d/WJH-9-613.PMC5424291.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Jian-Xiong Wu, MD, Professor, Chief,   Department of Hepatobiliary Surgery, National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences and  Peking Union Medical College, 17 Panjiayuan Nanli, Beijing  100021, China.",Non-OADS,/arxiv_data1/oa_pdf/5f/46/WJH-9-627.PMC5424292.pdf
World J Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i13.627World J Hepatol   2017  May 8; 9(13): 627-634 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/5f/46/WJH-9-627.PMC5424292.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/46/WJH-9-627.PMC5424292.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5f/46/WJH-9-627.PMC5424292.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Kenneth Siu Ho Chok, MS, Associate  Professor,  Department of Surgery, the University of Hong Kong,  102 Pok Fu Lam Road, Hong Kong, China.",Non-OADS,/arxiv_data1/oa_pdf/25/0c/WJH-9-635.PMC5424293.pdf
"In patients with multifocal tumor  (n = 20), resection margin of ≥ 1 cm was associated  with improved 1-year disease-free survival (40% vs 0%;  log-rank, P = 0.012).Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i13.635World J Hepatol   2017  May 8; 9(13): 635-641 ISSN 1948-5182 (online)",Non-OADS,/arxiv_data1/oa_pdf/25/0c/WJH-9-635.PMC5424293.pdf
World J Hepatol  2017; 9(13): 635 ­641   Available from: URL:  http://www.wjgnet.co m/1948 ­5182 /full/v9/ i13/635.,Non-OADS,/arxiv_data1/oa_pdf/25/0c/WJH-9-635.PMC5424293.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i13.635 INTRODUCTION Hepatocholangiocarcinoma (HCC-CC) is a rare disease  entity contributing to 1%-3% of primary hepatic malig - nancies[1-4].,Non-OADS,/arxiv_data1/oa_pdf/25/0c/WJH-9-635.PMC5424293.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/25/0c/WJH-9-635.PMC5424293.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Madhan Nellaiyappan, Resident,  Department of Medicine, Allegheny Health Network, 7th Floor  South Tower, 320 East North Ave, Pittsburgh, PA 15212,  United States.",Non-OADS,/arxiv_data1/oa_pdf/df/6a/WJH-9-642.PMC5424294.pdf
World J Hepatol  2017; 9(13): 642-644  Available from: URL:   http://www.wjgnet.com/ 1948-5182 /full/v9/i13/642.htm  DOI:  http://dx.doi.org/10.4254/wjh.v9.i13.,OADS,/arxiv_data1/oa_pdf/df/6a/WJH-9-642.PMC5424294.pdf
642Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i13.642World J Hepatol   2017  May 8; 9(13): 642-644 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/df/6a/WJH-9-642.PMC5424294.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/df/6a/WJH-9-642.PMC5424294.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Sinee Disthabanchong, MD, Professor  of Medicine, Division of Nephrology, Department of Medicine,  Faculty of Medicine, Ramathibodi Hospital, Mahidol University,  270 Rama VI Rd, Bangkok 10310,  Thailand.",Non-OADS,/arxiv_data1/oa_pdf/85/8a/WJN-6-100.PMC5424431.pdf
"Computed tomography, the gold World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.100World J Nephrol   2017 May 6; 6(3): 100-110 ISSN 2220-6124 (online)",Non-OADS,/arxiv_data1/oa_pdf/85/8a/WJN-6-100.PMC5424431.pdf
World J Nephrol  2017; 6(3): 100-110  Available  from: URL:  http://www.wjgnet.com/2220-6124/full/v6/i3/100.htm   DOI: http://dx.doi.org/10.5527/wjn.v6.i3.100 INTRODUCTION Vascular calcification (VC) is common among patients  with chronic kidney disease (CKD).,Non-OADS,/arxiv_data1/oa_pdf/85/8a/WJN-6-100.PMC5424431.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/85/8a/WJN-6-100.PMC5424431.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Dr. An-Hang Yang,  Institute of Clinical  Medicine, National Yang-Ming University, No.",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/WJN-6-111.PMC5424432.pdf
"We  recently reported that the intra-peritoneal administration  of CB receptor ligands, including CB 1 receptor antagonists World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.111World J Nephrol   2017 May 6; 6(3): 111-118 ISSN 2220-6124 (online)",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/WJN-6-111.PMC5424432.pdf
"World J Nephrol  2017; 6(3): 111-118   Available from: URL:  http://www.wjgnet.com/2220-6124/full/ v6/i3/111.htm  DOI: http://dx.doi.org/10.5527/wjn.v6.i3.111 REVIEW ARTICLE As chronic kidney disease progresses to end-stage  renal disease, uremia ensues requiring the use of  long-term dialysis therapy.",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/WJN-6-111.PMC5424432.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/WJN-6-111.PMC5424432.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Giorgos K Sakkas,  Faculty of Sport  and Health Sciences, University of St Mark and St John, Derriford  Rd, Plymouth PL6 8BH, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/c3/50/WJN-6-119.PMC5424433.pdf
There is evidence World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.119World J Nephrol   2017 May 6; 6(3): 119-122 ISSN 2220-6124 (online),Non-OADS,/arxiv_data1/oa_pdf/c3/50/WJN-6-119.PMC5424433.pdf
World J Nephrol  2017; 6(3): 119-122  Available from:  URL:  http://www.wjgnet.com/2220-6124/full/v6/i3/119.htm   DOI: http://dx.doi.org/10.5527/wjn.v6.i3.119 INTRODUCTION Chronic renal disease is nowadays recognised as a world­ wide public health problem[1] while cardiovascular diseases  are the main cause of mortality in end ­stage renal  patients receiving haemodialysis (HD) therapy[2].,Non-OADS,/arxiv_data1/oa_pdf/c3/50/WJN-6-119.PMC5424433.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c3/50/WJN-6-119.PMC5424433.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Massimo Iacoviello, MD, PhD, FESC,  FANMCO,  Cardiology Unit, Cardiothoracic Department, Policlinic  University Hospital, Piazza Giulio Cesare 11, 70124 Bari,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/WJN-6-123.PMC5424434.pdf
Core tip:  Kidney disease is a common condition affecting World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.123World J Nephrol   2017 May 6; 6(3): 123-131 ISSN 2220-6124 (online),Non-OADS,/arxiv_data1/oa_pdf/b5/f1/WJN-6-123.PMC5424434.pdf
wjgnet.com/2220 ­6124/full/v6/i3/123.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/f1/WJN-6-123.PMC5424434.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/WJN-6-123.PMC5424434.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Sylvie Perreault, BPharm, PhD, Full  Professor,  Faculty of Pharmacy, University of Montreal, Case  Postale 6128, Succursale Centre-Ville, Montreal, QC H3C 3J7,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/8a/21/WJN-6-132.PMC5424435.pdf
CONCLUSION Gout control seem to be associated with a significant World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.132World J Nephrol   2017 May 6; 6(3): 132-142 ISSN 2220-6124 (online) Case Control Study,Non-OADS,/arxiv_data1/oa_pdf/8a/21/WJN-6-132.PMC5424435.pdf
World J Nephrol  2017; 6(3): 132-142  Available from: URL:   http://www.wjgnet.com/2220-6124/full/v6/i3/132.htm  DOI:  http://dx.doi.org/10.5527/wjn.v6.i3.132 INTRODUCTION Gout is a chronic disease and one of the most common  inflammatory arthritis conditions among adults.,Non-OADS,/arxiv_data1/oa_pdf/8a/21/WJN-6-132.PMC5424435.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8a/21/WJN-6-132.PMC5424435.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Antonios H Tzamaloukas, MD, MACP,  Emeritus Professor  of Medicine, University of New Mexico  School of Medicine, Physician  (Raymond G. Murphy VA  Medical Center), Renal Section (111C), Raymond G. Murphy V A  Medical Center, 1501 San Pedro, SE, Albuquerque, NM 87108,  United States.",Non-OADS,/arxiv_data1/oa_pdf/5c/75/WJN-6-143.PMC5424436.pdf
METHODS Body weight (W) consists of fat-free mass (FFM) and World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.143World J Nephrol   2017 May 6; 6(3): 143-149 ISSN 2220-6124 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/5c/75/WJN-6-143.PMC5424436.pdf
"World J Nephrol  2017; 6(3): 143­149  Available from:  URL:  http://www.wjgnet.com/2220 ­6124/full/v6/i3/143.htm   DOI: http://dx.doi.org/10.5527/wjn.v6.i3.143INTRODUCTION The overall prognosis and survival of patients with  chronic diseases, including those whose end-stage renal  disease is treated by dialysis, is strongly linked to their  nutritional status.",Non-OADS,/arxiv_data1/oa_pdf/5c/75/WJN-6-143.PMC5424436.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5c/75/WJN-6-143.PMC5424436.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Sanjay Vikrant, MD, DM, FISN,  Professor, Head,  Department of Nephrology, Indira Gandhi  Medical College, Himachal Pradesh, Circular Road, Shimla  171001, India.",Non-OADS,/arxiv_data1/oa_pdf/18/89/WJN-6-150.PMC5424437.pdf
The mean duration of  arrival at hospital was 3.4 ± 3.7 d with a range of 1 to World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.150World J Nephrol   2017 May 6; 6(3): 150-161 ISSN 2220-6124 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/18/89/WJN-6-150.PMC5424437.pdf
wjgnet.com/2220-6124/full/v6/i3/150.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/89/WJN-6-150.PMC5424437.pdf
"Available from: URL: http://www.who.int/mediacentre/news/ notes /2010/antivenoms_20100504/en/ 3 Mohapatra B , Warrell DA, Suraweera W, Bhatia P, Dhingra N,  Jotkar RM, Rodriguez PS, Mishra K, Whitaker R, Jha P. Snakebite  mortality in India: a nationally representative mortality survey.",Non-OADS,/arxiv_data1/oa_pdf/18/89/WJN-6-150.PMC5424437.pdf
"Available from:  URL: http://en.wikipedia.org/wiki/Himachal_Pradesh 13 Bhardwaj A , Sokhey J.",Non-OADS,/arxiv_data1/oa_pdf/18/89/WJN-6-150.PMC5424437.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/18/89/WJN-6-150.PMC5424437.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Rubina Naqvi, MBBS, MD (Nephrology),  Fellow ISN, PGD Bioethics, Professor  of Nephrology, Sindh  Institute of Urology and Transplantation, Civil Hospital,  Sardar  Yaqoob Ali Khan Road, Karachi 74200,  Pakistan.",Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
Key words:  Paraphenylene diamine; Organophosphorus  compounds; Paraquat; Methanol; Poisons; Acute kidney  injuryWorld Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.162World J Nephrol   2017 May 6; 6(3): 162-167 ISSN 2220-6124 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
World J Nephrol  2017; 6(3): 162-167  Available from: URL:   http://www.wjgnet.com/2220-6124/full/v6/i3/162.htm  DOI: http:// dx.doi.org/10.5527/wjn.v6.i3.162 INTRODUCTION Paraphenylene diamine (PPD) is a derivative of analine.,Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
Available from: URL: https://en.wikipedia.org/wiki/ Tartaric_acid  8 Tartaric acid.,Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
"Available from: URL:  http://www.druginfosys.com/Drug.aspx?drugCode=1261&type=7  9 Oldenquist G , Salem M. Parenteral copper sulfate poisoning  causing acute renal failure.",Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
Available from: URL: http://www.sleuth- sayers.org/2012/02/daturas.html 14 Rat poison affect humans .,Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
"Available from: URL: https://www.reference.com/health/rat- poison-affect-humans-8e9186fdd121e4df 15 Nguyen BH , Thi TXN, Goldfarb DS, Stokes MB, Rabenou RA.",Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ab/94/WJN-6-162.PMC5424438.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Abdullah Ozkok, MD, Associate  Professor,  Department of Nephrology, Saglik Bilimleri University,  Umraniye Training and Research Hospital, Selimiye Mah.",Non-OADS,/arxiv_data1/oa_pdf/56/81/WJN-6-86.PMC5424439.pdf
World J Nephrol  2017; 6(3): 86-99   Available from: URL:  http://www.wjgnet.com/2220-6124/full/World Journal of  Nephrology WJN Submit a Manuscript: http://www.f6publishing.com DOI: 10.5527/wjn.v6.i3.86World J Nephrol   2017 May 6; 6(3): 86-99 ISSN 2220-6124 (online),Non-OADS,/arxiv_data1/oa_pdf/56/81/WJN-6-86.PMC5424439.pdf
Contrast-induced acute kidney injury v6/i3/86.htm  DOI: http://dx.doi.org/10.5527/wjn.v6.i3.86 INTRODUCTION Medical imaging has become an important diagnostic  and therapeutic tool in clinical medicine in the era of  great technological advances.,Non-OADS,/arxiv_data1/oa_pdf/56/81/WJN-6-86.PMC5424439.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/56/81/WJN-6-86.PMC5424439.pdf
To address the deviation  in HWE the Polish ACLR group was compared to a HapMap Central  European (CEU) CON group using data available on the National  Center for Biotechnology Information database of single nucleotide  polymorphisms (https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.,OADS,/arxiv_data1/oa_pdf/f9/d6/JBS-34-64582.PMC5424448.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/40/84/main.PMC5424531.pdf
E-mail address: wqiu67@bu.edu http://dx.doi.org/10.1016/j.trci.2016.12.002 2352-8737/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/40/84/main.PMC5424531.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/84/main.PMC5424531.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.trci.2016.12.002 .,OADS,/arxiv_data1/oa_pdf/40/84/main.PMC5424531.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/iew099.PMC5424536.pdf
The analysis was performed on the bPTP web server athttp://species.h-its.org/ptp/.,OADS,/arxiv_data1/oa_pdf/b1/f8/iew099.PMC5424536.pdf
(http://www.termitologia.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/iew099.PMC5424536.pdf
AutoDock 4.2 is currently being distributed  free of charge as open source under a GPL license at the WWW site:  http://autodock.scripps.edu.,Non-OADS,/arxiv_data1/oa_pdf/44/a6/PR-9-133.PMC5424553.pdf
"ADT is being distributed free of charge as  part of the MGLTools package, at the WWW site: http://mgltools.scripps.",Non-OADS,/arxiv_data1/oa_pdf/44/a6/PR-9-133.PMC5424553.pdf
Available from: http://www.epidemiologia.salud.gob.mx/anuario/html/ anuarios.html.,Non-OADS,/arxiv_data1/oa_pdf/44/a6/PR-9-133.PMC5424553.pdf
Available from: http://www.cenetec.salud.gob.mx/interior/gpc.html.,Non-OADS,/arxiv_data1/oa_pdf/44/a6/PR-9-133.PMC5424553.pdf
Available  from: http://www.encyclopedia.com/topic/Osha.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4e/e3/PR-9-156.PMC5424556.pdf
Available  from: http://www.efsa.europa.eu/en/efsajournal/pub/674.htm.,Non-OADS,/arxiv_data1/oa_pdf/54/e6/PR-9-161.PMC5424557.pdf
Available from: http://www.sigmaaldrich.,Non-OADS,/arxiv_data1/oa_pdf/54/e6/PR-9-161.PMC5424557.pdf
Available from:.http://www.who.int/diabetes/global‑report/ en/.,Non-OADS,/arxiv_data1/oa_pdf/6e/25/PR-9-182.PMC5424560.pdf
"8,9However, shRNAs are often produced at extremely high levels, and toxicity due to Received 21 November 2016; accepted 11 April 2017; http://dx.doi.org/10.1016/j.omtn.2017.04.011 .",Non-OADS,/arxiv_data1/oa_pdf/fd/16/main.PMC5424568.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/16/main.PMC5424568.pdf
"Libraries were constructed by standard methods.34Reads were mapped using TopHat2,35and differential expression was calculated using the DESeq2 package.36 SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fd/16/main.PMC5424568.pdf
Received 3 November 2016; accepted 14 April 2017; http://dx.doi.org/10.1016/j.omtn.2017.04.014 .,Non-OADS,/arxiv_data1/oa_pdf/3e/98/main.PMC5424569.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/98/main.PMC5424569.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3e/98/main.PMC5424569.pdf
http://www.alnylam.com/web/wp-content/ uploads/2012/11/ALNY-AASLD-FibrosisPosterXPanel-Nov2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3e/98/main.PMC5424569.pdf
335 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/78/main.PMC5424570.pdf
").Seung-Ki Min,1,3Sung Youn Jung,2 Hyun Ki Kang,2Seung Bin Jo,2 Myung-Jin Kim,1 and Byung-Moo Min2 1Department of Oral and Maxillofacial Surgery, Seoul National University School of Dentistry, Seoul 03080,Republic of Korea; 2Department of Oral Biochemistry and Program in Cancer and Developmental Biology, Dental Research Institute, Seoul National UniversitySchool of Dentistry, Seoul 03080, Republic of Korea http://dx.doi.org/10.1016/j.omtn.2017.04.016 3Present address: Oral Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-Do 10408, Republic of Korea Correspondence: Byung-Moo Min, Department of Oral Biochemistry and Program in Cancer andDevelopmental Biology, Seoul National UniversitySchool of Dentistry, 101 Daehak-Ro, Jongno-Gu,Seoul 03080, Republic of Korea.E-mail: bmmin@snu.ac.kr Correspondence: Myung-Jin Kim, Department of Oral and Maxillofacial Surgery, Seoul National University School of Dentistry, 101 Daehak-Ro, Jongno-Gu, Seoul 03080, Republic of Korea.E-mail: myungkim@snu.ac.kr REFERENCES 1.Xiao, B., Zhu, E.D., Li, N., Lu, D.S., Li, W., Li, B.S., Zhao, Y.L., Mao, X.H., Guo, G., Yu, P.W., and Zou,Q.M.",Non-OADS,/arxiv_data1/oa_pdf/05/78/main.PMC5424570.pdf
"To over-come this limitation, a lentivirus-prepackaged Cas9 protein (Cas9PLV) system was developed recently and was shown to be effective Received 9 January 2017; accepted 12 April 2017; http://dx.doi.org/10.1016/j.omtm.2017.04.002 .",Non-OADS,/arxiv_data1/oa_pdf/27/68/main.PMC5424571.pdf
153 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/68/main.PMC5424571.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.2017.04.002 .,Non-OADS,/arxiv_data1/oa_pdf/27/68/main.PMC5424571.pdf
"To address the limitations of the previously published vector, wedesigned a second-generation vector (AAV9/ hMECP2 (v2)) that, in Received 24 February 2017; accepted 13 April 2017; http://dx.doi.org/10.1016/j.omtm.2017.04.006 .",OADS,/arxiv_data1/oa_pdf/2e/c2/main.PMC5424572.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/c2/main.PMC5424572.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and four movies and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2e/c2/main.PMC5424572.pdf
"MeSH Keywords:  Colonic Neoplasms • Gastrointestinal Neoplasms • Helicobacter pylori  •  Lymphoma, B-Cell, Marginal Zone  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/902843Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medicine, Bronx Lebanon Hospital Center, Bronx, NY, U.S.A. 2 Department of Pathology, Bronx Lebanon Hospital Center, Bronx, NY, U.S.A. 3 Department of Medicine, Division of Gastroenterology, Bronx Lebanon Hospital  Center, Bronx, NY, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 491-497 DOI: 10.12659/AJCR.902843 491 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/8d/76/amjcaserep-18-491.PMC5424574.pdf
"1, Supplemental DigitalContent 1, http://links.lww.com/JIT/A473.",Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cji-40-187.PMC5424577.pdf
Available at: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/retina-37-819.PMC5424580.pdf
Available at: http://www.potentiapharma.com/about/ news.htm#30.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/retina-37-819.PMC5424580.pdf
Available at: http://soliris.net/resources/pdf/soliris_pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/retina-37-819.PMC5424580.pdf
Available at: http://alxn.com/research-developm ent/pipeline.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/retina-37-819.PMC5424580.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/85/opth-11-855.PMC5424599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 855–859Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  855Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13139 9 Ultrasound biomicroscopy value in evaluation of  restoration of ciliary muscles contractility after  cataract extraction ayser abd el-hameed  Fayed Ophthalmology Department, Faculty  of Medicine, Banha University, Banha,   egyptPurpose:  To assess the changes in the contractility of the ciliary muscle in eyes with presbyopia  before and after phacoemulsification and intracapsular lens implantation using ultrasound  biomicroscopy (UBM).",Non-OADS,/arxiv_data1/oa_pdf/72/85/opth-11-855.PMC5424599.pdf
"Keywords:  ciliary body, presbyopia, accommodation, intraocular lens, pilocarpine Introduction Accommodation is the ability of the eye to modify the overall refractive power to deliver a  sharp, image of near objects on the retina.1,2 The procedure is unquestionably administered  by ciliary muscle contraction, the ciliary body moves and releases strain on the zonules  that allow the lens equator to move away from the sclera, which allows the capsule to  mold the young lens into a thicker, more convex, and dioptrically powerful form.3,4 Details  concerning how ciliary muscle contraction influences zonular tension and the roles of the  posterior zonules, iris, and vitreous body in accommodation remain unclear.1,5,6 During accommodation, the ciliary muscles contract and the ciliary body moves  forward and inward, releasing tension on the zonules, which allows the lens equatorial  diameter to decrease with an increase in the lens anteroposterior thickness.1,2 Magnetic  resonance imaging has shown age-related decreases in the ciliary ring diameter in  humans, which might affect accommodation and presbyopia.2 Ultrasound biomicroscopy (UBM) has shown greater displacement of the character - istics contour points of the ciliary body in younger volunteers than in older volunteers  during accommodation.1,3Correspondence: ayser abd el-hameed  Fayed Ophthalmology Department, Faculty of  Medicine, Banha University, Banha, egypt Tel +20 1 3316 6869 Fax +20 1 3322 2817 email ayserfayed@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Fayed Running head recto: Changes in contractility of the ciliary muscle DOI: http://dx.doi.org/10.2147/OPTH.S131399",Non-OADS,/arxiv_data1/oa_pdf/72/85/opth-11-855.PMC5424599.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/72/85/opth-11-855.PMC5424599.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/85/opth-11-855.PMC5424599.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/10/cb/opth-11-841.PMC5424600.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 841–854Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  841Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11715 7 Optic cup segmentation: type-ii fuzzy thresholding  approach and blood vessel extraction ahmed almazroa1 sami alodhayb2 Kaamran raahemifar3 Vasudevan  lakshminarayanan1 1school of Optometry and Vision  science, University of Waterloo,   Canada; 2Binrushd Ophthalmic Center,   riyadh, saudi arabia; 3Department  of electrical engineering, ryerson  University, T oronto, CanadaAbstract:  We introduce here a new technique for segmenting optic cup using two-dimensional  fundus images.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/opth-11-841.PMC5424600.pdf
"Nayak et al7 presented cup segmentation based on morphologic operations Correspondence: ahmed almazroa Kellogg eye Center, 1000 Wall street,  ann arbor, Michigan 48105, Usa email almazroa@med.umich.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Almazroa et al Running head recto: Optic cup segmentation DOI: http://dx.doi.org/10.2147/OPTH.S117157",Non-OADS,/arxiv_data1/oa_pdf/10/cb/opth-11-841.PMC5424600.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/opth-11-841.PMC5424600.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/opth-11-841.PMC5424600.pdf
"Key Words:  Platelet shape changes, Cytoskeleton dynamics, Thrombosis, Aggregation, AdhesionAbstractReview Biomol  Ther 25(3), 223-230 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.138 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/f4/bt-25-223.PMC5424631.pdf
"224 https://doi.org/10.4062/biomolther.2016.138act as cross-linkers with approximately 1:10 ratios (Smyth et  al., 2010).",OADS,/arxiv_data1/oa_pdf/7b/f4/bt-25-223.PMC5424631.pdf
"226 https://doi.org/10.4062/biomolther.2016.138tin networks cross-linked orthogonally by filamin A (Hartwig et  al., 1999).",OADS,/arxiv_data1/oa_pdf/7b/f4/bt-25-223.PMC5424631.pdf
228 https://doi.org/10.4062/biomolther.2016.138platelet inhibition appears to be related to the modulation of  actin polymerization and morphological changes.,OADS,/arxiv_data1/oa_pdf/7b/f4/bt-25-223.PMC5424631.pdf
"230 https://doi.org/10.4062/biomolther.2016.138M., Malinski, T. and Radomski, M. W. (2005) Nanoparticle-induced  platelet aggregation and vascular thrombosis.",OADS,/arxiv_data1/oa_pdf/7b/f4/bt-25-223.PMC5424631.pdf
"Key Words:  Myelin, Fragile X mental retardation protein, Translational control, OligodendrocyteAbstractReview Biomol  Ther 25(3), 231-238 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.042 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/3a/bt-25-231.PMC5424632.pdf
"232 https://doi.org/10.4062/biomolther.2016.042White matter is the brain region underlying the gray matter,  composed of neuronal fibers coated with electrical insulation  called myelin (Fields, 2008).",OADS,/arxiv_data1/oa_pdf/96/3a/bt-25-231.PMC5424632.pdf
234 https://doi.org/10.4062/biomolther.2016.042might be dictated by the prior transport and availability of the  appropriate mRNAs in situ.,Non-OADS,/arxiv_data1/oa_pdf/96/3a/bt-25-231.PMC5424632.pdf
"236 https://doi.org/10.4062/biomolther.2016.042complex (RISC) (Jin et al., 2004).",OADS,/arxiv_data1/oa_pdf/96/3a/bt-25-231.PMC5424632.pdf
238 https://doi.org/10.4062/biomolther.2016.042691-700.,Non-OADS,/arxiv_data1/oa_pdf/96/3a/bt-25-231.PMC5424632.pdf
"Key Words:  GPCR, Acute tolerance, Desensitization, Gbg, b-Arrestin, Dopamine D 3 receptorAbstractOriginal Article Biomol  Ther 25(3), 239-248 (2017) *Corresponding Author E-mail: kmkim@jnu.ac.kr  Tel: +82-62-530-2936, Fax: +82-62-530-2949Received  Sep 1, 2016  Revised  Oct 8, 2016  Accepted  Nov 15, 2016 Published Online  Dec 16, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.193 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/9e/bt-25-239.PMC5424633.pdf
240 https://doi.org/10.4062/biomolther.2016.193stand whether common features or principles exist that can  predict or explain the acute tolerance of GPCRs.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bt-25-239.PMC5424633.pdf
242 https://doi.org/10.4062/biomolther.2016.193 BC147K-D R3 Veh DA D Mock co-IP Lysate IP/c98-Arr2 ReceptorD R3D R4D R2 F co-IP Lysate IP DR2/c98-Arr2DR2 Mock WT K149C H co-IP Lysate IP/c98-Arr2 ReceptorMock D R3D R-(IL2-D R) 32 D R-(IL3-D R) 32 D R2A K149C-D R2 Veh DA DA co-IP Lysate IP /c98-Arr2 FLAG-D R2 FLAG-D R3 /c98-Arr2 ReceptorC E co-IP Lysate IPMock /c981ARD R2 /c982ARD R2 /c98-Arr2 Receptor co-IP Lysate IP /c98-Arr2 FLAG-WT FLAG-C147K FLAG-S145/6AG /c98-Arr2 ReceptorsDR3 Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bt-25-239.PMC5424633.pdf
"244 https://doi.org/10.4062/biomolther.2016.193immunoprecipitation experiments and attempted to correlate  acute tolerance with interactions among the receptors, Gbg,  and b-arrestin2.",OADS,/arxiv_data1/oa_pdf/53/9e/bt-25-239.PMC5424633.pdf
246 https://doi.org/10.4062/biomolther.2016.193were also confirmed by GST pull-down assays.,OADS,/arxiv_data1/oa_pdf/53/9e/bt-25-239.PMC5424633.pdf
"248 https://doi.org/10.4062/biomolther.2016.193Shiina, T., Kawasaki, A., Nagao, T. and Kurose, H. (2000) Interaction  with b-arrestin determines the difference in internalization behavor  between b1- and b 2-adrenergic receptors.",OADS,/arxiv_data1/oa_pdf/53/9e/bt-25-239.PMC5424633.pdf
"Key Words:  Biflorin, N-methyl D-aspartate receptor, Cognition, Protein kinase C-ζAbstract https://doi.org/10.4062/biomolther.2016.058 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Received  Mar 15, 2016  Revised  Jun 9, 2016  Accepted  Jul 28, 2016 Published Online  Nov 8, 2016",Non-OADS,/arxiv_data1/oa_pdf/7c/00/bt-25-249.PMC5424634.pdf
"Morris water maze  The Morris water maze consists of a circular pool (90 cm  in diameter and 45 cm in height) with a featureless inner sur- 250 https://doi.org/10.4062/biomolther.2016.058Biomol  Ther 25(3), 249-258 (2017)",Non-OADS,/arxiv_data1/oa_pdf/7c/00/bt-25-249.PMC5424634.pdf
"252 https://doi.org/10.4062/biomolther.2016.058Biomol  Ther 25(3), 249-258 (2017)",Non-OADS,/arxiv_data1/oa_pdf/7c/00/bt-25-249.PMC5424634.pdf
"254 https://doi.org/10.4062/biomolther.2016.058Biomol  Ther 25(3), 249-258 (2017)",Non-OADS,/arxiv_data1/oa_pdf/7c/00/bt-25-249.PMC5424634.pdf
"256 https://doi.org/10.4062/biomolther.2016.058Biomol  Ther 25(3), 249-258 (2017)",Non-OADS,/arxiv_data1/oa_pdf/7c/00/bt-25-249.PMC5424634.pdf
"258 https://doi.org/10.4062/biomolther.2016.058Biomol  Ther 25(3), 249-258 (2017)",Non-OADS,/arxiv_data1/oa_pdf/7c/00/bt-25-249.PMC5424634.pdf
"Key Words:  Mechanical allodynia, GFAP, IL-10, Neuropathic pain, Substance P, Glial inactivationAbstractOriginal Article Biomol  Ther 25(3), 259-265 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.137 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/bt-25-259.PMC5424635.pdf
"260 https://doi.org/10.4062/biomolther.2016.137and intramuscular injection of SP attenuates mechanical al- lodynia in carrageen-induced inflammatory pain (Parenti et  al., 2012) and acid-induced chronic muscular pain (Lin et al.,  2012).",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/bt-25-259.PMC5424635.pdf
"262 https://doi.org/10.4062/biomolther.2016.137Watkins, 2009).",OADS,/arxiv_data1/oa_pdf/e6/a1/bt-25-259.PMC5424635.pdf
"264 https://doi.org/10.4062/biomolther.2016.137NK-1 receptor antagonist (L-703606) injected into the lateral  hypothalamus-induced antinociception following treatment  with carbachol, suggesting that SP could be involved in the  activation of the descending anti-nociceptive pathway and  induction of analgesia through noradrenergic-mediated de- scending inhibition after binding to its receptor, the NK1 re-ceptor (Holden et al., 2009; Muto et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/bt-25-259.PMC5424635.pdf
"Key Words:  New psychoactive substances, Cytokine, T cell activator, Tetanus toxin, Motor impairment, GlutamateAbstractOriginal Article Biomol  Ther 25(3), 266-271 (2017) *Corresponding Author E-mail: actpotyjs@korea.kr Tel: +82-43-719-5205, Fax: +82-43-719-5200Received  May 31, 2016  Revised  Jul 14, 2016  Accepted  Aug 4, 2016 Published Online  Nov 25, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.116 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/15/bt-25-266.PMC5424636.pdf
268 https://doi.org/10.4062/biomolther.2016.116er’s manual.,Non-OADS,/arxiv_data1/oa_pdf/db/15/bt-25-266.PMC5424636.pdf
270 https://doi.org/10.4062/biomolther.2016.116ing performance on the fixed bar test.,Non-OADS,/arxiv_data1/oa_pdf/db/15/bt-25-266.PMC5424636.pdf
"Key Words:  Fucoidan, Cerebral ischemia-reperfusion injury, MAPK pathwayAbstractOriginal Article Biomol  Ther 25(3), 272-278 (2017) *Corresponding Author E-mail: xinyinhu6887@126.com Tel: +86-17186416584, Fax: +86-17186416584Received  May 9, 2016  Revised  Aug 2, 2016  Accepted  Sep 1, 2016 Published Online  Nov 25, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.098 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/09/bt-25-272.PMC5424637.pdf
274 https://doi.org/10.4062/biomolther.2016.098or 160 mg/kg) to the rats and then induced the IRI model by  MCAO method.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/bt-25-272.PMC5424637.pdf
276 https://doi.org/10.4062/biomolther.2016.098κB inactivation in IRI-induced myocardial damage.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/bt-25-272.PMC5424637.pdf
278 https://doi.org/10.4062/biomolther.2016.098tive activities and antioxidant activities of the polysaccharides from  Saccharina japonica.,Non-OADS,/arxiv_data1/oa_pdf/3c/09/bt-25-272.PMC5424637.pdf
"Key Words:  Anti-inflammatory, Cinnamaldehyde, Coxsackievirus B3, Myocarditis AbstractOriginal Article Biomol  Ther 25(3), 279-287 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.070 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/bt-25-279.PMC5424638.pdf
"280 https://doi.org/10.4062/biomolther.2016.070tion, anti-bacterial, anti-viral, and anti-inflammation proper - ties (Beige et al., 1996; Youn et al., 2008).",OADS,/arxiv_data1/oa_pdf/ed/1d/bt-25-279.PMC5424638.pdf
"282 https://doi.org/10.4062/biomolther.2016.070RESUL TS Preparation of compounds There are several published synthetic routes for cinnam - aldehyde derivatives (Battistuzzi et al., 2003; Nordqvist et  al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/bt-25-279.PMC5424638.pdf
"284 https://doi.org/10.4062/biomolther.2016.070cantly decreased by the treatment of compound 4, 5 and in- terferon.",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/bt-25-279.PMC5424638.pdf
"286 https://doi.org/10.4062/biomolther.2016.070TNF-a, IL-1b and IL-6 production and mRNA and protein ex- pression in CVB3 infected neonatal rat cardiomyocytes.",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/bt-25-279.PMC5424638.pdf
"Key Words:  Drug-drug interaction, CYP450, OATP transporters, Rifampin, BosentanAbstractOriginal Article Biomol  Ther 25(3), 288-295 (2017) *Corresponding Author E-mail: lovelyhkm@korea.kr Tel: +82-43-719-5206, Fax: +82-43-719-5200 †The first two authors contributed equally to this work.Received  Jul 12, 2016  Revised  Sep 28, 2016  Accepted  Oct 27, 2016 Published Online  Feb 6, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.153 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/24/bt-25-288.PMC5424639.pdf
290 https://doi.org/10.4062/biomolther.2016.153cytes treated with drug were washed with PBS and 1 ml lysis  buffer was added.,Non-OADS,/arxiv_data1/oa_pdf/6c/24/bt-25-288.PMC5424639.pdf
292 https://doi.org/10.4062/biomolther.2016.153mM bosentan+200 mM rifampin (Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/24/bt-25-288.PMC5424639.pdf
"294 https://doi.org/10.4062/biomolther.2016.153in human hepatocytes (Menochet et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/6c/24/bt-25-288.PMC5424639.pdf
"Key Words:  Human foreskin keratinocyte, Immortalization, Toxicity assessment, Three-dimensional skin cultureAbstractOriginal Article Biomol  Ther 25(3), 296-307 (2017) *Corresponding Author E-mail: choongholee@dongguk.edu  Tel: +82-31-961-5214, Fax: +82-31-961-5206Received  Feb 28, 2017  Revised  Mar 7, 2017  Accepted  Mar 8, 2017 Published Online  Apr 6, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2017.043 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/bt-25-296.PMC5424640.pdf
"298 https://doi.org/10.4062/biomolther.2017.043ized HFKs, purelink® genomic DNA kits (Invitrogen, Carlsbad,  CA, USA) was used by following the manufacturer’s protocol.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/bt-25-296.PMC5424640.pdf
300 https://doi.org/10.4062/biomolther.2017.043was shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/bt-25-296.PMC5424640.pdf
"302 https://doi.org/10.4062/biomolther.2017.043their differentiation status in more accurate way, we decided  to detect expression levels of epithelial differentiation marker  proteins such as keratin 10 and involucrin by Western blot  analysis.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/bt-25-296.PMC5424640.pdf
"304 https://doi.org/10.4062/biomolther.2017.043Therefore, we hope immortalized HFKs will be a good replace - ment for HaCaT cell in vitro skin research.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/bt-25-296.PMC5424640.pdf
306 https://doi.org/10.4062/biomolther.2017.043ther study needs to be conducted to see if inability of retinoic  acid to induce differentiation maker proteins is due to HPV E6/ E7-induced immortalization or endogenous nature specific for  HFK7 cells.,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/bt-25-296.PMC5424640.pdf
"Key Words:  Urotensin II, Antagonist, KR-36996, GSK-1440115, Vascular smooth muscle, ProliferationAbstractOriginal Article Biomol  Ther 25(3), 308-314 (2017) *Corresponding Author E-mail: yisjung@ajou.ac.kr Tel: +82-31-219-3444, Fax: +82-31-219-3435 †The first two authors contributed equally to this work.Received  Sep 27, 2016  Revised  Oct 7, 2016  Accepted  Oct 27, 2016 Published Online  Feb 6, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.219 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/db/bt-25-308.PMC5424641.pdf
"310 https://doi.org/10.4062/biomolther.2016.219controlled salt solution (HCSS) incubated with 10 mM DCF- DA and 20% Pluronic F-127 for 30 min, and washed with  HCSS, as described previously (Lee and Jung, 2012).",Non-OADS,/arxiv_data1/oa_pdf/db/db/bt-25-308.PMC5424641.pdf
312 https://doi.org/10.4062/biomolther.2016.219and stent technology are widely used in the treatment of ath- erosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/db/db/bt-25-308.PMC5424641.pdf
314 https://doi.org/10.4062/biomolther.2016.219(2008) Palosuran inhibits binding to primate UT receptors in cell  membranes but demonstrates differential activity in intact cells and vascular tissues.,Non-OADS,/arxiv_data1/oa_pdf/db/db/bt-25-308.PMC5424641.pdf
"Key Words:  Autophagy, 5-Fluorouracil, SNUC5/5-FUR, Reactive oxygen species, Colon cancerAbstractOriginal Article Biomol  Ther 25(3), 315-320 (2017) Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.069 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/bt-25-315.PMC5424642.pdf
"316 https://doi.org/10.4062/biomolther.2016.069mal p53 function due to missense mutations in p53, have been  used for many research purposes, including anticancer drug  screening, and studies of multidrug resistance, microsatellite  instability, mutations in mismatch repair genes, and the TGF- b  signaling pathway (Ku and Park, 2005).",Non-OADS,/arxiv_data1/oa_pdf/c4/d4/bt-25-315.PMC5424642.pdf
318 https://doi.org/10.4062/biomolther.2016.069Detection of intracellular ROS The level of intracellular reactive oxygen species (ROS)  was detected on a FACSCalibur flow cytometer.,OADS,/arxiv_data1/oa_pdf/c4/d4/bt-25-315.PMC5424642.pdf
320 https://doi.org/10.4062/biomolther.2016.069ACKNOWLEDGMENTS This work was supported by a research grant from the Jeju  National University Hospital Research Fund of Jeju National  University in 2015.,Non-OADS,/arxiv_data1/oa_pdf/c4/d4/bt-25-315.PMC5424642.pdf
"Key Words:  Steroid sulfatase, Dehydroepiandrosterone, Integrin b1, FAK, MAPK/ERK pathwayAbstractOriginal Article Biomol  Ther 25(3), 321-328 (2017) *Corresponding Author E-mail: yjchun@cau.ac.kr Tel: +82-2-820-5616, Fax: +82-2-820-5616Received  Jul 17, 2016  Revised  Sep 2, 2016  Accepted  Oct 4, 2016 Published Online  Dec 13, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.155 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/84/bt-25-321.PMC5424643.pdf
"322 https://doi.org/10.4062/biomolther.2016.155lular signaling pathways such as NF-κB (Lamb et al., 2011),  Akt (Oloumi et al., 2004), and MAPK/ERK pathways (Lee et  al., 2012), and induces cell growth, polarity, motility, and dif- ferentiation (Guo and Giancotti, 2004).",OADS,/arxiv_data1/oa_pdf/d4/84/bt-25-321.PMC5424643.pdf
324 https://doi.org/10.4062/biomolther.2016.155then incubated overnight with specific primary antibody at a  1:1000 dilution in TBS-T. Horseradish peroxidase (HRP)- conjugated secondary antibody was incubated at 4°C for 2  h. Proteins were visualized with ECL (Thermo) and the band  intensity was measured using ChemiDoc XRS densitometer  and quantified by Quantity One software (Bio-Rad).,OADS,/arxiv_data1/oa_pdf/d4/84/bt-25-321.PMC5424643.pdf
326 https://doi.org/10.4062/biomolther.2016.155activation of integrin signaling by up-regulation of integrin b1  and fibronectin.,Non-OADS,/arxiv_data1/oa_pdf/d4/84/bt-25-321.PMC5424643.pdf
328 https://doi.org/10.4062/biomolther.2016.155tor induces integrin a6b1 to promote prostate tumor cell survival via  NF-κB and Bcl-xL Independently of PI3K signaling.,Non-OADS,/arxiv_data1/oa_pdf/d4/84/bt-25-321.PMC5424643.pdf
"Key Words:  Capsanthin, Anti-adipogenic, Lypolytic activity, Spontaneous locomotive activity, Adiponectin AbstractOriginal Article Biomol  Ther 25(3), 329-336 (2017) *Corresponding Author E-mail: bhhan3312@yahoo.co.kr Tel: +82-41-556-9166, Fax: +82-41-556-9165Received  Mar 6, 2017  Revised  Mar 18, 2017  Accepted  Mar 18, 2017 Published Online  May 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2017.048 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/48/bt-25-329.PMC5424644.pdf
330 https://doi.org/10.4062/biomolther.2017.048the adipogenesis model of murine preadipocyte cell line 3T3- L1.,Non-OADS,/arxiv_data1/oa_pdf/d0/48/bt-25-329.PMC5424644.pdf
332 https://doi.org/10.4062/biomolther.2017.048Spontaneous locomotive activity of mice Single mouse was accommodated in a cage which was  equipped with a wheel on which one way running exercise is  possible together with automatic digital counting system.,Non-OADS,/arxiv_data1/oa_pdf/d0/48/bt-25-329.PMC5424644.pdf
334 https://doi.org/10.4062/biomolther.2017.048control group showed unchanged.,Non-OADS,/arxiv_data1/oa_pdf/d0/48/bt-25-329.PMC5424644.pdf
"336 https://doi.org/10.4062/biomolther.2017.048Correlation of the adipocyte-derived protein adiponectin with insu- lin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.",Non-OADS,/arxiv_data1/oa_pdf/d0/48/bt-25-329.PMC5424644.pdf
"Key Words:  Activating transcription factor 3, Apoptosis, Coffee, Human colorectal cancer, KahweolAbstractOriginal Article Biomol  Ther 25(3), 337-343 (2017) *Corresponding Author E-mail: jjb0403@anu.ac.kr Tel: +82-54-820-7757, Fax: +82-54-820-6252Received  May 25, 2016  Revised  Jul 27, 2016  Accepted  Aug 23, 2016 Published Online  Nov 25, 2016 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.114 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/7c/bt-25-337.PMC5424645.pdf
338 https://doi.org/10.4062/biomolther.2016.114kahweol-mediated ATF3 expression and apoptosis in human  colorectal cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/03/7c/bt-25-337.PMC5424645.pdf
"340 https://doi.org/10.4062/biomolther.2016.114drich) and phosphatase inhibitor cocktail (Sigma-Aldrich), and  centrifuged at 15,000×g for 10 min at 4°C.",Non-OADS,/arxiv_data1/oa_pdf/03/7c/bt-25-337.PMC5424645.pdf
342 https://doi.org/10.4062/biomolther.2016.114transfected into HCT116 cells and treated with 50 mM of kah- weol.,Non-OADS,/arxiv_data1/oa_pdf/03/7c/bt-25-337.PMC5424645.pdf
"MeSH Keywords:  Alcohol Drinking • Association • Cohort Studies • Metabolic Syndrome X  Abbreviations:  MetS  – metabolic syndrome; BMI – body mass index; HDL – high density lipoprotein; OR – odds ratio;   CI – confidence interval  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901309Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Kohwang Medical Institute, School of Medicine, Kyung Hee University, Seoul,  Republic of Korea 2 Division of Food Science and Culinary Arts, Food and Nutrition Major, Shinhan  University, Gyeonggi, Republic of Korea 3 Department of Biomedical Laboratory Science, Shinhan University, Gyeonggi,  Republic of Koreae-ISSN 1643-3750 © Med Sci Monit, 2017; 23: 2104-2110  DOI: 10.12659/MSM.901309 2104 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]   [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]   [Chemical Abstracts/CAS] [Index Copernicus]CLINICAL RESEARCH This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/b6/7c/medscimonit-23-2104.PMC5424649.pdf
"MeSH Keywords:  Magnetic Resonance Imaging • Muscular Atrophy • Paraspinal Muscles • Scoliosis  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902455Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Orthopedics, Changzheng Hospital, Second Military Medical  University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e2/38/medscimonit-23-2089.PMC5424650.pdf
"MeSH Keywords:  Hip Fractures • Iliac Vein • May-Thurner Syndrome • Risk Factors • Venous Thrombosis  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901639Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Orthopedics, Shanghai Tenth People’s Hospital, School of Medicine,  Tongji University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/29/25/medscimonit-23-2078.PMC5424652.pdf
"MeSH Keywords:  Apoptosis • Esophageal Neoplasms • Phosphatidylinositol 3-Kinases • Saponins  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901183Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Neurosurgery, Children’s Hospital, Zhejiang University School of  Medicine, Hangzhou, Zhejiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/04/61/medscimonit-23-2096.PMC5424653.pdf
PR9 1 (2016) e575http://dx.doi.org/10.1097/PR9.0000000000000575 1 (2016) e575 www.painreportsonline.com 1,Non-OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
"Standard preprocessing of each subject’s fMRI data was performed using FSL 4.1.8 (FMRIB’s Software Library,http://www.fmrib.ox.ac.uk/fsl ).",OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
preprocessing are in supplementary information (available at http://links.lww.com/PR9/A2).,OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
Statistical z-value peak voxels for all maps referred below are in Table 2 and supplementary table 1 (available at http://links.lww.com/ PR9/A2).,Non-OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
"In addition, the correlation between VAS and log BDI scores remainedinsignificant ( r50.08, P50.63, supplementary figure 1, available at http://links.lww.com/PR9/A2).",OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
"These results remained consistent at a range of link densities (supplementary figure 2A, available at http://links.lww.com/PR9/A2); thus, our remaining results are reported at 10% link density, unless otherwise indicated.",OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
"Posthoc correlation of the average degree in the identified region and pain intensity werehighly significant ( r50.92, P,,0.001) (supplementary figure 3, available at http://links.lww.com/PR9/A2).",Non-OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
Supplemental files are available at http://links.lww.com/PR9/A2.,Non-OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
Supplemental Digital Content Supplemental Digital Content associated with this article can be found online at http://links.lww.com/PR9/A2.,Non-OADS,/arxiv_data1/oa_pdf/33/88/painreports-1-e575.PMC5424698.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.NEUROGENESIS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"1, e1300037 (8 pages)http://dx.doi.org/10.1080/23262133.2017.1300037",Non-OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"ORCID Cindi M. Morshead http://orcid.org/0000-0002-2444-8024 References [1] Till JE, McCulloch EA.",Non-OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Radiat Res 2012; 178:AV3-7; PMID:22870977; http://dx.doi.org/10.1667/RRAV01.1 [2] Reynolds BA, Weiss S. Generation of neurons and astro- cytes from isolated cells of the adult mammalian centralnervous system.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Science 1992; 255:1707-10;PMID:1553558; http://dx.doi.org/10.1126/science.1553558 [3] Siminovitch L, Mcculloch EA, Till JE.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"J CellPhysiol 1963; 62:327-36; http://dx.doi.org/10.1002/ jcp.1030620313[4] Till JE, McCulloch EA.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Trends Neurosci 2003; 26:125-31; PMID:12591214; http://dx.doi.org/10.1016/S0166-2236(03)00031-6 [7] Coles-Takabe BL, Brain I, Purpura KA, Karpowicz P, Zandstra PW, Morshead CM, van der Kooy D. Don ’t look: growing clonal versus nonclonal neural stem cellcolonies.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Nat Protoc 2012; 7:2005-12; PMID:23080272;http://dx.doi.org/10.1038/nprot.2012.123 [9] Leong C, Zhai D, Kim B, Yun SW, Chang YT.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Stem Cell Res 2013; 11:1314-22; PMID:24090932; http://dx.doi.org/10.1016/j.scr.2013.09.002 [10] Sachewsky N, Leeder R, Xu W, Rose KL, Yu F, van der Kooy D, Morshead CM.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Stem Cell Rep 2014; 2:810-24; http://dx.doi.org/10.1016/j.stemcr.2014.04.008 [11] Xu W, Sachewsky N, Azimi A, Hung M, Gappasov A, Morshead CM.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Stem Cells Dayt Ohio 2016; 35(2):485-96; http://dx.doi.org/10.1002/stem.2488 [12] Mich JK, Signer RA, Nakada D, Pineda A, Burgess RJ, Vue TY, Johnson JE, Morrison SJ.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Elife 2014; 3:e02669; PMID:24843006; http://dx.doi.org/10.7554/eLife.02669 [13] Llorens-Bobadilla E, Zhao S, Baser A, Saiz-Castro G, Zwadlo K, Martin-Villalba A. Single-cell transcriptomicsreveals a population of dormant neural stem cells thatbecome activated upon brain injury.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Cell Stem Cell 2015;17:329-40; PMID:26235341; http://dx.doi.org/10.1016/j.stem.2015.07.002 [14] Mayer C, Jaglin XH, Cobbs LV, Bandler RC, Streicher C, Cepko CL, Hippenmeyer S, Fishell G. Clonally relatedforebrain interneurons disperse broadly across both func-tional areas and structural boundaries.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Neuron 2015;87:989-98; PMID:26299473; http://dx.doi.org/10.1016/j.neuron.2015.07.011 [15] Niwa H, Miyazaki J, Smith AG.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
Nat Genet 2000; 24:372-6; PMID:10742100; http://dx.doi.org/10.1038/74199e1300037-6 W. XU ET AL.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Stem Cells Dayt Ohio 2001; 19:477-82; http://dx.doi.org/10.1634/stemcells.19-6-477 [17] Panchision DM, Pickel JM, Studer L, Lee SH, Turner PA, Hazel TG, McKay RD.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Proc Natl Acad Sci U S A 2004;101:17528-32; PMID:15574494; http://dx.doi.org/10.1073/ pnas.0407893101 [22] Tong CK, Alvarez-Buylla A.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Neuron 2014; 81:220.e1; http://dx.doi.org/10.1016/j.neuron.2013.12.004 [23] Gallagher D, Norman AA, Woodard CL, Yang G, Gauth- ier-Fisher A, Fujitani M, Vessey JP, Cancino GI, Sachew-sky N, Woltjen K, et al.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Cell Stem Cell 2013; 13:564-76; PMID:24209760; http://dx.doi.org/10.1016/j.stem.2013.10.002 [24] Hitoshi S, Seaberg RM, Koscik C, Alexson T, Kusunoki S, Kanazawa I, Tsuji S, van der Kooy D. Primitive neuralstem cells from the mammalian epiblast differentiate todeﬁnitive neural stem cells under the control of Notch signaling.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Genes Dev 2004; 18:1806-11; PMID:15289455; http://dx.doi.org/10.1101/gad.1208404 [25] Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, van der Kooy D. Direct neural fate speci ﬁcation from embry- onic stem cells: a primitive mammalian neural stem cellstage acquired through a default mechanism.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Neuron2001; 30:65-78; PMID:11343645; http://dx.doi.org/10.1016/S0896-6273(01)00263-X [26] Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telen-cephalon.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Dev Biol 1999; 208:166-88; PMID:10075850;http://dx.doi.org/10.1006/dbio.1998.9192 [27] Karpowicz P, Inoue T, Runciman S, Deveale B, Sea- berg R, Gertsenstein M, Byers L, Yamanaka Y, TondatS, Slevin J, et al.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
J Neurosci Off J Soc Neurosci 2007; 27:5437-47; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"org/10.1523/JNEURO SCI.0300-07.2007[28] Morshead CM, Reynolds BA, Craig CG, McBurney MW, Staines WA, Morassutti D, Weiss S, van der Kooy D.Neural stem cells in the adult mammalian forebrain: arelatively quiescent subpopulation of subependymal cells.Neuron 1994; 13:1071-82; PMID:7946346; http://dx.doi.org/10.1016/0896-6273(94)90046-9 [29] Morshead CM, van der Kooy D. Postmitotic death is the fate of constitutively proliferating cells in the subependy- mal layer of the adult mouse brain.",Non-OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
Cell Stem Cell2008; 3:265-78; PMID:18786414; http://dx.doi.org/ 10.1016/j.stem.2008.07.004 [31] Altman J.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Science 1962; 135:1127-8; PMID:13860748;http://dx.doi.org/10.1126/science.135.3509.1127 [32] Lois C, Alvarez-Buylla A.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Science 1994;264:1145-8; PMID:8178174; http://dx.doi.org/10.1126/science.8178174 [33] Morshead CM, Craig CG, van der Kooy D. In vivo clonal analyses reveal the properties of endogenous neural stemcell proliferation in the adult mammalian forebrain.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Cell 1999; 97:703-16;PMID:10380923; http://dx.doi.org/10.1016/S0092-8674(00) 80783-7 [35] Doetsch F, Garc /C19ıa-Verdugo JM, Alvarez-Buylla A. Cellu- lar composition and three-dimensional organization ofthe subventricular germinal zone in the adult mammalianbrain.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
Stem Cells Dayt Ohio 2009;27:2722-33; http://dx.doi.org/10.1002/stem.226 [39] Smart IH.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
PLoS Biol 2008; 6:e182; PMID:18651793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Neuroscience 2009;164:1044-56; PMID:19747531; http://dx.doi.org/10.1016/j.neuroscience.2009.09.006 [43] Bodega G, Su /C19arez I, Rubio M, Fern /C19andez B. Ependyma: phylogenetic evolution of glial ﬁbrillary acidic protein (GFAP) and vimentin expression in vertebrate spinalcord.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Histochemistry 1994; 102:113-22; PMID:7822213;http://dx.doi.org/10.1007/BF00269015 [44] Fiorelli R, Cebrian-Silla A, Garcia-Verdugo JM, Raine- teau O.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
Eur J Neurosci 2016; 43:1474-85; PMID:26946195; http://dx.doi.org/10.1111/ejn.13228 [47] Boggs JM.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Cell Mol Life Sci 2006; 63:1945-61; PMID:16794783;http://dx.doi.org/10.1007/s00018-006-6094-7 [48] Hou T, Shi Y, Cheng S, Yang X, Li L, Xiao C. Nogo-A expresses on neural stem cell surface.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
Int J Neurosci2010; 120:201-5; PMID:20374087; http://dx.doi.org/ 10.3109/00207450903506502 [49] Scadden DT.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Nature 2006; 441:1075-9; PMID:16810242; http://dx.doi.org/10.1038/nature04957 [50] Picard-Riera N, Nait-Oumesmar B, Baron-Van Evercoo- ren A. Endogenous adult neural stem cells: limits andpotential to repair the injured central nervous system.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Restricted proliferation and migration of postnatally generated neurons derived from the fore-brain subventricular zon e. Neuron 1993; 11:173-89; PMID:8338665; http://dx.doi.org/10.1016/0896-6273(93)90281-U [52] Lois C, Garc /C19ıa-Verdugo JM, Alvarez-Buylla A.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Exp BrainRes 1982; 46:315-23; PMID:7095040; http://dx.doi.org/10.1007/BF00238626 [54] Altman J, Das GD.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"J Comp Neurol 1965; 124:319-35; PMID:5861717; http://dx.doi.org/10.1002/cne.901240303 [55] Shihabuddin LS, Horner PJ, Ray J, Gage FH.",Non-OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Exp Neurol2001; 167:27-39; PMID:11161590; http://dx.doi.org/10.1006/exnr.2000.7539 [57] Piccin D, Tufford A, Morshead CM.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Neurobiol Aging 2014; 35:1669-79; PMID:24559648; http://dx.doi.org/ 10.1016/j.neurobiol aging.2014.01.026 [58] Gr /C19egoire CA, Goldenstein BL, Floriddia EM, Barnab /C19e- Heider F, Fernandes KJ.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Glia 2015;63:1469-82; PMID:25921491; http://dx.doi.org/10.1002/glia.22851 [59] Barnab /C19e-Heider F, G €oritz C, Sabelstr €om H, Takebayashi H, Pfrieger FW, Meletis K, Fris /C19en J.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Cell StemCell 2010; 7:470-82; PMID:20887953; http://dx.doi.org/10.1016/j.stem.2010.07.014 [60] Faiz M, Sachewsky N, Gasc /C19on S, Bang KW, Morshead CM, Nagy A.",OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
Cell Stem Cell 2015; 17:624-34; PMID:26456685; http://dx.doi.org/10.1016/j.stem.2015.08.002e1300037-8 W. XU ET AL.,OADS,/arxiv_data1/oa_pdf/91/f6/kngs-04-01-1300037.PMC5424705.pdf
"Based on the known 3D-structural motif for the saposin  family, we show how bioengineering techniques may be used to develop minimal peptide  constructs that maintain desirable structural properties and activities in biomedical applica- Received: August 4, 2016   Accepted after revision: September 27, 2016   Published online: November 16, 2016   Frans J. Walther, MD, PhD, FAAP   Los Angeles Biomedical Research Institute    Harbor-UCLA Medical Center   1124 West Carson Street, Torrance, CA 90502 (USA)   E-Mail fjwalther   @   ucla.edu  www.karger.com/bmh This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/99/5e/bmh-0001-0001.PMC5424708.pdf
"The  respective MB and S-MB sequences were analyzed with PASTA to as sess those regions  most likely to form β-sheet, particular in polar environments s uch as in aqueous buffer or  at the lipid-water interface (http://protein.cribi.unipd.it/pas ta;  [88, 89] ).",OADS,/arxiv_data1/oa_pdf/99/5e/bmh-0001-0001.PMC5424708.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3Endocrine Connections 6:3 172–178  J Y Choi, J W Yi et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3 Research J Y Choi  et al.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
TCGA gene expression data from RNA sequencing  were provided with level 3 RSEM (RNA-Seq by expectation– maximization) counts after upper quartile normalization  to maintain the standardization of different platforms  or housekeeping genes ( https://wiki.nci.nih.gov/ ).,OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
"Differentially expressed genes (DEG) and gene ontology  (GO) tests between two VDR groups were performed using  ‘EdgeR’ package, which is one of the bioinformatics tools  in Bioconductor ( https://www.bioconductor.org/ ) (11).",OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research J Y Choi  et al.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research J Y Choi  et al.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research J Y Choi  et al.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research J Y Choi  et al.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
Further experimental  validation should be performed to prove the biologic  influence of VDR and circulating vitamin D. Supplementary data This is linked to the online version of the paper at http://dx.doi.org/10.1530/ EC-17-0001.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0001 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research J Y Choi  et al.,Non-OADS,/arxiv_data1/oa_pdf/f4/fa/ec-6-172.PMC5424767.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 2Endocrine Connections 6:2 82–88  M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 2 Research M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivatives 4.0  International License.DOI: 10.1530/EC-16-0099 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Watanabe et al.,Non-OADS,/arxiv_data1/oa_pdf/c1/f9/ec-6-82.PMC5424769.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3Endocrine Connections 6:3 89–99  M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0113 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Nylander et al.,Non-OADS,/arxiv_data1/oa_pdf/79/95/ec-6-89.PMC5424770.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.139–150 Open Access6 3 1:6  6:3 139–150  M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0008 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Braga et al.,Non-OADS,/arxiv_data1/oa_pdf/51/76/ec-6-139.PMC5424772.pdf
"DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.53–62 Shikonin induces apoptosis in  MTC cellsC Hasenoehrl et al.Research Open Access61 53:6Endocrine ConnectionsAnti-tumor effects of shikonin  derivatives on human medullary thyroid carcinoma cells Carina Hasenoehrl1,†, Gert Schwach1, Nassim Ghaffari-Tabrizi-Wizsy1,2,  Robert Fuchs1, Nadine Kretschmer3, Rudolf Bauer3 and Roswitha Pfragner1 1Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University  of Graz, Graz, Austria 2SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz,  Graz, Austria 3Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria †(C Hasenoehrl is now at Institute of Experimental and Clinical Pharmacology, Medical University  of Graz, Graz, Austria) Abstract New treatment options are needed for medullary thyroid carcinoma (MTC), a highly  metastasizing neuroendocrine tumor that is resistant to standard radiotherapy and  chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
DOI: 10.1530/EC-16-0105 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.,Non-OADS,/arxiv_data1/oa_pdf/e9/cf/ec-6-53.PMC5424774.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdOpen Access6 3 Endocrine ConnectionsOpen Access A K Clift et al.ResearchSurvival prediction in small  bowel NET Predicting the survival of patients  with small bowel neuroendocrine tumours: comparison of 3 systems Ashley K Clift1, Omar Faiz2, Robert Goldin3, John Martin4, Harpreet Wasan1,  Marc-Olaf Liedke5, Erik Schloericke5, Anna Malczewska1,6, Guido Rindi7,  Mark Kidd8, Irvin M Modlin9 and Andrea Frilling1 1Department of Surgery and Cancer, Imperial College London, London, UK 2Department of Surgery, St Mark’s Hospital, London, UK 3Centre for Pathology, Imperial College London, London, UK 4Department of Gastroenterology, Imperial College London, London, UK 5Department of Surgery, Westkuesten Klinikum Heide, Heide, Germany 6Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland 7Institute of Anatomic Pathology, Universita Cattolica del Sacro Cuore, Rome, Italy 8Wren Laboratories, Branford, Connecticut, USA 9Emeritus Professor Gastrointestinal Surgery, School of Medicine, Yale University, New Haven,  Connecticut, USA Abstract Neuroendocrine tumours (NET) are clinically challenging due to their unpredictable  behaviour.",Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Figure 2 Kaplan–Meier plot of patient survival stratified by AJCC/UICC tumour  stage (P = 0.276).,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Figure 5 Receiver-operating characteristic curves for 5- (top) and 10-year (bottom)  survival (WHO/ENETS tumour grade).,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Figure 7 Kaplan–Meier plot of patient survival stratified by NET nomogram score  risk group (P = 0.031).,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
Supplementary data This is linked to the online version of the paper at http://dx.doi.org/   10.1530/EC-16-0114.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International   License.DOI: 10.1530/EC-16-0114 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research A K Clift et al.,Non-OADS,/arxiv_data1/oa_pdf/8e/af/ec-6-71.PMC5424775.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3Endocrine Connections 6:3 151–158  R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
Supplementary data This is linked to the online version of the paper at http://dx.doi.org/10.1530/ EC-17-0006.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
(available at: http://webarchive.nationalarchives.gov.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
uk/20050513213558/http://advisorybodies.doh.gov.uk/arsac/nfg-dec1998.pdf)  6 International Commission on Radiological Protection.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
"(available at: http://www.icrp.org/publication.asp?id=ICRP%20 Publication%20103)  7 Wall BF, Haylock R, Jansen JTM, Hillier MC, Hart D & Shrimpton PC.",Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
(available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/340147/HPA-CRCE-028_for_website.pdf).,OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-17-0006 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research R Casey et al.,Non-OADS,/arxiv_data1/oa_pdf/77/45/ec-6-151.PMC5424776.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 2Endocrine Connections 6:2 R1–7  G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Review G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Review G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Review G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Review G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Review G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0100 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Review G B Raglan et al.,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/ec-6-R1.PMC5424777.pdf
"DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .63–70 Role of attitudes and  intentions in adherenceE K Fai et al.Research Open Access62 63:6Endocrine ConnectionsCorrespondence  should be addressed to E K Fai Email  efai@umm.eduRole of attitudes and intentions in  predicting adherence to oral diabetes medications Emmanuel K Fai1, Cheryl Anderson2 and Victor Ferreros2 1University of Maryland Medical Center Midtown Campus, Baltimore, Maryland, USA 2Walden University, Minneapolis, Minnesota, USA Abstract The purpose of this quantitative study was to investigate the extent to which patient  attitudes and intentions predict adherence to the use of oral antihyperglycemic regimens in African Americans.",Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
"(available at:  http://www.who.int/chp/knowledge/ publications/adherence_report/en/ )   3   Haynes R, Ackloo E, Sahota N, McDonald H & Yao X.",Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
(available at:  http://www.diabetes.org ).,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0093 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research E K Fai et al.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/ec-6-63.PMC5424778.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3Endocrine Connections 6:3 159–171  O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0110 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research O A Sahin et al.,Non-OADS,/arxiv_data1/oa_pdf/09/72/ec-6-159.PMC5424779.pdf
"One is that, since the sequences of IDPs and IDRs  are typically poor in hydrophobic and other order-promoting *Correspondence to: Trevor P Creamer; Email: trevor.creamer@uky.edu Submitted: 08/30/2013; Revised: 09/06/2013; Accepted: 09/07/2013 http://dx.doi.org/10.4161/idp.26412 Citation: Creamer T. Transient disorder: Calcineurin as an example.",Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biophys J  2007 ; 92:1439 - 56; PMID:17158572 ; http://dx.doi.org/10.1529/ biophysj.106.094045 3.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Trends Biochem Sci  2012 ; 37:509- 16; PMID:22989858 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr Opin Struct Biol  2009 ; 19:31-8; PMID :19157855 ;  http://dx.doi.org/10.1016/j.sbi.2008.12.003 5.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Nat Rev Mol Cell Biol   2005 ; 6:197-208; PMID:15738986 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Science   2012 ; 337:1460 -1; PMID:22997313 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proteins  2000 ;  41:415-27; PMID:11025552 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochem J  2013 ; 449:307- 18; PMID:23240611 ; http://dx.doi.org/10.1042/ BJ20121346 10.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proteins  2003 ; 52:573- 84; PMID:12910457 ; http://dx.doi.org/10.1002/ prot.10437 11.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr Opin Struct Biol  2012 ; 22:643-50;  PMID:22999889 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Angew Chem Int Ed Engl   2002 ; 41:1098 -113; PMID:12491239 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Trends  Biochem Sci  2005 ; 30:283-6; PMID:15950869 ;  http://dx.doi.org/10.1016/j.tibs.2005.04.00515.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
J Am Chem Soc   2011 ; 133:7116 -20; PMID:21506571 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Trends Biochem Sci  2013 ; 38:337-44;  PMID:23764454 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochem Soc Trans  2012 ; 40:950-4;  PMID:22988846 ; http://dx.doi.org/10.1042/ BST20120096 18.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
ACS Chem Biol  2011 ; 6:1087 - 95; PMID :21815694 ; http://dx.doi.org/10.1021/ cb2002285 19.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Nat Chem Biol  2009 ; 5:29- 36; PMID:19029916 ; http://dx.doi.org/10.1038/ nchembio.130 20.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
F1000  Biol Rep  2013 ; 5:2; PMID:23361309 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr Opin Struct  Biol 2002 ; 12:54-60; PMID:11839490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Arch Biochem Biophys   2013 ; 531:80-9; PMID:23142500 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Protein Sci   2013 ; 22:693-724; PMID:23553817 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochim Biophys Acta  2013 ;  1834 :932-51; PMID:23269364 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Nat Struct Biol  1998 ; 5:568- 70; PMID:9665170 ; http://dx.doi.org/10.1038/823 26.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
J Am Chem Soc  2011 ; 133:9395 - 404; PMID :21627157 ; http://dx.doi.org/10.1021/ ja200617t 27.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
FEBS Lett  2013 ; 587:1081 - 8; PMID:23454209 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr Opin Struct Biol   2013 ; 23:436-42; PMID:23477949 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr  Opin Struct Biol  2010 ; 20:482-8; PMID:20591649 ;  http://dx.doi.org/10.1016/j.sbi.2010.06.002 31.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr Biol  2005 ;  15:R442 -3; PMID:15964258 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Trends Cell  Biol 2011 ; 21:91-103; PMID:21115349 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
"1H, 13C, 15N nuclear magnetic resonance  backbone assignments and secondary structure of  human calcineurin B.  Biochemistry  1994 ; 33:3540 - 7; PMID:8142351 ; http://dx.doi.org/10.1021/ bi00178a010 36.",Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Nature  1995 ; 378:641-4;  PMID:8524402 ; http://dx.doi.org/10.1038/378641a0 37.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proc Natl Acad Sci U S A  2002 ; 99:13522 - 6; PMID:12357034 ; http://dx.doi.org/10.1073/ pnas.212504399 38.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
J Mol Biol  2007 ; 369:1296 -306; PMID:17498738 ;  http://dx.doi.org/10.1016/j.jmb.2007.04.03239.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Structure  2007 ; 15:587- 97; PMID:17502104 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochem Biophys Res Commun  2003 ; 311:1095 - 102; PMID:14623295 ; http://dx.doi.org/10.1016/ S0006-291X(03)01537-7 41.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Cell  1995 ; 82:507-22; PMID:7543369 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proc Natl Acad Sci U S A   1983 ; 80:4291 -5; PMID:6576338 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochemistry  1989 ; 28:1868 -74; PMID:2541767 ;  http://dx.doi.org/10.1021/bi00430a066 44.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proteins  2001 ; 42:38-48;  PMID:11093259 ; http://dx.doi.org/10.1002/1097- 0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3 46.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
J Mol Biol  2012 ; 415:307-17;  PMID:22100452 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Cell 2007 ; 131:1047 - 58; PMID:18083096 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Low affinity Ca2+-binding sites  of calcineurin B mediate conformational changes  in calcineurin A.  Biochemistry  2000 ; 39:16147 - 54; PMID:11123943 ; http://dx.doi.org/10.1021/ bi001321q 49.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proc Natl Acad Sci U S A  2002 ; 99:12037 -42;  PMID:12218175 ; http://dx.doi.org/10.1073/ pnas.192206699 55.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Cell 1994 ;  79:437-47; PMID:7525078 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
"Sikkink  R, Haddy  A, MacKelvie  S, Mertz  P, Litwiller   R, Rusnak  F. Calcineurin subunit interactions:  mapping the calcineurin B binding domain on  calcineurin A.  Biochemistry  1995 ; 34:8348 - 56; PMID:7599126 ; http://dx.doi.org/10.1021/ bi00026a016 57.",OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Dual calcium ion regulation  of calcineurin by calmodulin and calcineurin B.   Biochemistry  1994 ; 33:6859 -66; PMID:8204620 ;  http://dx.doi.org/10.1021/bi00188a015 59.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochemistry   2001 ; 40:8808 -14; PMID:11467941 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proteins  2008 ; 73:19-27; PMID:18384083 ;  http://dx.doi.org/10.1002/prot.22032 64.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochemistry   2006 ; 45:738-45; PMID:16411749 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
"Majava  V, Kursula  P. Domain swapping and  different oligomeric States for the complex between  calmodulin and the calmodulin-binding domain  of calcineurin a.  PLoS One  2009 ; 4:e5402 ;  PMID:19404396 ; http://dx.doi.org/10.1371/ journal.pone.0005402 66.",OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proteins  2011 ; 79:765- 86; PMID:21287611 ; http://dx.doi.org/10.1002/ prot.22917 67.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Cell 2002 ; 108:739-42;  PMID:11955428 ; http://dx.doi.org/10.1016/ S0092-8674(02)00682-7,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Science  1992 ;  257:1251 -5; PMID :1519061 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Biochem Biophys Res Commun  2005 ; 334:674- 80; PMID:16009337 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Proteins  2006 ; 63:398- 410; PMID:16493654 ; http://dx.doi.org/10.1002/ prot.2087371.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
Curr Opin Struct Biol   2012 ; 22:21-9; PMID:22129832 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/28/kidp-01-01-10926412.PMC5424781.pdf
" PaPer Ty Pe www.landesbioscience.com Intrinsically Disordered Proteins  e25464-1Intrinsically Disordered Proteins 1, e25464; 2013; © 2013 Landes BiosciencereSear CH P aPer *Correspondence to: J Sivaraman; Email: dbsjayar@nus.edu.sg Submitted: 06/19/13; Accepted: 06/19/13 http://dx.doi.org/10.4161/idp.25464 Citation: Chichili V, Kumar V, Sivaraman J.",Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
A protein data bank (PDB) search   (http://www.pdb.org/pdb/home/home.do) shows that sev - eral linked protein-peptide complexes have been studied.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Protein Eng Des  Sel 2011; 24:635-48; PMID:21676899; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Curr Opin Struct  Biol 2002; 12:54-60; PMID:11839490; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
J Mol Biol 2003; 331:303-13;  PMID:12888339; http://dx.doi.org/10.1016/S0022- 2836(03)00721-6.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Mass Spectrom Rev  2006; 25:663-82; PMID:16477643; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Bioconjug Chem 2005; 16:741-50; PMID:16029014;  http://dx.doi.org/10.1021/bc050043a.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Nature 1996; 381:616-20;  PMID:8637599; http://dx.doi.org/10.1038/381616a0.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
EMBO J 2000; 19:5611- 24; PMID:11060013; http://dx.doi.org/10.1093/ emboj/19.21.5611.10.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
J Exp Med  2002; 195:571-81; PMID:11877480; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
EMBO J  2005; 24:2968-79; PMID:16079912; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
J Exp Med  2011; 208:91-102; PMID:21199956; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Anal Biochem 2003; 315:175- 82; PMID:12689827; http://dx.doi.org/10.1016/ S0003-2697(03)00007-1.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Sci  Rep 2013; 3:1392; PMID:23462742; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Biochemistry  2006; 45:738-45; PMID:16411749; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Electrophoresis 1997; 18:2714- 23; PMID:9504803; http://dx.doi.org/10.1002/ elps.1150181505.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Biochemistry  2003; 42:5143-50; PMID:12718558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Anal Biochem 2003; 315:175- 82; PMID:12689827; http://dx.doi.org/10.1016/ S0003-2697(03)00007-1.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Biochem Cell  Biol 1994; 72:109-16; PMID:7818844; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Acta  Crystallogr A 2008; 64:112-22; PMID:18156677;  http://dx.doi.org/10.1107/S0108767307043930.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Bioinformatics 2004; 20:45-50; PMID:14693807;  http://dx.doi.org/10.1093/bioinformatics/btg371.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
J Comput Chem  1998; 19:1639-62; http://dx.doi.org/10.1002/ (SICI)1096-987X(19981115)19:14<1639::AID- JCC10>3.0.CO;2-B.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Protein Sci 2002; 11:1729-37; PMID:12070326;  http://dx.doi.org/10.1110/ps.0202302.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Protein  Eng 1998; 11:707-13; PMID:9749924; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Biochemistry 1993; 32:13288-98; PMID:8241185;  http://dx.doi.org/10.1021/bi00211a042.33.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Curr  Opin Struct Biol 1996; 6:18-23; PMID:8696968;  http://dx.doi.org/10.1016/S0959-440X(96)80090-X.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
J Mol Bio  1993; 233:123-38; PMID:8377180; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Bioinformatics  2008; 24:1137-44; PMID:18326508; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Proteins 2003;  52:74-9; PMID:12784370; http://dx.doi.org/10.1002/ prot.10396.25.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Acta Crystallogr D Biol Crystallogr  2004; 60:2126-32; PMID:15572765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Acta Crystallogr D Biol Crystallogr  2004; 60:2184-95; PMID:15572771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Anal Biochem 2003; 315:175- 82; PMID:12689827; http://dx.doi.org/10.1016/ S0003-2697(03)00007-1.,OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
Biochemistry  1983; 22:4615-8; PMID:6313045; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kidp-01-01-10925464.PMC5424782.pdf
"However, it appears that all Disorder in the lifetime of a protein Vladimir N Uversky1,2,* 1Department of Molecular Medicine and Byrd Alzheimer’s Research Institute; Morsani College of Medicine, University of South Florida; Tampa, FL USA;  2Institute for Biological Instrumentation; Russian Academy of Sciences; Moscow Region, Russia Keywords:  intrinsically disordered  protein region; protein function; nascent  polypeptide chain; protein degradation;  protein biosynthesis *Correspondence to: Vladimir N Uversky;   Email: vuversky@health.usf.edu Submitted: 09/13/2013 Revised: 10/09/2013 Accepted: 10/10/2013 Published Online: 11/07/2013 http://dx.doi.org/10.4161/idp.26782",Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Q Rev Biophys  2011; 44:467-518;  PMID:21729349 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Curr  Opin Struct Biol 2011; 21:419-25;  PMID:21514142 ;  http://dx.doi.org/10.1016/j.sbi.2011.03.012 4.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Trends Biochem Sci 2012; 37:509- 16; PMID:22989858 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Protein Sci  2013; 22:693-724;  PMID:23553817 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Proteins 2000;  41:415-27;  PMID:11025552 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Mol Biol 2004; 337:635-45;  PMID :15019783 ;  http://dx.doi.org/10.1016/j.jmb.2004.02.002 9.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Genome Biol 2011; 12:R120;   PMID:22182830 ; http://dx.doi.org/10.1186/ gb-2011-12-12-r120 10.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biomol Struct Dyn 2012; 30:137-49;   PMID:22702725 ; http://dx.doi.org/10.1080/07391 102.2012.675145 11.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biomol Struct Dyn 2007; 24:325-42;   PMID:17206849 ; http://dx.doi.org/10.1080/07391 102.2007.10507123 14.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biopolymers 2013; 99:870- 87; PMID:23754493 ; http://dx.doi.org/10.1002/ bip.22298 17.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Mol Biol 1999; 293:321-31;   PMID:10550212 ; http://dx.doi.org/10.1006/ jmbi.1999.3110 19.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Mol Graph Model 2001; 19:26- 59; PMID :11381529 ; http://dx.doi.org/10.1016/ S1093-3263(00)00138-8 20.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Biotechnol  2001; 19:805-6;  PMID:11533628 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Adv  Protein Chem 2002; 62:25-49;  PMID:12418100 ;  http://dx.doi.org/10.1016/S0065-3233(02)62004-2 22.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochemistry 2002; 41:6573-82;  PMID:12022860 ;  http://dx.doi.org/10.1021/bi012159+ 23.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Curr Opin Struct Biol  2002; 12:54-60;  PMID:11839490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Protein Sci 2002;  11:739-56;  PMID:11910019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Eur J Biochem 2002;  269:2-12;  PMID:11784292 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Rev Mol Cell Biol  2005; 6:197-208;  PMID:15738986 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
FEBS J  2005; 272:5129-48;  PMID:16218947 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Mol Recognit 2005; 18:343- 84; PMID:16094605 ; http://dx.doi.org/10.1002/ jmr.747 29.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Prog Biophys Mol Biol 2008; 98:85-106;   PMID:18619997 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Chem Biol  2008; 4:229-30;  PMID:18347590 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Curr Opin Struct Biol 2008; 18:756- 64; PMID:18952168 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
BMC Genomics 2008;  9(Suppl 2):S1;  PMID:18831774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
BMC Genomics 2008;  9(Suppl 1):S1;  PMID:18366598 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Chem Soc Rev  2011; 40:1623-34;  PMID:21049125 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Curr Pharm Des 2013;  19:4191-213;  PMID:23170892 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Protein Sci  2013; 22:258-73;  PMID:23233352 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
PLoS Comput  Biol 2006; 2:e100;  PMID:16884331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Genome Biol 2006; 7:R45;  PMID:16780599 ;  http://dx.doi.org/10.1186/gb-2006-7-6-r45 42.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Proteins  2006; 62:309-15;  PMID:16299712 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Mol Cell 2001; 8:181-8;  PMID:11511371 ;  http://dx.doi.org/10.1016/S1097-2765(01)00293-3 45.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Crit Rev Biochem Mol Biol 2005;  40:243-67;  PMID:16257826 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Cell Mol Life Sci 2013; In  press;  PMID:23942625 ; http://dx.doi.org/10.1007/ s00018-013-1446-6 .,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Protein Sci 1998; 7:533- 44; PMID:9541384 ; http://dx.doi.org/10.1002/ pro.5560070301 49.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Chem Biol 2009; 5:778- 81; PMID:19841623 ; http://dx.doi.org/10.1038/ nchembio.233 50.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
FASEB J 2004; 18:1169-75;  PMID :15284216 ;  http://dx.doi.org/10.1096/fj.04-1584rev 51.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
FEBS Lett 2009; 583:88- 92; PMID:19071121 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochem Cell Biol  2010; 88:167-74;  PMID:20453919 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Chem Rev 2011; 111:1134-66;   PMID:21086986 ; http://dx.doi.org/10.1021/ cr100186d 54.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochem Soc Trans 2012;  40:963-8;  PMID:22988848 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Trends  Biochem Sci 2002; 27:527-33;  PMID:12368089 ;  http://dx.doi.org/10.1016/S0968-0004(02)02169-2 56.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Trends Biochem Sci 2012; 37:517-25;   PMID:23018052 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol Chem 2005; 280:27029-34;  PMID:15911614 ;  http://dx.doi.org/10.1074/jbc.M503934200 61.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochemistry 1997; 36:14572-6;  PMID:9398175 ;  http://dx.doi.org/10.1021/bi971800y 64.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol Chem 1997; 272:1761- 8; PMID:8999858 ; http://dx.doi.org/10.1074/ jbc.272.3.1761 65.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol  Chem 2000; 275:31573-80;  PMID:10896660 ;  http://dx.doi.org/10.1074/jbc.M003473200 67.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Gen Physiol  2000; 116:33-45;  PMID:10871638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol Chem 2000; 275:7811-7;  PMID:10713095 ;  http://dx.doi.org/10.1074/jbc.275.11.7811 69.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Crit Rev Biochem Mol Biol 2004;  39:297-317;  PMID :15763707 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Structure  2001; 9:377-87;  PMID:11377198 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J  Biol Chem 2004; 279:20529-38;  PMID :15023991 ;  http://dx.doi.org/10.1074/jbc.M401764200 72.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Structure 2004; 12:1901- 7; PMID:15458638 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Struct Mol Biol  2007; 14:556-63;  PMID :17515905 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Cell 2008; 135:691- 701; PMID:19013278 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol Chem 2010; 285:11243-51;   PMID:20139072 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Gen Physiol 2010; 136:483- 94; PMID:20876362 ; http://dx.doi.org/10.1085/ jgp.200910376 77.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochemistry 1998; 37:12689-99;  PMID:9737845 ;  http://dx.doi.org/10.1021/bi9806652 78.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Struct Biol  1998; 5:568-70;  PMID:9665170 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochimie 2002; 84:399-412;  PMID:12423783 ;  http://dx.doi.org/10.1016/S0300-9084(02)01455-4 80.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochemistry 2002; 41:2836- 43; PMID:11851431 ; http://dx.doi.org/10.1021/ bi012012i 81.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Philos Trans R Soc  Lond B Biol Sci 1995; 348:35-41;  PMID:7770484 ;  http://dx.doi.org/10.1098/rstb.1995.0043 84.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Trends Biochem Sci 2004; 29:593-600;   PMID:15501678 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol Chem 2002;  277:45529-36;  PMID:12221090 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Annu Rev  Cell Dev Biol 2002; 18:421-62;  PMID:12142282 ;  http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Structure  2013; 21:332-41;  PMID:23375259 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Protein Sci  2001; 10:560-71;  PMID:11344324 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Mol Biol 1997; 266:223-30;  PMID:9047359 ;  http://dx.doi.org/10.1006/jmbi.1996.0787 92.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Fold  Des 1997; 2:R17-26;  PMID:9135978 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Biochemistry 1986; 25:1847-51;  PMID :3707915 ;  http://dx.doi.org/10.1021/bi00356a00195.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Cell  1997; 91:431-4;  PMID:9390550 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nature 1999; 401:90-3;   PMID:10485712 ; http://dx.doi.org/10.1038/43481 97.,Non-OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Mol Cell  2000; 5:639-48;  PMID:10882100 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
J Biol Chem 1996; 271:27730-8;  PMID:8910366 ;  http://dx.doi.org/10.1074/jbc.271.44.2773099.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Mol Cell 2001; 8:1339-49;   PMID:11779508 ; http://dx.doi.org/10.1016/ S1097-2765(01)00407-5 100.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Mol Cell 2001; 7:627- 37; PMID:11463387 ; http://dx.doi.org/10.1016/ S1097-2765(01)00209-X 101.,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
Nat Struct Mol Biol 2004; 11:830-7;   PMID :15311270 ; http://dx.doi.org/10.1038/ nsmb814,OADS,/arxiv_data1/oa_pdf/98/be/kidp-01-01-10926782.PMC5424783.pdf
"Strains  have been initially defined as the isolates  of infectious prions characterized by the  specific incubation time of the disease,  characteristic neuropathological lesions,  and in some cases certain patterns in ani - mal behavior that are faithfully recapitu - lated upon serial passage.13,14 For example,  Hyper and Drowsy TSE strains lead to,  respectively, increased and decreased  activity of infected animals.15 It has been  shown that different disease strains cor - respond to distinct conformations of PrP  fibrils as they can be differentiated by  the protease cleavage pattern,16 antibody Strain phenomenon in protein aggregation Interplay between sequence and conformation Leonid Breydo* Department of Molecular Medicine; Morsani College of Medicine; University of South Florida; Tampa, FL USA Keywords:  prion, amyloid, strains,  protein aggregation, seeding *Correspondence to: Leonid Breydo;   Email: lbreydo@health.usf.edu Submitted: 11/08/2013  Accepted: 11/08/2013 Published Online: 01/01/2013 http://dx.doi.org/10.4161/idp.27130",Non-OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Science 1973; 181:223- 30; PMID:4124164 ; http://dx.doi.org/10.1126/ science.181.4096.223 2.,Non-OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Science 1982; 216:136-44;   PMID:6801762 ; http://dx.doi.org/10.1126/ science.6801762 3.,Non-OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Nature  1967; 215:1043-4;  PMID:4964084 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Nature  1967; 214:764-6;  PMID:4963878 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Science 2004; 305:673-6;   PMID :15286374 ; http://dx.doi.org/10.1126/ science.1100195 6.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Biochim Biophys Acta 2013;  1834:932-51;  PMID:23269364 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Biochim Biophys Acta 2010; 1804:1231- 64; PMID:20117254 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Brain Pathol  1998; 8:499-513;  PMID:9669700 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Cell 2012; 148:1188-203;   PMID:22424229 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Cell 2012; 149:968-77;  PMID:22632966 ;  http://dx.doi.org/10.1016/j.cell.2012.05.007 12.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Int J Cell Biol 2013;  2013:583498;  PMID:24187553 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Brain Pathol 2013; 23:321- 32; PMID:23587138 ; http://dx.doi.org/10.1111/ bpa.12045 15.,Non-OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Protein Sci 2001; 10:854-63;  PMID:11274476 ;  http://dx.doi.org/10.1110/ps.39201 Figure  2.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Neurobiol Dis 2006; 23:717-24;   PMID:16876426 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
Proc Natl Acad Sci U S A 2009; 106:20417-22;   PMID :19915150 ; http://dx.doi.org/10.1073/ pnas.0910350106 21.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
J Biol Chem 1998;  273:32230-5;  PMID:9822701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
J Biol Chem 2013; 288:29846-61;   PMID:23974118 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
PLoS Pathog  2013; 9:e1003702;  PMID:24130496 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/41/kidp-01-01-10927130.PMC5424784.pdf
